20-F 1 u92488e20vf.htm CHARTERED SEMICONDUCTOR MANUFACTURING LTD CHARTERED SEMICONDUCTOR MANUFACTURING LTD
Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 

FORM 20-F

     
(Mark One)    
 
o   Registration statement pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934.
 
    OR
 
þ   Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
 
    For the fiscal year ended December 31, 2004.
 
    OR
 
o   Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Commission File Number 000-27811

CHARTERED SEMICONDUCTOR MANUFACTURING LTD.
(Exact name of Registrant as specified in its charter)

Republic of Singapore
(Jurisdiction of incorporation or organization)

60 Woodlands Industrial Park D
Street 2, Singapore 738406
+65-6362 2838
(Address of principal executive offices)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

     
Title of Each Class
None
  Name of Each Exchange on Which Registered
Not Applicable

Securities registered pursuant to Section 12(g) of the Act:
American Depositary Shares,
each represented by ten Ordinary Shares, par value S$0.26 per share.
(Title of class)

Securities for which there is a reporting
obligation pursuant to Section 15(d) of the Act:
Not Applicable

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 2,509,238,524 Ordinary Shares as of December 31, 2004.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

         
  Yes  þ   No  o  

Indicate by check mark which financial statement item the registrant has elected to follow.

         
  Item 17  o   Item 18  þ  
 


 


TABLE OF CONTENTS

             
Certain Definitions and Conventions        
Presentation of Certain Financial Information        
 
           
           
 
           
  IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS     4  
  OFFER STATISTICS AND EXPECTED TIMETABLE     4  
  KEY INFORMATION     4  
  INFORMATION ON OUR COMPANY     22  
  OPERATING AND FINANCIAL REVIEW AND PROSPECTS     38  
  DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES     58  
  MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS     70  
  FINANCIAL INFORMATION     73  
  THE OFFER AND LISTING     73  
  ADDITIONAL INFORMATION     75  
  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK     88  
  DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES     90  
 
           
           
 
           
  DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES     90  
  MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS     90  
  CONTROLS AND PROCEDURES     90  
           
  AUDIT COMMITTEE FINANCIAL EXPERT     91  
  CODE OF ETHICS     91  
  PRINCIPAL ACCOUNTANT FEES AND SERVICES     91  
  EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES     92  
  PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS     92  
 
           
           
 
           
  FINANCIAL STATEMENTS     92  
  FINANCIAL STATEMENTS     92  
  EXHIBITS     93  
 
           
         
 
           
     
 EX-4.5 Facility Agreement dated Dec 23,2004 by and among the company as Borrower, JPMorgan as Lender, Export-Import Bank of the United States & JPMorgan as Facility Agent
 EX-4.6 Facility Agreement dated Dec 23,2004 by and among the company as Borrower, SMBC OCBC as Lenders and Arrangers
 EX-4.7 Facility Agreement dated Dec 23, 2004 by and between the company as Borrower and SMBC as Lender
 EX-4.8 Facility Agreement dated Dec 22, 2004 by and between the company as Borrower and BOA as Lender
 EX-4.9 Letter of Confirmation from Goldman Sachs Intl to the company supplementing the ISDA Master Agreement (Multi-currency-Cross Border) together with the Schedule to the Master Agreement
 EX-4.38 Amendment No.3 to "SF" Process Development and Cost Sharing Agreement
 EX-4.39 Amendment No. 4 to "SF" Process Development and Cost Sharing Agreement
 EX-4.45 Sub-Lease dated Oct 19, 2004 by and between Singapore Technologies Pte Ltd and the company relating to Private Lots A12787 and A12787(a) Mukim No.13 Sembawang
 EX-4.47 Sub-Lease dated Oct 19, 2004 by and between Singapore Technologies Pte Ltd and the company relating to Private Lot A12787(b) Mukim No. 13
 EX-4.50 Novation Agreement dated Dec 31, 2004 relating to the Agreement for Sub-License & Sub-Lease A12787(d) Sub-License&Sub-Lease A12787(d)
 EX-4.53 Novation Agreement dated Dec 31, 2004 relating to the Agreement for Sub-License & Sub-Lease A12787 (e)
 EX-10 Consent of KPMG
 EX-12.1 Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 EX-12.2 Certification of the Vice President and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 EX-13.1 Certification of the President and Chief Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 EX-13.2 Certification of the Vice President and Chief Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

2


Table of Contents

CERTAIN DEFINITIONS AND CONVENTIONS

Unless otherwise specified, when we refer to “Singapore dollars” and “S$,” we are referring to Singapore dollars, the legal currency of Singapore. When we refer to “U.S. dollars,” “dollars,” “$” and “US$,” we are referring to United States dollars, the legal currency of the United States or U.S.

PRESENTATION OF CERTAIN FINANCIAL INFORMATION

Our financial statements are reported in U.S. dollars and presented in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. This document includes the financial statements of our equity-method joint venture company, Silicon Manufacturing Partners Pte Ltd, or SMP. In this document, any discrepancies in any table between totals and the sums of the amounts listed are due to rounding.

Our shares are listed on both the Nasdaq National Market, or Nasdaq, under the symbol “CHRT” and the Singapore Exchange Securities Trading Limited, or the Singapore Exchange, under the symbol “Chartered”.

Certain Singapore dollar amounts contained in this document have been translated to U.S. dollars as of December 31, 2004, which was at an exchange rate of S$1.645 = $1.00. No representation is made that the Singapore dollar or the U.S. dollar amounts shown in this document could have been or could be converted at such rate or at any other rate.

The share and per share data and American Depositary Share, or ADS, and per ADS data in this document for year 2002 and prior periods reflect a retroactive adjustment to give effect to our eight-for-ten rights offering which we completed in October 2002 (the “October 2002 Rights Offering”). The share price information contained in this document was derived from Bloomberg L.P.

Certain reclassifications have been made in prior years’ financial information to conform to classifications used in the current year.

3


Table of Contents

PART I

ITEM 1.   IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not applicable.

ITEM 2.   OFFER STATISTICS AND EXPECTED TIMETABLE

Not applicable.

ITEM 3.   KEY INFORMATION
 
A.   SELECTED FINANCIAL DATA

You should read the following selected financial data in conjunction with our consolidated financial statements and related notes and “Item 5. Operating and Financial Review and Prospects” included in this document. The selected consolidated balance sheet data as of December 31, 2000, 2001 and 2002 and the selected consolidated statements of operations data for the years ended December 31, 2000 and 2001 are derived from our audited consolidated financial statements. However, we have not included our audited consolidated financial statements for those periods in this document. The selected consolidated balance sheet data as of December 31, 2003 and 2004 and the selected consolidated statements of operations data for each of the years in the three year period ended December 31, 2004 are derived from our audited consolidated financial statements included elsewhere in this document which have been audited by KPMG, independent registered public accounting firm. Our consolidated financial statements are prepared in accordance with U.S. GAAP.

                                         
    Years Ended December 31,  
    2000     2001     2002     2003     2004  
    (in thousands, except per share data and ratios)  
Consolidated Statements of Operations Data:
                                       
Net revenue
  $ 1,134,104     $ 462,656     $ 449,241     $ 551,911     $ 932,131  
Cost of revenue
    749,582       665,261       628,726       648,330       769,318  
 
                             
Gross profit (loss)
    384,522       (202,605 )     (179,485 )     (96,419 )     162,813  
 
                             
Operating expenses:
                                       
Research and development
    74,876       82,897       95,285       124,057       118,281  
Fab start-up costs
    27,481       13,329       8,338       9,219       33,199  
Sales and marketing
    35,019       38,659       41,182       38,748       37,751  
General and administrative
    78,788       41,908       43,356       40,758       35,552  
Stock-based compensation
    2,778       763       (253 )     4       3  
Other operating expenses (income), net
    11,570 (1)           10,025 (2)     (11,001 )(3)     (10,699 )(4)
 
                             
Total operating expenses
    230,512       177,556       197,933       201,785       214,087  
 
                             
Operating income (loss)
    154,010       (380,161 )     (377,418 )     (298,204 )     (51,274 )
Other income (expense):
                                       
Equity in income (loss) of SMP
    7,588       (92,683 )     (84,846 )     23,194       27,563  
Other income
    12,926       19,718       23,632       23,186       52,299 (5)
Interest income
    54,546       46,225       16,637       12,168       11,530  
Interest expense
    (17,561 )     (39,652 )     (41,661 )     (42,222 )     (30,093 )
Foreign exchange gain (loss), net
    8,414       4,216       (1,966 )     (733 )     1,320  
 
                             
Income (loss) before income taxes and minority interest
    219,923       (442,337 )     (465,622 )     (282,611 )     11,345  
Income tax expense
    (18,704 )     (14,244 )     (7,029 )     (11,671 )     (4,774 )
 
                             
Income (loss) before minority interest
    201,219       (456,581 )     (472,651 )     (294,282 )     6,571  
Minority interest in loss of CSP
    43,547       72,629       55,563       9,491        
 
                             
Net income (loss) prior to cumulative effect adjustment
    244,766       (383,952 )     (417,088 )     (284,791 )     6,571  
Cumulative effect adjustment for change in accounting principle(6)
                      (6,421 )      
 
                             
Net income (loss)(7)
  $ 244,766     $ (383,952 )   $ (417,088 )   $ (291,212 )   $ 6,571  
 
                             

4


Table of Contents

                                         
    Years Ended December 31,  
    2000     2001     2002     2003     2004  
    (in thousands, except per share data and ratios)  
Basic and diluted net earnings (loss) per share(8)
  $ 0.16     $ (0.24 )   $ (0.23 )   $ (0.12 )   $ 0.00  
Number of shares used in computing net earnings (loss) per share:
                                       
Basic
    1,543,893       1,588,969       1,799,106       2,502,294       2,508,376  
Diluted
    1,568,971       1,588,969       1,799,106       2,502,294       2,516,942  
Net earnings (loss) per ADS(8):
                                       
Basic
  $ 1.59     $ (2.42 )   $ (2.32 )   $ (1.16 )   $ 0.03  
Diluted
  $ 1.56     $ (2.42 )   $ (2.32 )   $ (1.16 )   $ 0.03  
Number of ADSs used in computing net earnings (loss) per ADS:
                                       
Basic
    154,389       158,897       179,911       250,229       250,838  
Diluted
    156,897       158,897       179,911       250,229       251,694  
Other Data(9) (unaudited)
                                       
Ratio of earnings to fixed charges
    7.09X                         0.60X  
Deficiency of earnings available to cover fixed charges
          354,919       381,225       301,421       19,268  
                                         
    As of December 31,  
    2000     2001     2002     2003     2004  
    (in thousands)  
Consolidated Balance Sheet Data
                                       
Cash and cash equivalents and term deposits
  $ 924,116     $ 1,041,616     $ 1,210,925     $ 905,472     $ 569,399  
Working capital(10)
    548,721       642,487       942,059       682,322       177,746  
Total assets
    3,217,122       3,144,342       3,333,463       3,021,027       3,090,012  
Short-term borrowings and current portion of long-term debt
    156,343       198,160       64,001       223,660       352,985  
Current installments of obligations under capital leases
    7,822                          
Other long-term debt
    426,120       914,070       1,115,930       989,092       882,745  
Share capital
    279,893       280,480       443,713       444,953       445,531  
Total shareholders’ equity
    1,969,283       1,582,632       1,785,459       1,494,555       1,505,631  


(1)   In 2000, we recorded a charge of $11.6 million to reflect the impairment charge on a licensing agreement.
 
(2)   In 2002, we recorded a charge of $10.0 million associated with a workforce re-sizing and a fixed asset impairment charge.
 
(3)   In 2003, the following items were recorded under the other operating expenses/(income) line:

  a)   A gain of $27.5 million associated with the cancellation of the company’s employee bonus award plan;
 
  b)   A gain of $4.9 million resulting from equipment disposition;
 
  c)   An impairment charge of $9.0 million on certain machinery and equipment which were classified as held for sale in 2003, as part of the company’s fab capacity rationalization; and
 
  d)   A restructuring charge of $12.4 million relating to the phase out of the company’s Fab 1.

(4)   Included in 2004 other operating expenses line was a gain of $10.4 million resulting from an equipment disposition with CSMC Technologies Corporation (“CSMC”).
 
(5)   Included in 2004 other income line was a gain of $14.3 million from the sale of technology to CSMC and an income of $16.1 million arising from the closure of a pending grant claim associated with a previously terminated joint technology development agreement.
 
(6)   Effective January 1, 2003, the company adopted the provisions of Statement of Financial Accounting Standards (“SFAS”) No. 143, “Accounting for Asset Retirement Obligations”, which addresses financial accounting and reporting for obligations associated with the retirement of long-lived assets and associated asset retirement costs. This resulted in a cumulative effect loss of $6.4 million, after a reduction in minority interest of $0.5 million for 2003. The cumulative effect loss represents the depreciation and accretion expense that would have been recorded previously if SFAS No. 143 had been in effect in prior years.

5


Table of Contents

(7)   The pioneer tax status of our fabs had the effect of increasing (decreasing) basic and diluted net earnings (loss) per share by $(0.04), $(0.02) and $0.00 and basic and diluted net earnings (loss) per ADS by $(0.36), $(0.15) and $0.02 for the years ended December 31, 2002, 2003 and 2004, respectively.
 
(8)   For 2003, basic and diluted net loss per share prior to cumulative effect adjustment is $(0.11) and basic and diluted net loss per ADS prior to cumulative effect adjustment is $(1.14).
 
(9)   For purposes of calculating the ratio of earnings to fixed charges and the deficiency of earnings available to cover fixed charges, if any, earnings consists of income (loss) before income taxes, minority interest, cumulative effect adjustment and equity in income (loss) of equity affiliates, plus fixed charges and amortization of capitalized interest, less interest capitalized. Fixed charges consist of interest expensed and capitalized, plus amortization of capitalized expenses related to indebtedness, plus one-third of rental expenses on operating leases (such amounts representing the estimated interest portion of rental expense). No preference dividends were made during the period indicated.
 
(10)   Working capital is calculated as the excess of current assets over current liabilities. Included in current assets are cash and cash equivalents and term deposits.

B.   CAPITALIZATION AND INDEBTEDNESS

Not applicable.

C.   REASONS FOR THE OFFER AND USE OF PROCEEDS

Not applicable.

D.   RISK FACTORS

Chartered Semiconductor Manufacturing Ltd., or Chartered, wishes to caution readers that the following important factors, and those important factors described in other reports and documents submitted to, or filed with, the United States Securities and Exchange Commission, among other factors, could affect our results. If any of the following risks actually occur, our business, results of operations and financial condition would likely suffer and actual results could differ materially from those expressed in any forward-looking statements made by us, or on our behalf.

(I)   RISKS RELATED TO OUR FINANCIAL CONDITION

We have a history of losses and this may continue.

Since our inception in 1987, we have incurred significant net losses. This was true even in years in which our revenue increased. In 2001, 2002 and 2003, we incurred net losses of $384.0 million, $417.1 million and $291.2 million respectively. For the year ended December 31, 2004, we generated a net income of $6.6 million.

As of December 31, 2004, we had an accumulated deficit of $1,118.7 million. We cannot assure you that our profitability in 2004 can be sustained or that we would not incur losses in the future. Please see “Item 3. Key Information — Selected Financial Data” and “Item 5. Operating and Financial Review and Prospects” for information regarding our financial condition.

We need to continuously improve our device yields, maintain high capacity utilization and optimize the technology mix of our semiconductor wafer production.

The key factors that affect our profit margin are our ability to:

—   continuously improve our device yields;
 
—   maintain high capacity utilization; and
 
—   optimize the technology mix of our semiconductor wafer production.

The term “device yields” means the actual number of usable semiconductor devices on a semiconductor wafer in relation to the total number of devices on the wafer. Our device yields directly affect our ability to attract and retain customers, as well as the prices of our products.

6


Table of Contents

The term “capacity utilization” means the actual number of semiconductor wafers we have processed at a fabrication facility, or fab, in relation to the total number of wafers we have the capacity to process. Where we refer to capacity utilization in this document, such capacity utilization includes the utilization of our allocated capacity with SMP. Our capacity utilization affects our operating results because a large percentage of our operating costs are fixed. For example, in 2001, 2002 and the first half of 2003, weak market demand and a worldwide over-capacity of semiconductor wafer supply resulted in low utilization rates at our fabs. In 2004, our average capacity utilization improved to 80% from 58% in 2003. This was primarily driven by the sequential growth in shipments during the first two quarters of the year. However, we started seeing market weakness from second half of June 2004 due to excess inventories in the semiconductor companies and softening in certain end markets. The weak market demand and over capacity have had and may continue to have a negative effect on our company. Other factors potentially affecting capacity utilization rates are the complexity and mix of the wafers produced, overall industry conditions, operating efficiencies, the level of customer orders, mechanical failure, disruption of operations due to expansion of operations or relocation of equipment and fire or natural disaster.

Because the price of wafers varies significantly, the mix of wafers produced affects revenue and profitability. The value of a wafer is determined by the complexity of the device on the wafer. Production of devices with higher level functionality and greater system-level integration requires more manufacturing steps than the production of less complex devices and commands higher wafer prices. However, increasing the complexity of devices that we manufacture does not necessarily lead to increased profitability because the higher wafer prices for such devices may be offset by depreciation and other costs associated with an increase in capital expenditures needed to manufacture such devices.

If we are unable to continuously improve our device yields, maintain high capacity utilization or optimize the technology mix of our wafer production, we may not be able to achieve our profit margin in which case the market price of our securities could fall.

Our operating results fluctuate from quarter-to-quarter which makes it difficult to predict our future performance.

Our revenue, expenses and operating results have varied significantly in the past and may fluctuate significantly from quarter-to-quarter in the future due to a number of factors, many of which are outside our control. These factors include, among others:

—   the cyclical nature of both the semiconductor industry and the markets served by our customers;
 
—   changes in the economic conditions of geographical regions where our customers and their markets are located;
 
—   shifts by integrated device manufacturers, or IDMs, between internal and outsourced production;
 
—   inventory and supply chain management of our customers;
 
—   the loss of a key customer or the postponement of an order from a key customer or the failure of a key customer to pay accounts receivables in a timely manner;
 
—   the occurrence of accounts receivables write-offs;
 
—   the rescheduling or cancellation of large orders;
 
—   the rescheduling or cancellation of planned capital expenditures;
 
—   our inability to qualify new processes or customer products in a timely manner;
 
—   the return of wafers due to quality or reliability issues;
 
—   malfunction of our wafer production equipment;
 
—   unforeseen delays or interruptions in our plans for new fabrication facilities;
 
—   the timing and volume of orders relative to our available production capacity;

7


Table of Contents

—   our ability to obtain raw materials and equipment on a timely and cost effective basis;
 
—   environmental events or industrial accidents such as fires or explosions;
 
—   our susceptibility to intellectual property rights disputes;
 
—   our ability to continue with existing and to enter into new partnerships, technology and supply alliances on mutually beneficial terms;
 
—   actual capital expenditures exceeding planned capital expenditures;
 
—   currency and interest rate fluctuations that may not be adequately hedged; and
 
—   technological changes.

Due to the factors noted above and other risks discussed in this section, many of which are beyond our control, you should not rely on quarter-to-quarter comparisons to predict our future performance. Unfavorable changes in any of the above factors may seriously harm our company. In addition, it is possible that in some future periods our operating results may be below the expectations of public market analysts and investors. In this event, the price of our securities may underperform or fall.

We expect to incur substantial capital and research and development expenditures in connection with our growth plans and may require additional financing that may not be available.

Our business and the nature of our industry require us to make substantial capital expenditures leading to a high level of fixed costs. We expect to incur significant capital expenditures in connection with our growth plans and technology upgrades or migrations. For example, in 2001, 2002 and 2003, we incurred $489.6 million, $419.5 million and $220.8 million in capital expenditures, respectively. We invested $686.3 million in capital expenditures in 2004 primarily in equipping Fab 7 as part of its phase 1 ramp to 15,000 300-mm wafers per month capacity with the balance mainly for capacity additions at leading-edge technologies in Fab 6. In addition, we expect our aggregate capital expenditures in 2005 to be approximately $750 million, of which approximately 85% is expected to be for equipping Fab 7 to 9,000 300-mm wafers per month capacity by end 2005 (which is part of our Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity), with the balance primarily for capacity additions at leading-edge technologies in Fab 6. For more details on the equipping costs of Fab 7, see “Item 5. Operating and Financial Review and Prospects — Liquidity and Capital Resources”. We also expect to incur approximately $130 million for research and development in 2005.

We also anticipate that from time to time we may expand and add equipment to increase the capacity of our existing fabs, two of which are owned through joint ventures with third parties. We may require additional financing to complete such equipping. The foregoing expenditures will be made in advance of sales. Given the fixed cost nature of our business, we may incur losses if our revenue does not adequately offset the level of depreciation resulting from our capital expenditures, as occurred in 2001, 2002 and 2003. Additionally, our actual expenditures may exceed our planned expenditures for a variety of reasons, including changes in our growth plan, our process technology, market conditions, customer requirements, interest rates and other factors.

We may require additional financing to fund our future growth plans and technology upgrades and migrations. There can be no assurance that additional financing will be available at all or, if available, that such financing will be obtained on terms favorable to us or that any additional financing will not be dilutive to our shareholders or creditors. In addition, a portion of our borrowings is guaranteed by Singapore Technologies Pte Ltd, or Singapore Technologies, our controlling shareholder prior to December 31, 2004. On December 31, 2004, Temasek Holdings (Private) Limited, or Temasek, as part of the rationalization plan to manage Temasek’s capital structure more efficiently, acquired all of Singapore Technologies’ interest in our company (“ST Restructuring”). As a result, we may not be able to obtain similar credit guarantees in the future.

8


Table of Contents

We have a high level of debt. If we are unable to make interest and principal payments on our debt, it could seriously harm our company.

We have now and will continue to have a significant amount of debt. Our high level of debt and the covenants contained in our financing documents such as financial, shareholding and other restrictive covenants which are customary to loan documents could have important consequences to our company. For example, they could:

—   increase our vulnerability to general adverse economic and industry conditions;
 
—   limit our ability to pursue our growth plan and technology upgrades or migrations;
 
—   require us to seek the lender’s consent prior to paying dividends on our ordinary shares;
 
—   require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, thereby reducing the availability of our cash flow to fund capital expenditures, working capital and other general corporate purposes;
 
—   limit our flexibility in planning for, or reacting to, changes in our business and the semiconductor industry; and
 
—   limit our ability to incur additional borrowings or raise additional financing through equity or debt instruments.

We cannot assure you that we will be able to make interest and principal payments on debt incurred in connection with our growth if the average selling prices or demand for our semiconductor wafers are lower than expected.

(II)   RISKS RELATED TO OUR OPERATIONS

The cyclical nature of the semiconductor industry and the periodic over-capacity that results from this may seriously harm our company.

The semiconductor industry has historically been highly cyclical and, at various times, has experienced significant economic downturns characterized by production over-capacity, reduced product demand and rapid erosion of average selling prices. For example, after experiencing average utilization rates around 100% in 2000, our average utilization rates in 2002 and 2003 fell to 37% and 58% respectively.

Historically, companies in the semiconductor industry have expanded aggressively during periods of increased demand, as we and our competitors have done. As a result, periods of over-capacity in the semiconductor industry have frequently followed periods of increased demand. We expect this pattern to be repeated in the future. In addition, the markets for semiconductors are characterized by rapid technological change, intense competition and fluctuations in end-user demand. In 2004, our average utilization rate was 80% compared to 58% in 2003. This was primarily driven by the sequential growth in shipments during the first two quarters of the year. However, we started seeing market weakness from second half of June 2004 due to excess inventories in the semiconductor companies and softening in certain end markets. We cannot assure you that the industry will recover in 2005 and beyond. Future downturns in the semiconductor industry may also be severe and could seriously harm our company.

A decrease in demand and average selling prices for end-use applications of semiconductor products such as communications equipment, personal computers, computer peripherals and consumer products may significantly decrease the demand for our services and may result in a decrease in our revenue and gross profit margin.

A significant percentage of our revenue is derived from customers who use our manufacturing services to make semiconductors for communications equipment, personal computers, computer peripherals and consumer products. Any significant decrease in the demand for communications equipment, personal computers, computer peripherals or consumer products may decrease the demand for our services and could seriously harm our company. In addition, the declining average selling prices in these end markets could place significant downward pressure on the prices of the components that are used in such equipment. If the average selling prices of such equipment continue to decrease, the downward pricing pressure on components produced by our company may reduce our revenue and therefore reduce our gross profit margin significantly.

9


Table of Contents

We depend on a small number of customers for a significant portion of our revenue.

We have been largely dependent on a small number of customers for a substantial portion of our business. Our top ten customers accounted for approximately 59% and 66% of our total net revenue in 2003 and 2004, respectively. Our top five customers in 2004, in order of revenue significance were Broadcom, Agilent Technologies, MediaTek, Freescale and Agere Systems. Collectively, our top five customers accounted for approximately 52% of total net revenue in 2004, compared with 41% in the previous year. Broadcom, Agilent Technologies and MediaTek each exceeded 10% of total net revenue in 2004. We expect that we will continue to be dependent upon a relatively limited number of customers for a significant portion of our revenue. We cannot assure you that revenue generated from these customers, individually or in the aggregate, will reach or exceed historical levels in any future period. Loss or cancellation of business from, significant changes in scheduled deliveries to, quality or reliability issues raised by, or decreases in the prices of services sold to, any of these customers could seriously harm our company.

We may not be able to implement new technology as it becomes available which may affect our ability to produce advanced products at competitive prices.

The semiconductor industry is rapidly developing and the technology used is constantly evolving. If we do not anticipate the technology evolution and rapidly adopt new and innovative technology, we may not be able to produce sufficiently advanced products at competitive prices. There is a risk that our competitors may adopt new technology before we do, resulting in our loss of market share. If we do not continue to produce the most advanced products at competitive prices, our customers may use the services of our competitors instead of our services, which could seriously harm our company.

We depend on our technology partners to advance our portfolio of process technologies.

Enhancing our manufacturing process technologies is critical to our ability to provide services for our customers. We intend to continue to advance our process technologies through internal research and development efforts and technology alliances with leading semiconductor companies. Although we have an internal research and development team focused on developing new semiconductor manufacturing process technologies, we are dependent on our technology partners to advance our portfolio of process technologies. For example, in March 2004, we extended our joint development agreement with International Business Machines, or IBM, and Infineon Technologies AG, or Infineon, to include Samsung Electronics Co., Ltd, or Samsung (“March 2004 agreement”). Under the March 2004 agreement, IBM, Infineon, Samsung and Chartered are jointly developing a common advanced foundry manufacturing process technology at 65nm, as well as variants tuned for high performance and low power. For more information on the joint development agreements with IBM, Infineon and Samsung, please see “Item 4. Information On Our Company — Business Overview — Research and Development”.

We depend on our joint development agreement with IBM for faster introduction of 90nm and 45nm process technologies and our March 2004 agreement with IBM, Infineon and Samsung for faster introduction of 65nm process technology. If there are problems in the successful implementation of our joint development agreements with the IBM, Infineon and Samsung, this would not only result in our having incurred costs, but would also adversely impact our strategy in targeting “first-source” business and time-to-market, as we would then require even more time to access or develop similar technologies. If this were to happen, it could seriously harm our company.

Our technology alliances have been and may from time to time be subject to changes, including changes in the technology partner’s business strategy (as was the case with Agere Systems Inc’s fab-lite strategy and Agilent Technologies ceasing technology development for certain technology nodes). For more information on these changes, please see “Item 4. Information On Our Company — Business Overview — Strategic Alliances — Chartered Silicon Partners”. Although the changes we have experienced so far have not had a significant impact on our company’s performance, there can be no assurance that this will continue to be the case.

If we are unable to continue our technology alliances with our partners on mutually beneficial economic terms, if we are unable to comply with any restrictions contained in our technology alliance agreements, or if we are unable to enter into new technology alliances with other leading semiconductor companies, we may not be able to continue providing our customers with leading-edge process technologies, which could seriously harm our company.

10


Table of Contents

Our ability to successfully partner with Electronic Design Automation, intellectual property and design service providers to meet customers’ design needs depends on the availability and quality of the relevant services, tools and technologies and our ability to meet our customers’ schedule and budget requirements.

We have established relationships with Electronic Design Automation (EDA), intellectual property and design service providers. Together we work to develop a complete design platform that is production-proven and tailored to our customers’ design needs. Our ability to successfully meet our customers’ design needs depends on the availability and quality of the relevant services, tools and technologies, and on whether we, together with our EDA, intellectual property and design service providers, are able to meet customers’ schedule and budget requirements. Difficulties or delays in these areas may adversely affect the success of our partnerships with EDA, intellectual property and design service providers and consequently, our ability to attract or serve customers, and thereby could seriously harm our company.

Our customers do not place purchase orders far in advance. Therefore, we do not have any significant backlog.

Our customers generally do not place purchase orders far in advance. In addition, due to the cyclical nature of the semiconductor industry, our customers’ purchase orders have varied significantly from period-to-period. As a result, we do not typically operate with any significant backlog. The lack of a significant backlog makes it difficult for us to forecast our net revenue in future periods. Moreover, our expense levels are based in part on our expectations of future revenue and we may be unable to adjust costs in a timely manner to compensate for revenue shortfalls. We expect that in the future our revenue in any quarter will continue to be substantially dependent upon purchase orders received in that quarter. We cannot assure you that any of our customers will continue to place orders with us in the future at the same levels as in prior periods.

We depend on our strategic alliances relating to Fab 5 and Fab 6. Termination or modification of either of these alliances could seriously harm our company.

We currently have two strategic alliances relating to the operation of Fab 5 and Fab 6. Our equity-method joint venture company, SMP, which owns and operates Fab 5, is a joint venture with Agere Systems Singapore Pte Ltd (formerly Lucent Technologies Microelectronics Pte. Ltd.), a subsidiary of Agere Systems Inc. Chartered Silicon Partners Pte Ltd, or CSP, which owns and operates Fab 6, is a joint venture with Agilent Technologies Europe B.V., EDB Investments Pte Ltd, or EDB Investments and Singapex Investments Pte Ltd, or Singapex, an indirect wholly-owned subsidiary of Temasek. Our alliances with these companies gave us access to select leading-edge process technologies, moderated our development costs and capital expenditures in the initial years and we believe that our alliances with these companies will increase our fab utilization rates and access to business on an ongoing basis. The termination of either of these alliances or any modification of either alliance which adversely affects our rights under the alliance could seriously harm our company. Please see “Item 4. Information On Our Company — Business Overview — Strategic Alliances — Chartered Silicon Partners” and “Item 4. Information On Our Company — Business Overview — Strategic Alliances — Silicon Manufacturing Partners” for a more detailed description of these alliances.

We may not be able to compete successfully in our industry.

The worldwide semiconductor foundry industry is highly competitive. We compete with dedicated foundry service providers such as Taiwan Semiconductor Manufacturing Corporation, or TSMC, United Microelectronics Corporation, or UMC, and Semiconductor Manufacturing International Corporation, or SMIC, as well as the foundry operation services of some integrated device manufacturers or IDMs such as IBM. IDMs principally manufacture and sell their own proprietary semiconductor products, but may offer foundry services. Further, there have been a number of new entrants to the semiconductor foundry industry. In particular, foundries in China, Malaysia and Korea are now becoming increasingly significant. Our competitors may have greater access to capital and substantially greater production, research and development, marketing and other resources than we do. As a result, these companies may be able to compete more aggressively over a longer period of time than we can.

A number of semiconductor manufacturers, including our primary competitors, have announced plans to increase their manufacturing capacity (including setting up fabrication facilities in Singapore). As a result, we expect that there will be a significant increase in worldwide semiconductor capacity over the next few years. If growth in demand for this capacity fails to match the growth in supply, or occurs more slowly than anticipated, there may be

11


Table of Contents

more intense competition and pressure on the pricing of our services. Any significant increase in competition may erode our profit margin and weaken our earnings.

The principal elements of competition in the wafer foundry market include technical competence, time-to-market, research and development quality, available capacity, device yields, customer service, price, design services, access to intellectual property, EDA, and tool support. We cannot assure you that we will be able to compete successfully in the future, which could seriously harm our company.

Our business depends in part on our ability to obtain and preserve intellectual property rights.

Our ability to compete successfully and achieve future growth will depend, in part, on our ability to protect our proprietary technology and our intellectual property, as well as the intellectual property of our customers. We seek to protect proprietary information and know-how through the use of confidentiality and non-disclosure agreements and limited access to and distribution of proprietary information. As of December 31, 2004, we had filed an aggregate of 1,927 patent applications worldwide, (982 of which had been filed in the U.S.) and held an aggregate of 1,068 issued patents worldwide (696 of which are issued U.S. patents) relating to our production processes. We intend to continue to file patent applications when and where appropriate to protect our proprietary technologies. The process of seeking patent protection may take a long time and be expensive. We cannot assure you that patents will be issued from pending or future applications or that, if patents are issued, they will not be challenged, invalidated or circumvented or that the rights granted under the patents will provide us with meaningful protection or any commercial advantage. In addition, we cannot assure you that the Asian countries in which we market our services will protect our intellectual property rights to the same extent as the U.S. Additionally, we cannot assure you that our competitors will not develop, patent or gain access to similar know-how and technology, or reverse engineer our processes, or that our confidentiality and non-disclosure agreements upon which we rely to protect our trade secrets and other proprietary information will be effective. The occurrence of any such events could seriously harm our company. Please see “Item 4. Information On Our Company — Intellectual Property” for a more detailed description of our proprietary technology.

We may be subject to intellectual property rights disputes.

Our ability to compete successfully depends on our ability to operate without infringing the proprietary rights of others. We have no means of knowing what patent applications have been filed in the U.S. and elsewhere. Although we are not currently a party to any material litigation involving patent infringement, the semiconductor industry is characterized by frequent litigation regarding patent and other intellectual property rights. As is typical in the semiconductor industry, we have from time to time received communications from third parties asserting patents that cover certain of our technologies and alleging infringement of certain intellectual property rights of others. We expect to receive similar communications in the future. In the event any third party were to make a valid claim against us or our customers, we could be required to:

—   discontinue using certain process technologies which could cause us to stop manufacturing certain semiconductors;
 
—   pay substantial monetary damages;
 
—   seek to develop non-infringing technologies, which may not be feasible; or
 
—   seek to acquire licenses to the infringed technology which may not be available on commercially reasonable terms, if at all.

Our company could be seriously harmed by such developments. Litigation, which could result in substantial costs to us and diversion of our resources, may also be necessary to enforce our patents or other intellectual property rights or to defend us against claimed infringement of the rights of others. If we fail to obtain necessary licenses or if litigation relating to patent infringement or other intellectual property matters occurs, it could seriously harm our company.

We may experience difficulty in obtaining insurance coverage resulting in increased costs.

While we have been able to obtain adequate insurance coverage in the past and while we do not expect to experience any significant increase in premium rates of insurance coverage for 2005, we cannot assure you that we will continue to be able to do so in the future. For example, following the tragic events of September 11, 2001,

12


Table of Contents

the premiums we paid for the renewal of our insurance coverage commencing from January 2002 were 2.2 times more than the premiums we paid for such coverage for the previous year. In the event that we fail to secure adequate coverage in the future, we could be seriously harmed by the occurrence of a loss that is not covered.

(III)   RISKS RELATING TO MANUFACTURING

We may experience difficulty in achieving acceptable device yields, product performance and delivery times as a result of manufacturing problems.

The process technology for the manufacture of semiconductor wafers is highly complex, requires advanced and costly equipment and is continuously being modified or changed in an effort to improve device yields and product performance. Microscopic impurities such as dust and other contaminants, difficulties in the production process, disruptions in the supply of utilities or defects in the key materials and tools used to manufacture wafers can cause a percentage of the wafers to be rejected or individual semiconductors on specific wafers to be non-functional, which in each case negatively affects our device yields. We have, from time to time, experienced production difficulties that have caused delivery delays, lower than expected device yields and the replacement of certain vendors of manufacturing equipment used in our production processes. We may also experience difficulty achieving acceptable device yields, product performance and product delivery times in the future as a result of manufacturing problems. In addition, we may also encounter difficulties in our manufacturing processes as we migrate some of our wafer production from 200-mm to 300-mm. These problems may result from, among other things, production failures, capacity constraints, construction delays, increasing production at new facilities, upgrading or expanding existing facilities or changing our process technologies, human errors, equipment malfunction or process contamination. Any of these problems could seriously harm our company.

We depend on our vendors of raw materials, supplies and equipment and do not typically have long-term supply contracts with them.

We depend on our vendors of raw materials and supplies. To maintain competitive manufacturing operations, we must obtain from our vendors, in a timely manner, sufficient quantities of quality materials and supplies at acceptable prices. We obtain most of our materials and supplies, including critical materials such as raw semiconductor wafers, from a limited number of vendors. This is especially the case as we continue to expand our manufacturing capabilities for advanced technologies and where the raw materials, supplies and equipment required for such advanced technologies are not only available from a limited number of vendors but may also be in limited quantity as well as require a long lead time. We purchase most of our key materials and supplies on a blanket purchase order basis. We typically do not have long term contracts with our vendors. As a result, from time to time due to capacity constraints, vendors have extended lead times or limited the supply of required materials and supplies to us. Consequently, from time to time, and particularly during periods of sudden increase in demand, we have experienced and may experience difficulty in obtaining quantities of raw materials that we need on a timely basis. Further, where we only have one qualified supplier for materials and supplies and a need subsequently arises to look to other alternative suppliers, we would have to qualify these alternative suppliers, and such qualification could lead to delays in production and seriously harm our company.

In addition, from time to time, we may reject materials and supplies that do not meet our specifications, resulting in declines in output or device yields, which may in turn adversely affect our revenue. We cannot assure you that we will be able to obtain sufficient quantities of raw materials and other supplies of an acceptable quality. If our ability to obtain sufficient quantities of raw materials and other supplies in a timely manner is substantially diminished or if there are significant increases in the costs of raw materials, it could seriously harm our company.

We also depend on a limited number of manufacturers and vendors that make and sell the complex equipment we use in our manufacturing processes. In periods of high market demand, the lead times from order to delivery and complete qualification of some of this equipment could be as long as 15 months, or even longer if, as a result of reduced orders placed in the preceding period, we are accorded less favorable priority by manufacturers and vendors. If there are delays in the delivery of this equipment or if there are increases in the cost of this equipment, it could seriously harm our company. Further, the long lead time reduces our flexibility in responding to changing market conditions. Please see “Item 4. Information On Our Company — Business Overview — Equipment and Materials” for additional information regarding our relationships with our suppliers of materials and equipment.

13


Table of Contents

We depend on assembly and test subcontractors for our semiconductor assembly and testing requirements.

Semiconductor assembly and test operations are an integral part of the supply chain, and involve specialized equipment and technology. As we do not have such in-house assembly and test capabilities and facilities, we depend on assembly and test subcontractors to provide us with the assembly, test and wafer bumping services. We currently subcontract to STATS ChipPAC Ltd (formerly known as ST Assembly Test Services Ltd), or STATS ChipPAC, as well as to United Test and Assembly Center Limited, or UTAC, ASE Singapore Pte. Ltd., ASE Test Limited and Advanced Semiconductor Engineering, Inc., or collectively ASE, a significant amount of orders for assembly and testing services. STATS ChipPAC, UTAC and ASE may, from time to time, experience production interruption due to, among other things, technical problems occurring during the assembly and testing processes. Because STATS ChipPAC, UTAC and ASE are our major providers of these services, any prolonged interruption in their operations could seriously harm our company.

As we migrate to more advanced technologies which may require access to advanced packaging and wafer bumping services, we may experience difficulties in securing such access in a timely manner due to the limited number of vendors providing such services.

As our company migrates to more advanced technologies and devices that require very high pin counts, the need for advanced packaging and wafer bumping services may increase. The advanced packaging technology is new and there may be initial problems resulting from this. Although we are working with our vendors to qualify them on wafer bumping in printing and plating technology, we cannot assure you that the qualification would be successful or without delays or that we would have ready access to the limited capacity. In addition, as there are currently no appropriate 200-mm and 300-mm wafer bumping capabilities in Singapore, we will have to work with our vendors to establish the capabilities in Singapore or look for such capabilities elsewhere. We cannot assure you that we would have ready and timely access to such capabilities. If we are unable to gain access to such advanced packaging and wafer bumping services in a timely manner, or if there are delays in the qualification of such technology, or if there are disruptions in such services, this may adversely impact our ability to secure business for the more advanced technology nodes and thereby could seriously harm our company.

We are subject to the risk of loss due to fire because the materials we use in our manufacturing processes are highly flammable.

We use highly flammable materials such as silane and hydrogen in our manufacturing processes and are therefore subject to the risk of loss arising from fire. Although we have implemented industry acceptable risk management controls at our manufacturing locations, the risk of fire associated with these materials cannot be completely eliminated and, in the past, we have had minor interruptions in production as a result of fire. We maintain insurance policies to guard against losses caused by fire. While we believe our insurance coverage for damage to our property and disruption of our business due to fire is adequate, we cannot assure you that it would be sufficient to cover all of our potential losses. If any of our fabs were to be damaged or cease operations as a result of a fire, it would temporarily reduce manufacturing capacity and could seriously harm our company.

Our failure to comply with certain environmental regulations could seriously harm our company.

We are subject to a variety of laws and governmental regulations in Singapore relating to the use, discharge and disposal of toxic or otherwise hazardous materials used in our production process. While we believe that we are currently in compliance in all material respects with such laws and regulations, if we fail to use, discharge or dispose of hazardous materials appropriately, our company could be subject to substantial liability or could be required to suspend or modify our manufacturing operations at significant cost to us. In addition, we could be required to pay for the cleanup of our properties if they are found to be contaminated even if we are not responsible for the contamination. We maintain insurance policies to guard against certain types of losses resulting from unintended and unexpected pollution caused by our company. While we believe our insurance coverage is adequate, we cannot assure you that it would be sufficient to cover all our potential losses.

14


Table of Contents

(IV)   RISKS RELATING TO OUR INFRASTRUCTURE

We face several risks in constructing and equipping new fabrication plants.

Where we expand by constructing new fabrication plants, there will be certain uncontrollable events that could delay the project or increase the costs of construction and equipping, even if we take the project management and planning steps we believe are necessary to complete the new fabrication plants on schedule and within budget. Such potential events include:

—   a major design and/or construction change caused by changes to the initial building space utilization plan or equipment layout;
 
—   technological, capacity and other changes to our plans for new fabrication plants necessitated by changes in market conditions;
 
—   shortages and late delivery of building materials and facility equipment;
 
—   delays in the installation, commissioning and qualification of our facility equipment;
 
—   a long and intensive wet season that limits construction;
 
—   a shortage of foreign construction workers or a change in immigration laws preventing such workers from entering Singapore;
 
—   strikes and labor disputes;
 
—   on-site construction problems such as industrial accidents, fires and structural collapse;
 
—   delays in securing the necessary governmental approvals and land lease;
 
—   delays arising from modifications in capacity expansion plans as a result of uncertainty in economic conditions; and
 
—   delays arising from demand exceeding supply and long lead times for delivery of equipment during periods of growth in the industry.

We depend on key personnel and due to the shortage of skilled labor in Singapore, we may have difficulty attracting and retaining sufficient numbers of skilled employees.

Our success depends to a significant extent upon the continued service of our key senior executives and our engineering, marketing, customer services, manufacturing, support and other personnel. In addition, in connection with our future growth plans, we are likely to need a greater number of experienced engineers and other employees in the future. Despite the current economic environment, the competition for skilled professionals remains intense and there is a shortage of such personnel in Singapore. Accordingly, we must recruit our personnel internationally. This is more expensive than hiring personnel locally, and therefore increases our operating costs. As of December 31, 2004, a majority of our employees were citizens of countries other than Singapore. We expect demand for personnel in Singapore to increase significantly in the future, particularly as new wafer fabrication facilities, including those of our competitors, are established in Singapore.

We use stock options and employee share purchase plans as compensation tools to attract and retain our personnel. Recent changes to the accounting standards applicable to our company will require us to record stock-based compensation charges in the future as a result of these plans. If we were to terminate these plans, or were to modify such plans with decreased benefits to employees or were to reduce the stock grants made under these plans to avoid or minimize an adverse impact on our financial results, we may become uncompetitive from an employee compensation perspective and may not be able to continue to attract and/or retain required personnel, which could seriously harm our company.

If we were to lose the services of any of our existing key personnel without adequate replacements, or were unable to attract and retain experienced personnel as we grow, it could seriously harm our company. For example, although we strive to retain employees that we send on assignments with our technology partners such as IBM, we

15


Table of Contents

cannot assure you that we will be successful in retaining these employees or that if our employees leave, our technology partners would re-train their replacements. If our employees leave, this may limit our ability to benefit from the alliances and could seriously harm our company. We do not carry insurance to protect us against the loss of any of our key personnel.

(V)   RISKS RELATED TO COVENANTS IN OUR AGREEMENTS

Many of our loans, including loans incurred by our subsidiary CSP, contain various financial and other covenants. Among other things, these covenants require the maintenance of certain financial ratios (including total debt to net worth) and that Temasek owns, directly or indirectly, at least a certain percentage of our outstanding shares. The loans also require that we own, directly or indirectly, at least a certain percentage of our subsidiary’s outstanding shares. If we fail to comply with these covenants, we could be in a default under these loans and the lenders would have the right to accelerate our obligation to repay the outstanding borrowings under these loans. Such a default could also cause cross-defaults under other loans and could seriously harm us.

In addition, many of our loans require that we obtain prior written consent from our lenders prior to incurring indebtedness or creating security interests over our assets. Consequently, although we have been able to obtain such lender consent in the past, we may be limited in our ability to obtain future financing. Any inability to obtain such future financing could seriously harm our company.

(VI)   RISKS RELATED TO INVESTMENTS IN A CONTROLLED CORPORATION

Temasek controls our company and its interests may conflict with the interests of our other shareholders.

As of December 31, 2004, pursuant to the ST Restructuring, Temasek through its affiliate, beneficially owns 60.19% of our outstanding ordinary shares. As a result, Temasek is able to exercise control over many matters requiring approval by our shareholders, including the election of directors and approval of significant corporate transactions.

We also have contractual and other business relationships with Temasek and several of its affiliates and may engage in material transactions from time to time. Although the Audit Committee of our Board of Directors will review all material transactions between our company and Temasek and such affiliates, circumstances may arise in which the interests of Temasek and such affiliates could conflict with the interests of our other shareholders. Because Temasek, through its affiliate, beneficially owns a significant portion of our ordinary shares, it could delay or prevent a change in control of our company, even if a transaction of that nature would be beneficial to our other shareholders. Our Articles of Association do not contain any provision requiring that Temasek and/or its affiliates own at least a majority of our ordinary shares. Please see “Item 7. Major Shareholders and Related Party Transactions” for additional information regarding our relationship with Temasek, Singapore Technologies and its affiliates.

(VII)   RISKS RELATED TO INVESTMENT IN A CORPORATION WITH INTERNATIONAL OPERATIONS

Economic conditions where our customers and their markets are located may have a negative impact on our revenue.

A significant portion of our revenue is derived from sales to customers whose semiconductors are used in products that are sold in the U.S., Taiwan, Japan, Europe and other countries in East and Southeast Asia. Our results of operations in the future could be negatively impacted if the economic environment in these countries deteriorates. For example, in 1998, many countries in Asia experienced considerable currency volatility and depreciation, high interest rates and declining asset values. As a result, there was a general decline in business and consumer spending and a decrease in economic growth as compared with prior years. Our results of operations in 1998 were affected by overall regional economic conditions because demand for semiconductor products generally rises as the overall level of economic activity increases and falls as activity decreases. In 2001, the semiconductor industry experienced its sharpest contraction on record as weakening global economic conditions contributed to a severe decline in the demand for electronic products that use semiconductors. While the semiconductor industry recovery accelerated in the second half of 2003 into the first half of 2004, we started seeing market weakness from the second half of June 2004 due to excess inventories in the semiconductor companies and softening in certain end

16


Table of Contents

markets. We cannot assure you that the industry will recover in 2005 and beyond. Future downturns in the semiconductor industry may also be severe and could seriously harm our company.

Terrorist attacks or a war could adversely affect our business, results of operations and financial condition.

Terrorist attacks, such as the attacks of September 11, 2001 in the U.S. and other acts of violence or war, have the potential to have a direct impact on our customers. To the extent that such attacks affect or involve the U.S. and any other places in which our customers’ markets are located, our business may be significantly impacted.

In addition, terrorist attacks or another war could adversely impact the transportation of our products, resulting in an adverse impact on our business, results of operations and financial condition and thereby could seriously harm our company.

Outbreak of an infectious disease or any other serious public health concerns in Asia (including Singapore) and elsewhere could adversely impact our business, results of operations and financial condition.

The outbreak of an infectious disease in Asia (including Singapore) and elsewhere, together with any resulting restrictions on travel or quarantines imposed, could have a negative impact on the economies, financial markets and business activities in countries in which our end markets are located and thereby adversely impact our revenue. Examples are the outbreak in 2003 of Severe Acute Respiratory Syndrome, or SARS, in East Asia and the outbreak of Avian Influenza, or Bird Flu, in Asia. While we took precautionary measures in response to the outbreak of SARS in 2003, we cannot assure you that any precautionary measures we may take against SARS or any other infectious diseases in the future would be effective. A future outbreak of an infectious disease or any other serious public health concern could seriously harm our company.

We operate internationally and are therefore affected by problems in other countries.

Our principal customers are located in the U.S., Taiwan, Japan and Europe and our principal vendors are located in the U.S., Japan, Taiwan, Korea and Europe. As a result, we are affected by economic and political conditions in those countries, including:

—   fluctuations in the values of currencies;
 
—   changes in labor conditions;
 
—   longer payment cycles;
 
—   greater difficulty in collecting accounts receivable;
 
—   burdens and costs of compliance with a variety of foreign laws;
 
—   political and economic instability;
 
—   increases in duties and taxation;
 
—   imposition of restrictions on currency conversion or the transfer of funds;
 
—   limitations on imports or exports;
 
—   expropriation of private enterprises; and
 
—   reversal of the current policies (including favorable tax and lending policies) encouraging foreign investment or foreign trade by our host countries.

The geographical distances between Asia, the Americas and Europe also create a number of logistical and communications challenges. Although we have not experienced any serious harm in connection with our international operations, we cannot assure you that such problems will not arise in the future.

17


Table of Contents

Exchange rate fluctuations may increase our costs and capital expenditures, which could affect our operating results and financial position.

Our financial statements are prepared in U.S. dollars. Our net revenue is generally denominated in U.S. dollars and our operating expenses are generally incurred in U.S. dollars and Singapore dollars. Our capital expenditures are generally denominated in U.S. dollars, Euro, Singapore dollars and Japanese Yen. Although we hedge a portion of the resulting net foreign exchange position through the use of forward exchange contracts, we are still particularly affected by fluctuations in exchange rates between the U.S dollar and the above mentioned currencies. Any significant fluctuation in exchange rates may lead to an increase in our costs and capital expenditures, which could adversely affect our operating results and financial position.

We may be a passive foreign investment company.

Based on our asset composition and operations, we do not believe that we were a passive foreign investment company, or PFIC, during 2004. However, there can be no assurances that we will not be a PFIC in 2005 or in a later year. If the “passive income” earned by us exceeds 75% or more of our “gross income”, we will be a PFIC under the “income test”. In addition, we will be a PFIC under the “asset test” if at least 50% of the quarterly average value of our assets is attributable to assets that produce or are held to produce passive income. The determination of the value of our assets will be based in part on the market price of our ordinary shares and ADSs. Because we have historically held, and may continue to hold a substantial amount of passive assets, there is a substantial risk that we may be a PFIC in 2005 or in a later year. Passive income for PFIC purposes includes, among other things, interest, dividends, royalties, rents and annuities. If we were to become a PFIC at any time during a U.S. person’s holding period, such U.S. person holding ordinary shares or ADSs would be required, if the “mark to market” election were not made, to pay an interest charge on certain distributions from us or upon a sale or other disposition of ordinary shares or ADSs and face other adverse tax consequences. Please see “Item 10. Additional Information — Taxation — U.S. Federal Taxation — PFIC Rules.” It is strongly urged that U.S. persons holding ordinary shares or ADSs consult their own tax advisers regarding the application of the PFIC rules.

Our public shareholders may have more difficulty protecting their interests than they would as shareholders of a U.S. corporation.

Our corporate affairs are governed by our Memorandum and Articles of Association and by the laws governing corporations incorporated in Singapore. The rights of our shareholders and the responsibilities of the members of our Board of Directors under Singapore law may be different from those applicable to a corporation incorporated in the U.S. Therefore, our public shareholders may have more difficulty in protecting their interests in connection with actions taken by our management, members of our Board of Directors or our controlling shareholder than they would as shareholders of a corporation incorporated in the U.S. For example, controlling shareholders in U.S. corporations are subject to fiduciary duties while controlling shareholders in Singapore corporations are not subject to such duties. Please see “Item 7. Major Shareholders and Related Party Transactions” for a discussion relating to our controlling shareholder, Temasek and its affiliates.

It may be difficult for you to enforce any judgment obtained in the U.S. against us or our affiliates.

Our company is incorporated under the laws of the Republic of Singapore. Many of our directors and senior management, and some of the experts named in this document, reside outside the U.S. In addition, virtually all of our assets and the assets of those persons are located outside the U.S. As a result, it may be difficult for investors to effect service of process within the U.S. upon us or any of these persons or to enforce in the U.S. any judgment obtained in the U.S. courts against us or any of these persons, including judgments based upon the civil liability provisions of the federal securities laws of the U.S. or any state or territory of the U.S.

Judgments of the U.S. courts based upon the civil liability provisions of the federal securities laws of the U.S. are not enforceable in Singapore courts and there is doubt as to whether Singapore courts will enter judgments in original actions brought in Singapore courts based solely upon the civil liability provisions of the federal securities laws of the U.S.

Singapore law contains provisions that could discourage a takeover of our company.

The Singapore Code on Take-overs and Mergers contains certain provisions that may delay, deter or prevent a future take-over or change in control of our company. Any person acquiring an interest (either on his own or together with parties acting in concert with him) in 30% or more of our voting shares may be required to extend a

18


Table of Contents

take-over offer for our remaining voting shares in accordance with the Singapore Code on Take-overs and Mergers. A take-over offer may also be required to be made if a person holding between 30% and 50% (both inclusive) of our voting shares (either on his own or together with parties acting in concert with him) acquires an additional 1% of our voting shares in any six-month period. These provisions may discourage or prevent certain types of transactions involving an actual or threatened change of control of our company. Some of our shareholders, which may include you, may therefore be disadvantaged as a transaction of that kind might have allowed the sale of the shares at a price above the prevailing market price.

(VIII)   RISKS RELATED TO OUR SECURITIES AND OUR TRADING MARKET

The future sales of securities by our company or existing shareholders may hurt the price of our securities.

If we or our shareholders sell a large number of our securities in the public market, including sales under the shelf registration statement we filed on March 12, 2001, the trading price of such securities could decrease dramatically. Any perception that these sales could occur could also result in a dramatic decline in the trading price of our securities. These sales also might make it more difficult for us to sell securities in the future at a time and at a price that we deem appropriate. All of our outstanding shares are freely tradable in Singapore and in the U.S. (in the form of ADSs), except that the shares owned by our affiliates, including Singapore Technologies Semiconductors Pte Ltd, or ST Semiconductors, may only be sold in the U.S. if they are registered or if they qualify for an exemption from registration, including under Rule 144 under the Securities Act of 1933, or the Securities Act. On March 12, 2001, we filed a shelf registration statement registering $4,000,000,000 of securities, of which $1,791,000,000 relate to securities we may issue from time to time and $1,000,000,000 relates to ordinary shares that ST Semiconductors may offer from time to time.

The market prices of our securities have been and may continue to be highly volatile.

The market prices of our securities have fluctuated widely and may continue to do so. For example, from our initial public offering in October 1999 through December 31, 2004, the trading price of our ADSs, adjusted for the October 2002 Rights Offering, has ranged from a high of $95.07 per ADS to a low of $3.48 per ADS. During the same period, the trading price of our ordinary shares, adjusted for the October 2002 Rights Offering, has ranged from a high of S$16.03 per ordinary share to a low of S$0.63 per ordinary share. Many factors could cause the market prices of our securities to rise and fall. Some of these factors include:

—   actual or anticipated variations in our quarterly operating results;
 
—   announcements of technological innovations;
 
—   changes in estimates of our performance or recommendations by financial analysts;
 
—   market conditions in the semiconductor industry and economy as a whole;
 
—   introduction of new services by us or our competitors;
 
—   changes in market valuations of other foundries and semiconductor companies;
 
—   announcements made by us or our competitors of significant acquisitions, strategic partnerships or joint ventures;
 
—   announcements made by our customers of their performance or financial results and of their foundry alliances and relationships;
 
—   market rumors or speculation about our business, operations, capital raising, change in our controlling shareholder or affairs;
 
—   issue of additional equity or equity linked offerings;
 
—   significant reduction or increase of shareholding by our controlling shareholder;

19


Table of Contents

—   additions or departures of key personnel; and
 
—   other events or factors, many of which are beyond our control.

The financial markets in the U.S., Singapore and other countries have experienced significant price and volume fluctuations, and market prices of technology companies have been and continue to be extremely volatile. Volatility in the prices of our securities may be caused by factors outside of our control and may be unrelated or disproportionate to our operating results. In the past, following periods of volatility in the market price of a public company’s securities, securities class action litigation has often been instituted against that company. Such litigation could result in substantial costs and a diversion of our management’s attention and resources.

The Singapore securities market is relatively small and more volatile than the U.S. markets and may cause the market price of our securities to fluctuate.

The Singapore Exchange is relatively small and more volatile than stock exchanges in the U.S. and certain other European countries. As of December 31, 2004, there were 462 companies listed on the Main Board of the Singapore Exchange and the aggregate market capitalization of listed equity securities of these companies was approximately S$446.4 billion. For the year ended December 31, 2004, the average daily equity trading value on the Singapore Exchange (including shares traded on the CLOB International trading system) was approximately S$153.5 million, with an annualized aggregate trading value of approximately S$176.9 billion. The relatively small market capitalization of, and trading volume on, the Main Board of the Singapore Exchange may cause the market price of securities of listed companies, including our securities, to fluctuate in both the domestic and the international markets.

Your voting rights with respect to the ADSs are limited by the terms of the deposit agreement for the ADSs.

Holders may exercise voting rights with respect to the ordinary shares represented by ADSs only in accordance with the provisions of the deposit agreement relating to the ADSs. There are no provisions under Singapore law or under our Articles of Association that limit ADS holders’ ability to exercise their voting rights through the depositary with respect to the underlying ordinary shares. However, there are practical limitations upon the ability of ADS holders to exercise their voting rights due to the additional procedural steps involved in communicating with such holders. For example, our Articles of Association require us to notify our shareholders at least 14 days in advance of any annual general meeting unless a special resolution is to be passed at that meeting, in which case at least 21 days’ notice must be given. Our ordinary shareholders will receive notice directly from us and will be able to exercise their voting rights by either attending the meeting in person or voting by proxy.

ADS holders, by comparison, will not receive notice directly from us. Rather, in accordance with the deposit agreement, we will provide the notice to the depositary, which will in turn, as soon as practicable thereafter, mail to holders of ADSs:

—   the notice of such meeting;
 
—   voting instruction forms; and
 
—   a statement as to the manner in which instructions may be given by holders.

To exercise their voting rights, ADS holders must then instruct the depositary how to vote their shares. Because of this extra procedural step involving the depositary, the process for exercising voting rights will take longer for ADS holders than for holders of ordinary shares. ADSs for which the depositary does not receive timely voting instructions will not be voted at any meeting.

Except as described in this document, holders will not be able to exercise voting rights attaching to the ADSs.

Your ability to participate in any rights offering of our company is limited.

We distributed in October 2002 and may, from time to time, distribute rights to our shareholders, including rights to acquire securities under the deposit agreement relating to the ADSs. The depositary will not offer rights to holders in any jurisdictions unless both the rights and the securities to which such rights relate are either exempt from registration under the applicable securities laws of such jurisdictions or are registered in accordance with the

20


Table of Contents

provisions of such laws. However, we are under no obligation to file a registration statement with respect to any such rights or underlying securities or to endeavor to cause such a registration statement to be declared effective. Accordingly, holders of our securities may be unable to participate in rights offerings by us and may experience dilution of their holdings as a result.

FORWARD-LOOKING STATEMENTS CONTAINED IN THIS DOCUMENT MAY NOT BE REALIZED

This document contains forward-looking statements, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements are, including without limitation:-

—   statements relating to our business strategy;
 
—   our outlook for 2005;
 
—   our capacity utilization rate, production capacity and production capacity mix;
 
—   the equipping of our fabrication facilities, and the commencement of commercial production of Fab 7;
 
—   our sourcing agreements with IBM and manufacturing of 90nm SOI products beginning in mid-2005;
 
—   our sourcing and manufacturing technology agreements with Advanced Micro Devices, Inc. and manufacturing of AMD64 microprocessors in 2006;
 
—   the timing of the trough of the semiconductor market cycle;
 
—   our expectation that 0.13um, 0.11um and 90nm technologies will be a large contributor to our revenue in 2005;
 
—   our 2005 planned capital expenditures, research and development expenditures, depreciation and amortization and wafer capacity;
 
—   the increase of the advanced capacity (0.13um and smaller process geometry technologies);
 
—   our sources of liquidity, cash flow, funding needs and financings;
 
—   our expectation that utilization in 0.35um and above technologies will be higher than 0.25um and 0.18um technologies;
 
—   the reduction of our breakeven point to 75% utilization by the end of 2005 and the equipping and ramping of Fab 7 to a breakeven position at 9,000 wafers per month (300-mm) capacity by end 2005;
 
—   our near-term and long-term outlook in the foundry services market; and
 
—   the expected qualification of all of our fabrication facilities under the ISO/TS 16949 standard of certification.

These forward looking statements reflect our current views with respect to future events and financial performance, and are subject to certain risks and uncertainties, which could cause actual results to differ materially from historical results or those anticipated. Among the factors that could cause actual results to differ materially are:

—   changes in the market outlook and trends;
 
—   the growth rate of fabless companies and the outsourcing strategy of integrated device manufacturers;
 
—   the rate of the semiconductor market recovery; economic conditions in the United States as well as globally;
 
—   customer demands, unforeseen delays or interruptions in our plans for our fabrication facilities (including Fab 7);
 
—   the performance level of and technology mix in our fabrication facilities;
 
—   our progress on leading edge products;
 
—   access to or delays in technological advances or our development of process technologies;
 
—   the successful implementation of our partnership, technology and supply alliances (including our joint development agreements with IBM, Infineon and Samsung);
 
—   changes in capacity allocation in process technology mix, changes in our capacity plans, unavailability of materials, equipment, manpower, expertise and timely regulatory approvals;
 
—   the availability of financings and the terms thereof; and
 
—   terrorist attacks, another war, or the possibility of another outbreak of SARS or any other infectious disease in Singapore as well as various parts of the world.

Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be attained. In addition to the foregoing factors, a description of certain other risks and uncertainties which cause actual results to differ materially can be found in “Item 3. Key Information — Risk Factors.” You are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s current analysis of future events. We undertake no obligation to publicly

21


Table of Contents

update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

ITEM 4.   INFORMATION ON OUR COMPANY
 
A.   HISTORY AND DEVELOPMENT OF OUR COMPANY

Chartered’s full legal name is Chartered Semiconductor Manufacturing Ltd. Chartered is a limited liability company incorporated in the Republic of Singapore in 1987. Our principal executive and registered offices are located at 60 Woodlands Industrial Park D, Street 2, Singapore 738406. Our telephone number is +65-6362-2838. Information pertaining to our company and our SEC filings are available on our website, www.charteredsemi.com. However, information contained in our website does not constitute a part of this document.

Our agent in the U.S. for the purpose of our securities filings is our subsidiary, Chartered Semiconductor Manufacturing, Inc., 1450 McCandless Drive, Milpitas, California 95035, telephone +1-408-941-1100.

In 1997, Chartered acquired equity interests in CSP and in SMP. For more information on this, please refer to “Item 4. Information On Our Company — Business Overview — Strategic Alliances”.

We have one significant subsidiary, CSP, a Singapore company incorporated in 1997 in which we have a 51% equity interest. For information on our other subsidiaries, please see “Item 4. Information On Our Company — Organizational Structure”.

Our principal capital expenditures for the fiscal years 2002, 2003 and 2004 comprised mainly of the purchase of semiconductor equipment for the equipping of fabs. Our capital expenditures amounted to $419.5 million in 2002, $220.8 million in 2003 and $686.3 million in 2004. We expect our aggregate capital expenditures in 2005 to be approximately $750 million, of which approximately 85% is expected to be for equipping Fab 7 to 9,000 300-mm wafers per month capacity by end 2005 (which is part of our Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity), with the balance primarily for capacity additions at leading-edge technologies in Fab 6. For more details on the equipping costs of Fab 7, see “Item 5. Operating and Financial Review and Prospects — Liquidity and Capital Resources”.

For the year 2004, our capital expenditures were financed mainly from borrowings under our existing credit facilities and cash balances. A more detailed discussion of credit facilities can be found under “Item 5. Operating and Financial Review and Prospects — Liquidity and Capital Resources”.

B.   BUSINESS OVERVIEW

DESCRIPTION OF BUSINESS

Chartered is one of the world’s top dedicated semiconductor foundries. We provide comprehensive wafer fabrication services and technologies to semiconductor suppliers and systems companies. We focus on providing foundry services to customers that serve high-growth, technologically advanced applications, in the communication, computer and consumer applications.

We currently own, or have an interest in, 5 fabrication facilities — Fabs 2, 3, 5, 6 and 7, all of which are located in Singapore. Fab 7 is the company’s first 300-mm facility. Fab 7 commenced pilot production at the end of 2004 and is scheduled for commercial production in mid-2005.

In February 2003, we announced our plans to phase out Fab 1, our only 150-mm fab, and consolidate its business into Fab 2 over an estimated 13 month transition period, with the aim of reducing our fixed cost base as well as consolidating all Singapore fab operations onto our main campus in Woodlands. The consolidation process completed as scheduled and Fab 1 ceased operations at the end of March 2004.

We have service operations in 9 locations and in 8 countries in North America, Europe and Asia.

22


Table of Contents

INDUSTRY BACKGROUND

Semiconductors are critical components used in an increasingly wide variety of applications, such as computer systems, communications equipment and systems, automobiles, consumer products and industrial automation and control systems. As performance has increased and size and cost have decreased, the use of semiconductors in these applications has grown significantly.

Historically, the semiconductor industry was composed primarily of companies which designed and manufactured semiconductors in their own fabrication facilities. These companies are known as integrated device manufacturers, or IDMs. In the mid-1980s, fabless semiconductor companies, which focused on design and marketing and utilized external manufacturing capacity, began to emerge. Fabless companies initially relied on the excess capacity provided by IDMs. As the semiconductor industry continued to grow, fabless companies and IDMs began to seek reliable and dedicated sources of wafer fabrication services. This need is being met by the development of independent companies, known as foundries, that focus primarily on providing wafer fabrication services to semiconductor suppliers and systems companies.

The semiconductor industry generally experiences seasonality which is mainly driven by demand fluctuations for the electronic products that use semiconductor integrated circuits. The sequential growth of semiconductor revenue in the first quarter is typically weaker compared to that of other quarters.

THE GROWTH OF THE SEMICONDUCTOR FOUNDRY INDUSTRY

Semiconductor suppliers presently face increasing demands to offer new products that provide higher performance and greater functionality at lower prices. To compete successfully, they must also minimize the time it takes to bring a product to market. High performance semiconductors, which contain millions of transistors, are extraordinarily challenging to design and even more challenging to manufacture. Additionally, these high-performance semiconductors can only be produced in fabs that employ the most advanced semiconductor process technologies.

According to recent industry research reports and company announcements, the cost of a state-of-the-art 300-mm fab is approximately $3 billion, which is approximately six times higher than the cost a decade ago. Today, only large and well-capitalized or funded companies can support the substantial technology and investment requirements of building state-of-the-art fabs. In addition, for companies to justify the enormous cost of a new fab, a high level of capacity utilization is essential to ensure that fixed costs are fully absorbed. These trends have led to the rapid growth in demand in the recent years for advanced semiconductor manufacturing services provided by semiconductor foundries.

Foundry services are now utilized by nearly every major semiconductor company in the world. Historically, IDMs have used foundry services for their incremental manufacturing needs. Given the high cost of implementing 300-mm technology and the mounting pressure on them to improve profit margins and accelerate time-to-market, we expect IDMs to utilize foundries more extensively in the future for their core manufacturing needs.

THE REQUIREMENTS OF A FULL-SERVICE FOUNDRY

As demand for foundry services has grown, many semiconductor suppliers are seeking highly committed partners that meet their manufacturing technology requirements. These partners must be able to provide the following:

Systems Integration Expertise. Business and consumer demand for convergent solutions that perform multiple functions that classically were done by different individual devices has increased dramatically. Fueling this demand has been growth in the merging of data communications, telecommunications, wireless and consumer markets. This has resulted in greater demand for faster, smaller semiconductors that integrate an increasing number of functions onto a single device at a lower cost. This need for increased system-level integration requires semiconductor foundries to offer specialized expertise in a number of areas. These include the integration of logic, which processes data, and memory, which stores data, into a single device and mixed-signal technologies which translate data between analog and digital form. The foundry market has been asked to also provide and support access to third party intellectual property and design solutions as the customer base increasingly focuses on system-level expertise and passes on to its foundry more of the design and product implementation efforts.

23


Table of Contents

Leading-Edge Process Technologies. Semiconductor foundries must also provide a range of manufacturing process technologies from standard CMOS (complementary metal oxide silicon) to technologies that enable extremely fast transmission and processing speeds, such as specialized CMOS for wireless applications and the use of copper interconnect for very high speed devices. Foundries must also continue to offer smaller process geometries which allows for the integration of more functions in the same size device or more devices per wafer.

Long-Term Relationships. As foundries become more integral to the overall manufacturing strategies of their customers, it has become increasingly important for foundries to form long-term relationships with them. Semiconductor suppliers and systems companies need assurance that their foundry suppliers will continue to provide sufficient advanced manufacturing capacity to keep pace with their customers’ growth, and develop and make available advanced process technologies capable of producing next-generation products. These relationships must be also flexible, allowing customers to respond to the variable nature of the semiconductor market.

Security. When using foundry services, semiconductor suppliers, systems companies and their partners entrust highly valuable and proprietary intellectual property to the foundries manufacturing their devices. These customers demand foundry partners who understand the importance of protecting intellectual property.

THE CHARTERED SOLUTION

Chartered is one of the world’s leading semiconductor foundries. We provide comprehensive wafer fabrication services and technologies to semiconductor suppliers and systems companies and enable seamless integration of the semiconductor design and manufacturing processes. By doing so, we enable our customers to bring high-performance, highly-integrated products to market rapidly and cost effectively.

Chartered’s partnership approach allows us to work with customers early on in the product definition stage, often sharing resources, knowledge and even physical assets, to jointly develop solutions, thus giving our partners the flexibility to adapt quickly to new market opportunities.

Chartered has developed an array of technologies and capabilities to drive converging applications. Our fabrication facilities support the leading-edge requirements for high-bandwidth, feature-rich wireless and wired applications. We have proven expertise in mixed signal and radio frequency complementary metal oxide silicon, or RF CMOS, enabling technologies essential to the convergence of computer, communication and consumer applications.

In order to augment our internal development efforts, we have entered into strategic alliances and technology alliances with leading semiconductor companies such as our strategic alliance with Agere in SMP and our technology alliances with IBM, Infineon and Samsung. For more details on these strategic alliances and technology alliances, see “Item 4. Information On Our Company — Business Overview — Strategic Alliances — Silicon Manufacturing Partners” and “Item 4. Information On Our Company — Business Overview — Research and Development”.

We have established relationships with leading EDA, intellectual property and design services providers. Together we develop a process platform tailored to our customers’ needs and that is production-proven so as to facilitate first-pass success. We offer design solutions for a variety of applications and process nodes, giving customers valuable freedom of choice when it comes to EDA and intellectual property selection. Customers get early access to design rules and other important manufacturing specifications so that they can be incorporated into designs early. In March 2004, we launched the Chartered-IBM Cross-Foundry Design Enablement Program, or Design Enablement Program, starting at 90nm and have six leading design solution providers as partners to the program. The Design Enablement Program sets a new standard for foundry compatibility, design portability and flexible sourcing between our company and IBM. In 2004, we also expanded our design services partnership network to improve our customers’ access to more expertise, broader choices and greater flexibility for their chip development.

Having successfully launched our e-Business initiative with customers, we have further progressed on two fronts. We have enhanced the integration between our e-Business systems and our quality systems. At the same time, we have extended, and continue to extend, e-Business connectivity with our other partners such as mask shops, test and assembly houses and material suppliers through a number of initiatives. As a result, we now have a more tightly integrated supply chain. For more information on our e-Business initiative, please see “Item 4. Information On Our Company — Business Overview — Customer Service”.

24


Table of Contents

We believe that our customers value Chartered as a trusted, customer-oriented service provider which adopts a collaborative approach to the foundry industry. All of our manufacturing operations are located in Singapore, a politically and economically stable nation with laws that protect our customers’ proprietary technology.

BUSINESS STRATEGY

Our objective is to be a leading worldwide full-service provider of wafer foundry services to semiconductor suppliers and systems companies focused on high-growth applications that require a high degree of system-level integration. Key elements of our strategy include:

(a)   Improve Top-Line Growth By Targeting First Source Business While Continuing To Serve The Markets For Mature Technologies

Our ability to engage customers at increasingly advanced technologies, the strengthening of our technology roadmap resulting from our joint development agreements with IBM, Infineon and Samsung and the expansion of our third-party network of pre-qualified EDA, intellectual property and design services solutions, have allowed us to target substantially more “first source” business. “First source” business refers to being selected as the first manufacturing source for customers’ new product introductions and it typically commands higher prices and profit margins.

As mature technology products remain a growing and important part of Chartered’s business, we will also continue to focus on increasing our reach into mature markets. We place an emphasis on leveraging our capabilities in mixed-signal and RF CMOS processes with complete solutions for our niche technologies for products such as smart cards, Radio Frequency Identification, or RFID tags, display drivers and power management for mobile products.

(b)   Optimize Our Capacity Base

We aim to optimize our capacity base by rapidly expanding capability for advanced technologies, reducing excess capacity at mature technology nodes and adopting a “borderless fab” approach targeted at improving asset utilization and increasing flexibility and scalability across all our fabs.

Advanced Technologies. As part of our plan to expand our capability for advanced technologies, we intend to expand our production capacity for 0.13um and smaller process geometry technologies to meet the anticipated needs of our customers. Wafer capacity is expected to be approximately 140 thousand 200-mm wafers per month by end 2005, an increase of approximately 27% from capacity level at end 2004. For the same period, advanced capacity (0.13um and smaller process geometry technologies) is planned to increase and represent approximately 33% of the total expected wafer capacity. We believe that increasing our foundry capacity in smaller or advanced process geometry technology will allow us to take advantage of the market opportunities opening up to Chartered as a result of the rapid technology progress we have made in recent years.

Mature Technologies. We intend to utilize our capacity for mature technologies by developing niche technologies, targeting strategic partnerships for volume production and working towards establishing a manufacturing presence in China with appropriate partners to leverage on our equipment assets, technology and expertise in mature processes. With the aim of reducing our fixed cost base, in March 2004 we consolidated Fab 1’s (our only 150-mm fab) business into Fab 2 on the main campus in Woodlands and Fab 1 ceased operations at the end of March 2004.

(c)   Focus On Solutions That Support The Growing Trend Of Product Convergence

We are focused on providing foundry services to customers that serve high-growth convergence applications which require a high degree of functional integration. These customers compete based on differentiated products, rapid time-to-market and device performance, as opposed to suppliers of less complex commodity semiconductor products, which compete primarily on price and manufacturing capacity. Many of our customers use our custom solution of technology and services to manufacture their products for applications such as cable modems, wireless, office automation products and consumer connectivity products.

25


Table of Contents

(d)   Provide A Complete Range Of Services

We are continuing to expand our range of services so that we can effectively meet our customers’ evolving needs. Our goal is to seamlessly integrate the design and manufacturing process with a wide array of services, tools and technologies. The services we currently make available to our customers, in conjunction with our partners, include a number of EDA design tools, design libraries, third party intellectual property and process technologies that have been validated for our manufacturing process. We also offer our customers full turnkey services which include wafer fabrication, assembly and test.

(e)   Offer Leading Process Technology

We intend to continually expand our portfolio of process technologies in line with our customers’ requirements for timing and performance for use with their products. The schedule and first level definition of the new process technologies being developed, and to be developed, are provided by our technology roadmaps. The current roadmaps cover 2005 and 2006 and 90nm and 65nm logic processes, including the generic, low power and high speed variants. The roadmaps also cover 90nm mixed signal and RF modules and 0.18um high voltage and eFLASH processes.

The current development programs for logic are directed to 65nm technology node. In August 2003, we extended the IBM joint development agreement to include Infineon and in March 2004, we further extended the joint development agreement with IBM and Infineon to include Samsung (“March 2004 agreement”). The March 2004 agreement replaces and is in substitution of the joint development agreement with IBM and Infineon. Under the March 2004 agreement, IBM, Infineon, Samsung and Chartered are jointly developing a common advanced foundry manufacturing process technology at 65nm, as well as variants tuned for high performance and low power. Please see “Item 4. Information On Our Company — Business Overview — Research and Development” for more details on this joint development agreement.

In December 2004, we expanded our joint development efforts with IBM under our joint development agreement entered into with IBM in November 2002 to include 45nm bulk CMOS process technology. The IBM joint development agreement is designed to provide customers with greater access to leading-edge semiconductor technologies and sourcing flexibility. The development of both 65nm and 45nm are being carried out at IBM’s facilities in East Fishkill.

In the case of mixed signal technologies, which employ additional devices such as metal-insulator-metal capacitors and poly silicon resistors that must be characterized for mixed-signal operation, timing typically follows the introduction of the logic development schedule. For RF CMOS, still more devices such as inductors and varactors must be developed and characterized and modeled. This process builds on the mixed signal and the logic processes, and is generally expected to be ready for pilot production within six months after the logic process becomes available. BiCMOS, which integrates bipolar transistors with the CMOS and selected modules from mixed signal and RF CMOS, comes to pilot production later.

The availability of logic, mixed-signal RFCMOS, BiCMOS, SiGe and embedded memories technologies enables us to provide process solutions essential to the convergence of computer, communication and consumer applications.

(f)   Enhance And Expand Alliances

We intend to leverage and expand our existing alliances and to establish new alliances with leading companies that offer complementary technologies, products and services. We believe that our alliances with semiconductor technology leaders and providers of design tools, intellectual property, design services and assembly and test services have given us access to select leading-edge system technologies. These alliances have also enhanced our development efforts and have the potential to increase our fab utilization rates. We also believe that by establishing these alliances and working closely with leading companies who are also existing or future customers, such as Agere Systems, IBM and Infineon, we are better positioned to win future business with them.

In August 2003, we entered into an arrangement with CSMC Technologies Corporation, or CSMC, a leading 150mm Chinese integrated circuit foundry services company for equipment sale, technology licensing, operational assistance and customer referral. We have by December 31, 2004, completed the transfer of our proven 150mm technologies which will be used to serve the China market and other customers globally with specific mature technology requirements.

26


Table of Contents

MANUFACTURING FACILITIES

As of December 31, 2004, we own or have an interest in 5 fabs, all of which are located in Singapore. Our company had previously operated Fab 1, which ceased operations at the end of March 2004. Fabs 2 and 3 are wholly-owned and operated by our company. We do not have a Fab 4. Fab 5 is owned and operated by SMP, our joint venture company with Agere Systems Singapore Pte. Ltd., a subsidiary of Agere Systems Inc. Fab 6 is owned and operated by CSP, our joint venture company with Agilent Technologies Europe B.V., EDB Investments Pte Ltd and Singapex Investments Pte Ltd, an indirect-wholly owned subsidiary of Temasek.

Fab 7 is the company’s first 300-mm facility and is wholly owned and operated by our company. Fab 7 commenced pilot production at the end of 2004 and is scheduled for commercial production in mid-2005.

Our fab capacity plans have been updated consistent with our company’s efforts to better align manufacturing capability with our growing market opportunities in advanced technologies. The following table reflects our wafer capacity figures as of December 31, 2004 for each of our fabs and the fab of our equity-method joint venture company, SMP (Fab 5).

                     
    Fab 2   Fab 3   Fab 5 (SMP)(1)   Fab 6 (CSP)(1)   Fab 7
Production commenced
  1995   1997   1999   2000   2005(2)
 
                   
Current capacity(3)
  42,500 wafers per month   23,000 wafers per month   23,000 wafers per month   27,000 wafers per month  
 
                   
Estimated full capacity(4)
  45,000 wafers per month   23,000 wafers per month   23,000 wafers per month   37,000 wafers per month   30,000 wafers per month(5)
 
                   
Wafer size
  Eight-inch
(200-mm)
  Eight-inch
(200-mm)
  Eight-inch
(200-mm)
  Eight-inch
(200-mm)
  Twelve-inch
(300-mm)
 
                   
Process Technologies
  0.6 to 0.3um(6)   0.35 to 0.18um(6)   0.25 to 0.13um(6)   0.25 to 0.11um(6)   0.13um and smaller process geometry technologies(6)
 
                   
Manufacturing Technologies(7)
  Digital; Mixed Signal; RF CMOS; SRAM; Flash Memory; HVCMOS; EEPROM; DMOS; BiCMOS, BiPolar; OTP   Digital; Mixed Signal; RF CMOS; SRAM   Digital; RF CMOS; BiCMOS; Mixed Signal; eSRAM   High performance, high-density CMOS; high density SRAM Mixed Signal; RF CMOS   Digital; high-density SRAM; RF CMOS; Mixed Signal; SOI
 
                   
Clean room
  109,000 sq. ft. Class-1 SMIF(8)   81,000 sq. ft. Class-1 SMIF(8)   96,540 sq. ft. Class-1 SMIF(8)   126,000 sq. ft. Class-1 SMIF(8)   181,000 sq. ft. Class-1 SMIF(8)


(1)   With respect to Fab 5 and Fab 6, the information includes capacity of our strategic partners.
 
(2)   Pilot production commenced at the end of 2004 and commercial production is scheduled for mid-2005.
 
(3)   Current capacity is the production output capability based on current process technology mix using the installed set of equipment in the fab as of December 31, 2004.

27


Table of Contents

(4)   Estimated full capacity is the production output capability based on our current and anticipated process technology mix, which may vary. Unlike current capacity which is computed based on the currently installed set of equipment in the fab, estimated full capacity assumes that the fab is fully utilized to its maximum capacity, based on planned equipment additions and anticipated technology mix. Our projections of estimated full capacity have varied from previous projections in terms of number of wafers because of revisions to our earlier plans, including changes to our capacity expansion plans and capacity allocation in process technology mix. Such changes reflect developments in market conditions and demand.
 
(5)   Equivalent to 67,500 eight-inch wafers per month. A conversion rate of 2.25 is utilized in determining the number of eight-inch equivalent wafers to that of twelve-inch wafers. We are taking a phased approach to the full equipping of Fab 7 to 30,000 300-mm wafers per month, and this is expected to take a number of years and will be paced by customer demand and industry conditions. We intend to ramp Fab 7 to 9,000 300-mm wafers per month capacity by end 2005.
 
(6)   Some of these manufacturing processes are preliminary and their successful implementation depends on various factors, including our ability to achieve advances in process technology or to obtain access to advanced process technology developed by others, or in the case of our 0.18um capability in Fab 3, our ability to leverage on certain tool capacities in SMP. These fabs can be retrofitted to achieve smaller process geometry technologies than those shown above.
 
(7)   Some of these manufacturing technologies are preliminary and their successful implementation depends on various factors, including our ability to achieve advances in manufacturing technology or to obtain access to advanced manufacturing technology developed by others. EEPROMs are electrically erasable programmable read-only memory devices. SRAMs are static random access memory devices. eSRAMs are embedded static random access memory devices. CMOS means complementary metal oxide silicon. RF CMOS means radio frequency complementary metal oxide silicon. BiCMOS means bipolar complementary metal oxide silicon. HVCMOS refers to high voltage complementary metal oxide silicon. DMOS refers to double diffused vertical MOSFET. OTP refers to one time programmable memory. SOI means silicon on insulator.
 
(8)   Class 1 is a measurement of air cleanliness in which the amount of particles is controlled to no more that 1 particle at 0.5um per cubic foot of air. SMIF means standard mechanical interface.

All our production fabs generally operate 24 hours per day, 7 days per week. The only exceptions are where scheduled maintenance requires a facility shut-down, or in periods of weak demand where we idle fabs that are not required to meet manufacturing schedules to reduce certain operating costs, as was the case from time to time in 2001 and 2002 and as may be the case in the future, depending on customer demand. Regular maintenance is otherwise performed concurrently with production. Whether we choose to carry out scheduled maintenance requiring a facility shut-down or regular maintenance performed concurrently with production depends on which is more appropriate at any given time, having regard to minimizing disruption to our production schedule.

The following table sets forth information regarding the total wafer output by each of our fabs, the fab of our equity-method joint venture company, SMP, and the fab of our subsidiary, CSP, during the past five years:

                                         
    Total Output(1) (in thousands)  
Fab   2000     2001     2002     2003     2004  
Fab 1(2)
    180       96       97       121       33  
Fab 2
    524       168       149       247       454  
Fab 3
    210       113       94       134       212  
Fab 5 (SMP)(3)(4)
    73       7       28       116       114  
Fab 6 (CSP)(3)
    13       14       77       104       222  


(1)   Total output of revenue-generating eight-inch equivalent wafers.
 
(2)   Fab 1 ceased operations at the end of March 2004.
 
(3)   Fab 5 commenced production in 1999 and Fab 6 commenced production in 2000.
 
(4)   Includes only Chartered’s output.

QUALITY ASSURANCE PROGRAMS

We have implemented systems to ensure high quality service to customers and manufacturing reliability at our facilities in Singapore. Our in-house laboratory is equipped with advanced analytical tools and provides the necessary equipment and resources for our research and development and engineering staff to continuously enhance product quality and reliability. Our quality assurance staff comprises engineers, technicians and other employees who monitor and control our manufacturing processes.

28


Table of Contents

Our production facilities in Singapore, Fabs 2, 3, 5 and 6 have been certified by a third party certification body to QS 9000, an internationally recognized quality standard and since May 2003, to the more exacting ISO 9000:2000 standard. These standards include the requirement for continuous improvement, emphasizing on defect prevention, variation reduction and reduction of waste in the supply chain. The certification processes involve periodically subjecting production processes and quality management systems to stringent third-party review and verification. Our customers often look to QS 9000 and ISO 9000 certification as a threshold indication of our quality control standards. We have work in progress to achieve a yet higher standard of certification, ISO/TS 16949, and expect to qualify all our production facilities to this new standard by July 2005.

Our company is committed to continuous improvement by the application of Six Sigma methodology, a well-recognized means of making breakthrough improvements in business and manufacturing processes and solving chronic problems. We have trained a substantial number of engineers and managers to Black and Green Belt standards. We also apply 8D methodology for smaller, more straightforward problems on a daily basis. In addition, most of our engineers have been trained in Design of Experiments and application of statistical tools and techniques.

STRATEGIC ALLIANCES

Chartered Silicon Partners

Our subsidiary, Chartered Silicon Partners Pte Ltd, or CSP, was established in March 1997 and is a joint venture between Chartered (51%), EDB Investments Pte Ltd, or EDB Investments (26.5%), Agilent Technologies Europe B.V. (15%) (previously Hewlett-Packard Europe B.V.), and Singapex Investments Pte Ltd, or Singapex (7.5%).

CSP owns and operates Fab 6. Pursuant to a cost sharing agreement, we perform certain management and corporate support activities for the benefit of CSP including accounting, financial, sales and marketing. Under this agreement, CSP is allocated a portion of our costs in performing such activities.

From March 1997 until October 2001, we, Agilent Technologies Europe B.V. and EDB Investments had a 51%, 30% and 19% equity interest in CSP, respectively. The ownership was restructured in October 2001 when Agilent Technologies Europe B.V. sold one-half of its 30% share in CSP to Singapex and EDB Investments, in equal proportion, resulting in Chartered, EDB Investments, Agilent Technologies Europe B.V. and Singapex owning 51%, 26.5%, 15% and 7.5% equity interest in CSP, respectively. Although Agilent Technologies Europe B.V. had a 2-year option from October 2002 to reacquire the ownership interest that was sold, Agilent Technologies Europe B.V. did not exercise the option within the stipulated 2-year period and consequently, the option lapsed in October 2004.

We and Agilent Technologies, Inc. contributed the process technologies needed by CSP. Such process technologies are licensed to CSP for its own use and CSP cannot sub-license them to others. We also cross-license the rights to use such technologies to one another. These cross-licenses allow our respective companies to use the process technologies and related intellectual property licensed to CSP in our respective manufacturing facilities for our general businesses even if such are not related to CSP. Agilent Technologies, Inc. has ceased its technology development for technology nodes beyond 0.25um, and as such, Agilent Technologies, Inc. will cease to contribute any process technologies involving these technology nodes to CSP and CSP will instead rely solely on the process technologies contributed by our company.

Pursuant to our joint venture agreement, the CSP alliance will continue indefinitely so long as there are two or more parties to the alliance. Before any transfer of an interest in CSP can occur, the non-transferring parties may exercise a right of first refusal with respect to the interests proposed to be transferred. Upon a serious, uncured default, the non-defaulting parties have the right to purchase all of the defaulting party’s interest for fair value, as defined in the agreement. Upon a change of control of a party, the other parties have the right to purchase, at fair value, all of such party’s interest.

The reduction in Agilent Technologies Europe B.V.’s ownership in CSP in 2001 also had an impact on Agilent Technologies, Inc.’s obligation to purchase a minimum number of wafers per year and rights to purchase a maximum number of wafers per year from CSP. This reduction automatically resulted in a reduction in Agilent Technologies, Inc.’s maximum capacity entitlement and in the financial obligation associated with its minimum

29


Table of Contents

wafer purchase commitment requirement. As Agilent Technologies Europe B.V. did not exercise its option to reacquire the ownership interest, Agilent Technologies, Inc.’s maximum capacity entitlement and minimum wafer purchase commitment requirement remains unchanged.

With the reduction of Agilent Technologies Europe B.V.’s ownership in CSP in 2001, the parties also agreed that directors appointed by Agilent Technologies Europe B.V. would no longer have voting rights although they would still remain on CSP’s Board of Directors and retain all their other existing rights and obligations. In addition, Agilent Technologies Europe B.V. is no longer a member of CSP’s management committee. CSP’s Board of Directors comprises eight directors. As long as we own more than 50% of CSP, we can elect four of the directors. Agilent Technologies Europe B.V. can elect two directors as long as it owns at least 15% of CSP, EDB Investments can elect one director as long as it holds any ownership interest in CSP and Singapex can elect one director as long as it holds 7.5% of CSP.

U.S. GAAP generally requires consolidation of all majority owned (greater than 50%) subsidiaries. CSP is a consolidated subsidiary. Due to cumulative losses, the minority interest equity was reduced to zero in the first quarter of 2003. Therefore losses from that point forward have been charged entirely to our consolidated statements of operations.

Silicon Manufacturing Partners

In December 1997, we entered into the SMP strategic alliance with Lucent Technologies Microelectronics Pte. Ltd., or Lucent Technologies Microelectronics, now known as Agere Systems Singapore Pte Ltd, or Agere Systems Singapore, relating to the joint venture ownership of Fab 5.

Agere Systems Singapore has a 51% equity interest in SMP and we have a 49% equity interest. SMP’s Board of Directors comprises five directors, three of which are elected by Agere Systems Singapore and two of which are elected by us. We nominate the chairman of the Board of Directors and the general manager, while Agere Systems Singapore names the finance director.

Pursuant to an assured supply and demand agreement that both the joint venture partners signed with SMP, we are each required to purchase a specified percentage of Fab 5’s output. However, if one party does not purchase its share of wafers, the other party is entitled to utilize that unused capacity. In the event such other party does not utilize the unused capacity, the party who does not purchase its entitlement will be required to compensate SMP for any unrecovered costs it incurs in connection with such unused capacity. Under the assured supply and demand agreement mentioned above, there was no allocated wafer capacity billable to us for 2004.

Pursuant to our agreement, the SMP strategic alliance continues indefinitely until it is terminated by written notice from or by either party. Neither party may give such written notice of termination prior to February 2006, and the termination of the alliance will take effect two years from the date of such termination notice. In addition, the parties may only transfer their interests to their respective affiliates. Upon our dissolution, winding up or liquidation, Agere Systems Singapore can purchase all of our interests in SMP for fair value, as defined in the agreement. Upon our serious, uncured breach, Agere Systems Singapore has the right to sell all of its interest in SMP to us at the higher of fair value or the value of its interest based on SMP’s net book value, as defined in the agreement. Upon Agere Systems Singapore’s dissolution, winding up or liquidation, we have the right to purchase all of its interest in SMP for fair value. Upon Agere Systems Singapore’s serious, uncured breach, we have the right to purchase all of its interest in SMP at 90% of fair value. Upon a change of control of a party, the other party has the right to purchase, at fair value, all of such party’s interest in SMP.

Pursuant to a cost sharing agreement, we perform certain management and corporate support activities for the benefit of SMP including accounting, financial and human resources. Under this agreement, SMP is allocated a portion of our costs in performing such activities.

We and Agere Systems Singapore contribute the process technologies needed by SMP. Such process technologies are licensed to SMP for its own use and SMP cannot sublicense them to others. The licensed technologies are categorized as restricted and unrestricted technologies. We and Agere Systems Singapore also cross-license the unrestricted technologies to one another. These cross-licenses allow our respective companies and subsidiaries to use certain process technologies and related intellectual property licensed to SMP in our respective manufacturing facilities for our general businesses even if such uses are not related to SMP. We do not cross-license the restricted technologies with one another, which means that only SMP can use such restricted process technologies and intellectual property.

30


Table of Contents

SMP owns and operates Fab 5, which is adjacent to our Fab 3 building. SMP owns the equipment used in Fab 5 and leases the space for Fab 5 from us. With effect from October 2001, we together with Agere Systems Singapore agreed to run Fab 5 and Fab 3 as one integrated operation, while retaining the existing ownership and corporate structure of SMP. The fabs shared a single shell but had two separate administrative structures prior to their operational integration. By implementing this change, we and Agere Systems Singapore are able to free up key technical resources and also provide enhanced flexibility and better utilization of the combined equipment base.

We account for our 49% investment in SMP using the equity method. Under the strategic alliance agreement, the parties do not share SMP’s net results in the same ratio as the equity holding. Instead, each party is entitled to the gross profits from sales to the customers that it directs to SMP, after deducting its share of the overhead costs of SMP. Accordingly, we account for our due share of SMP’s net results based on the gross sales to the customers that we direct to SMP, after deducting our 49% share of the overhead costs.

In September 2004, we entered into a Supplemental Agreement to the Joint Venture Agreement (see “Item 19. Exhibits — Exhibit 4.16”) to provide that SMP can pay dividends out of the profits of the venture determined on a year to year basis rather than a cumulative basis as previously was the case.

OVERVIEW OF WAFER FABRICATION SERVICES

Wafer fabrication is an intricate process that requires many distinct steps. Each step in the manufacturing process must be completed with extreme accuracy in order for finished semiconductor devices to work as intended. The processes required to take raw wafers and turn them into finished semiconductor devices are accomplished through a series of steps that can be summarized as follows:

Pre-fabrication services

Circuit Design. Producing a semiconductor device involves designing the layout of its components and designating the interconnections between each component. The result is a pattern of components and connections that defines the function of the semiconductor device. In highly complex circuits, there may be more than 40 layers of electronic patterns.

We do not design semiconductor devices for our customers. If requested, we assist our customers in the design process by providing them with access to our partners’ EDA tools, design libraries and intellectual property and design services which are proven and have been qualified for our manufacturing processes. Our field engineers assist our customers during the development process to ensure that their designs can be successfully manufactured in volume.

Mask Making. The design for each layer of a semiconductor wafer is imprinted on a photographic negative, called a mask. The mask is the blueprint for each specific layer of the semiconductor wafer. We do not manufacture masks for our customers but provide a service through third party mask shops.

Wafer fabrication

Wafer Manufacturing. Transistors and other circuit elements comprising a semiconductor device are formed by repeating a series of processes in which a photosensitive material is deposited on the wafer and exposed to light through a mask. The unwanted material is then etched away, leaving only the desired circuit pattern on the wafer. This process is repeated for each mask layer. The final step in the wafer fabrication process is to visually and electronically inspect each individual semiconductor device, known as wafer probe, in order to identify the operable semiconductor devices for assembly.

We manufacture semiconductors using CMOS and BiCMOS processes. CMOS is the most widely used process technology because it requires lower power than other technologies and allows dense placement of components onto a single semiconductor device. The low power consumption and high-density characteristics of the CMOS process allow the continued development of high performance semiconductor devices that are smaller and faster. BiCMOS process technology combines bipolar’s attribute of high speed with the high density and low power consumption of CMOS. We use CMOS or a combination of CMOS and BiCMOS for the fabrication of logic, mixed-signal and memory semiconductor wafers.

31


Table of Contents

We manufacture a variety of semiconductor wafers for a full range of end market applications including communication, computing, and consumer electronics. Examples of the types of semiconductors we manufacture are as follows:

Logic. All digital electronic systems, such as computing devices, are controlled by logic semiconductor devices, which process data. Microcontrollers, microprocessors, digital signal processors, and graphics chipsets are all logic devices. We manufacture logic semiconductor wafers primarily for the computing, consumer and communications markets.

Mixed-Signal. Mixed-signal semiconductor devices combine analog and digital devices on a single semiconductor device to process both analog signals and digital data. Mixed-signal semiconductor devices are used in applications including wireless equipment, fiber optic communications and data networking. We make mixed-signal semiconductor wafers using both CMOS and BiCMOS processes.

Memory. Memory devices store data and can be manufactured as stand-alone devices or embedded in system semiconductor devices, which combine a number of functions, such as logic and memory components. We manufacture stand-alone memory devices including EPROM, EEPROM, SRAM and Flash memory and embedded memory including eSRAM, eEEPROM, and eFLASH (embedded memory that can be erased in a flash) memories. For more information on what these mean, please see “Item 4. Information On Our Company — Business Overview — Manufacturing Facilities”. Memory is used in a range of products from computers and mobile phones to “smart” chip cards.

Wafer Probe. We provide all aspects of the wafer fabrication process except for wafer probe, which, if requested by the customer, is outsourced to a qualified third party. All steps in the wafer manufacturing process are controlled by our computer-integrated manufacturing, or CIM, system. The CIM system allows us to monitor equipment performance, wafer processing steps, and the wafers themselves throughout the fabrication process.

Other services

Assembly and Test. After fabrication and wafer probe, the wafers are transferred to assembly and test facilities. The assembly process protects the semiconductor device, facilitates its integration into electronic systems and enables the dissipation of heat. Following assembly, each semiconductor device’s functionality, voltage, current and timing are tested. After testing, the completed semiconductor device is either shipped to the semiconductor device supplier or directly to its final destination.

Although we are an independent foundry specializing in wafer fabrication, we offer our customers the option to purchase from us finished semiconductor products that have been assembled and tested (turnkey services). When requested by the customer, we outsource assembly and testing of the fabricated semiconductor devices. Alternatively, our customers may directly arrange with assembly and test facilities for these services. Testing includes wafer probe and final testing of assembled semiconductor devices. After final testing, the semiconductor devices are returned to the customer or drop-shipped according to our customers’ specifications.

CUSTOMERS AND MARKETS

We manufactured semiconductors for over 100 different active customers in 2004. Our top five customers in 2004, in order of revenue significance were: Broadcom, Agilent Technologies, MediaTek, Freescale and Agere Systems. Collectively, our top five customers accounted for approximately 52% of our total net revenue in 2004, compared with 41% in the previous year. Broadcom, Agilent Technologies and MediaTek each exceeded 10% of our total net revenue in 2004 compared with 2003 where only Broadcom exceeded 10% of our total revenue.

The following table sets forth our top five customers for 2004 in order of revenue:

     
Customer   Representative Products Or Applications
Broadcom
  LAN switches/routers and ethernet transceivers, cable modem and set-top boxes
Agilent Technologies
  Computer peripherals, mobile phone handsets and networking products
MediaTek
  Optical storage and DVD players/recorders
Freescale
  Wired and wireless communications
Agere Systems
  Mobile phones, computer peripherals and mobile communications infrastructure

32


Table of Contents

We categorize a sale geographically based on the country in which the customer is headquartered. The following table sets forth the geographical distribution of our revenue for the periods indicated:

By Percentage:

                         
    2002     2003     2004  
Americas
    71 %     64 %     68 %
Europe
    8 %     13 %     9 %
Asia-Pacific
    11 %     18 %     20 %
Japan
    10 %     5 %     3 %
 
                 
Total
    100 %     100 %     100 %
 
                 

By $ (in thousands):

                         
    2002     2003     2004  
Americas
  $ 315,660     $ 351,930     $ 631,150  
Europe
    38,643       72,249       85,125  
Asia-Pacific
                       
- Singapore
    2,043       2,862       3,392  
- Others
    48,928       100,071       179,206  
Japan
    43,967       24,799       33,258  
 
                 
Total
  $ 449,241     $ 551,911     $ 932,131  
 
                 

We expect that the majority of our sales will continue to be made to companies headquartered in the U.S. or to overseas affiliates of U.S. companies. All of our sales are direct sales to our customers with delivery in Singapore. We provide customer support in the U.S. through a wholly-owned subsidiary located in Milpitas, California which has an additional office in Austin, Texas. We also maintain customer support offices in Hsin-Chu, Taiwan; Yokohama, Japan; Paris, France; London, United Kingdom; Munich, Germany and Shanghai, China. In 2004, we consolidated some of our U.S. operations within our Austin office, thereby eliminating the need for an office in Boston, Massachusetts.

Our customers generally do not place their purchase orders far in advance. As a result, we do not typically operate with any significant backlog.

We currently allocate a portion of our wafer manufacturing capacity to certain customers under several types of agreements.

CUSTOMER SERVICE

We focus on providing a high level of customer service in order to attract customers and maintain their on-going loyalty. Our culture emphasizes responsiveness to customer needs, flexibility and delivery accuracy. In particular, in the area of flexibility, we work closely with customers to understand their needs and collaborate with them to deliver a solution that is customized to address their requirements. Our customer-oriented and collaborative approach is especially evident in two prime functional areas of customer interaction, customer design development and manufacturing services.

We emphasize very close interaction with customers throughout the design development and prototyping process. We provide for an account manager to be assigned early in the design development process who coordinates an account team composed of marketing, EDA, silicon engineering, third-party partner and customer service/logistical support. The account team is supported by additional marketing and customer engineering staff in Singapore.

After the design moves into manufacturing production, on-going customer support is provided through all phases of the manufacturing process. The account manager teams with a dedicated customer service representative, along with marketing and customer engineering support teams at the factory.

Our customers continue to have secure, on-line access to design and manufacturing information at Chartered via our recently upgraded Chartered On-Line Access System (COLAS). We are aware that e-Business is a journey

33


Table of Contents

and we are continuing to progress further on our path to provide our customers with increasing visibility into the supply chain. As a first step, we have implemented B2B connectivity with all our test and assembly and mask shop partners, which provides us with critical information from our partners near real time. Even more importantly, our customers are also able to access the same information received from our test and assembly and mask shop partners via the COLAS system. We plan to continue to enhance integration and transparency for our customers.

RESEARCH AND DEVELOPMENT

The semiconductor industry is characterized by rapid and relentless technical advances. We believe effective research and development is essential to our success, as that research and development spawns the leading-edge technologies that are critical to attracting and retaining customers who design highly sophisticated semiconductors. In 2002 and 2003, we invested $95.3 million and $124.1 million, respectively, in research and development. Those investments represented 21.2% and 22.5% of our net revenue for the respective periods. In 2004, our research and development expenses, including our share of expenses related to the IBM joint-development agreement, were $118.3 million, or 12.7% of our net revenue for the year. As of December 31, 2004, we employed 280 professionals in our research and development department, 49 of whom have PhDs.

Our investment in research and development allows us to continue developing new and advanced processes down to the 45nm technology node. The research and development programs are structured to ensure that our baseline manufacturing processes accommodate new technology modules that are the heart of highly differentiated system-level applications.

Periodically, we update our technology roadmap based on industry trends, expected customer adoption of the technology and our internal development plans.

In August 2003, we extended the IBM joint development agreement to include Infineon and in March 2004, we further extended the joint development agreement with IBM and Infineon to include Samsung. The March 2004 agreement replaces and is in substitution of the joint development agreement with IBM and Infineon. Under the March 2004 agreement, IBM, Infineon, Samsung and Chartered are jointly developing a common advanced foundry manufacturing process technology at 65nm, as well as variants tuned for high performance and low power (See “Item 19. Exhibits — Exhibit 4.42”). Additionally, the parties may explore an extension to the March 2004 agreement to include 45nm technology.

In December 2004, we expanded our joint development efforts with IBM under our joint development agreement entered into with IBM in November 2002 to include 45nm bulk CMOS process technology. The IBM joint development agreement is designed to provide customers with greater access to leading-edge semiconductor technologies and sourcing flexibility. The development of both 65nm and 45nm are being carried out at IBM’s facilities in East Fishkill.

We have received research grants from various agencies of the Government of Singapore. These grants provide funding for a portion of our research and development related capital expenditures, for the training and staffing costs associated with some of our process technology development programs. $19.0 million of such grants were disbursed to us in 2004. The grants are disbursed based on the amount of expenditures incurred and achievement of program milestones. The main conditions attached to the grants are the completion of the project to which the grant relates and the certification of the qualifying costs incurred.

EQUIPMENT AND MATERIALS

We depend on a limited number of manufacturers that make and sell the complex equipment that we use in our manufacturing processes. The principal pieces of equipment we use to manufacture semiconductors are scanners, steppers, tracks, etchers, furnaces, wet stations, implanters, sputterers, chemical vapor deposition, chemical mechanical planarization equipment, and metrology equipment. In periods of high market demand, the lead times from order to delivery and complete qualification of some of such equipment can extend beyond 15 months. We seek to manage this process through early reservation of appropriate delivery slots and constant communication with our suppliers.

34


Table of Contents

Our manufacturing processes use highly specialized materials, including semiconductor wafers (including SOI wafers), chemicals, gases, targets, quartz, equipment spare parts and consumables and masks. We depend on our vendors of these materials and seek to have more than one vendor for our material requirements. To maintain competitive manufacturing operations, we must obtain from our vendors, in a timely manner, sufficient quantities of quality materials at acceptable prices. We source most of our materials, including critical items such as semiconductor wafers, from a limited group of vendors. We purchase most of our key materials on a blanket purchase order basis. We typically do not have long term contracts with our vendors. For those materials that are wholly procured from one source, we continuously look to identify and qualify alternative sources of supply. We have agreements with key material vendors under which they hold inventory on consignment for us. We are not under any obligation to purchase inventory that is held on consignment until we actually use it. We typically work with our suppliers to forecast our raw material requirements up to six months in advance.

INTELLECTUAL PROPERTY

Our success depends in part on our ability to obtain patents, licenses and other intellectual property rights covering our production processes. To that end, we have acquired certain patents and patent licenses and intend to continue to seek patents on our production processes.

As of December 31, 2004, we had filed an aggregate of 1,927 patent applications worldwide, (982 of which had been filed in the U.S.) and held an aggregate of 1,068 issued patents worldwide (696 of which are issued U.S. patents). Of the 982 aggregate applications filed in the U.S., 696 had been issued as of December 31, 2004 and 17 had been allowed but not issued. Those 17 allowed patents will be issued if and when we pay the applicable issuance fee. (Note: References to aggregate figures include not only the figures for the year itself but figures for previous years as well. Accordingly, if an aggregate of 1,927 patent applications have been filed as of December 31, 2004, these include not only the patent applications filed in 2004 but all patent applications previously filed by the company.)

The number of patents filed by us in 2003 and 2004 were 199 and 90 respectively and the number of patents issued to us in 2003 and 2004 were 133 and 198 respectively.

Our issued patents have expiration dates ranging from 2011 to 2023. All of the allowed and pending patents will expire after 2024. We have also entered into various patent licenses and cross-licenses with major semiconductor companies. We may choose to renew our present licenses or to obtain additional technology licenses in the future. There can be no assurance that any such licenses could be obtained on commercially reasonable terms.

Our ability to compete also depends on our ability to operate without infringing the proprietary rights of others. The semiconductor industry is generally characterized by frequent litigation regarding patent and other intellectual property rights. We have from time to time received communications from third parties asserting patents that cover certain of our technologies and alleging infringement of certain intellectual property rights of others. We expect that we will receive similar communications in the future. Irrespective of the validity or the successful assertion of such claims, we could incur significant costs and devote significant management resources to the defense of these claims which could seriously harm our company. There is no such material litigation currently pending against us. Additionally, we market services in several countries in Asia which may not protect our intellectual property rights to the same extent as the U.S.

COMPETITION

The worldwide semiconductor foundry industry is highly competitive. Our principal competitors are TSMC, UMC and SMIC. Our competitors may have greater access to capital and substantially greater production, research and development, marketing and other resources than we do. As a result, these companies may be able to compete more aggressively over a longer period of time than we can. In addition, several new dedicated foundries have entered the semiconductor industry, arising from new foundries being established in China and Malaysia. These new foundries have commenced operations and compete directly with us. Any significant increase in competition may erode our profit margins and weaken our earnings.

A number of semiconductor manufacturers, including our primary competitors, are setting up fabrication facilities, including 300-mm wafers fabrication facilities, in Singapore and other parts of the world and to increase their manufacturing capacity. As a result, we expect that there will be a significant increase in worldwide semiconductor

35


Table of Contents

capacity during the next few years. If growth in demand for this capacity fails to match the growth in supply or occurs more slowly than anticipated, there may be more intense competition and pressure on the pricing of our services may result.

The principal elements of competition in the wafer foundry market include technical competence, time-to-market, research and development, quality, available capacity, device yields, customer service, price, design services, access to intellectual property and EDA tool support.

ENVIRONMENTAL MATTERS AND COMPLIANCE

We have implemented an extensive environmental management system. This system is third party certified through an internationally recognized ISO 14001 certifying body. This system enables our operations to identify applicable environmental regulations and assist in evaluating compliance status. Programs are established at manufacturing locations to ensure that all accidental spills and discharges are properly addressed.

We are subject to a variety of laws and governmental regulations in Singapore relating to the use, discharge and disposal of toxic or otherwise hazardous materials used in our production process. While we believe that we are currently in compliance in all material respects with such laws and regulations and have management systems in place to continue to be in compliance, if we fail to use, discharge or dispose of hazardous materials appropriately, we could subject our company to substantial liability or could be required to suspend or adversely modify our manufacturing operations. In addition, we could be liable for remedial measures if our properties were found to be contaminated even if we were not responsible for such contamination.

INSURANCE

We maintain industrial all risk insurance for our facilities, equipment and inventories. The insurance for fabs (including our strategic alliance fabs) and their equipment covers physical damage and consequential losses from natural disaster, business interruption and certain other risks up to their respective policy limits except for exclusions as defined in the policy. We also maintain public liability insurance for losses to others arising from our business operations and carry insurance for business interruption resulting from such events. In addition, we also maintain product liability insurance for damages sustained by others for bodily injury or property damage caused by our product(s) except for exclusions as defined in the policy. Our insurance policies also cover public liability and actions by our employees. Some of our insurance coverage for SMP is under Agere’s global group insurance policies.

In addition, we also have various insurance policies in place which cover our employees with the exception that prior to December 31, 2004, some of our key employees were covered under insurance policies held by Singapore Technologies through its group insurance policy. We paid our pro rata share of the costs of such Singapore Technologies group insurance policies. Some of our insurance coverage were provided through affiliates of Singapore Technologies. Some of our insurance coverage for SMP is under Agere’s global group insurance program. With the ST Restructuring, we are now covering our key employees under our company’s own group insurance.

While we believe that our insurance coverage is adequate, significant damage to any of our production facilities, whether as a result of fire or other causes, could seriously harm our company. We do not insure against the loss of key personnel.

C.   ORGANIZATIONAL STRUCTURE

Prior to December 31, 2004, Chartered was part of the Singapore Technologies group of companies. As of December 31, 2004, Chartered is part of the Temasek group of companies. A description of the group and Chartered’s position within the group may be found at “Item 7. Major Shareholders and Related Party Transactions — Related Party Transactions — The Singapore Technologies Group”.

36


Table of Contents

Currently, Chartered has 5 subsidiaries, the particulars of which are as follows:

             
    Country of   Date of   Proportion of
Name of Subsidiary   Incorporation   Incorporation   Ownership Interest
Chartered Silicon Partners Pte Ltd
  Singapore   March 1997   51%
Chartered Semiconductor Manufacturing, Inc.
  U.S.   June 1991   100%
Chartered Semiconductor Japan Kabushiki Kaisha
  Japan   October 2000   100%
Chartered Semiconductor Taiwan Ltd
  Taiwan   August 2000   100%
Chartered Semiconductor Europe Ltd
  England and Wales   March 2001   100%

D.   PROPERTY, PLANT AND EQUIPMENT
 
(a)   Leases

All of our fabrication facilities and our corporate offices are located in Singapore. Our company had previously operated Fab 1, which ceased operations at the end of March 2004, on land leased from Ascendas Land (Singapore) Pte Ltd, or Ascendas, a private company wholly-owned by Jurong Town Corporation, or JTC, a statutory board established by the Government of Singapore to develop and manage industrial estates in Singapore. The lease runs until 2017 with a conditional option to extend for another 30 years. Following the cessation of our Fab 1 operations, we are evaluating our options with regards to the future of the lease of Fab 1.

Fabs 2 and 3 and our corporate offices are located on land which we leased from Singapore Technologies, which in turn leased the land from JTC. Pursuant to the ST Restructuring, Singapore Technologies’ rights, title, interest and obligations under the sub-leases have been transferred to Terra Investments Pte. Ltd., or Terra, a wholly owned subsidiary of Temasek. These leases run until 2024 with conditional options to extend for another 30 years. The sub-leases for Fab 2 and Fab 3 require us to make rental payments to Terra at rates equal to the rent paid by Terra to JTC for the subject land through 2006 for Fab 2 and 2024 for Fab 3. The rental rates may be re-negotiated thereafter. The sub-leases are registered with the Singapore Land Authority (see “Item 19. Exhibits — Exhibit 4.45 and Exhibit 4.47”).

CSP leased the land on which Fab 6 is located from Singapore Technologies, which in turn leased it from JTC. Pursuant to the ST Restructuring, Singapore Technologies’ rights, title, interest and obligations under the sub-leases have been transferred to Terra (see “Item 19. Exhibits — Exhibit 4.50”). The lease runs until 2027 with a conditional option to extend for an additional 30 years. CSP is required to make rental payments to Terra at rates equal to the rent paid by Singapore Technologies to JTC for the subject land through 2027.

Fab 7 is located on land leased to Singapore Technologies by JTC. The lease runs until 2030 with a conditional option to extend for an additional 30 years. Pursuant to the ST Restructuring, Singapore Technologies’ rights, title, interest and obligations under the Agreement for Sub-Licence and Sub-Lease have been transferred to Terra (see “Item 19. Exhibits — Exhibit 4.53”). We have obtained the Temporary Occupation Permit for Fab 7 from the Building and Construction Authority and we will be entering into a sub-lease with Terra for the land for a term of 30 years less 1 day with rental payments equal to the rent paid by Terra to JTC.

(b)   Production Capacity & Utilization

For information on our wafer capacity for each of our fabs and the fab of our equity-method joint venture company, SMP, please see “Item 4. Information On Our Company — Business Overview — Manufacturing Facilities.”

The following table reflects our capacity utilization in our fabs, including our share of SMP.

Utilization Table

Data including Chartered’s share of SMP

                                         
Thousand 8" equivalent wafers   4Q 2003     1Q 2004     2Q 2004     3Q 2004     4Q 2004  
Total wafers shipped
    235.0       268.4       279.2       287.1       200.8  
Total capacity
    332.8       331.8       308.0       322.5       327.0  
Utilization
    71 %     81 %     90 %     89 %     61 %

37


Table of Contents

Capacity by Fab

                                                 
Thousand 8" equivalent wafers   4Q 2003     1Q 2004     2Q 2004     3Q 2004     4Q 2004     Est 1Q 2005  
Fab 1*
    45.5       45.2                          
Fab 2
    131.2       129.8       129.8       131.2       131.8       130.6  
Fab 3
    60.2       61.6       64.4       73.0       73.0       71.4  
Fab 5 (Chartered’s share)
    34.4       34.4       36.3       37.2       37.0       34.5  
Fab 6
    61.5       60.8       77.5       81.1       85.2       80.5  
 
                                   
Total
    332.8       331.8       308.0       322.5       327.0       317.0  
 
                                   

*   Fab 1 ceased operations as of March 31, 2004

(c)   Fab 7

We are taking a phased approach to the equipping of Fab 7 to the full planned capacity of 30,000 300-mm wafers per month capacity, and this is expected to take a number of years and will be paced by customer demand and industry conditions. We expect the total cost of phase 1, in order to equip Fab 7 with a capacity of 15,000 300-mm wafers per month, to be approximately $1.7 billion. At completion, the total investment of Fab 7 is expected to be approximately $2.7 billion to $3 billion. As of December 31, 2004, we have spent $637.9 million on the equipping of Fab 7 as part of its phase 1 ramp. We expect our aggregate capital expenditures in 2005 to be approximately $750 million, of which 85% is expected to be for equipping Fab 7 to 9,000 300-mm wafers per month capacity by end 2005 (which is part of our Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity). Fab 7 is scheduled to begin commercial production in mid-2005.

(d)   Total Wafer Capacity for Year 2005

We expect a wafer capacity of approximately 140 thousand wafers (eight-inch equivalent) per month by end 2005, an increase of approximately 27% from capacity level at end 2004. For the same period, advanced capacity (0.13um and smaller process geometry technologies) is planned to increase and represent approximately 33% of the total expected wafer capacity.

ITEM 5.   OPERATING AND FINANCIAL REVIEW AND PROSPECTS

The following discussion of our financial condition and results of operations should be read in conjunction with the consolidated financial statements and the related notes included elsewhere in this document. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause future results to differ significantly from those projected in the forward-looking statements include, but are not limited to, those discussed below and elsewhere in this document particularly in the cautionary risk factors described in “Item 3. Key Information — Risk Factors” above.

INDUSTRY OVERVIEW

According to the Semiconductor Industry Association (SIA), the compound annual growth rate for the worldwide semiconductor industry is expected to be 11% to 12% during the period from 2004 to 2007. However, the semiconductor industry is highly cyclical. For example, according to the SIA, the worldwide semiconductor industry contracted by approximately 32% from 2000 to 2001, then grew by approximately 18% from 2002 to 2003 and by approximately 28% sequentially in 2004. Fabs can take several years to plan, construct and begin operations. Therefore, during periods of favorable market conditions, semiconductor manufacturers, which include dedicated foundry service providers, often begin building new fabs in response to anticipated demand growth for semiconductors. As these new fabs commence operations, a significant amount of manufacturing capacity is made available to the semiconductor market resulting from the steep initial ramp-up of these fabs. In the absence of growth in demand, or if growth occurs more slowly than anticipated, this sudden increase in supply results in semiconductor manufacturing over-capacity, which can lead to sharp drops in utilization of semiconductor fabs and put pressure on prices.

Semiconductor manufacturing is very capital intensive in nature. For example, in 2000 and 2001, we incurred $963.8 million and $489.6 million in capital expenditures, respectively. Even in the midst of challenging economic conditions in 2002, we invested $419.5 million in capital expenditures, primarily in equipping Fab 6 and for the purchase of equipment for research and development use, as part of our continuing strategy of positioning ourselves to serve market needs. We invested $220.8 million in capital expenditures in 2003, focused primarily on leading-edge technologies. In 2004, we invested $686.3 million in capital expenditures, primarily in equipping Fab

38


Table of Contents

7 as part of its phase 1 ramp to 15,000 300-mm wafers per month capacity, with the balance mainly for capacity additions at leading-edge technologies in Fab 6. A high percentage of the cost of operating a fab is fixed, therefore increases or decreases in capacity utilization rates can have a significant effect on profitability. The unit cost of a wafer generally decreases as fixed overhead charges, such as depreciation expense on the facility and semiconductor manufacturing equipment, are allocated over a larger number of units produced.

As the price of wafers varies significantly, the mix of wafers produced affects revenue and profitability. The value of a wafer is determined by the complexity of the device on the wafer. Production of devices with higher-level functionality and greater system-level integration requires more manufacturing steps and commands higher wafer prices. However, increasing the complexity of devices that we manufacture does not necessarily lead to increased profitability, because the higher wafer prices for such devices may be offset by depreciation and other costs associated with an increase in the capital expenditures needed to manufacture such devices. The prices for wafers of a given level of technology and device complexity will decline over the product life cycle and foundries must continue to migrate to increasingly sophisticated technologies to maintain the same level of profitability. This requires continuous capital investment and depends on other factors, as discussed in the risk factors, “We Need to Continuously Improve Our Device Yields, Maintain High Capacity Utilization and Optimize the Technology Mix of Our Semiconductor Wafer Production” and “We May Not Be Able To Compete Successfully In Our Industry” and elsewhere in this document.

Our capacity was at maximum utilization from the second quarter of 1999 through the third quarter of 2000. During this period of capacity utilization, our gross profits and net income showed progressive improvement as better economies of scale and operating leverage took effect on the back of rising demand. In the fourth quarter of 2000, the semiconductor market turned down and our utilization rate declined. The industry contraction in 2001 was the most severe in its history and largely as a result of this, our average utilization rate in 2001 and 2002 was 35% and 37%, respectively. Because of this, we suffered significant net losses in 2001 and in 2002. As the semiconductor industry recovered, our average capacity utilization improved to 58% in 2003. Primarily driven by sequential growth in shipments during the first two quarters of the year, our average capacity utilization increased further to 80% in 2004. Correspondingly, our net loss in 2003 decreased significantly, and we reported a net income in 2004. The average capacity utilization, based on 8” equivalent wafers, from 2000 to 2004 is as follows:

                                         
    2000     2001     2002     2003     2004*  
Utilization
  100%   35%   37%   58%   80%

*   Fab 1 ceased operations at the end of March 2004

2004 OVERVIEW

The semiconductor industry recovery, which began in late 2002, accelerated in the second half of 2003 into the first half of 2004. In line with this, we reported sequential revenue growth of 25.0% and 12.0% respectively in first and second quarters of 2004. However we started seeing market weakness from the second half of June 2004 due to excess inventories in the semiconductor companies and the softening in certain end markets. This resulted in a sequentially flat third quarter followed by a sequential decline of 25.9% in net revenue in fourth quarter of 2004. The weakness was concentrated in our 0.18um and 0.25um capacity, which is mainly in Fab 3, primarily due to customer concentration in these technologies. Due to the same reason, our equity in income of SMP went down from $21.9 million in first half of 2004 to $5.7 million in second half of 2004. We were unable to diversify the customer base during preceding quarters of high demand, since a significant amount of our 0.18um and 0.25um capacity was utilized by our top customers. For second half of 2004, utilization of our combined 0.18um and 0.25um capacity was lower than the company average of 75%.

Despite a weaker second half of 2004, we registered year-over-year revenue growth of 68.9% in 2004. The revenue growth in 2004 reflects a favorable market environment in the first half of 2004 and also the progress we have made in the execution of our strategy announced in February 2003. In 2004, we increased 0.13um revenue by 263.0% from $48.7 million in 2003 to $176.9 million in 2004, accounting for 33.5% of the dollar revenue growth.

During the year, we continued with our efforts to promote market acceptance of the Chartered-IBM leading-edge cross-foundry technology platform and expand our network of third party intellectual property and design service providers. In addition, Samsung joined the technology development partnership with IBM, Chartered and Infineon at the 65nm node, reinforcing the merits of such technology platform.

39


Table of Contents

In 2004, we announced two sourcing agreements, which we believe reflect the growing confidence in our leading-edge capabilities and unique foundry position. IBM awarded a sourcing agreement under which we will manufacture selected 90nm SOI (silicon on insulator) products for IBM in volume-driven, high performance solutions beginning in mid-2005. We also entered into sourcing and manufacturing technology agreements with Advanced Micro Devices, Inc., or AMD, under which we will manufacture AMD64 microprocessors commencing in 2006.

After securing our first 90nm volume customer, we began equipment move-in at Fab 7, our first 300-mm fab, at the end of March 2004. Fab 7 moved into pilot production at the end of 2004 and is scheduled for commercial production in mid-2005.

In support of capacity ramp of Fab 7, we are implementing PDF Solutions’ Characterization Vehicle Infrastructure to improve the robustness of our leading-edge processes in Fab 7. In addition, we will be integrating portions of AMD’s Automated Precision Manufacturing (APM) into our automation and yield management systems in Fab 7. These technologies and methodologies should help to improve yield at a faster pace during the capacity ramp up in Fab 7.

We secured financing during 2004 to support Fab 7’s phase 1 ramp to 15,000 300-mm wafers per month capacity. This included a $653 million term loan facility from JPMorgan Chase Bank, N.A., or JP Morgan, guaranteed by the Export-Import Bank of the United States, a $200 million term loan facility (with the option to increase the facility by $100 million) from Sumitomo Mitsui Banking Corporation and Oversea-Chinese Banking Corporation, a $50 million term loan facility from Bank of America, and a $150 million revolving credit facility from Sumitomo Mitsui Banking Corporation.

BUSINESS OUTLOOK

As we enter 2005, there is still some level of uncertainty in the market regarding inventory levels and the timing of industry recovery. Though it is difficult to predict the exact timing, based on our customer feedback, we expect to see the trough of the cycle within a couple of quarters. We expect 0.13um, 0.11um and 90nm technologies to be a large contributor to our revenue in 2005,as we ramp up production in these technology nodes.

As the industry continues to work through the excess inventory coupled with the usual seasonal slowness in the first quarter, our first quarter of 2005 revenue is expected to be down approximately 2% to 6% from the fourth quarter of 2004. In the first quarter of 2005, we see weakness in the communications and computer sectors, partially offset by strength in the consumer sector. The momentum in advanced technology shipments is expected to continue and 0.13um and smaller process geometry technologies revenue are expected to grow 15% sequentially and represent slightly over 30% of our revenue in the first quarter of 2005.

On our mature technologies, we expect utilization in 0.35um and above technologies to be higher than 0.25um and 0.18um technologies in the coming quarters, due to the better customer line-up and product diversity in Fab 2. We plan to continue to diversify our customer and product exposure in our 0.18um and 0.25um technologies base by offering value-added solutions like One Time Programmable memory, embedded flash memory, High Voltage and Radio Frequency technologies for growing markets such as display, power management and micro-controller applications.

Our capacity was approximately 109 thousand 200-mm wafers per month in the fourth quarter 2004. Our plan is to ramp Fab 7 to 9,000 300-mm wafers per month capacity by end 2005, which is part of our Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity. Accordingly, we estimate our wafer capacity to be approximately 140 thousand 200-mm wafers per month by end 2005, an increase of approximately 27% from capacity level at end 2004. For the same period, advanced capacity (0.13um and smaller process geometry technologies) is planned to increase and represent approximately 33% of the total expected wafer capacity.

We recorded a net income of $6.6 million for 2004, after three consecutive years of net losses. For sustained profitability, we plan to bring down our breakeven point to 75% utilization, which is approximately 10 percentage points below our current level, by the end of 2005. As part of our cost structure, this will require that we ramp Fab 7 to a breakeven position at 9,000 300-mm wafers per month capacity by end 2005.

40


Table of Contents

CRITICAL ACCOUNTING POLICIES

The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenue and expenses during the reporting period. Estimates are based on historical experience, current conditions and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates. We believe the following critical accounting policies require us to make significant judgments and estimates in the preparation of our consolidated financial statements:

Depreciation and amortization of long-lived assets

Our results of operations are generally affected by the capital-intensive nature of our business. A large proportion of our cost of revenue is fixed in nature. The major component of our fixed costs included in our cost of revenue relates to depreciation on property, plant and equipment, and amortization of technology license arrangements.

We depreciate wafer fab buildings over 20 years, mechanical and electrical installations in the fabs over 10 years, and equipment and machinery over 5 years using the straight-line method. We amortize technology licenses over the shorter of the license period or the estimated useful life of the license, which on weighted average is over 7 years using the straight-line method. These lives represent our estimate of the periods that we expect to derive economic benefits from the assets. In estimating these useful lives and recoverable salvage values of our property, plant and equipment and technology licenses and in determining whether subsequent revisions to the useful lives and salvage values are necessary, we consider the likelihood of technological obsolescence arising from changes in production techniques, technology, market demand and intended use. We routinely review the remaining estimated useful lives and salvage values of our property, plant and equipment and our technology licenses to determine if such lives and values should be adjusted. There have been no significant changes to our estimates of useful lives or salvage values during any of the last 3 years. However, actual useful lives may be shorter or longer than our estimates. If we had used different estimates of useful lives of our long-lived assets, our results might have been materially different.

Recoverability of long-lived assets

We also routinely review our long-lived assets that are held for disposal for impairment in comparison to their fair values, and we review assets that are held and used, including technology licenses, for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We perform impairment tests for groups of assets related to the lowest level of identifiable independent cash flows. In determining the appropriate asset groupings, we must make subjective judgments in identifying the independent cash flows that can be related to each asset group considering our foundry model and the degree of interchangeability of the various components of our manufacturing capacity. We consider the degree to which the asset group’s revenue depend on the revenue-producing activities of one or more other asset groups and the availability of financial information on such asset groups. In some cases, it is not practical to identify the cash flows associated with a particular asset or group of assets due to the integrated nature of our production process and the multi-technology capability of our process equipment. The result of our analysis is that we have identified the lowest level of identifiable independent cash flows as our individual fabs.

The determination of recoverability is based on an estimate of undiscounted cash flows expected to result from the use of the asset group and its eventual disposition. The estimate of cash flows is based upon, among other things, certain assumptions about expected future operating performance, ASP, utilization rates and other factors. If the sum of the undiscounted cash flows (excluding interest) is less than the carrying value, an impairment charge is recognized for the amount that the carrying value of the asset exceeds its fair value, based on the best information available, including discounted cash flow analysis. However, due to the cyclical nature of our industry and changes in our business strategy, market requirements, or the needs of our customers, we may not always be in a position to accurately anticipate declines in the utility of our equipment or licenses until they occur.

We recorded equipment impairment charges in 2002 of $4.8 million resulting from a decision to abandon certain production processes, and again in 2003 and 2004 of $9.0 million and $1.0 million, respectively, resulting from decisions to rationalize capacity and therefore to sell certain equipment.

41


Table of Contents

However, if we made different estimates of our future cash flows or fair values of our assets held for sale then we might have reached different conclusions regarding impairments, and therefore our results might have been materially different.

Valuation of inventory

Our inventories primarily consist of work in progress and are stated at the lower of standard cost, which approximates actual costs determined on the weighted average basis, or market (net realizable value).

Cost. We determine the cost of each wafer based on estimates of the materials, labor, and other costs incurred in each process step associated with the manufacture of our products. We allocate labor and overhead costs to each step in the wafer production process based on normal fab capacity utilization, with un-recovered costs arising from abnormal underutilization of capacity expensed when incurred. The unit cost of a wafer generally decreases as fixed overhead charges are allocated over a larger number of units produced. Conversely, during periods of low utilization of capacity, the unit cost of a wafer would generally increase.

Net realizable value. We routinely review our inventories for their saleability and for indications of obsolescence to determine if inventories should be recorded at net realizable value. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make a sale. In estimating the net realizable value of our inventories, we consider the likelihood of changes in market demand for our inventories. Judgments and estimates regarding future selling prices and level of demand must be made and used in connection with evaluating whether such write-downs are needed and in what amount in any accounting period.

As of December 31, 2003 and December 31, 2004, we carried an inventory reserve of $28.4 million and $30.2 million, respectively, to write-down certain inventory to net realizable value. Subsequent to these write-downs, we sold or disposed of certain portions of such inventories. The amounts ultimately realized for the years ended December 31, 2003 and 2004 were at or near to the net realizable value we had estimated, resulting in no significant additional impact to our gross margins in each of those years.

If we made different estimates of normal and abnormal capacity utilization, allocation of costs to different process steps, future demand for existing inventory, or inventory selling prices, we might have reached different conclusions regarding inventory values, and therefore our results might have been materially different.

Revenue recognition

We derive revenue primarily from fabricating semiconductor wafers, and to a lesser extent, for certain arrangements, from providing associated subcontracted assembly and test services as well as pre-fabrication services such as engineering services.

When our arrangements include multiple elements, we divide the deliverables into separate units of accounting using certain specified criteria. From July 1, 2003 onwards, we adopted the methodology in FASB Emerging Issues Task Force Issue 00-21, “Revenue Arrangements with Multiple Deliverables” (“EITF 00-21”). A typical arrangement includes pre-fabrication services such as engineering services, fabricating semiconductor wafers, and providing associated assembly and test services. The total consideration is allocated to each component of the multiple-element arrangement based on fair values.

Revenue for each unit of accounting is recognized when the contractual obligations have been performed and, where applicable, delivery has occurred and title and risk of loss has passed to the customer, there is evidence of a final understanding between us and our customers as to the specific terms of the agreed upon sales, selling prices to the customers are fixed or determinable and collection of the sales revenue is reasonably assured. Generally this results in revenue recognition upon shipment of wafers. Our revenue per wafer is generally dependent upon the wafer yield. Revenue represents the invoiced value of goods and services supplied, excluding goods and services tax, less allowances for estimated sales returns. If we made different judgments and estimates regarding the components of our multiple-element arrangements or their fair values our results might have been materially different.

42


Table of Contents

Other arrangements include sale of equipment and licensing of intellectual property. In allocating the total arrangement consideration between equipment and licensing of intellectual property, we use the residual method based on the fair value of equipment sold. The estimate of fair value of equipment is based on the resale prices of similar equipment sold on the used equipment market. However, if we made different estimates of fair value of equipment, the allocation of income between gain on asset sales and income from intellectual property sales might have been materially different.

We also receive income-related grants to subsidize training and research and development expenses. Income is recognized on these grants when we believe it is probable that expenditures already incurred will constitute qualifying expenditures for purposes of reimbursement under the grants that have been awarded. If we made different estimates of the amount or timing of qualifying expenditures our results might have been materially different.

Sales returns allowances

The process technology for the manufacture of semiconductor wafers is highly complex. The presence of contaminants, difficulties in the production process, disruption in the supply of utilities or defects in key materials and tools can all cause reductions in device yields and increase the risk of sales returns. We make estimates of wafer yield and potential sales returns related to current period product revenue. We provide for such returns and costs based upon historical experience and our estimate of the level of future claims. Additionally, we accrue for specific items at the time their existence is known and the amounts are estimable. We have charged $10.9 million, $5.9 million, and $4.8 million to results of our operations for sales returns for 2002, 2003, and 2004, respectively. Sales returns as a percentage of net revenue may fluctuate from year to year and not necessarily follow the net revenue trend due to specific claims in any particular period related to certain new processes and variations in wafer yield. We typically experience lower sales returns as the manufacturing processes mature and higher sales returns on new processes. Our actual sales returns have not historically been significantly different from our estimates, and our method of estimating sales returns and the significant assumptions used have been consistently determined over the past three years.

Significant management judgments and estimates must be made and used in connection with determining revenue per wafer and in establishing the sales return allowances in any accounting period. However, had we made different estimates of wafer yield or future sales returns our results might have been materially different.

Collectibility of accounts receivable

Similarly, we must make estimates of the collectibility of our accounts receivable. We believe that we adequately manage our credit risk through our credit evaluation process, credit policies, and credit control and collection procedures. We review our accounts receivable on a periodic basis and make specific allowances when there is doubt as to the collectibility of individual receivable balances. In evaluating the collectibility of individual receivable balances we consider the age of the balance, the customer’s historical payment history, their current credit-worthiness and current economic trends. However, if we made different estimates of collectibility of individual receivable balances our results might have been materially different. Movements in the allowance for doubtful accounts are as follows:

                         
    2002     2003     2004  
Beginning
  $ 4,036     $ 2,460     $ 1,083  
Utilized in year
    (1,078 )     (1,022 )     (38 )
Charge for the year
    478       351       1,106  
Reversal of specific allowances due to collection
    (976 )     (706 )     (973 )
Ending
  $ 2,460     $ 1,083     $ 1,178  
 
                 

43


Table of Contents

RESULTS OF OPERATIONS

The following table sets forth certain operating data as a percentage of net revenue for the periods indicated:

                         
    Years ended December 31,  
    2002     2003     2004  
Net revenue
    100.0 %     100.0 %     100.0 %
Cost of revenue
    140.0       117.5       82.5  
 
                 
Gross profit (loss)
    (40.0 )     (17.5 )     17.5  
 
                 
 
                       
Operating expenses:
                       
Research and development
    21.2       22.5       12.7  
Fab start-up costs
    1.9       1.7       3.6  
Sales and marketing
    9.2       7.0       4.0  
General and administrative
    9.6       7.4       3.8  
Other operating expenses (income), net
    2.2       (2.0 )     (1.1 )
 
                 
Total operating expenses
    44.1       36.6       23.0  
 
                 
Operating loss
    (84.1 )     (54.1 )     (5.5 )
Other income (expense):
                       
Equity in income (loss) of SMP
    (18.9 )     4.2       3.0  
Other income
    5.4       4.3       5.6  
Interest income
    3.7       2.2       1.2  
Interest expense
    (9.3 )     (7.7 )     (3.2 )
Exchange gain (loss), net
    (0.4 )     (0.1 )     0.1  
 
                 
Income (loss) before income taxes and minority interest
    (103.6 )     (51.2 )     1.2  
Income tax expense
    (1.6 )     (2.1 )     (0.5 )
 
                 
Income (loss) before minority interest
    (105.2 )     (53.3 )     0.7  
Minority interest in loss of CSP
    12.4       1.7        
 
                 
Net income (loss) prior to cumulative effect adjustment
    (92.8 )     (51.6 )     0.7  
Cumulative effect adjustment for change in accounting principle
          (1.2 )      
 
                 
Net income (loss)
    (92.8 )%     (52.8 )%     0.7 %
 
                 

The following table sets forth a breakdown of revenue by market sector for the periods indicated:

                         
    Years ended December 31,  
    2002     2003     2004  
Communications
    36 %     46 %     51 %
Computer
    46       33       30  
Consumer
    14       17       15  
Other
    4       4       4  
 
                 
Total
    100 %     100 %     100 %
 
                 

The following table sets forth a breakdown of revenue by geographical region for the periods indicated:

                         
    Years ended December 31,  
    2002     2003     2004  
Americas
    71 %     64 %     68 %
Europe
    8       13       9  
Asia-Pacific
    11       18       20  
Japan
    10       5       3  
 
                 
Total
    100 %     100 %     100 %
 
                 

The following table sets forth a breakdown of revenue by technology (um) for the periods indicated:

                         
    Years ended December 31,  
    2002     2003     2004  
0.13 and below
    0 %     9 %     19 %
Up to 0.18
    26       15       16  
Up to 0.25
    23       21       19  
Up to 0.35
    28       30       29  
Above 0.35
    23       25       17  
 
                 
Total
    100 %     100 %     100 %
 
                 

44


Table of Contents

YEARS ENDED DECEMBER 31, 2003 AND DECEMBER 31, 2004

Net revenue

We derive revenue primarily from fabricating semiconductor wafers, and to a lesser extent, for certain arrangements, from providing associated subcontracted assembly and test services, and pre-fabrication services such as engineering services. The semiconductor industry recovery began to accelerate in the second half of 2003 and continued into the first half of 2004. However, we started seeing market weakness from the second half of June 2004 due to excess inventories in the semiconductor companies and the softening in certain end markets and we experienced a sequential revenue decline of 25.9% in the fourth quarter of 2004. The demand weakness was concentrated in our 0.18um and 0.25um capacity and attributed to five of our larger customers, even though our engagements with these customers are in diverse end markets. Despite a weaker fourth quarter 2004, we registered year-over-year revenue growth of 68.9% in 2004. Net revenue was $932.1 million in 2004, up 68.9% compared to $551.9 million in 2003. This increase was primarily the result of higher demand. Shipments in 2004 were 921.0 thousand wafers, an increase of 52.0% compared to 606.0 thousand wafers in 2003, due to higher demand. ASP increased by 11.1% to $1,012 per wafer from $911 per wafer over the same period, primarily due to richer product and customer mix.

In 2003, the communications sector, which represented 46% of our total revenue, was our highest revenue contributor, followed by the computer sector at 33% of our total revenue. Primarily due to a significant increase in demand from mobile phone handset and LAN switches/routers customers, communications sector revenue increased by 88% between 2003 and 2004. Concurrently, computer sector revenue increased by 50% over the same period mainly due to significant increases in revenue of the optical storage and PC peripherals markets, arising primarily from a significant increase in shipments to these markets. As a result, communications and computer sector revenue represented 51% and 30%, respectively, of our total revenue in 2004.

Net revenue by geographical region increased by 79%, 77%, 34% and 18% in the Americas, Asia Pacific, Japan and Europe regions, respectively, in 2004 as compared to 2003. This was primarily driven by increased shipments to all geographical regions in 2004. The Americas continued to be our largest contributor to revenue, representing 68% of our total revenue in 2004, an increase from 64% of our total revenue in 2003.

Fab 1 ceased operations at the end of March 2004, having successfully transitioned a significant portion of on-going business to Fab 2. Our first quarter 2004 revenue benefited approximately $10 million from end-of-life and safety stock purchases by Fab 1 customers.

Cost of revenue and gross profit (loss)

Cost of revenue includes depreciation expense, amortization of certain technology licenses, attributed overheads, cost of labor and materials as well as subcontracted expenses for assembly and test services. Cost of revenue increased by 18.7% from $648.3 million in 2003 to $769.3 million in 2004 despite a 52.0% increase in volumes. Depreciation continued to be a significant portion of our cost of revenue, comprising of 58.6% and 50.8% of the cost of revenue in 2003 and 2004, respectively.

The unit cost of a wafer generally decreases as fixed overhead charges, such as depreciation expense on the facility and semiconductor manufacturing equipment, are allocated over a larger number of units produced. Cost per wafer shipped decreased by 22.0% from $1,070 in 2003 to $835 in 2004 due to higher volumes and to a lesser extent, cost savings and avoidance from our cost reduction programs. In 2003, as a percentage of net revenue, we recorded a gross loss of 17.5% of net revenue. Primarily due to significantly higher revenue, we recorded a gross profit of 17.5% of net revenue in 2004.

Research and development expenses

Research and development (R&D) expenses consist primarily of our share of expenses related to the IBM joint-development agreement for 90nm and 65nm technologies, salaries and benefits for research and development personnel, depreciation of research and development equipment and expenses for development wafers. Research and development expenses decreased by 4.7%, from $124.1 million in 2003 to $118.3 million in 2004, primarily due to lower R&D expenditures related to 0.13um process. Our investment in research and development allows us to continue developing new and advanced processes down to the 45nm technology node. The research

45


Table of Contents

and development programs are structured to ensure that our baseline manufacturing processes accommodate new technology modules that are the heart of highly differentiated system-level applications. We expect to incur approximately $130 million for research and development in 2005.

Fab start-up costs

Fab start-up costs, all related to Fab 7, increased by 260.1% from $9.2 million in 2003 to $33.2 million in 2004, as the activity level increased in support of the company’s plan to begin commercial production by mid-2005. We began equipment move-in at Fab 7, our first 300-mm fab, at the end of March 2004. Fab 7 achieved functional 0.13um 300-mm wafers within 5 months of equipment move-in, and launched engineering 300-mm wafers for both our 0.11um process and the Chartered-IBM 90nm platform in 2004. We expect fab start-up costs for the first quarter of 2005 to increase sequentially by approximately $7 million compared to fourth quarter of 2004.

Sales and marketing expenses

Sales and marketing expenses, which primarily consist of expenses associated with overseas offices, payroll related costs for sales and marketing personnel, Electronic Design Automation (EDA) related expenses and costs related to customer prototyping activities, decreased by 2.6% from $38.7 million in 2003 to $ 37.8 million in 2004. The decrease was primarily due to lower financial support for customer prototyping activities. As a percentage of net revenue, sales and marketing expenses decreased from 7.0% to 4.0% over the same period.

General and administrative expenses

General and administrative (G&A) expenses consist primarily of salaries and benefits for administrative personnel, depreciation of non-production equipment, consultancy, legal and professional fees, and recruitment and training expenses. G&A expenses decreased by 12.8% from $40.8 million in 2003 to $35.6 million in 2004. This is primarily due to a gain of $3.0 million associated with the resolution of contingencies related to a technology license agreement, a gain of $1.1 million associated with the resolution of a supplier advance that was previously considered doubtful of recovery and a decrease in payroll related expenses, partially offset by an impairment charge of $1.7 million resulting from the migration to an enhanced manufacturing system in 2004.

Other operating expenses (income), net

Other operating income, net, of $10.7 million in 2004 primarily related to a gain of $10.4 million resulting from an equipment disposition with CSMC and resolution of a goods and services tax matter of $4.9 million, partially offset by Fab 1 restructuring charges of $4.6 million. Fab 1 ceased operations at the end of March 2004, as planned. A summary of estimated and actual restructuring and related costs incurred arising from the shutdown of Fab 1 is disclosed in Note 20 of the consolidated financial statements.

Other operating income, net, of $11.0 million in 2003 related to the following items:

•   A gain of $27.5 million associated with the cancellation of the company’s employee bonus award plan.
 
•   A gain of $4.9 million resulting from equipment disposition.

Partially offset by:

•   A restructuring charge of $12.4 million relating to the phase out of the company’s Fab 1.
 
•   An impairment charge of $9.0 million on certain machinery and equipment that were classified as held for sale on December 31, 2003, as part of company’s fab capacity rationalization.

Further details are disclosed in Note 20 of the consolidated financial statements.

Equity in income (loss) of SMP

Equity in income of SMP was $23.2 million in 2003 compared to an income of $27.6 million in 2004, primarily due to lower depreciation charge and no interest cost in the second half of 2004 as a result of early repayment of bank loans by SMP. As with the results of our majority-owned fabs, the equity in income or loss of SMP can have a

46


Table of Contents

material effect on our consolidated statements of operations. In 2003, the equity in income of SMP was $23.2 million compared to our net loss of $291.2 million. The equity in income of SMP was $27.6 million in 2004 compared to our net income of $6.6 million.

As SMP can have a material effect on our consolidated statements of operations, we have provided the following information on our total business base revenue, which includes our share of SMP revenue, for the 2 fiscal years ended December 31, 2004. SMP is a minority-owned joint venture company and is not consolidated under U.S. GAAP. The following table provides a reconciliation showing comparable data based on net revenue determined in accordance with U.S. GAAP, which do not include our share of SMP:

                 
    2004     2003  
    (in millions)  
Net revenue (U.S. GAAP)
  $ 932.1     $ 551.9  
Chartered’s share of SMP revenue
  $ 170.8     $ 175.8  
Net revenue including Chartered’s share of SMP
  $ 1,102.9     $ 727.7  

Additionally, the following table provides information that indicates the effect of SMP’s operations on some of our non-U.S. GAAP performance indicators:

                                 
    2004     2003  
    Excluding     Including     Excluding     Including  
    Chartered’s share     Chartered’s share     Chartered’s share     Chartered’s share  
    of SMP     of SMP     of SMP     of SMP  
Shipments (in thousands)*
    921.0       1,035.5       606.0       722.2  
ASP per wafer
    $1,012       $  1,065       $   911       $1,008  


*   Eight-inch equivalent wafers

Other income

Other income increased by 125.6% from $23.2 million in 2003 to $52.3 million in 2004, primarily due to the recognition of a gain of $14.3 million from the sale of technology to CSMC as well as from higher grant income, in particular from the recognition of income of $16.1 million arising from the closure of a pending grant claim associated with a previously terminated joint technology development agreement.

Interest income and interest expense

Net interest expense decreased by 38.2% from $30.1 million in 2003 to $18.6 million in 2004, primarily due to higher interest capitalization associated with the capital expenditure related to Fab 7 and Fab 6.

Income tax expense

Currently, we pay tax on interest income, rental income and other income not specifically exempted from income tax. Each of our existing fabs has been exempted from income tax on profits from the sale of manufactured goods for ten years following the date specified production milestones are achieved. Income taxes decreased from $11.7 million in 2003 to $4.8 million in 2004. The decrease was primarily due to reversal of $9.8 million of accrued taxes resulting from the resolution of certain matters related to the closure of Fab 1 (please see Item 5. Operating and Financial Review and Prospects — Special Tax Status” for further discussion), partially offset by a $3.6 million tax on income on the sale of technology to CSMC.

Minority interest in CSP

None of the losses in CSP were allocated to the minority interest in 2004, compared to $9.5 million in 2003. Due to cumulative losses, the minority interest equity was reduced to zero in the first quarter of 2003. Therefore losses from that point forward have been charged entirely to our consolidated statements of operations. The result of this on our consolidated statements of operations was an additional loss of $55.8 million for 2004.

47


Table of Contents

YEARS ENDED DECEMBER 31, 2002 AND DECEMBER 31, 2003

Net revenue

Net revenue was $551.9 million in 2003, up 22.9% compared to $449.2 million in 2002. This increase was primarily the result of higher demand, partially offset by a decline in ASP. Shipments in 2003 were 606.0 thousand wafers, an increase of 45.3% compared to 417.0 thousand wafers in 2002, due to higher demand. ASP decreased by 15.4% to $911 per wafer from $1,077 per wafer over the same period, primarily due to customer mix and pricing pressure, partially offset by substantially higher shipments of advanced technology products in 2003.

In 2002, the computer sector, which represented 46% of our total revenue, was our highest revenue contributor, followed by the communications sector at 36% of our total revenue. Primarily due to a significant increase in shipments to the mobile phone handset and LAN switches/routers markets, which use more advanced technology in their fabrication coupled with higher ASP in these products, communications sector revenue increased by 56% between 2002 and 2003. Concurrently, computer sector revenue declined by 12% over the same period mainly due to product and customer mix. As a result of this shift, communications and computer sector revenue represented 46% and 33%, respectively, of our total revenue in 2003.

As a result of customer mix changes, net revenue by geographical region increased by 104%, 87% and 12% in the Asia Pacific, Europe and the Americas regions, respectively, in 2003 as compared to 2002. The Japan region recorded a decline of 44% over the same period. The Americas continued to be our largest contributor to revenue, representing 64% of our total revenue in 2003, down from 71% of our total revenue in 2002.

Cost of revenue and gross loss

Cost of revenue increased by 3.1% from $628.7 million in 2002 to $648.3 million in 2003 despite a 45.3% increase in volumes. Cost per wafer shipped decreased by 29.0% from $1,508 in 2002 to $1,070 in 2003 due to higher volumes, lower depreciation, and cost savings and avoidance from our cost reduction programs. Gross loss as a percentage of net revenue improved across the same period, from 40.0% to 17.5%, as higher volumes and reduced cost per wafer more than offset the unfavorable impact of a lower ASP.

Research and development expenses

R&D expenses increased by $28.8 million, or 30.2%, from $95.3 million in 2002 to $124.1 million in 2003, due to increased investments to accelerate the company’s technology roadmap which provide customers a breadth of processes, enabling systems-level integration.

Beginning in the first quarter of 2003, R&D expenses include our share of expenses related to the IBM joint-development agreement for 90nm technologies, announced in November 2002. This additional expense in 2003 was partially offset by lower expenses for development wafers as our 0.13um process was completed and released to production during the year.

Sales and marketing expenses

Sales and marketing expenses decreased by 5.9% from $41.2 million in 2002 to $38.7 million in 2003. The decrease was primarily due to lower costs related to prototyping activities. As a percentage of net revenue, sales and marketing expenses decreased from 9.2% to 7.0% over the same period.

General and administrative expenses

G&A expenses decreased by 5.4% from $43.1 million in 2002 to $40.8 million in 2003, primarily due to a decrease in payroll related expenses.

Other operating expenses (income), net

Other operating expenses (income), net, were a net gain of $11.0 million in 2003 and related to the following items:

•   A gain of $27.5 million associated with the cancellation of the company’s employee bonus award plan.

48


Table of Contents

•   A gain of $4.9 million resulting from equipment disposition.

Partially offset by:

•   A restructuring charge of $12.4 million relating to the phase out of the company’s Fab 1.
 
•   An impairment charge of $9.0 million on certain machinery and equipment that have been classified as held for sale on December 31, 2003, as part of company’s fab capacity rationalization.

In 2002, we recorded a charge of $5.2 million associated with the workforce re-sizing announced in October 2002 and a fixed asset impairment charge of $4.8 million. The restructuring charge relating to workforce re-sizing reflects the costs of the compensation package paid to the affected employees. Further details are disclosed in Note 20 of the consolidated financial statements.

Equity in income (loss) of SMP

Equity in loss of SMP was $84.8 million in 2002 compared to an income of $23.2 million in 2003, primarily due to significantly higher revenue from Chartered’s portion of SMP.

Interest income and interest expense

Net interest expense increased by 20.1% from $25.0 million in 2002 to $30.1 million in 2003. The increase was primarily due to lower interest income as a result of lower interest rates on fixed deposit balances in 2003.

Income tax expense

Currently, we pay tax on interest income, rental income and other income not specifically exempted from income tax. Each of our existing fabs, other than Fab 1, has been exempted from income tax on profits from the sale of manufactured goods for 10 years following the date specified production milestones are achieved. We have been granted post-pioneer status for Fab 1 which allows us to pay a concessionary tax rate of 10% effective January 1, 2001 with respect to certain qualifying income earned by Fab 1. Income taxes increased from $7.0 million in 2002 to $11.7 million in 2003. The increase was primarily due to higher taxes payable on Fab 1’s taxable income. In 2002, tax expense for Fab 1 was accrued based on the concessionary post-pioneer rate of 10%. In 2003, this tax expense was accrued based on the full corporate tax rate of 22% because we will not be able to fulfill the conditions required to maintain our post-pioneer status as a result of the restructuring of Fab 1.

Please see “Item 5. Operating and Financial Review and Prospects — Special Tax Status” for an update of the status.

Minority interest in CSP

Minority interest in loss of CSP decreased from $55.6 million in 2002 to $9.5 million in 2003. Due to cumulative losses, the minority interest equity was reduced to zero in the first quarter of 2003. Therefore losses from that point forward have been charged entirely to our consolidated statements of operations. The result of this on our consolidated statements of operations was an additional loss of $74.3 million for 2003.

QUARTERLY RESULTS

The following table sets forth certain unaudited consolidated financial information, including as a percentage of net revenue, for the 8 fiscal quarters ended December 31, 2004. We believe that all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts stated below to present fairly the selected quarterly information when read in conjunction with our consolidated financial statements and the related notes included elsewhere in the document. Our consolidated statements of operations have varied and may continue to vary significantly from quarter-to-quarter and are not necessarily indicative of the results of any future period. See “Item 3. Key Information — Risk Factors — Risks Related To Our Financial Condition — Our Operating Results Fluctuate From Quarter-To-Quarter Which Makes It Difficult To Predict Our Future Performance”.

49


Table of Contents

                                                                 
    Quarter ended
(in millions $)
 
    Mar 31, 2003     Jun 30, 2003     Sep 30, 2003     Dec 31, 2003     Mar 31, 2004     Jun 30, 2004     Sep 30, 2004     Dec 31, 2004  
Consolidated Statements of Operations Data:
                                                               
Net revenue
    103.8       127.6       137.7       182.8       228.4       255.8       257.3       190.6  
Cost of revenue
    157.3       160.0       159.4       171.7       183.8       195.8       199.8       189.9  
 
                                               
Gross profit (loss)
    (53.5 )     (32.4 )     (21.7 )     11.1       44.6       60.0       57.5       0.7  
 
                                               
Operating expenses
                                                               
Research and development
    32.5       30.6       30.3       30.7       29.9       32.3       27.7       28.5  
Fab start-up costs
    2.1       2.2       2.5       2.3       3.6       8.1       11.6       9.9  
Sales and marketing
    10.0       10.2       8.3       10.2       8.7       10.2       9.9       8.9  
General and administrative
    10.0       9.3       10.8       10.7       6.3       12.1       9.1       8.0  
Other operating expenses (income), net
    (24.8 )     (1.1 )     3.3       11.6       3.1       0.7       (4.5 )     (10.0 )
 
                                               
Total operating expenses
    29.8       51.2       55.2       65.5       51.6       63.4       53.8       45.3  
 
                                               
 
                                                               
Operating income (loss):
    (83.3 )     (83.6 )     (76.9 )     (54.4 )     (7.0 )     (3.4 )     3.7       (44.6 )
Other income (expense):
                                                               
Equity in income (loss) of SMP
    1.9       (2.2 )     8.8       14.7       11.4       10.4       16.1       (10.4 )
Other income
    4.7       8.6       4.6       5.2       7.7       17.0       2.8       24.8  
Interest income
    3.7       3.3       2.7       2.4       2.5       3.0       2.6       3.4  
Interest expense
    (9.7 )     (10.4 )     (11.7 )     (10.3 )     (10.2 )     (9.0 )     (6.2 )     (4.6 )
Exchange gain (loss), net
    0.2       (0.5 )     0.4       (0.9 )     0.0       0.3       (0.3 )     1.3  
 
                                               
Income (loss) before income taxes and minority interest
    (82.5 )     (84.8 )     (72.1 )     (43.3 )     4.4       18.3       18.7       (30.1 )
Income tax benefit (expense)
    (2.8 )     (5.2 )     (3.8 )     0.1       (2.5 )     (3.0 )     (2.5 )     3.3  
 
                                               
Income (loss) before minority interest
    (85.3 )     (90.0 )     (75.9 )     (43.2 )     1.9       15.3       16.2       (26.8 )
Minority interest in loss of CSP
    9.5                                            
 
                                               
Net income (loss) prior to cumulative effect adjustment
    (75.8 )     (90.0 )     (75.9 )     (43.2 )     1.9       15.3       16.2       26.8  
Cumulative effect adjustment for change in accounting principle
    (6.4 )                                          
 
                                               
Net income (loss)
    (82.2 )     (90.0 )     (75.9 )     (43.2 )     1.9       15.3       16.2       (26.8 )
 
                                               
                                                                 
    Quarter ended
(as a percentage of net revenue)
 
    Mar 31, 2003     Jun 30, 2003     Sep 30, 2003     Dec 31, 2003     Mar 31, 2004     Jun 30, 2004     Sep 30, 2004     Dec 31, 2004  
Consolidated Statements of Operations Data:
                                                               
Net revenue
    100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %
Cost of revenue
    151.5       125.4       115.8       93.9       80.5       76.6       77.6       99.6  
 
                                               
Gross profit (loss)
    (51.5 )     (25.4 )     (15.8 )     6.1       19.5       23.4       22.4       0.4  
 
                                               
Operating expenses
                                                               
Research and development
    31.3       24.0       22.0       16.8       13.1       12.6       10.8       14.9  
Fab start-up costs
    2.1       1.7       1.8       1.3       1.6       3.2       4.5       5.2  
Sales and marketing
    9.6       8.0       6.0       5.6       3.8       3.9       3.8       4.7  
General and administrative
    9.6       7.3       7.9       5.9       2.7       4.8       3.5       4.2  
Other operating expenses (income), net
    (23.9 )     (0.8 )     2.4       6.3       1.4       0.3       (1.7 )     (5.2 )
 
                                               
Total operating expenses
    28.7       40.2       40.1       35.9       22.6       24.8       20.9       23.8  
 
                                               
                                                                 
    Quarter ended
(as a percentage of net revenue)
 
    Mar 31, 2003     Jun 30, 2003     Sep 30, 2003     Dec 31, 2003     Mar 31, 2004     Jun 30, 2004     Sep 30, 2004     Dec 31, 2004  
Operating income (loss)
    (80.2 )     (65.6 )     (55.9 )     (29.8 )     (3.1 )     (1.4 )     1.5       (23.4 )
Other income (expense):
                                                               
Equity in income (loss) of SMP
    1.9       (1.7 )     6.4       8.0       5.0       4.1       6.2       (5.5 )
Other income
    4.6       6.8       3.4       2.8       3.4       6.7       1.1       13.0  
Interest income
    3.6       2.6       2.0       1.3       1.1       1.2       1.0       1.8  
Interest expense
    (9.4 )     (8.2 )     (8.5 )     (5.7 )     (4.5 )     (3.5 )     (2.4 )     (2.4 )
Exchange gain (loss), net
    0.2       (0.4 )     0.3       (0.5 )     (0.0 )     0.1       (0.1 )     0.7  
 
                                               
Income (loss) before income taxes and minority interest
    (79.3 )     (66.5 )     (52.3 )     (23.9 )     1.9       7.2       7.3       (15.8 )
Income tax benefit (expense)
    (2.7 )     (4.0 )     (2.8 )     0.1       (1.1 )     (1.2 )     (1.0 )     1.7  
 
                                               
Income (loss) before minority interest
    (82.0 )     (70.5 )     (55.1 )     (23.8 )     0.8       6.0       6.3       (14.1 )
Minority interest in loss of CSP
    9.1                                            
 
                                               
Net income (loss) prior to cumulative effect adjustment
    (72.9 )     (70.5 )     (55.1 )     (23.8 )     0.8       6.0       6.3       (14.1 )
Cumulative effect adjustment for change in accounting principle
    (6.2 )                                          
 
                                               
Net income (loss)
    (79.1 )%     (70.5 )%     (55.1 )%     (23.8 )%     0.8 %     6.0 %     6.3 %     (14.1 )%
 
                                               

50


Table of Contents

Net revenue

The semiconductor industry recovery began to accelerate in the second half of 2003 and continued into the first half of 2004. We recorded sequential quarterly increases in shipments from the first quarter of 2003 to the third quarter of 2004, which was driven primarily by customers in our communications sector. Correspondingly, our net revenue also increased quarterly from the first quarter 2003 to the second quarter 2004.

However, we started seeing market weakness from the second half of June 2004 due to excess inventories in the semiconductor companies and the softening in certain end markets. This resulted in a sequentially flat third quarter followed by a sequential decline of 25.9% in net revenue in fourth quarter of 2004. The weakness was concentrated in our 0.18um and 0.25um capacity, which is mainly in Fab 3, primarily due to customer concentration in these technologies. We were unable to diversify the customer base during preceding quarters of high demand, since a significant amount of our 0.18um and 0.25um capacity was utilized by our top customers.

Gross margin

Cost of revenue includes depreciation expense, amortization of certain technology licenses, attributed overheads, cost of labor and materials as well as subcontracted expenses for assembly and test services. The unit cost of a wafer generally decreases as fixed overhead charges, such as depreciation expense on the facility and semiconductor manufacturing equipment, are allocated over a larger number of units produced. Gross margin improved in each of the quarters from first quarter of 2003 to second quarter of 2004, primarily due to sequential increases in quarterly net revenue.

In third quarter of 2004, gross margin was down 4.1% sequentially from $60.0 million, or 23.4% of revenue in second quarter of 2004, primarily due to increased costs associated with Fab 6 capacity ramp and lower utilization in Fab 6. Gross margin declined further by 98.7% sequentially in the fourth quarter of 2004 primarily due to lower revenue as overall market demand fell, partially offset by sale amounting to $1.6 million of certain inventories for which we had previously written down to an estimated net realizable value of $Nil in the third quarter of 2004. Such sale improved the gross margin by approximately $1.6 million in the fourth quarter of 2004. Compared to the fourth quarter of 2003, gross margin decreased by 93.2% in the fourth quarter of 2004 despite slightly higher net revenue primarily due to lower work-in-progress production in fourth quarter of 2004.

Research and development expenses

Research and development (R&D) expenses consist primarily of our share of expenses related to the IBM joint-development agreement for 90nm and 65nm technologies (beginning in first quarter of 2003), salaries and benefits for research and development personnel, depreciation of R&D equipment and expenses for development wafers. R&D expenses decreased sequentially in the second quarter of 2003 primarily due to lower engineering wafer lots related to 0.13um process and remained at approximately similar levels through the quarters thereafter and up to the first quarter of 2004. The increase in the second quarter of 2004 was primarily due to an increase in EDA development costs. R&D expenses decreased sequentially in the third quarter of 2004 primarily due to lower R&D expenditures relate to development of 0.13um derivative process and remained at an approximately similar level in the fourth quarter of 2004.

Fab start-up costs

Fab start-up costs, all related to Fab 7, remained at approximately similar levels through the quarters in 2003. The start-up costs started to increase from the first quarter of 2004, as we began equipment move-in at Fab 7, our first 300-mm fab, in the first quarter of 2004. Fab 7 achieved functional 0.13um 300-mm wafers within 5 months of equipment move-in and launched engineering 300-mm wafers for both our 0.11um process and the Chartered-IBM 90nm platform. Fab 7 moved into pilot production at the end of 2004.

Other operating expenses (income), net

In the first quarter of 2003, we recorded a net gain of $24.8 million, related to a gain of $27.5 million associated with the cancellation of the company’s employee bonus award plan partly offset by a restructuring charge of $2.7 million associated with the phase out of Fab 1. We recorded a total of $9.7 million in restructuring charges in the remaining quarters of 2003. In the second quarter of 2003, we recorded a $4.9 million gain resulting from equipment disposition. In the fourth quarter of 2003, we recorded an impairment charge of $9.0 million on certain machinery and equipment that have been classified as held for sale on December 31, 2003, as part of the company’s fab capacity rationalization.

51


Table of Contents

In 2004, we recorded a total of $4.6 million in restructuring charges related to Fab 1, mainly incurred in the first quarter of 2004. In the third quarter of 2004, we recorded an income of $4.9 million related to resolution of a goods and services tax matter. In the fourth quarter of 2004, we also recorded a gain of $10.4 million resulting from an equipment disposition with CSMC.

Equity in income (loss) of SMP

As with the results of our majority-owned fabs, the equity in income or loss of SMP can have a material effect on our quarterly consolidated statements of operations. We recognized equity in income of SMP in each of the quarters for the period from third quarter of 2003 to third quarter of 2004, primarily due to growing SMP revenue over that period. However, primarily due to significantly lower demand, in the fourth quarter of 2004, we recorded equity in loss of SMP of $10.4 million compared to the net loss of $26.8 million. The equity in income or loss of SMP for the 8 fiscal quarters ended December 31, 2004 were significant amounts when compared to the net income or net loss of the respective fiscal quarters during that period.

As SMP can have a material effect on our consolidated statements of operations, we have provided the following information on our total business base revenue, which includes our share of SMP revenue, for the 8 fiscal quarters ended December 31, 2004. SMP is a minority-owned joint venture company and is not consolidated under U.S. GAAP. The following table provides a reconciliation showing comparable data based on net revenue determined in accordance with U.S. GAAP, which do not include our share of SMP:

                                                                 
    Mar 31, 2003     Jun 30, 2003     Sep 30, 2003     Dec 31, 2003     Mar 31, 2004     Jun 30, 2004     Sep 30, 2004     Dec 31, 2004  
    (in millions)  
Net revenue (U.S. GAAP)
  $ 103.8     $ 127.6     $ 137.7     $ 182.8     $ 228.4     $ 255.8     $ 257.3     $ 190.6  
Chartered’s share of SMP revenue
  $ 38.2     $ 35.5     $ 47.6     $ 54.4     $ 55.3     $ 52.3     $ 49.2     $ 14.1  
Net revenue including Chartered’s share of SMP
  $ 142.0     $ 163.1     $ 185.3     $ 237.2     $ 283.7     $ 308.1     $ 306.5     $ 204.7  

Additionally, the following tables provide information that indicates the effect of SMP’s operations on some of our non-U.S. GAAP performance indicators:

                                                                 
    Mar 31, 2003     Jun 30, 2003     Sep 30, 2003     Dec 31, 2003  
    Excluding     Including     Excluding     Including     Excluding     Including     Excluding     Including  
    Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s  
    share of     share of     share of     share of     share of     share of     share of     share of  
Quarter ended   SMP     SMP     SMP     SMP     SMP     SMP     SMP     SMP  
Shipments (in thousands)*
    111.6       135.4       140.1       166.8       153.7       185.0       200.6       235.0  
ASP per wafer
  $ 931     $ 1,049     $ 911     $ 978     $ 896     $ 1,002     $ 911     $ 1,010  

*   Eight-inch equivalent wafers

52


Table of Contents

                                                                 
    Mar 31, 2004     Jun 30, 2004     Sep 30, 2004     Dec 31, 2004  
    Excluding     Including     Excluding     Including     Excluding     Including     Excluding     Including  
    Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s     Chartered’s  
    share of     share of     share of     share of     share of     share of     share of     share of  
Quarter ended   SMP     SMP     SMP     SMP     SMP     SMP     SMP     SMP  
Shipments (in thousands)*
    232.8       268.4       244.0       279.2       252.4       287.1       191.8       200.8  
ASP per wafer
    $   981       $1,057       $1,048       $1,103       $1,019       $1,068       $  994       $1,019  

*   Eight-inch equivalent wafers

Other income

In each of the 8 fiscal quarters ended December 31, 2004, we recognized research and development and training grant income and rental income. We also recognized a gain of $5.9 million and $2.8 million associated with intellectual property licensing in the second quarter of 2003 and first quarter of 2004, respectively. In the second quarter of 2004, we recognized higher grant income, in particular from the recognition of an income of $16.1 million arising from the closure of a pending grant claim associated with a previously terminated joint technology development agreement. Other income in the fourth quarter of 2004 included a gain of $14.3 million related to the sale of technology to CSMC and training grant income of $8.4 million.

Interest expense

Interest expense remained at approximately similar levels through the quarters in 2003 and to second quarter of 2004. Interest expense declined sequentially by 30.6% in the third quarter of 2004 and decreased further by 25.6% in the fourth quarter of 2004. These decreases are primarily due to higher interest capitalization associated with the capital expenditure related to Fab 7 and Fab 6.

Minority interest in CSP

Due to cumulative losses, the minority interest equity was reduced to zero in the first quarter of 2003. Therefore losses from that point forward have been charged entirely to our consolidated statements of operations. In 2003, the result of this on our consolidated statements of operations was additional losses of $10.7 million, $22.4 million, $23.8 million and $17.4 million for the first, second, third and fourth quarter of 2003, respectively. In 2004, the result of this on our consolidated statements of operations was additional losses of $12.6 million, $8.4 million, $15.8 million and $19.0 million for the first, second, third and fourth quarter of 2004, respectively.

LIQUIDITY AND CAPITAL RESOURCES

Current and expected liquidity

As of December 31, 2004, our principal sources of liquidity included $569.4 million in cash and term deposits, and $1,116.6 million of unutilized banking facilities consisting of term loans, short-term advances and bankers’ guarantees.

Our current target is to maintain a cash and term deposits balance as of December 31, 2005 of approximately $500 million based on our existing cash on hand and term deposits of approximately $569 million, planned draw downs of approximately $774 million of our existing credit facilities, estimated net capacity deposits of approximately $93 million and expected cash outflows for debt repayments of approximately $502 million and capital expenditures of approximately $750 million. We expect that depreciation and amortization will be approximately $515 million in 2005, compared to $437.6 million in 2004. We generated cash flows from operations of $48.1 million and $331.7 million for 2003 and 2004, respectively, and expect to continue to generate cash flow from operations in 2005. Our ability to generate operating cash flow in 2005 will depend largely on future operations and other factors, as discussed in the risk factor, “Our Operating Results Fluctuate From Quarter-to-Quarter Which Makes It Difficult To Predict Our Future Performance” and elsewhere in this document.

53


Table of Contents

In August 2004, we entered into a bilateral option transaction with Goldman Sachs International as counter-party, to pro-actively manage our 2.5% convertible notes issued in April 2001 (Convertible Notes). Under the transaction, the counter-party may purchase 214.8 million of our shares at the price of $0.93 per share (approximately S$1.60 per share, based on an exchange rate of $1.00 = S$1.71). The number of shares under the option transaction is equal to the number of shares that were originally planned for issuance under the Convertible Notes. The option transaction, which is contractually separate from the Convertible Notes, increases the likelihood that we will issue the shares originally planned for issuance upon conversion of the Convertible Notes by lowering the conversion price. If completed, we will receive approximately $200 million that could be used to partially repay the Convertible Notes. The option transaction is exercisable by Goldman Sachs International from January 2, 2005 and will expire on April 2, 2006, matching the maturity date of the Convertible Notes. The option transaction also has a feature that allows us to elect for early termination if the trading price of our ordinary shares listed and quoted on the Singapore Exchange rises and remains above $1.17 for a defined period of time.

In December 2004, we entered into an agreement for a $653 million term loan facility from JP Morgan, guaranteed by the Export-Import Bank of the United States (Exim Loan). The Exim Loan is divided into two tranches and has an availability period of between 2 to 4 years. It will be used to finance the purchase of Fab 7 equipment from U.S. vendors and will be drawn down in accordance with the equipment purchases per the ramp schedule. Each tranche will be repaid over a period of 5 years. The funding cost of the Exim Loan, excluding arrangement and related fees, is expected to be around London Interbank Offered Rate (LIBOR) plus 50 basis points.

We also finalized a $200 million term loan facility (with the option to increase the facility by $100 million) from Sumitomo Mitsui Banking Corporation and Oversea-Chinese Banking Corporation, a $50 million term loan facility from Bank of America, and a $150 million revolving credit facility from Sumitomo Mitsui Banking Corporation. The blended interest cost for these loans, excluding any one time arrangement and related fees, is approximately LIBOR plus 150 basis points. The interest cost is dependent on our forecasted draw down schedule. All these credit facilities are expected to support Fab 7 ramp to its full phase 1 capacity of 15,000 300-mm wafers per month.

We are taking a phased approach to the equipping of Fab 7 to the full planned capacity of 30,000 300-mm wafers per month capacity, and this is expected to take a number of years and will be paced by customer demand and industry conditions. We expect the total cost of phase 1, in order to equip Fab 7 with a capacity of 15,000 300-mm wafers per month, to be approximately $1.7 billion. At completion, the total investment of Fab 7 is expected to be approximately $2.7 billion to $3 billion. As of December 31, 2004, we have spent $637.9 million on the equipping of Fab 7 as part of its phase 1 ramp. We expect our aggregate capital expenditures in 2005 to be approximately $750 million, of which 85% is expected to be for equipping Fab 7 to 9,000 300-mm wafers per month capacity by end 2005 (which is part of our Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity). Fab 7 is scheduled to begin commercial production in mid-2005. As of December 31, 2004, we had commitments on contracts for capital expenditures of $312.9 million. We expect our aggregate research and development expenditures to be approximately $130 million in 2005, compared to $118.3 million in 2004.

Based on our current level of operations, we believe that our cash on hand, planned use of existing credit facilities, credit terms with our vendors, and projected cash flows from operations will be sufficient to meet our 2005 capital and research and development expenditures and working capital needs. However, we may require additional financing to fund our future growth activities. We believe in maintaining maximum flexibility when it comes to financing our business. We regularly evaluate our current and future financing needs and may take advantage of favorable market conditions to raise additional financing.

There can be no assurance that our business will generate and continue to generate sufficient cash flow to fund our liquidity needs in the future, or that additional financing will be available or, if available, that such financing will be obtained on terms favorable to us or that any additional financing will not be dilutive to our shareholders.

Historic operating cash flows

In 2004, net cash provided by operating activities was $331.7 million, compared to $48.1 million in 2003. The $283.6 million improvement in cash provided by operating activities was primarily a result of higher revenues in

54


Table of Contents

2004. In addition, in 2004, we had higher collections from SMP. These improvements were partially offset by higher payments on our payables and other current liabilities.

Historic investing cash flows and capital expenditures

Net cash used in investing activities was $732.7 million in 2004 and $384.3 million in 2003. Investing activities consisted primarily of capital expenditures totaling $686.3 million in 2004 and $220.8 million in 2003. Investing activities in 2004 also included payments for technology license fees, the placement of a deposit to secure wafer capacity and placement of term deposits, offset by proceeds from sale of property, plant and equipment and other assets.

The nature of our industry is such that, in the short-term, we may reduce our capital expenditures by delaying planned capital expenditures in response to a difficult business environment, such as the one that existed in 2001 and 2002. However, the semiconductor market is characterized by rapid technological change and the importance of economies of scale, which we expect to result in significant capital expenditure requirements. Factors that may affect our level of future capital expenditures include the degree and the timing of technological changes within our industry, changes in demand for the use of our equipment and machinery as a result of changes to our customer base and the level of growth within our industry.

Capital expenditures in 2004 were mainly related to the equipping of Fab 7 as part of its phase 1 ramp and capacity additions at leading-edge technologies in Fab 6. Capital expenditures in 2003 were mainly related to capacity additions at leading-edge technologies in Fab 6.

Historic financing cash flows

Net cash provided by financing activities was $34.9 million and $30.8 million in 2004 and 2003, respectively. This was primarily due to the draw down of credit facilities of $125.0 million and $318.0 million in 2003 and 2004, respectively, partly offset by repayment of term loans during the same period.

Research and development and training grants

In 2004, we received $19.0 million in research grants from various agencies of the Government of Singapore, which are included in operating cash flows. These grants provide funding for a portion of our research and development related capital expenditures and for the training and staffing costs associated with some of our process technology development programs. The grants are disbursed to us based on the amount of expenditures incurred, achievement of program milestones and certification of the costs incurred. The main condition attached to the grants is the completion of the project to which the grant relates.

Off-balance sheet arrangements

As of December 31, 2004, we did not have any significant off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

Outstanding loans

As of December 31, 2004, CSP has a U.S. dollar term loan with several banks and financial institutions for capital expenditures and equipment (CSP Second Phase Credit Agreement). The loan was first put in place on September 28, 2000 and matures on September 28, 2006. (See “Item 19. Exhibits — Exhibits 4.1.1 to 4.1.4”). The loan is for an amount of $820.0 million, which had been fully drawn as of December 31, 2004, and $589.1 million is outstanding as of December 31, 2004. The loan carries an interest rate of 0.60% to 0.85% (depending on certain criteria relating to wafer starts and debt to net worth ratio) above the LIBOR rates for U.S. dollar deposits quoted by specified banks to the lender. As of December 31, 2004, this rate was 3.2375%. Interest is payable quarterly in U.S. dollars and principal is amortized in 6 semi-annual installments commencing March 28, 2004. Borrowings under this facility are secured by a floating charge over a CSP project bank account and a fixed charge over CSP’s debt service reserve account, both of which were established pursuant to this loan. The fixed charge over CSP’s debt service reserve account will not permit the use of funds in that account by CSP for as long as the loan remains outstanding.

In addition, as of December 31, 2004, CSP has a loan from the Economic Development Board, or EDB, denominated in Singapore dollars for capital expenditures and equipment signed in November 1999 (CSP-EDB

55


Table of Contents

loan) of which $45.6 million (S$75.0 million) is outstanding as of December 31, 2004. The loan has an interest rate of 4.25% and matures on March 1, 2006. While the loan is unsecured, it is backed by a bank guarantee from a syndicate of banks related to surviving provisions from a third party loan (CSP First Phase Credit Agreement) that had been fully repaid.

On April 2, 2001, we issued $575 million of convertible notes, which bear interest at the rate of 2.50% per year and have a yield to maturity of 5.25% per year. The conversion price of the Convertible Notes is S$4.7980 per share (equivalent to approximately $26.7701 per ADS) as of December 31, 2004 and reflects a retroactive adjustment due to our October 2002 Rights Offering. We may redeem all or a portion of the Convertible Notes at any time on or after April 2, 2003 at a price to yield of 5.25 % per year on the redemption date if our shares or ADSs trade at 125% of the conversion price for a period of 20 days in any consecutive 30 trading day period. We have entered into interest rate swaps to hedge the interest rate obligations and accreting portion of the Convertible Notes. Please see “Item 11. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk”. In August 2004, we entered into a bilateral option transaction with Goldman Sachs International as counter-party to pro-actively manage our Convertible Notes. Under the transaction, the counter-party may purchase 214.8 million of our shares at the price of $0.93 per share (approximately S$1.60 per share, based on an exchange rate of $1.00 = S$1.71). Please see “Item 5.Operating And Financial Review and Prospects – Liquidity And Capital Resources – Current And Expected Liquidity” for more details on our bilateral option transaction with Goldman Sachs International.

As of December 31, 2004, we also had a loan from EDB for capital expenditures and equipment with an outstanding principal amount of $28.1 million (S$46.2 million). The loan is denominated in Singapore dollars and we fully hedge both interest and principal payments against fluctuations in foreign exchange rates. The loan bears interest of 4.0%. The loan agreement is unsecured and guaranteed by Singapore Technologies. The loan matures on September 1, 2005. Interest is payable semi-annually and principal is payable in equal semi-annual installments which commenced on September 1, 1999.

Loan Covenant Compliance

Some of our outstanding loans and the unutilized banking facilities available to us, including loans incurred by our subsidiary, CSP, contain various financial, shareholding and other restrictive covenants which are customary to loan documents.

Under the financial covenants, we are required to maintain certain financial conditions and/or ratios such as consolidated net worth, total debt to net worth ratio and historical debt service coverage ratio. We are allowed to substantially increase CSP’s net worth to enable CSP to satisfy its total debt to net worth ratio for the CSP loan agreements. In 2002, we effected such an increase in CSP’s net worth by converting inter-company amounts payable by CSP into a loan from us to CSP (“Chartered Loan”). The amount of the Chartered Loan to CSP is increased from time to time by converting additional inter-company amounts payable by CSP in order to enable CSP to satisfy the total debt to net worth ratio. The amounts under the Chartered Loan are subordinated to the amounts due by CSP to its other lenders.

Under the shareholding covenants, Temasek is required to own, directly or indirectly, a certain percentage of our outstanding shares. The covenants also require that we own, directly or indirectly, at least a certain percentage of our subsidiary’s outstanding shares. If Temasek or we fail to comply with these covenants, we could be in a default under these loans and the lenders would have the right to require us to repay or accelerate our obligation to repay the outstanding borrowings under these loans. In some cases, a default could also cause cross-defaults under other loans and could seriously harm us.

In addition, the outstanding loans and the unutilized banking facilities available to us impose other restrictive covenants which are customary to loan documents such as the restriction from incurring further indebtedness, creating security interest over our assets, payment of dividends, disposal of our assets, merger and corporate restructuring.

If we fail to comply with the loan covenants, we could be in a default situation under the loans and the lenders would have the right to require us to repay or accelerate our obligation to repay the outstanding borrowings under the loans. In some cases, a default could also cause cross-defaults under other loans and could seriously harm us.

56


Table of Contents

Contractual Obligations

The following table sets forth the payments due for specific contractual obligations as of December 31, 2004:

                                                         
    Expected Payment Date
(in thousands)
 
    2005     2006     2007     2008     2009     Thereafter     Total  
Long-term debt
  $ 352,985     $ 882,745                           $ 1,235,730  
Operating leases(1)
    8,735       7,017     $ 5,069     $ 4,955     $ 4,864     $ 73,670       104,310  
Purchase obligations(2) under:
                                                       
Capital expenditures
    307,383       5,500                               312,883  
Technology agreements
    79,169       68,550       73,250       38,250       3,250       3,250       265,719  
Other
    32,272       188       188       188       188       630       33,654  
Other long-term liabilities
          62,549                         15,364       77,913  
 
                                         
Total
  $ 780,544     $ 1,026,549     $ 78,507     $ 43,393     $ 8,302     $ 92,914     $ 2,030,209  
 
                                         

(1)   We do not have any capital lease obligations as of December 31, 2004.
 
(2)   We have not included purchase obligations that have been recorded on our consolidated balance sheet as of December 31, 2004. These obligations amounted to $129.1 million, $8.9 million and $128.0 million for capital expenditures, technology agreements and other purchase obligations primarily relating to operating expenses, respectively.

Our material contractual obligations also include a commitment to SMP. Pursuant to an assured supply and demand agreement that both the joint venture partners signed with SMP, we are each required to purchase a specified percentage of SMP’s available capacity. However, if one party does not purchase its share of wafers, the other party is entitled to utilize that unused capacity. In the event such other party does not utilize the unused capacity, the party who does not purchase its entitlement will be required to compensate SMP for any unrecovered costs it incurs in connection with such unused capacity. Under the assured supply and demand agreement mentioned above, there was no allocated wafer capacity billable to us for the year ended December 31, 2004.

We have disclosed the expected timing of payment of obligations and the amounts to be paid based on current information. Timing of payments and actual amounts paid may be different depending on the time of receipt of goods or services or changes to agreed-upon amounts or events for some obligations.

SPECIAL TAX STATUS

We have been granted pioneer status under the Economic Expansion Incentives (Relief from Income Tax) Act Chapter 86 of Singapore for:

  •   the manufacture of integrated circuits using submicron technology at Fab 2 for a 10-year period beginning July 1, 1996;
 
  •   the manufacture of integrated circuits using submicron technology at Fab 3 for a 10-year period beginning July 1, 1999; and
 
  •   the wafer fabrication of Application Specific Integrated Circuits (ASIC) and other advanced semiconductor devices at Fab 6 for a 10-year period beginning September 1, 2003.

Under the Economic Expansion Incentives (Relief from Income Tax) Act (Chapter 86) of Singapore, we have also been granted:

  •   post-pioneer enterprise status for the manufacture of integrated circuits using submicron technology at Fab 2 for a 5-year period beginning July 1, 2006;
 
  •   development and expansion incentive status for the manufacture of integrated circuits using submicron technology at Fab 3 for a 5-year period beginning July 1, 2009; and
 
  •   development and expansion incentive status for the wafer fabrication of ASICs and other advanced semiconductor devices at Fab 6 for a 5-year period beginning September 1, 2013.

57


Table of Contents

During the period for which our pioneer status is effective, subject to our compliance with certain conditions, income from our pioneer trade (that is, sale of integrated circuits) is exempt from Singapore income tax. During the periods for which our post-pioneer status and development and expansion incentive status are effective, subject to our compliance with certain conditions, income from our post-pioneer trade and development and expansion activities are taxed at a concessionary rate of 10%. The income tax exempt profits arising from the pioneer trade may be distributed as tax-exempt dividends, and holders of ordinary shares are not subject to Singapore income tax on such dividends. Please see “Item 10. Additional Information — Taxation — Singapore Taxation — Income Tax” for information regarding the taxation of dividends. Losses accumulated before the pioneer status period cannot be carried forward. Losses accumulated in the pioneer status period may be carried forward and may be offset against profits from the same pioneer trade arising after the expiration of the pioneer status period, subject to our compliance with certain conditions. Profits arising during pioneer status offset any accumulated pioneer loss carry forward balance. Without this exemption from income tax or the concessionary tax rate of 10%, we would be subject to income tax at the applicable corporate income tax rate that is currently 20% for the year ended December 31, 2004. Interest income is not exempt from taxation during the pioneer status period or entitled to the concessionary tax rate during the post-pioneer status period or the development and expansion incentive status period.

The development and expansion incentive status for wafer fabrication of integrated circuits at Fab 1 required us to fulfill certain conditions during the 5-year period beginning January 1, 2001. In February 2003, we announced our plan to consolidate the business of Fab 1 into Fab 2. Although we were not able to fully fulfill the conditions required to maintain our development and expansion incentive status for Fab 1, the relevant authority nevertheless extended such status through December 31, 2004.

RECENT ACCOUNTING PRONOUNCEMENTS NOT YET ADOPTED

In November 2004, the FASB issued FASB Statement No. 151 (“FAS 151”), “Inventory Costs”, an amendment of ARB No. 43, Chapter 4. The amendments made by Statement 151 clarified that abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) should be recognized as current-period charges and required the allocation of fixed production overheads to inventory based on the normal capacity of the production facilities. The guidance is effective for inventory costs incurred during fiscal years beginning after June 15, 2005. The initial adoption of FAS 151 is not expected to have any material impact on the company’s financial condition and consolidated statements of operations.

In December 2004, the FASB published FASB Statement No. 123 (revised 2004) (“FAS 123(R)”), “Share-Based Payment”. FAS 123(R) requires that the compensation cost relating to share-based payment transactions be recognized in financial statements. That cost will be measured based on the fair value of the equity or liability instruments issued. Public entities will be required to apply FAS 123(R) as of the first interim or annual reporting period that begins after June 15, 2005. FAS 123(R) replaces FASB Statement No. 123, “Accounting for Stock-Based Compensation”, and supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees”.

The company has begun, but has not yet completed, evaluating the impact of adopting FAS 123(R) on its results of operations. The company currently determines the fair value of stock-based compensation using a Black-Scholes option pricing model. In connection with evaluating the impact of adopting FAS 123(R), the company is also considering the potential implementation of different valuation models to determine the fair value of stock-based compensation, although no decision has yet been made. However, the company does believe the adoption of FAS 123(R) may have a material impact on its results of operations, regardless of the valuation technique used. If the company were to continue to use a Black-Scholes option pricing model consistent with its current practice and based on existing issued and outstanding stock options as of December 31, 2004, the adoption of FAS 123(R) on July 1, 2005 is expected to result in approximately additional compensation expense of $5 million to $6 million after taxes for the second half of 2005.

ITEM 6.   DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
 
A.   DIRECTORS AND SENIOR MANAGEMENT

The following table sets forth, as of December 31, 2004, the name, age and position of each director and member of senior management of our company.

58


Table of Contents

             
Name   Age   Position
Board Of Directors (1)
           
James A. Norling (2)(3)(5)
    62     Chairman of the Board
Lim Ming Seong (3)(5)
    57     Deputy Chairman of the Board
Chia Song Hwee (2)
    42     Director
Sum Soon Lim (3)(4)(5)
    61     Director
Robert E. La Blanc (4)
    70     Director
Andre Borrel (3)(4)(5)
    68     Director
Charles E. Thompson (3)(5)
    75     Director
Tsugio Makimoto, PhD
    67     Director
Tay Siew Choon (2)(3)(5)
    57     Director
Peter Seah Lim Huat (2)(3)(5)
    58     Director
Philip Tan Yuen Fah (4)
    60     Director
 
           
Senior Management (1)
           
Chia Song Hwee
    42     President and Chief Executive Officer
Ang Kay Chai
    45     Senior Vice President, Fab Operations
Michael J. Rekuc
    55     Senior Vice President, Worldwide Sales and Marketing
Sun Shi-Chung, PhD
    57     Senior Vice President, Technology Development
George Thomas
    51     Vice President and Chief Financial Officer
Ang Tang Yong
    47     Vice President, Quality, Reliability Assurance and Support Operations
Roy Kannan
    52     Vice President and Chief Information Officer
Ng Seng Huwi
    47     Vice President, Human Resources
Tan Seng Chai
    42     Vice President, Strategy Resources

(1)   A portion of our directors (including our President and Chief Executive Officer) are elected at each annual general meeting of shareholders. The number of directors retiring and eligible to stand for re-election each year varies, but generally, it is equal to one-third of the board, with the directors who have been in office longest since their re-election or appointment standing for re-election. Our contracts with senior management and/or directors do not have fixed expiry dates but can be terminated by either party through notice provisions.
 
(2)   Member of the Executive Committee.
 
(3)   Member of the Executive Resource and Compensation Committee, or the ERCC.
 
(4)   Member of the Audit Committee.
 
(5)   Member of the Nominating Committee.

Biographical Information

JAMES A. NORLING
James A. Norling has served on our Board of Directors since March 1, 2001 and as our Chairman of the Board since August 1, 2002. Mr. Norling also served as interim Chief Executive Officer from May 2002 to June 2002. He has 37 years of working experience in the electronics industry. Mr. Norling was with Motorola Inc. from 1965 to 2000 holding various positions, including President of the Semiconductor Products Sector in 1986, President of the Europe, Middle East and Africa region in 1993, Deputy to the Chief Executive Officer in 1998 and President of the Personal Communications Sector in 1999 until his retirement. He has previously served as a board member and the Chairman of the Semiconductor Industry Association. Mr. Norling is currently a board member of Harley-Davidson, Inc. Mr. Norling holds a B.Sc and a Masters degree in Electrical Engineering from the University of Illinois.

LIM MING SEONG
Lim Ming Seong has served on our Board of Directors since November 1987 and as our Deputy Chairman of the Board since August 1995. Mr. Lim currently sits on the boards of various companies, including as Deputy Chairman of STATS ChipPAC Ltd (formerly known as ST Assembly Test Services Ltd) and Chairman of CSE Global Ltd. After joining Singapore Technologies Pte Ltd in December 1986, Mr. Lim has held various senior positions in the Singapore Technologies group. Prior to joining Singapore Technologies Pte Ltd, Mr. Lim was with the Ministry of Defence of Singapore. Mr. Lim received his Bachelor of Science (Honors) in Mechanical

59


Table of Contents

Engineering from the University of Toronto and his Diploma in Business Administration from the University of Singapore. Mr. Lim also participated in the Advanced Management Programs at INSEAD and Harvard University.

CHIA SONG HWEE
Chia Song Hwee has served on our Board of Directors and as our President and Chief Executive Officer since June 2002. Prior to his appointment, Mr. Chia had served as our Chief Administrative Officer since September 2000, as our Senior Vice President since February 2000 and as our Chief Financial Officer since December 1997. Mr. Chia was our Director of Finance from April 1996 to December 1997. Since joining our company in 1996, his responsibilities have steadily expanded to include the areas of finance, strategic development, technology alliances and legal. From May 1992 through December 1994, Mr. Chia was Regional Financial Controller (Asia and Middle East) for Anadrill Technical Services, Inc. From January 1995 to April 1996, Mr. Chia was Regional Controller (Asia, Australia and Middle East) for Sedco Forex Technical Services, Inc. Mr. Chia received his Bachelor of Business (Accountancy), with distinction, from Edith Cowan University, Australia and is a member of CPA Australia.

SUM SOON LIM
Sum Soon Lim has served on our Board of Directors since February 1994. He is currently a corporate adviser to Temasek Holdings (Private) Limited. Prior to the cessation of operations of Singapore Technologies Pte Ltd on December 31, 2004, Mr. Sum was also a corporate adviser to Singapore Technologies Pte Ltd. Mr. Sum had worked with the Singapore Economic Development Board, DBS Bank, J.P. Morgan Inc., Overseas Union Bank Ltd and Nuri Holdings (S) Pte Ltd, a private investment holding company. He is also a member of the Securities Industry Council. Mr. Sum currently also sits on the board of various companies, including CapitaLand Ltd, Singapore Health Services Pte Ltd, Singapore Technologies Telemedia Pte Ltd and Singapore Press Holdings Ltd. He is also a Commissioner in P.T. Indonesian Satellite Corporation. Mr. Sum received his B.Sc (Honors) in Production Engineering from the University of Nottingham, England.

ROBERT E. LA BLANC
Robert E. La Blanc has served on our Board of Directors since May 1998 and is the President of Robert E. La Blanc Associates, Inc., an information technologies consulting and investment banking firm. From 1979 to 1981, Mr. La Blanc was Vice Chairman of Continental Telecom, Inc. and from 1969 to 1979, a General Partner of Salomon Brothers Inc. Mr. La Blanc has also held various senior positions within companies in the telecommunications industry including AT&T, Bell Telephone Laboratories and New York Telephone Company. Mr. La Blanc received his B.E.E. from Manhattan College and his MBA from New York University. Mr. La Blanc also is a graduate of the Operating Engineers Program at Bell Telephone Laboratories and the USAF Communications Officers School.

ANDRE BORREL
Andre Borrel has served on our Board of Directors since July 1998 and is currently working as a consultant in the semiconductor industry. Prior to joining our Board of Directors, Mr. Borrel was Senior Vice President and General Manager of Communications, Power and Signal Technology Group at Motorola Inc. Mr. Borrel is also an Officer of the French National Order of Merit and holds a Master Degree in Electronics from “Ecole Nationale Superieure des Telecommunications” in Paris, France.

CHARLES E. THOMPSON
Charles E. Thompson has served on our Board of Directors since September 1998 and is currently working as a consultant in the information technology/semiconductor technology industry. From 1973 to 1996, Mr. Thompson was World Marketing Senior Vice President at Motorola Inc. Prior thereto, Mr. Thompson was Computer Department Sales Director at General Electric. Mr. Thompson received his Bachelor of Science in Mathematics from the University of Washington.

TSUGIO MAKIMOTO, PhD
Tsugio Makimoto has served on our Board of Directors since September 1999 and has more than 40 years of working experience in the semiconductor industry. He is currently a corporate adviser to Sony Corporation or Sony. Prior to joining Sony, Dr. Makimoto has worked for Hitachi Ltd since 1959 where he has held various senior positions, including Executive Managing Director in 1993, Senior Executive Managing Director in 1997 and Corporate Chief Technologist since 1998. Dr. Makimoto was an auditor of Hitachi Chemical Corporation from 2000 to 2003. He was also nominated a Fellow of the Institute of Electrical and Electronics Engineers, Inc. in 1997. Dr. Makimoto was also a visiting professor at Toyo University (1999-2001).

60


Table of Contents

TAY SIEW CHOON
Tay Siew Choon has served on our Board of Directors since July 2001. Mr. Tay was formerly a corporate advisor to Singapore Technologies Pte Ltd which ceased operations on December 31, 2004. Prior to that, he was Managing Director and Chief Operating Officer in Singapore Technologies Pte Ltd. From 1998 to 2000, Mr. Tay was the Managing Director and Deputy Chief Executive Officer of SembCorp Industries Ltd and has held various senior positions in Singapore Technologies Industrial Corporation Ltd. Mr. Tay currently also sits on the board of various companies including STATS ChipPAC Ltd (formerly known as ST Assembly Test Services Ltd), ST Telemedia Pte Ltd, SNP-LeeFung Holdings Limited, Straco Corporation Limited and Pan-United Corporation Ltd. He is currently Chairman of SNP Corporation Ltd and Deputy Chairman of Green Dot Capital Pte Ltd, a wholly owned subsidiary of Temasek Holdings (Private) Limited. Mr. Tay received his Bachelor of Engineering (Electrical) (Honors) Degree from Auckland University and his Masters of Science in Systems Engineering from the former University of Singapore (now National University of Singapore).

PETER SEAH LIM HUAT
Peter Seah has served on our Board of Directors since January 2002. Mr. Seah is currently a member of the Temasek Advisory Panel. Prior to the cessation of operations of Singapore Technologies Pte Ltd on December 31, 2004, Mr. Seah was the President and Chief Executive Officer of Singapore Technologies Pte Ltd. Before joining Singapore Technologies Pte Ltd, he was a banker for 32 years, 22 of which were with the Overseas Union Bank Ltd and before that with Citibank. He retired from his position as Vice Chairman and CEO at Overseas Union Bank Ltd in September 2001. Mr. Seah currently sits on the board of various companies including SembCorp Industries Ltd, CapitaLand Ltd, ST Engineering Ltd and STATS ChipPAC Ltd (formerly known as ST Assembly Test Services Ltd). Mr. Seah graduated from the University of Singapore in 1968 with an honors degree in Business Administration. For his public service, he was awarded the Public Service Medal (1995) as well as the Public Service Star (1999) by the Singapore Government.

PHILIP TAN YUEN FAH
Philip Tan has served on our Board of Directors and as our Chairman of the Audit Committee since October 2003. He is currently an independent consultant and also sits on the board of companies such as Overseas Union Insurance Ltd and Singapore Food Industries Ltd. Mr. Tan is a veteran in the banking and financial industry. He retired in 2002 from Overseas Union Bank Ltd after holding various positions since joining the company in 1979. Mr. Tan holds a Bachelor of Accountancy from the University of Singapore and a Bachelor of Law from the University of Wolverhampton, UK. In addition, Mr. Tan also holds a graduate diploma in Business Administration from the Manchester Business School, UK. He is a Certified Public Accountant and a member of the Accounting Standards Committee of the Institute of Certified Public Accountants of Singapore. He is also a Chartered Management Accountant of the Chartered Institute of Management Accountants of UK and a Fellow of CPA (Australia).

ANG KAY CHAI
Ang Kay Chai has served as our Senior Vice President, Fab Operations, since September 2002. Mr. Ang is responsible for manufacturing strategy and operational excellence across all of Chartered’s fabs. Mr. Ang returned to Chartered after spending four years at Silterra Malaysia Sdn, Bhd., where he was responsible for fab operations. There, he led teams in technology partner selection, green field fab startup, transfer of 0.25um and 0.18um technology and development of foundry-compatible process capabilities. Prior to that, Mr. Ang spent nine years at Chartered where he led the initial conception, development and ramp of Fab 2 and Fab 3. Mr. Ang first joined Chartered in 1989 and was one of the pioneers on Chartered’s Fab 1 team. Mr. Ang holds a Master of Science degree in Engineering from the University of Texas and a Bachelor of Engineering degree from the National University of Taiwan.

MICHAEL J. REKUC
Michael J. Rekuc has served as our Senior Vice President, Worldwide Sales and Marketing since August 2003. He has the overall responsibility for global sales, marketing and services, customer support and regional business operations. From January 1999 to July 2003, Mr. Rekuc served as our President of our Americas operations. Mr. Rekuc brings nearly 30 years of electronics and semiconductor industry experience. From 1976 until joining Chartered in January 1999, Mr. Rekuc held sales, management and director positions in the semiconductor product sector of Motorola Inc. His last few positions at Motorola Inc. included worldwide responsibilities as global sales director for wireless subscriber systems and a 2-year role as vice president and sales director for PC, computing and peripherals. Mr. Rekuc holds a BSEE from Lawrence University of Michigan.

SUN SHI-CHUNG, PhD
Sun Shi-Chung has served as our Senior Vice President, Technology Development since December 2001. Dr. Sun has the overall responsibility for technology development and execution according to the competitive technology

61


Table of Contents

roadmap. Dr. Sun has more than 29 years of experience in the semiconductor industry. He joined us from Promos Technologies in Taiwan, where he was the head of research and development. During his career, he has held various positions with TSMC, Advanced Micro Devices Inc., Catalyst Semiconductor, Hewlett-Packard and AT & T Bell Labs. Dr. Sun received his PhD in electrical engineering from Stanford University, his M.S. in electrical engineering from the State University of New York and his B.S. in electrical engineering from National Cheng Kung University in Taiwan. Dr. Sun has been awarded several U.S. patents with several more pending, and his work has been featured in more than 100 technical publications.

GEORGE THOMAS
George Thomas has served as our Vice President and Chief Financial Officer since June 2002 and has overall responsibility for our company’s finance, investor relations and legal functions. From September 2000 to June 2002, Mr. Thomas served as Vice President, Finance. He joined our company in May 2000 as Group Controller. Mr. Thomas began his Finance/Accounting career with Canadian Met-Chem, a subsidiary of U.S. Steel Corporation as Internal Auditor and Senior Accounts Executive in 1978. From June 1983 to April 2000, he held various positions at Schlumberger’s Sedco Forex Division, including Controller, Operations-Worldwide, Regional Controller, Asia & Australia, Controller, Indonesia Operations, and Finance Manager of Arabian Drilling Company, a joint venture between Schlumberger and Petromin. He has served on the Board of Directors of Chartered Silicon Partners Pte Ltd since April 2001 and the Board of Directors of Silicon Manufacturing Partners Pte Ltd as an alternate director since July 2003. Mr. Thomas received his Bachelor Degree in Commerce and in General Law. He is also a member of the Institute of Chartered Accountants of India.

ANG TANG YONG
Ang Tang Yong has served as our Vice President, Quality, Reliability Assurance and Support Operations since July 2002 and has overall responsibility for facilities, supply management and quality assurance. Mr. Ang first joined our company in 1993 as Facilities Director and during the next seven years served consecutively as Vice President and Operations Manager of our Fab 1, General Manager of Silicon Manufacturing Partners Pte Ltd, and as General Manager of Chartered Silicon Partners Pte Ltd. Mr. Ang has more than 20 years of working experience in the semiconductor industry. Prior to joining our company, Mr. Ang held positions in the United States and Singapore with AT&T, Hitachi and Texas Instruments. From March 2001 to July 2002, he was president of Ellipsiz, a provider of semiconductor engineering and manufacturing services, headquartered in Singapore. Mr. Ang received a diploma in electrical engineering from Singapore Polytechnic and a master’s degree in business administration from the State University of New York.

ROY KANNAN
Roy Kannan has served as our Vice President and Chief Information Officer (CIO) since September 2003. Mr. Kannan is responsible for our global information technology organization and for driving our company’s strategic initiative to extend a virtual business systems network for supporting the business systems network for supporting the business requirements of customers, partners, suppliers and employees. He joined us from the RGM group, a multi-divisional conglomerate, where he was the CIO. His responsibilities included the revamp of the company’s data, voice, network and security infrastructure, as well as the management of information systems (IS) operations and data centers. During Mr. Kannan’s more than 20 years of experience in the IS industry, he has held senior positions at leading IS solutions companies such as Compaq, Mastek, Digital Equipment and Patni. Mr. Kannan holds a Bachelor of Chemical Engineering Degree from the Indian Institute of Technology, Madras, and a post-graduate diploma in management from the Indian Institute of Management, Ahmedabad.

NG SENG HUWI
Ng Seng Huwi has served as our Vice President, Human Resources since July 2003. Mr. Ng is responsible for the overall development and implementation of policies and processes in our company’s human resources management system. Mr. Ng brings with him extensive work experience in a number of large multi-national companies. He joined us from Praxair Inc., where he was vice president of Asia Human Resources with responsibilities that included ensuring organizational effectiveness, improving productivity and managing performance. During his 23-year professional career, Mr. Ng has lived and worked around the world, holding a variety of human resources, engineering and operations positions in global companies, including Schlumberger, Unilever and ICI. Mr. Ng holds a Bachelor of Engineering (Honors) from the University of Aberdeen in Scotland and an MBA from the University of Sheffield, England.

TAN SENG CHAI
Tan Seng Chai has served as our Vice President, Strategy Resources since July 2003. Mr. Tan has overall responsibility for the coordination of Chartered’s long-term strategic initiatives and serves as the liaison with the

62


Table of Contents

management team, as well as the external communication teams. Prior to his appointment, Mr. Tan served as our Vice President, Human Resources from July 1999 to July 2003. He joined our company in April 1996 as a human resource manager. Mr. Tan has more than 17 years of experience in the semiconductor industry. He began his career at National Semiconductor in 1987 where he held various positions in engineering, production and human resource management. Mr. Tan later joined Creative Technology Ltd in 1994 and prior to joining our company, he was Creative Technology Ltd’s Senior Manager, Human Resource. Mr. Tan holds a Bachelor of Engineering (Hons) from the National University of Singapore in 1987 and a M.Sc (Industrial and System Eng) from the National University of Singapore in 1991.

B.   COMPENSATION OF DIRECTORS AND SENIOR MANAGEMENT

The aggregate compensation we paid to or accrued for all of our directors and senior management for services rendered to us and our subsidiaries during the fiscal years ended December 31, 2003 and December 31, 2004 were approximately $3.0 million and $3.4 million respectively. The increase in the aggregate compensation in 2004 was mainly due to the increase in senior management’s salary as a result of the restoration of their pay cut in January 2004. The pay cut was effected in June 2002. We also provide our directors and our senior management with customary director or senior management insurance, as appropriate.

The table below sets out the compensation paid to our directors during the fiscal year ended December 31, 2004:

                                         
    Salary (1)     Bonus (2)     Others (3)     Director’s Fees (4)     Total  
    (in $ thousands)  
James A. Norling
                      85       85  
Lim Ming Seong
                      45       45  
Chia Song Hwee
    416             29             445  
Sum Soon Lim
                      40       40  
Robert E. La Blanc
                      45       45  
Andre Borrel
                      53       53  
Charles E. Thompson
                      45       45  
Tsugio Makimoto
                      35       35  
Tay Siew Choon
                      39       39  
Peter Seah Lim Huat
                      35       35  
Philip Tan Yuen Fah
                      38       38  
 
                             
Total as of December 31, 2004
    416             29       460       905  
 
                             
Total as of December 31, 2003
    295       11       34       431       771  
 
                             

(1)   Base salary (inclusive of employers’ Central Provident Fund (CPF)). The increase in Mr. Chia Song Hwee’s salary in 2004 was due to the restoration of a 30% pay cut in January 2004. The pay cut was effected in June 2002.
 
(2)   Economic Value Added (EVA) (inclusive of employers’ CPF).
 
(3)   Allowances (inclusive of employers’ CPF) and others.
 
(4)   The increase in Directors’ fees in 2004 was due to the restoration of a 50% cut in the Directors’ attendance fees in January 2004. The cut in the attendance fees was effected in 2001.

During 2004, we also granted options to purchase 4,855,000 ordinary shares to our directors and senior management. These options were granted under our 1999 Option Plan. The exercise prices of these options range from S$1.02 to S$1.70. The expiration dates of these options range from February 27, 2009 to July 30, 2014, subject to annual vesting requirements.

In 2004, except for a quarterly bonus paid in the first quarter of 2004 relating to the performance of fourth quarter of 2003, no other bonus was paid or accrued to our senior management. Our President and Chief Executive Officer does not have a guaranteed minimum annual bonus. None of our directors receive benefits upon termination of their appointment in their capacity as directors.

C.   BOARD PRACTICES

63


Table of Contents

BOARD COMPOSITION

Our Articles of Association set the minimum number of directors at two. As of December 31, 2004, we have 11 directors. A portion of our directors (including our President and Chief Executive Officer) are re-elected at each annual general meeting of shareholders. The number of directors retiring and eligible to stand for re-election each year varies, but generally it is equal to one-third of the board, with the directors who have been in office longest since their re-election or appointment standing for re-election. Mr. Lim Ming Seong, our Deputy Chairman of the Board will be retiring at the annual general meeting of shareholders to be held on April 28, 2005 and will not be seeking re-election.

As of December 31, 2004, Temasek, through its affiliate, beneficially owns 60.19% of our outstanding ordinary shares. As such, it is able to control actions over many matters requiring approval by our shareholders, including the election of directors.

Under the Nasdaq rules, companies that satisfy the definition of a “Controlled Company” may be exempt from certain regulatory requirements. The regulatory requirements which a “Controlled Company” is exempt from include:

(i)   the requirement that the majority of Board members must be independent;
 
(ii)   the requirement that the compensation committee must be comprised solely of independent directors, or that compensation of our senior management must be made by a majority of the independent directors on the full Board; and
 
(iii)   the requirement that the nomination committee must be comprised solely of independent directors or that nominations must be made by a majority of the independent directors on the full Board.

A “Controlled Company” is defined as a company of which more than 50% of the voting power is held by an individual, group or another company. As Singapore Technologies (prior to December 31, 2004) and Temasek (with effect from December 31, 2004) through its affiliate owns more than 50% of our outstanding ordinary shares, our company falls under the definition of “Controlled Company” and our Board has resolved to rely on the exemption for a “Controlled Company” as provided under the Nasdaq rules. However, our Board may from time to time review this decision.

In addition, the current Nasdaq rules require that our Audit Committee be comprised solely of independent directors. Although one of our Audit Committee members does not qualify as an independent director under the Nasdaq rules, we are currently exempt from this requirement pursuant to an exemption we previously received from Nasdaq. In the event we are no longer able to rely on this exemption in the future, we anticipate that we would rely on the Nasdaq rule which permits one non-independent director to be appointed to the Audit Committee for a period of up to two years if the Board makes a determination that, under exceptional and limited circumstances, the director’s membership on the committee is in the best interests of the company and its shareholders.

The Board of Directors held 4 meetings during the fiscal year ended December 31, 2004, all of which were regularly scheduled meetings. The Board of Directors also held meetings without senior management in regular sessions which are generally held immediately after a regularly scheduled Board meeting.

COMMITTEES OF THE BOARD OF DIRECTORS

(a)   Executive Committee

The Executive Committee of our Board of Directors was established to enable our Board to delegate some of its powers and functions regarding the governing of the affairs of the company and its subsidiaries to the Executive Committee in order to facilitate timely decision-making processes within the limits of authority as determined by our Board. The members of the Executive Committee are Messrs. James A. Norling (chairman), Peter Seah Lim Huat, Tay Siew Choon and Chia Song Hwee. The Executive Committee held 4 meetings during the fiscal year ended December 31, 2004.

(b)   Audit Committee

64


Table of Contents

The Audit Committee of our Board of Directors consists of four members. The Audit Committee reviews, acts on and reports to the Board of Directors regarding various auditing and accounting matters. In particular, the Audit Committee reviews the financial statements of our company, the scope and results of annual audits (both internal and external), the recommendation of our independent auditors and the response of our company’s management to both the internal and external audits. The Audit Committee meets up at least once a year with the external and internal auditors without the presence of management. It also oversees related party transactions, including all material transactions between us and the Singapore Technologies group (prior to December 31, 2004) and Temasek group (with effect from December 31, 2004). In December 2004, the Audit Committee adopted a Whistleblower Programme to encourage ethical conduct and facilitate disclosures. In addition, the Audit Committee has also established a Business Ethics and Review Committee to implement and administer our company’s policies on ethical conduct and to receive, retain, investigate and act on complaints and concerns of employees regarding violations of our company’s human resource policies addressing employee business practices and code of ethics.

The members of the Audit Committee are Messrs. Philip Tan Yuen Fah (chairman), Sum Soon Lim, Robert E. La Blanc and Andre Borrel. The Audit Committee held 7 meetings during the fiscal year ended December 31, 2004.

(c)   Executive Resource and Compensation Committee

The Executive Resource and Compensation Committee, or the ERCC, of our Board of Directors oversees executive compensation and development in our company with the goal of building capable and committed management teams through competitive compensation, focused management and progressive policies which can attract, motivate and retain a pool of talented executives to meet our current and future growth plans. The ERCC establishes compensation policies for key executives, approves salary reviews, bonuses and incentives for key executives, approves share incentives, including share options and share ownership for executives, approves key appointments and reviews succession plans for key positions, and oversees the development of key executives and talented executives.

The members of the ERCC are Messrs. Peter Seah Lim Huat (chairman), James A. Norling, Andre Borrel, Lim Ming Seong, Charles E. Thompson, Sum Soon Lim and Tay Siew Choon. The ERCC held 4 meetings during the fiscal year ended December 31, 2004.

(d)   Nominating Committee

The Nominating Committee, or the NC, of our Board of Directors was established primarily to support and advise the company in ensuring that the Board of the company is comprised of individuals who are best able to discharge their responsibilities as directors having regard to the law and the highest standards of governance. The NC is responsible for recommending suitable candidates to the Board for election as directors of the company focusing, in particular, on candidates who can add value to the management through their contributions in the relevant strategic business areas and who collectively will result in a strong and diverse board. The members of the NC are Messrs. Peter Seah Lim Huat (chairman), James A. Norling, Andre Borrel, Lim Ming Seong, Charles E. Thompson, Sum Soon Lim and Tay Siew Choon. The NC held 4 meetings during the fiscal year ended December 31, 2004.

(e)   Budget Committee

We dissolved our Budget Committee on April 29, 2004 as most of its functions had been taken over by the other committees. Prior to its dissolution, the Budget Committee of our Board of Directors was responsible for reviewing our annual budget and our quarterly financial performance in relation to our budget as well as our capital spending and financial plans. The members of the Budget Committee were Messrs. Andre Borrel (chairman), Lim Ming Seong, Sum Soon Lim and Tay Siew Choon.

D.   EMPLOYEES

As of December 31, 2004 our total staff strength (including employees of our subsidiary, CSP) was 3,606 employees. The following tables sets forth the total number of employees, as of the dates indicated by functional responsibility and by geographical locations.

65


Table of Contents

                         
    No. of employees as of December 31,  
Functions   2002     2003     2004  
Engineering
                       
(Modules, YE, Process Integration, Product Engineering, JV Technology, Metrology)
    1,214       1,186       1,410  
Manufacturing Operations
    1,047       890       900  
Manufacturing Support
    589       591       572  
Research and Development
    279       225       253  
Administration, Marketing and Finance
    414       391       471  
 
                 
Total
    3,543       3,283       3,606  
 
                 
                         
    No. of employees as of December 31,  
Geographical Locations   2002     2003     2004  
Singapore
    3,417       3,161       3,479  
Americas
    87       84       87  
Europe
    21       17       17  
Asia-Pacific (other than Singapore)
    18       21       23  
 
                 
Total
    3,543       3,283       3,606  
 
                 

In February 2003, we announced our plans to phase out Fab 1 and to consolidate its business into Fab 2 over an estimated 13-month transition period. The consolidation process was completed as scheduled and Fab 1 ceased operations at the end of March 2004. As a result of our consolidation of business, we redeployed 126 of our Fab 1 employees to work at our other Fabs and released the remaining 363 employees.

Our employees are not covered by any collective bargaining agreements and are not members of a union. We have not experienced any strikes or work stoppages by our employees. We consider our relationship with our employees to be good.

We provide our employees with customary compensation and benefit plans, including employee bonus plans, an employee share option plan and an employee share purchase plan. Employees of SMP, our 49% owned affiliate, are eligible to receive option grants under our company’s employee share option plan subject to certain exceptions as provided in the plan. In addition, employees of SMP also participate in an employee share purchase plan with terms substantially similar to the share purchase plan for our employees. Please see “Item 6. Directors, Senior Management and Employees — Employee Benefit Plans” for a discussion of our share option plan and our share purchase plan.

E.   SHARE OWNERSHIP FOR DIRECTORS AND SENIOR MANAGEMENT

The following table sets forth certain information with respect to the beneficial ownership of our ordinary shares for each of our directors and our president and chief executive officer and all of our directors and senior management as a group as of December 31, 2004, based on an aggregate of 2,509,238,524 ordinary shares outstanding as of such date.

                 
    Ordinary Shares (1)  
    Beneficially Owned (2)  
Directors   Number        
James A. Norling
    1,662,631          
Lim Ming Seong
    414,436          
Chia Song Hwee
    3,467,041          
Sum Soon Lim
    997,490          
Robert E. La Blanc
    432,964       Please  
Andre Borrel
    646,800       See  
Charles E. Thompson
    488,792   >   Note (4)  
Tsugio Makimoto
    326,546       below  
Tay Siew Choon
    454,073          
Peter Seah Lim Huat
    240,330          
Philip Tan Yuen Fah
    85,000          
All directors and senior management (3) as a group (19 persons)
    14,288,625          

66


Table of Contents

(1)   The number of ordinary shares listed in this table includes ordinary shares held directly or in the form of ADSs.
 
(2)   Gives effect to the ordinary shares issuable within 60 days from December 31, 2004 upon the exercise of all options and other rights beneficially owned by the indicated shareholders on that date. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and investment power with respect to ordinary shares. Except for 36,000 shares held by James A. Norling and 120,020 shares held by Michael J. Rekuc which are jointly held, the persons named in the table have sole voting and sole investment control with respect to all ordinary shares beneficially owned.
 
(3)   None of our directors or senior management individually owns 1% or more of our outstanding shares.
 
(4)   Less than 1% of our outstanding shares.

SHARE OPTIONS FOR DIRECTORS

The following table contains information pertaining to share options held by directors as of December 31, 2004.

                         
    As of December 31, 2004     Exercise price S$     Exercise period  
James A. Norling
    58,609       4.05     28/03/2002 to 28/03/2006
 
    58,609       4.26     15/08/2002 to 15/08/2006
 
    58,609       3.46     22/02/2003 to 22/02/2007
 
    1,172,195       3.88     01/05/2002 to 01/05/2012
 
    58,609       1.86     30/08/2003 to 30/08/2007
 
    50,000       0.72     28/02/2004 to 28/02/2008
 
    60,000       1.10     29/08/2004 to 29/08/2008
 
    110,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Lim Ming Seong
    58,609       4.05     28/03/2002 to 28/03/2006
 
    58,609       4.26     15/08/2002 to 15/08/2006
 
    58,609       3.46     22/02/2003 to 22/02/2007
 
    58,609       1.86     30/08/2003 to 30/08/2007
 
    45,000       0.72     28/02/2004 to 28/02/2008
 
    45,000       1.10     29/08/2004 to 29/08/2008
 
    90,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Chia Song Hwee
    10,467       1.18     28/10/1997 to 28/10/2006
 
    20,935       1.00     28/11/1998 to 28/11/2007
 
    61,704       0.80     30/11/1998 to 29/11/2008
 
    26,444       0.80     30/04/1999 to 29/04/2009
 
    234,439       2.86     29/10/1999 to 29/10/2009
 
    70,331       2.86     29/04/2000 to 29/10/2009
 
    410,268       14.24     06/04/2001 to 06/04/2010
 
    527,487       10.12     03/10/2001 to 03/10/2010
 
    263,743       4.05     28/03/2002 to 28/03/2011
 
    263,743       4.26     15/08/2002 to 15/08/2011
 
    234,439       3.46     22/02/2003 to 22/02/2012
 
    2,344,391       1.86     30/08/2003 to 30/08/2012
 
    300,000       0.72     28/02/2004 to 28/02/2013
 
    700,000       1.10     29/08/2004 to 29/08/2013
 
    1,000,000 +     1.70     27/02/2005 to 27/02/2014
 
    220,000 +     1.02     30/07/2004 to 30/07/2014
 
                       
Sum Soon Lim
    93,775       14.24     06/04/2001 to 06/04/2005
 
    93,775       10.12     03/10/2001 to 03/10/2005
 
    46,887       4.05     28/03/2002 to 28/03/2006
 
    46,887       4.26     15/08/2002 to 15/08/2006
 
    46,887       3.46     22/02/2003 to 22/02/2007
 
    46,887       1.86     30/08/2003 to 30/08/2007
 
    25,000       0.72     28/02/2004 to 28/02/2008
 
    35,000       1.10     29/08/2004 to 29/08/2008
 
    60,000 +     1.70     27/02/2005 to 27/02/2009

67


Table of Contents

                         
    As of December 31, 2004     Exercise price S$     Exercise period  
Robert E. La Blanc
    23,443       14.24     06/04/2001 to 06/04/2005
 
    58,609       10.12     03/10/2001 to 03/10/2005
 
    29,304       4.05     28/03/2002 to 28/03/2006
 
    29,304       4.26     15/08/2002 to 15/08/2006
 
    29,304       3.46     22/02/2003 to 22/02/2007
 
    29,304       1.86     30/08/2003 to 30/08/2007
 
    25,000       0.72     28/02/2004 to 28/02/2008
 
    35,000       1.10     29/08/2004 to 29/08/2008
 
    60,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Andre Borrel
    93,775       14.24     06/04/2001 to 06/04/2005
 
    93,775       10.12     03/10/2001 to 03/10/2005
 
    46,887       4.05     28/03/2002 to 28/03/2006
 
    46,887       4.26     15/08/2002 to 15/08/2006
 
    46,887       3.46     22/02/2003 to 22/02/2007
 
    46,887       1.86     30/08/2003 to 30/08/2007
 
    40,000       0.72     28/02/2004 to 28/02/2008
 
    45,000       1.10     29/08/2004 to 29/08/2008
 
    85,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Charles E. Thompson
    58,609       14.24     06/04/2001 to 06/04/2005
 
    58,609       10.12     03/10/2001 to 03/10/2005
 
    29,304       4.05     28/03/2002 to 28/03/2006
 
    29,304       4.26     15/08/2002 to 15/08/2006
 
    29,304       3.46     22/02/2003 to 22/02/2007
 
    29,304       1.86     30/08/2003 to 30/08/2007
 
    25,000       0.72     28/02/2004 to 28/02/2008
 
    35,000       1.10     29/08/2004 to 29/08/2008
 
    60,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Tsugio Makimoto
    11,721       14.24     06/04/2001 to 06/04/2005
 
    58,609       10.12     03/10/2001 to 03/10/2005
 
    29,304       4.05     28/03/2002 to 28/03/2006
 
    29,304       4.26     15/08/2002 to 15/08/2006
 
    29,304       3.46     22/02/2003 to 22/02/2007
 
    29,304       1.86     30/08/2003 to 30/08/2007
 
    25,000       0.72     28/02/2004 to 28/02/2008
 
    35,000       1.10     29/08/2004 to 29/08/2008
 
    60,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Peter Seah Lim Huat
    23,443       3.46     22/02/2003 to 22/02/2007
 
    46,887       1.86     30/08/2003 to 30/08/2007
 
    40,000       0.72     28/02/2004 to 28/02/2008
 
    45,000       1.10     29/08/2004 to 29/08/2008
 
    85,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Tay Siew Choon
    23,443       4.26     15/08/2002 to 15/08/2006
 
    29,304       3.46     22/02/2003 to 22/02/2007
 
    234,439       3.88     01/05/2002 to 01/05/2007
 
    46,887       1.86     30/08/2003 to 30/08/2007
 
    25,000       0.72     28/02/2004 to 28/02/2008
 
    35,000       1.10     29/08/2004 to 29/08/2008
 
    60,000 +     1.70     27/02/2005 to 27/02/2009
 
                       
Philip Tan Yuen Fah
    85,000 +     1.70     27/02/2005 to 27/02/2009

+   Options that were granted in 2004.

68


Table of Contents

EMPLOYEE BENEFIT PLANS

Share Option Plan 1999

On March 30, 1999, we adopted our Share Option Plan 1999 (“1999 Option Plan”). The purpose of the plan is to put our company in a competitive position as an employer. Options granted under the 1999 Option Plan may be non-statutory options or incentive stock options intended to qualify under Section 422 of the U.S. Internal Revenue Code.

The 1999 Option Plan is administered by the ERCC. Our employees, employees of SMP, our outside directors and consultants are eligible to receive option grants subject to certain exceptions as provided in the 1999 Option Plan. An individual who owns more than 10% of the total combined voting power of all classes of our outstanding shares is not eligible for the grant of options unless:

—   the exercise price of the option is at least 110% of the fair market value of a share on the date of grant; and
 
—   in the case of an incentive stock option, such option by its terms is not exercisable after the expiration of five years from the date of grant.

The aggregate number of shares that may be issued under the 1999 Option Plan and under any other share incentive and option schemes or agreements may not exceed 227,647,883 shares, as adjusted from 197,160,000 to give effect to the October 2002 Rights Offering.

If an outstanding option expires for any reason or is cancelled or otherwise terminated, the shares allocable to the unexercised portion of such option will again be available for the purposes of the plan and all other share incentive and option schemes approved by the ERCC. The exercise price of an incentive stock option shall not be less than 100% of the fair market value of a share on the date of grant. In no event will the exercise price for an option be below par value.

The exercisability of options outstanding under the 1999 Option Plan may be fully or partially accelerated under certain circumstances such as a change in control of our company, as defined in the 1999 Option Plan.

Each grant under the 1999 Option Plan is evidenced by a share option agreement and the term of options granted may not exceed 10 years from the date of grant. If the optionee’s service with us is terminated, the optionee’s outstanding options, to the extent then exercisable, remain exercisable for a specified period (which is based on the reason for the termination) following the date of termination. All options which are not exercisable at the date of termination lapse when the optionee’s service terminates.

As of December 31, 2004, options to purchase 112,654,252 ordinary shares were issued and outstanding under our 1999 Option Plan, of which 21,157,751 were held by our directors and senior management. The exercise prices of these outstanding options range from S$0.72 to S$14.24 and the expiration dates of these options range from April 6, 2005 to July 30, 2014.

The 1999 Option Plan will terminate automatically on January 28, 2009, ten years after the date on which the Board adopted the 1999 Option Plan. The ERCC may amend, suspend or terminate the 1999 Option Plan at any time and for any reason, provided that any amendment which increases the number of shares available for issuance under the 1999 Option Plan, or which materially changes the class of persons who are eligible for the grant of incentive share options, will be subject to the approval of our shareholders.

Employee Share Purchase Plans

In May 2001, we implemented a Chartered Employee Share Purchase Plan 2001 (“the Chartered ESPP 2001”) and a Share Purchase Plan for Employees of SMP (“the SMP ESPP 2001”). The purpose of the plans was to put our respective companies in a competitive position as an employer. Employees purchase shares from our respective companies through payroll deductions.

The aggregate number of shares that were available for purchase under the Chartered ESPP 2001 and the SMP ESPP 2001, was an aggregate number of 11,721,955 shares.

69


Table of Contents

All available shares under the Chartered ESPP 2001 and the SMP ESPP 2001 were issued and allotted by the end of February 2004, and as a result, both the Chartered ESPP 2001 and the SMP ESPP 2001 were terminated.

A new Chartered Employee Share Purchase Plan (the “Chartered ESPP 2004”) and a new Share Purchase Plan for employees of SMP (the “SMP ESPP 2004”) were approved by shareholders at our last Annual General Meeting held on April 29, 2004. The aggregate number of shares that are available for purchase under the Chartered ESPP 2004 and the SMP ESPP 2004, is an aggregate number of 30,000,000 shares with a limit of 3,000,000 shares per calendar year (and a limit of 1,500,000 shares per offering period). The first offering period of the new Chartered ESPP 2004 and the SMP ESPP 2004 commenced on September 1, 2004 and ended on February 28, 2005. A total of 1,496,640 shares were issued on March 2, 2005 during this first offering period.

EQUITY COMPENSATION PLAN INFORMATION AS OF DECEMBER 31, 2004

                         
                    (c)  Number of securities  
                      remaining available for  
    (a)  Number of securities to     (b)  Weighted-average       future issuance under  
      be issued upon exercise of       exercise price of       equity compensation plans  
      outstanding options,       outstanding options,       (excluding securities in  
Plan Category     warrants and rights       warrants and rights       column (a))  
                   
Equity compensation plans approved by shareholders
    112,654,252     $ 2.36       123,144,753  
 
                       
Equity compensation plans not approved by shareholders
    N.A. *     N.A. *     N.A. *
 
                       
Total
    112,654,252     $ 2.36       123,144,753  

*   Note: The company does not have any equity compensation plans which have not been approved by shareholders

ITEM 7.   MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
 
A.   MAJOR SHAREHOLDERS

The following table sets forth certain information with respect to each person or group of affiliated persons who is known by us to beneficially own 5% or more of our ordinary shares as of December 31, 2004 based on an aggregate of 2,509,238,524 ordinary shares outstanding as of such date:

                 
    Ordinary Shares(1)  
    Beneficially Owned(2)  
Shareholders Holding 5% Or More(3)   Number     Percentage  
Singapore Technologies Semiconductors Pte Ltd
    1,510,324,883       60.19 %

(1)   The number of ordinary shares listed in this table includes ordinary shares held directly or in the form of ADSs.
 
(2)   Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and investment power with respect to ordinary shares. Unless otherwise indicated, the persons named in the table have sole voting and sole investment control with respect to all ordinary shares beneficially owned.
 
(3)   ST Semiconductors is a wholly-owned subsidiary of Temasek. Temasek may be therefore deemed to beneficially own the shares owned by ST Semiconductors, because it is the parent company of ST Semiconductors.

Our company is majority owned by ST Semiconductors. Prior to the ST Restructuring, ST Semiconductors was a wholly owned subsidiary of Singapore Technologies and as such, Singapore Technologies was deemed to beneficially own the shares owned by ST Semiconductors, because it was the parent company of ST Semiconductors.

70


Table of Contents

However, pursuant to the ST Restructuring and Temasek’s acquisition of all of Singapore Technologies’ shareholdings in ST Semiconductors, Singapore Technologies has ceased to be the parent company of ST Semiconductors and accordingly, Singapore Technologies no longer has any deemed interest in our company. Singapore Technologies has ceased to be a substantial shareholder of our company with effect from December 31, 2004.

As of December 31, 2004, 835,782 of our ordinary shares, representing 0.03% of our outstanding shares, were held by a total of 113 holders of record with addresses in the U.S.. As of the same date, 2,733,428 of our ADSs (representing 27,334,280 ordinary shares), representing 1.09% of our outstanding shares, were held by a total of 13 registered holders of record with addresses in the U.S.. Since certain of these ordinary shares and ADSs were held by brokers or other nominees, the number of record holders in the U.S. may not be representative of the number of beneficial holders or their country of residence.

B.   RELATED PARTY TRANSACTIONS

The Singapore Technologies Group

Prior to the ST Restructuring on December 31, 2004, Singapore Technologies was our substantial shareholder and was a holding company for a group of companies. Singapore Technologies had 5 principal business groups: engineering, technology, infrastructure, property and financial services.

Pursuant to the ST Restructuring, Temasek acquired all of Singapore Technologies’ interest in our company. Temasek is owned by the Minister for Finance (Incorporated) of Singapore and is an Asia investment company with investments in a range of industries: telecommunications and media, financial services, property, transportation and logistics, energy and resources, infrastructure, engineering and technology, as well as pharmaceuticals and biosciences.

As of December 31, 2004, Temasek, through its affiliate, beneficially owns 60.19% of our outstanding ordinary shares and, as a result, is able to control actions over many matters requiring approval by our shareholders, including the election of directors and approval of significant corporate transactions. Mr. Peter Seah Lim Huat is a member of the Temasek Advisory Panel and Mr. Sum Soon Lim is a corporate adviser to Temasek.

We also have contractual and other business relationships with Singapore Technologies and several of its affiliates and we may also engage in material transactions with Singapore Technologies and several of its affiliates from time to time. Consequently, conflicts of interest may arise between us in certain circumstances. However, we are not obligated to conduct any business with members of the Singapore Technologies group if the costs of doing so are greater than they would be if we were conducting business with unaffiliated third parties.

Financial Support Provided By Singapore Technologies

In 2004, we had contracted with Singapore Technologies a majority of our forward purchases of foreign exchange. From time to time, we advance funds to or borrow funds from Singapore Technologies at interest rates comparable to rates offered by commercial banks in Singapore. We also participate with Singapore Technologies and/or its affiliates in a pooled cash management arrangement managed by a bank where cash balances are pooled and daily cash surpluses or shortfalls may, on a short-term basis, be lent to or borrowed from other Singapore Technologies affiliates participating in the arrangement at prevailing interbank rates. We also place short-term deposits with Singapore Technologies and/or its affiliates having maturities of less than three months. The interest income received in 2002, 2003 and 2004 was $7.5 million, $6.7 million and $2.9 million respectively. Singapore Technologies also provided us with a short-term credit facility. Pursuant to the ST Restructuring, these activities have discontinued, except for outstanding forward exchange contracts at year end with Singapore Technologies which will be held until maturity.

As of December 31, 2004, $28.1 million of our debt was guaranteed by Singapore Technologies. Notwithstanding the ST Restructuring, Singapore Technologies has agreed to continue to guarantee such debt until it is repaid in 2005.

71


Table of Contents

Corporate Services Provided By Singapore Technologies

In 2004, we had a service agreement with Singapore Technologies pursuant to which it provided us with management and corporate support services, such as treasury, cash management, internal audit, training and executive resources, information technology, bank guarantees and provision of standby credit facilities. In return for those services, support and benefits, we paid Singapore Technologies an annual management fee based on a service based fee arrangement. The management fee was itemized to allow us to compare them with similar services provided by unrelated third parties. In addition, we reimbursed Singapore Technologies for the third-party costs and expenses it incurred on our behalf. Pursuant to the ST Restructuring, the service agreement with Singapore Technologies was terminated with effect from December 31, 2004 and we will now perform these services internally or directly contract with other service providers.

In 2002, 2003 and 2004 management fees paid or payable to Singapore Technologies amounted to $4.0 million, $3.4 million and $2.7 million, respectively. In addition, we reimbursed Singapore Technologies for costs and expenses incurred on our behalf, principally certain of our payroll expenses paid through Singapore Technologies. Such reimbursements totaled $14.8 million, $8.5 million and $7.1 million in 2002, 2003 and 2004, respectively.

Other Transactions With The Singapore Technologies Group

In 2004, we transacted business with Singapore Technologies and several of its affiliates in the normal course of our respective businesses.

We paid STATS ChipPAC $10.4 million, $13.5 million and $19.1 million in 2002, 2003 and 2004 respectively, for services rendered in those years. We also paid other affiliates of Singapore Technologies $1.4 million, $1.4 million and $2.2 million in 2002, 2003 and 2004, respectively, for services rendered in those years. We purchased $0.3 million, $0.2 million and $0.4 million in assets from affiliates of Singapore Technologies in 2002, 2003 and 2004, respectively.

Our company had previously operated Fab 1, which ceased operations at the end of March 2004, on land leased from Ascendas Land (Singapore) Pte Ltd, or Ascendas, a private company wholly-owned by Jurong Town Corporation, or JTC, a statutory board established by the Government of Singapore to develop and manage industrial estates in Singapore. The lease runs until 2017 with a conditional option to extend for another 30 years. Following the cessation of our Fab 1 operations, we are evaluating our options with regards to the future of the lease of Fab 1.

Fabs 2 and 3 and our corporate offices are located on land which we leased from Singapore Technologies which in turn leased the land from JTC. Pursuant to the ST Restructuring, Singapore Technologies’ rights, title, interest and obligations under the sub-leases have been transferred to Terra. These leases run until 2024 with conditional options to extend for another 30 years. The sub-leases for Fab 2 and Fab 3 require us to make rental payments to Terra at rates equal to the rent paid by Terra to JTC for the subject land through 2006 for Fab 2 and 2024 for Fab 3. The rental rates may be re-negotiated thereafter.

CSP leased the land on which Fab 6 is located from Singapore Technologies, which in turn leased it from JTC. Pursuant to the ST Restructuring, Singapore Technologies’ rights, title, interest and obligations under the sub-lease have been transferred to Terra. The lease runs until 2027 with a conditional option to extend for an additional 30 years. CSP is required to make rental payments to Terra at rates equal to the rent paid by Terra to JTC for the subject land through 2027.

Fab 7 is located on land leased to Singapore Technologies by JTC. The lease runs until 2030 with a conditional option to extend for an additional 30 years. Pursuant to the ST Restructuring, Singapore Technologies’ rights, title, interest and obligations under the Agreement for Sub-Licence and Sub-Lease have been transferred to Terra. We have obtained the Temporary Occupation Permit for Fab 7 from the Building and Construction Authority and will be entering into a sub-lease with Terra for the land for a term of 30 years less 1 day with rental payments equal to the rent paid by Terra to JTC.

Lease payments made to Ascendas for Fab 1 and Singapore Technologies for Fabs 2, 3, 6 and 7 for the years ended December 31, 2002, 2003 and 2004 were approximately $2.1 million, $2.8 million and $2.8 million respectively.

In 2004, some of our insurance coverage were held under various insurance policies which were negotiated and maintained by Singapore Technologies but billed directly to us. This enabled us to benefit from the group rates

72


Table of Contents

negotiated by Singapore Technologies. Pursuant to the ST Restructuring, we will be maintaining our own insurance policies under our company’s group insurance.

We also engaged in transactions with other companies directly or indirectly controlled by Temasek in the ordinary course of business. These transactions, such as, phone services from Singapore Telecom and airline tickets from Singapore Airlines are at their prevailing market rates/prices (including where appropriate, preferential rates and discounts) and on customary terms and conditions and are generally not subject to review by the Audit Committee.

C.   INTERESTS OF EXPERTS AND COUNSEL

Not applicable.

ITEM 8.   FINANCIAL INFORMATION

Please see “Item 18. Financial Statements” for a list of financial statements filed under Item 17.

EXPORT SALES

Please see “Item 4. Information On Our Company — Business Overview — Customers and Markets.”

DIVIDEND POLICY

In December 1995 and January 1997, we paid a cash dividend on our ordinary shares in an amount equivalent to $87,000 and $93,000, respectively, for the purpose of qualifying our ordinary shares as “trustee stock” eligible for investment by account holders of the Central Provident Fund, a mandatory employee pension plan administered by the Government of Singapore. Except for these dividends, we have not, since our inception, declared or paid any cash dividends on our ordinary shares. We do not currently anticipate paying any cash dividends for 2004. We may, by ordinary resolution, declare dividends at a general meeting, but we may not pay dividends in excess of the amount recommended by our Board of Directors. Our Board of Directors may also declare interim dividends without seeking shareholder approval. We must pay all dividends out of our profits or pursuant to Section 69 of the Companies Act Chapter 50 of Singapore, or the Companies Act. In making its recommendation, our Board of Directors will consider, among other things, our future earnings, operations, capital requirements and general financial condition, as well as general business conditions and other factors which our Board of Directors may determine are appropriate. Some of our loan agreements restrict the payment of dividends without the prior consent of the lender. We currently intend to retain future earnings, if any, to finance expansion of our business.

LEGAL PROCEEDINGS

As of December 31, 2004, we are not involved in any legal proceedings that we believe would be harmful to our company.

ITEM 9.   THE OFFER AND LISTING

PRICE RANGE OF OUR ADSs AND ORDINARY SHARES

The following table sets forth, for the periods indicated, the high and low last reported sales prices per ADS and ordinary share since trading on October 29, 1999 as furnished by Nasdaq and the Singapore Exchange. The initial public offering price of our ADSs on October 29, 1999 was $20.00 per ADS and S$3.344 per ordinary share. Per ADS and per share prices below reflect the adjustment due to the October 2002 Rights Offering.

(a)   Annual high and low market prices

                 
    Nasdaq  
    High     Low  
January 1, through December 31, 2000
  $ 95.07     $ 23.71  
January 1, through December 31, 2001
  $ 32.37     $ 14.72  
January 1, through December 31, 2002
  $ 27.10     $ 3.94  
January 1, through December 31, 2003
  $ 11.00     $ 3.48  
January 1, through December 31, 2004
  $ 11.35     $ 5.76  

73


Table of Contents

                 
    Singapore Exchange  
    High     Low  
January 1, through December 31, 2000
  S$ 16.03     S$ 4.11  
January 1, through December 31, 2001
  S$ 5.46     S$ 2.59  
January 1, through December 31, 2002
  S$ 4.81     S$ 0.71  
January 1, through December 31, 2003
  S$ 1.93     S$ 0.63  
January 1, through December 31, 2004
  S$ 1.89     S$ 0.92  

(b)   Quarterly high and low market prices

                 
    Nasdaq  
    High     Low  
January 1, through March 31, 2003
  $ 5.17     $ 3.48  
April 1, through June 30, 2003
  $ 5.75     $ 3.50  
July 1, through September 30, 2003
  $ 9.01     $ 5.29  
October 1, through December 31, 2003
  $ 11.00     $ 8.51  
January 1, through March 31, 2004
  $ 11.35     $ 8.50  
April 1, through June 30, 2004
  $ 10.55     $ 7.54  
July 1, through September 30, 2004
  $ 8.13     $ 5.80  
October 1, through December 31, 2004
  $ 6.65     $ 5.76  
                 
    Singapore Exchange  
    High     Low  
January 1, through March 31, 2003
  S$ 0.90     S$ 0.63  
April 1, through June 30, 2003
  S$ 1.00     S$ 0.64  
July 1, through September 30, 2003
  S$ 1.54     S$ 0.92  
October 1, through December 31, 2003
  S$ 1.93     S$ 1.44  
January 1, through March 31, 2004
  S$ 1.89     S$ 1.49  
April 1, through June 30, 2004
  S$ 1.76     S$ 1.33  
July 1, through September 30, 2004
  S$ 1.40     S$ 1.01  
October 1, through December 31, 2004
  S$ 1.11     S$ 0.92  

(c)   Monthly high and low market prices

                 
    Nasdaq  
    High     Low  
September 1, through September 30, 2004
  $ 6.61     $ 5.98  
October 1, through October 31, 2004
  $ 6.65     $ 5.92  
November 1, through November 30, 2004
  $ 6.55     $ 6.21  
December 1, through December 31, 2004
  $ 6.54     $ 5.76  
January 1, through January 31, 2005
  $ 6.37     $ 5.62  
February 1, through February 28, 2005
  $ 7.37     $ 6.16  
                 
    Singapore Exchange  
    High     Low  
September 1, through September 30, 2004
  S$ 1.09     S$ 1.02  
October 1, through October 31, 2004
  S$ 1.11     S$ 1.01  
November 1, through November 30, 2004
  S$ 1.09     S$ 1.01  
December 1, through December 31, 2004
  S$ 1.07     S$ 0.92  
January 1, through January 31, 2005
  S$ 1.01     S$ 0.92  
February 1, through February 28, 2005
  S$ 1.20     S$ 1.00  

The last reported sale price of the ADSs as quoted on Nasdaq on February 28, 2005 was $6.71 per ADS. The last reported sale price of the ordinary shares as quoted on the Singapore Exchange on February 28, 2005 was S$1.10 per ordinary share.

Please see “Item 3. Key Information — Risk Factors — Risks Related to Our Securities and Our Trading Market” regarding the nature of the trading market for our ADSs and ordinary shares.

74


Table of Contents

ITEM 10.   ADDITIONAL INFORMATION
 
A.   SHARE CAPITAL

Not applicable.

B.   OUR MEMORANDUM AND ARTICLES OF ASSOCIATION

A summary of various provisions in our Memorandum and Articles of Association is provided below. This summary is qualified in its entirety by reference to our Memorandum and Articles of Association (see “Item 19. Exhibits — Exhibit 1”).

Objects and purposes

Our objects and purposes are found in paragraph 3 of our Memorandum of Association. Our main object and purpose includes, but is not limited to, the business of manufacturing, assembling and testing semiconductor components and related activities.

Directors

A Director is not entitled to vote in respect of any contract or arrangement or any other proposal whatsoever in which he has any interest, directly or indirectly. A Director will not be counted in the quorum at a Board of Directors’ meeting in relation to a resolution in which he is not entitled to vote.

The ordinary remuneration of our Directors is determined by our shareholders in general meeting. Our Directors determine the payment of extra remuneration to an executive Director, a Director who serves on a Directors’ committee or to a Director who performs services which are outside the scope of the ordinary duties of a Director. Our Directors have the power to determine pensions and other retirement, superannuation, death or disability benefits for an executive Director and to fix the remuneration of a President or Chief Executive Officer.

Our Directors may exercise all powers of our company to borrow money, to mortgage or charge its undertaking, property and uncalled capital and to issue debentures and other securities.

At each annual general meeting, at least one-third of our Directors must retire from office by rotation. A retiring Director is eligible for re-election and the Directors to retire every year are those who have been longest in office since their last re-election or appointment. A Director holding office as President or Chief Executive Officer is subject to retirement by rotation as with the other Directors of the company.

No shares are required to be held by a Director for director’s qualification.

No person over the age of 70 years may be appointed as a Director of our company unless an ordinary resolution is passed at our company’s annual general meeting to appoint such person as a Director.

New ordinary shares

We have only one class of shares, known as ordinary shares. New ordinary shares may only be issued with the prior approval in a general meeting of our shareholders. The approval, if granted, will lapse at the conclusion of the annual general meeting following the date on which the approval was granted or the date by which such annual general meeting is required to be held, whichever is earlier. Our shareholders have given us general authority to issue any remaining approved but unissued ordinary shares prior to our next annual general meeting. Subject to the foregoing, the provisions of the Companies Act and any special rights attached to any shares currently issued, all new ordinary shares are under the control of our Board of Directors who may allot and issue the same with such rights and restrictions as it may think fit, provided that new ordinary shares may not be issued to transfer a controlling interest in our company without the prior approval in general meeting of our shareholders. Our shareholders are not entitled to pre-emptive rights under our Articles of Association.

Our Directors may make calls upon our shareholders in respect of any moneys unpaid on their shares (whether on account of the nominal value of the shares, or when permitted, by way of premium) but subject to the terms of

75


Table of Contents

issue of such shares. This call right does not apply to our currently outstanding ordinary shares, all of which are fully paid.

Transfer of ordinary shares

There is no restriction on the transfer of fully paid ordinary shares except where required by law. Our Board of Directors may only decline to register any transfer of ordinary shares which are not fully paid shares or ordinary shares on which we have a lien. Ordinary shares may be transferred by a duly signed instrument of transfer in any form acceptable to our Board of Directors. Our Board of Directors may also decline to register any instrument of transfer unless, among other things, it has been duly stamped and is presented for registration together with the share certificate and such other evidence of title as they may require. We will replace lost or destroyed certificates for ordinary shares if the applicant pays a fee which will not exceed S$2 and furnishes any evidence and indemnity that our Board of Directors may require.

General meetings of shareholders

We are required to hold an annual general meeting every year. Our Board of Directors may convene an extraordinary general meeting whenever it thinks fit and must do so if shareholders representing not less than 10% of the total voting rights of all shareholders request in writing that such a meeting be held. In addition, two or more shareholders holding not less than 10% of our issued share capital may call a meeting. Unless otherwise required by law or by our Articles of Association, voting at general meetings is by ordinary resolution, requiring an affirmative vote of a simple majority of the votes cast at that meeting. An ordinary resolution suffices, for example, for the appointment of directors. A special resolution, requiring the affirmative vote of at least 75% of the votes cast at the meeting, is necessary for certain matters under Singapore law, including the voluntary winding up of the company, amendments to our Memorandum and Articles of Association, a change of our corporate name and a reduction in our share capital, share premium account or capital redemption reserve fund. We must give at least 21 days’ notice in writing for every general meeting convened for the purpose of passing a special resolution. Ordinary resolutions generally require at least 14 days’ notice in writing. The notice must be given to every shareholder who has supplied us with an address in Singapore for the giving of notices and must set forth the place, the day and the hour of the meeting and, in the case of special business, the general nature of that business.

Voting rights

A shareholder is entitled to attend, speak and vote at any general meeting, in person or by proxy. A proxy need not be a shareholder. A person who holds ordinary shares through the book-entry clearance system maintained by The Central Depository (Pte) Limited, or CDP, will only be entitled to vote at a general meeting as a shareholder if his name appears on the depository register maintained by CDP 48 hours before the general meeting. Except as otherwise provided under our Articles of Association, two or more shareholders holding at least 331/3% of our issued and fully paid up ordinary shares must be present in person or by proxy to constitute a quorum at any general meeting. Under our Articles of Association, on a show of hands, every shareholder present in person and each proxy shall have one vote, and on a poll, every shareholder present in person or by proxy shall have one vote for each ordinary share held. A poll may be demanded in certain circumstances, including by the chairman of the meeting or by any shareholder present in person or by proxy and entitled to vote.

Dividends

We may, by ordinary resolution of our shareholders, declare dividends at a general meeting, but we may not pay dividends in excess of the amount recommended by our Board of Directors. We must pay all dividends out of our profits; however, we may capitalize our share premium account and apply it to pay dividends, if such dividends are satisfied by the issue of shares to our shareholders. Our Board of Directors may also declare interim dividends without seeking shareholder approval. All dividends are paid pro rata among the shareholders in proportion to the amount paid up on each shareholder’s ordinary shares, unless the rights attaching to an issue of any ordinary share provide otherwise. Unless otherwise directed, dividends are paid by cheque or warrant sent through the post to each shareholder at his registered address. Notwithstanding the foregoing, our payment to CDP of any dividend payable to a shareholder whose name is entered in the depository register shall, to the extent of payment made to CDP, discharge us from any liability to that shareholder in respect of that payment.

76


Table of Contents

Bonus and rights issue

Our Board of Directors may, with the approval of our shareholders at a general meeting, capitalize any reserves or profits (including profit or monies carried and standing to any reserve or to the share premium account) and distribute the same as bonus shares credited as paid-up to the shareholders in proportion to their shareholdings. Our Board of Directors may also issue rights to take up additional ordinary shares to shareholders in proportion to their shareholdings. Such rights are subject to any conditions attached to such issue and the regulations of any stock exchanges on which we are listed.

Liquidation or other return of capital

If our company liquidates or in the event of any other return of capital, holders of ordinary shares will be entitled to participate in the distribution of any surplus assets in proportion to their shareholdings.

Limitations on rights to hold or vote shares

Except as described in “Voting Rights” above, there are no limitations imposed by our Articles of Association on the rights of shareholders who are non-resident in Singapore to hold or exercise voting rights attached to ordinary shares.

Provisions discriminating against any existing or prospective holder of shares

There are no provisions in our Articles of Association discriminating against any existing or prospective holder of shares as a result of a shareholder owning a substantial number of shares.

Take-overs

The Singapore Code on Take-overs and Mergers, or the Take-Over Code regulates the acquisition of, among others, ordinary shares of public companies and contains certain provisions that may delay, deter or prevent a future take-over or change in control of our company. Any person acquiring an interest, either on his own or together with parties acting in concert with him, in 30% or more of our voting shares or, if such person holds, either on his own or together with parties acting in concert with him, between 30% and 50% (both inclusive) of our voting shares, and acquires additional voting shares representing more than 1% of our voting shares in any six-month period, may be required to extend a take-over offer for the remaining voting shares in accordance with the provisions of the Take-Over Code.

“Parties acting in concert” comprise individuals or companies who, pursuant to an arrangement or understanding (whether formal or informal), co-operate, through the acquisition by any of them of shares in a company, to obtain or consolidate effective control of that company. Certain persons are presumed (unless the presumption is rebutted) to be acting in concert with each other. They are as follows: a company and its related and associated companies and companies whose associated companies include any of these companies; a company and its directors (including their close relatives, related trusts and companies controlled by any of the directors, their close relatives and related trusts); a company and its pension funds and employee share schemes; a person and any investment company, unit trust or other fund whose investment such person manages on a discretionary basis; a financial or other professional adviser and its client in respect of shares held by the adviser and persons controlling, controlled by or under the same control as the adviser and all the funds managed by the adviser on a discretionary basis, where the shareholdings of the adviser and any of those funds in the client total 10% or more of the client’s equity share capital; directors of a company (including their close relatives, related trusts and companies controlled by any of such directors, their close relatives and related trusts) which is subject to an offer or where the directors have reason to believe a bona fide offer for the company may be imminent; partners; and an individual and his close relatives, related trusts, any person who is accustomed to act in accordance with his instructions and companies controlled by the individual, his close relatives, his related trusts or any person who is accustomed to act in accordance with his instructions.

Subject to certain exceptions, a take-over offer must be in cash or be accompanied by a cash alternative at not less than the highest price paid by the offeror or parties acting in concert with the offeror within the preceding six months.

77


Table of Contents

Under the Take-Over Code, where effective control of a company is acquired or consolidated by a person, or persons acting in concert, a general offer to all other shareholders is normally required. An offeror must treat all shareholders of the same class in an offeree company equally. A fundamental requirement is that shareholders in the company subject to the takeover offer must be given sufficient information, advice and time to consider and decide on the offer.

Indemnity

As permitted by Singapore law, our Articles of Association provide that, subject to the Companies Act, we will indemnify our Board of Directors and officers against any liability incurred in defending any proceedings, whether civil or criminal, which relate to anything done or omitted to have been done as an officer, director or employee and in which judgment is given in their favor or in which they are acquitted or in connection with any application under any statute for relief from liability in respect thereof in which relief is granted by the court. We may not indemnify our Directors and officers against any liability which by law would otherwise attach to them in respect of any negligence, default, breach of duty or breach of trust of which they may be guilty in relation to our company.

Substantial shareholdings

The Companies Act and the Securities and Futures Act Chapter 289 of Singapore require the substantial shareholders of our company to give notice to our company and the Singapore Exchange, including particulars of their interest and the circumstances by reason of which they have such interest, within two business days of their becoming substantial shareholders of our company and of any change in the percentage level of their interest.

Under the Companies Act, a person has a substantial shareholding in our company if he has an interest (or interests) in one or more voting shares in our company and the nominal amount of that share (or the aggregate amount of the nominal amounts of those shares) is not less than 5 per cent. of the aggregate of the nominal amount of all voting shares in our company.

“Percentage level”, in relation to a substantial shareholder, means the percentage figure ascertained by expressing the aggregate of the nominal amount of our voting shares in which the substantial shareholder has an interest or interests immediately before or (as the case may be) immediately after the relevant time as a percentage of the nominal amount of all the voting shares in our company, and, if it is not a whole number, rounding that figure down to the next whole number.

Minority rights

The rights of minority shareholders of Singapore-incorporated companies are protected under Section 216 of the Companies Act, which gives the Singapore courts a general power to make any order, upon application by any shareholder of our company, as they think fit to remedy any of the following situations:

—   if the affairs of our company are being conducted or the powers of our Board of Directors are being exercised in a manner oppressive to, or in disregard of the interests of, one or more of our shareholders; or
 
—   if our company takes an action, or threatens to take an action, or our shareholders pass a resolution, or propose to pass a resolution, which unfairly discriminates against, or is otherwise prejudicial to, one or more of our shareholders, including the applicant.

Singapore courts have wide discretion as to the reliefs they may grant and those reliefs are in no way limited to those listed in the Companies Act itself. Without prejudice to the foregoing, Singapore courts may:

—   direct or prohibit any act or cancel or vary any transaction or resolution;
 
—   regulate the conduct of our affairs in the future;
 
—   authorize civil proceedings to be brought in the name of, or on behalf of, our company by a person or persons and on such terms as the courts may direct;
 
—   provide for the purchase of a minority shareholder’s shares by the other shareholders or by our company and, in the case of a purchase of shares by us, a corresponding reduction of our share capital;

78


Table of Contents

—   provide that the Memorandum or Articles of Association be amended; or
 
—   provide that our company be wound up.

C.   MATERIAL CONTRACTS

The following is a summary of each contract that is material to us and which was entered into by us in the last 2 years. These agreements are also listed in “Item 19 — Exhibits”.

(a)   Loan agreements

CSP Loan Agreements

CSP entered into a Loan Agreement with a syndicate of banks and ABN Amro Bank N.V., Singapore Branch, as agent in September 2000 for an amount of up to $820 million (known as the “CSP Second Phase Credit Agreement”). On September 18, 2003, CSP entered into a Supplemental Agreement to the Second Phase Credit Agreement to extend the availability period of the loan for a further one year period. See “Item 19. Exhibits — Exhibit 4.1.2”.

In 2002, we sought consents from one or more of our lenders and several of CSP’s lenders to allow us to substantially increase CSP’s net worth to enable CSP to satisfy a total debt to net worth ratio for the CSP Second Phase Credit Agreement. Such increase in CSP’s net worth was effected by converting amounts payable by CSP to us into a loan from us to CSP (the “Chartered Loan”).

In obtaining the consents, the CSP Second Phase Credit Agreement was amended to provide for the subordination of the amount of the Chartered Loan to the amounts due by CSP to its other lenders. For a copy of the Letter Agreement incorporating the Subordination Agreement, see “Item 19. Exhibits — Exhibit 4.1.4”, and for a copy of the Subordination Agreement, see “Item 19. Exhibits — Exhibit 4.1.3”.

Chartered Loan Agreements

EXIM Loan

On December 23, 2004, we entered into a facility agreement as borrower with JPMorgan Chase Bank, N.A, or JP Morgan, as lender, Export-Import Bank of the United States, or Exim, and JP Morgan as facility agent (see “Item 19. Exhibits — Exhibit 4.5”). Pursuant to this agreement, we secured a $653 million term loan facility from JP Morgan, guaranteed by Exim. The facility is divided into 2 tranches, has an availability period of between 2 to 4 years, and each tranche will be repaid over a period of 5 years. The loan is to support the Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity. It will be used to finance the purchase of Fab 7 equipment from vendors in the U.S. and will be drawn down in accordance with the equipment purchases per the ramp schedule in Fab 7.

SMBC/OCBC Term Loan

On December 23, 2004, we entered into a facility agreement as borrower with Sumitomo Mitsui Banking Corporation, or SMBC, and Oversea-Chinese Banking Corporation Limited, or OCBC, as lenders and arrangers, pursuant to which the lenders have agreed to provide us with a $200 million term loan facility (with a $100 million green-shoe option) (see “Item 19. Exhibits — Exhibit 4.6”). The facility has an availability period of 3 months from the date of the facility agreement. The repayment period will commence from the end of the 30th month from the date of the first draw down, and the amount drawn down is to be repaid in 6 equal semi-annual installments. The facility is for our working capital requirements, and it is expected to support the Fab 7 phase 1 ramp to 15,000 300-mm wafers per month capacity.

79


Table of Contents

SMBC Revolving Loan

On December 23, 2004, we entered into a facility agreement as borrower with SMBC as lender, pursuant to which SMBC has agreed to provide us with a $150 million revolving facility (see “Item 19. Exhibits — Exhibit 4.7”). The facility has an availability period of 12 months from the date of the facility agreement. Each advance shall be repaid at the end of each interest period, and the facility may be redrawn on a revolving basis, provided that all loan outstanding balances shall be fully repaid within 1 year from the date of the facility agreement. The facility is for our working capital requirements, and it is expected to support the Fab 7 phase 1 ramp of 15,000 300-mm wafers per month capacity.

BOA Term Loan

On December 22, 2004, we entered into a facility agreement as borrower with Bank of America, or BOA as lender, pursuant to which BOA has agreed to provide us with a $50 million term loan facility (see “Item 19. Exhibits — Exhibit 4.8”). The facility has an availability period of 3 months from the date of the facility agreement, and is repayable as a lump sum repayment 36 months after the date of the facility agreement. The facility is for our working capital requirements, and it is expected to support the Fab 7 phase 1 ramp of 15,000 300-mm wafers per month capacity.

Goldman Sachs International

In August 2004, we entered into a bilateral option transaction with Goldman Sachs International, as counter-party, to pro-actively manage our Convertible Notes due April 2, 2006 (see “Item 19. Exhibits — Exhibit 4.9”). Please see “Item 5. Operating and Financial Review Prospects — Liquidity and Capital Resources — Current and expected liquidity” for additional information regarding our bilateral option transaction with Goldman Sachs International.

(b)   Strategic alliances

CSP

Our subsidiary, CSP, is a joint venture between Chartered (51%), EDB Investments (26.5%), Agilent Technologies Europe B.V. (15%) (previously Hewlett-Packard Europe B.V.), and Singapex Investments Pte Ltd, or Singapex (7.5%).

As part of Agilent Technologies, Inc.’s strategy that led to Agilent Technologies Europe B.V. reducing its ownership in CSP in October 2001, Agilent Technologies Europe B.V. relinquished the voting rights of its nominees on the Board of Directors of CSP. The parties entered into Amendment No. 1 dated January 31, 2002 to the Restated Joint Venture Agreement dated October 23, 2001 to effect such change (see “Item 19. Exhibits — Exhibit 4.11”).

SMP

We entered into a Joint Venture Agreement with Lucent Technologies Microelectronics Pte Ltd, now known as Agere Systems Singapore Pte Ltd, to form the Silicon Manufacturing Partners strategic alliance relating to the joint ownership of Fab 5. In September 2004, we entered into a Supplemental Agreement to the Joint Venture Agreement (see “Item 19. Exhibits — Exhibit 4.16”) to provide that SMP can pay dividends out of the profits of the venture determined on a year to year basis rather than a cumulative basis as previously was the case.

As part of the SMP alliance, we also entered into a License and Technology Agreement with SMP and Lucent Technologies Microelectronics Pte. Ltd. This agreement has been amended several times, with the last amendment made on July 1, 2003 (See “Item 19. Exhibits — Exhibit 4.23”) to provide for additional process technologies to be transferred (for a summary of this arrangement, see “Item 4. Information on Our Company — Business Overview — Strategic Alliances — Silicon Manufacturing Partners”).

80


Table of Contents

(c)   Technology transfer, licenses, joint development and other related agreements

Agere Systems

We entered into a Technology Transfer Agreement with Lucent Technologies Inc., now known as Agere Systems Inc. in February 1998 to transfer technology to one another. Under this Agreement, Lucent and our company transferred to one another 0.25um process technology. The agreement has been amended several times, with the last amendment made on March 28, 2002 (see “Item 19. Exhibits — Exhibit 4.27”), for the purpose of updating the list of process technologies transferred to one another.

We also entered into a Patent License Agreement with Agere Systems Inc. in January 1998 which was amended in 2000. Under this Agreement, Agere Systems Inc. and our company granted to one another a license to use certain of each other’s patents and for us to provide wafer capacity to Agere Systems Inc. in lieu of royalty payments for the use of Agere Systems Inc.’s patents.

In September 2002, we entered into a Letter Agreement with Agere Systems Inc. (see “Item 19. Exhibits — Exhibit 4.30”), where in exchange for our agreement to waive Agere Systems Inc.’s capacity shortfall fees under our manufacturing agreement with them, Agere Systems Inc. agreed to treat our royalty obligations under the patent license agreement with Agere Systems Inc. as satisfied until such time as Agere Systems Inc.’s ownership interest in SMP falls below 49%. Thereafter, the existing provisions in the patent license agreement allowing us to offset royalty payments in exchange for the provision of short and long term flexibility in wafer capacity to Agere Systems Inc. continue to apply.

IBM

We entered into a Patent Cross-License Agreement with IBM dated January 1, 2001 (see “Item 19. Exhibits — Exhibit 4.32”). Under this agreement, IBM and our company granted to one another a license to use certain of each other’s patents. This agreement was amended effective as of November 26, 2002, to expand the scope of the licenses and to extend the term of the licenses granted to each party (see “Item 19. Exhibits — Exhibit 4.33”).

Effective as of November 26, 2002, we entered into the following agreements with IBM: “SF” Process Development and Cost Sharing Agreement (see “Item 19. Exhibits — Exhibit 4.34”), Copper/Related FEOL Technology License Agreement (see “Item 19. Exhibits — Exhibit 4.35”) and Refundable Cross Deposit Agreement (see “Item 19. Exhibits — Exhibit 4.40”).

The “SF” Process Development and Cost Sharing Agreement provides for the development of 90 nm and 65 nm logic processes on 300-mm silicon wafers. Effective as of March 9, 2004, the “SF” Process Development and Cost Sharing Agreement was amended and restated to address certain matters between the parties pertaining to the “SF” Process 65nm/45nm Development and Cost Sharing Agreement which the parties entered into together with Infineon and Samsung (see “Item 19. Exhibits — Exhibit 4.37”). The “SF” Process Development and Cost Sharing Agreement was further amended effective as of November 5, 2004 to expand the parties’ agreement with regard to design kit models for the 300-mm Wafer 90nm Bulk CMOS Process Development Project under the “SF” Process Development and Cost Sharing Agreement, as previously amended and the coordination of related activities (see “Item 19. Exhibits — Exhibit 4.38”). More recently on December 15, 2004, the “SF” Process Development and Cost Sharing Agreement was further amended to extend parties’ collaboration to include 45nm technologies (see Item 19. Exhibits – Exhibit 4.39”).

Under the Copper/Related FEOL Technology License Agreement, IBM transferred and licensed to Chartered certain know-how and skills relating to certain copper back end of line and related front end of line techniques. Under the Refundable Cross Deposit Agreement, each of IBM and Chartered would deposit certain funds with the other party to secure certain manufacturing capacity in each other’s facility. In addition, effective as of December 19, 2003, a Supplemental Agreement to the Refundable Cross Deposit Agreement was entered into to revise some of the terms relating to the deposit and pricing of the goods sold by Chartered to IBM (see “Item 19. Exhibits — Exhibit 4.41”).

81


Table of Contents

IBM, Infineon and Samsung

As of March 5, 2004, we extended the “SF” Process 65nm/45nm Development and Cost Sharing Agreement” with IBM and Infineon to include Samsung (see “Item 19. Exhibits — Exhibit 4.42”). This agreement replaces and is in substitution of the “SF” Process 65nm/45nm Development and Cost Sharing Agreement dated June 26, 2003 by and amongst IBM, Infineon and Chartered. For more information on this agreement with IBM, Infineon and Samsung, please see “Item 4. Information on Our Company — Business Overview — Research and Development”.

Motorola

We entered into a Patent License Agreement with Motorola Inc., or Motorola, dated July 1, 2003 (see “Item 19. Exhibits — Exhibit 4.43”). Under this Agreement, Motorola and our company granted to one another a license to use certain of each other’s patents.

(d) Leases

Please see “Item 4. Information On Our Company — Property, Plant and Equipment — Leases” for information on our leases.

D.   EXCHANGE CONTROLS

Currently, no exchange control restrictions exist in Singapore. There are no provisions under Singapore law or under our Articles of Association that limit our ADS holders’ ability to exercise their voting rights. However, under the deposit agreement for the ADSs, there may be practical limitations upon the ability of our ADS holders to exercise their voting rights. Please see “Item 3. Key Information — Risk Factors — Risks Related to Our Securities And Our Trading Market — Your voting rights with respect to the ADSs are limited by the terms of the deposit agreement for the ADSs” regarding the practical limitations applicable to holders of our ADSs with respect to voting rights.

Exchange rates

Fluctuations in the exchange rate between the Singapore dollar and the U.S. dollar will affect the U.S. dollar equivalent of the Singapore dollar price of the ordinary shares on the Singapore Exchange and, as a result, are expected to affect the market price of ADSs. These fluctuations will also affect the U.S. dollar conversion by the depositary of any cash dividends paid in Singapore dollars on the ordinary shares represented by ADSs or any other distribution received by the depositary in connection with the payment of dividends on the ordinary shares.

The following table sets forth, for the fiscal years indicated, information concerning the exchange rates between Singapore dollars and U.S. dollars based on the average of the noon buying rate in the City of New York on the last business day of each month during the period for cable transfers in Singapore dollars as certified for customs purposes by the Federal Reserve Bank of New York. The table illustrates how many Singapore dollars it would take to buy one U.S. dollar.

                                 
    Singapore Dollars Per U.S. $1.00  
    Noon Buying Rate  
Fiscal Year Ended December 31,   Average (1)     High     Low     Period End  
2000
    1.7250       1.7600       1.6535       1.7315  
2001
    1.7937       1.8540       1.7275       1.8470  
2002
    1.7908       1.8525       1.7310       1.7352  
2003
    1.7432       1.7838       1.6990       1.6990  
2004
    1.6870       1.7291       1.6308       1.6319  
                 
Month   High     Low  
September 2004
    1.7065       1.6847  
October 2004
    1.6915       1.6628  

82


Table of Contents

                 
Month   High     Low  
November 2004
    1.6675       1.6367  
December 2004
    1.6531       1.6308  
January 2005
    1.6496       1.6303  
February 2005
    1.6518       1.6240  


(1)   The average of the daily Noon Buying Rates on the last business day of each month during the year.

Certain Singapore dollar amounts contained in this document have been translated to U.S. dollars as of December 31, 2004, at an exchange rate of S$1.645 = $1.00. No representation is made that the Singapore dollar or U.S. dollar amounts shown in this document could have been or could be converted at such rate or at any other rate.

E.   TAXATION

SINGAPORE TAXATION

The following discussion is a summary of the material Singapore income tax, stamp duty and estate duty consequences of the purchase, ownership and disposal of the ordinary shares or ADSs (collectively the “securities”) to a holder of the securities that is not resident in Singapore. This discussion does not purport to be a comprehensive description of all of the Singapore tax considerations that may be relevant to a decision to purchase, own or dispose of the securities and does not purport to deal with the Singapore tax consequences applicable to all categories of investors. Holders of the securities and prospective purchasers of the securities should consult their own tax advisers as to the Singapore or other tax consequences of the purchase, ownership or disposal of the securities including, in particular, the effect of any foreign, state or local tax laws to which they are subject.

This discussion is based on tax laws in effect in Singapore and on administrative and judicial interpretations of these tax laws, as of the date of this document, all of which are subject to change, possibly on a retroactive basis.

Income tax

General. Non-resident corporate taxpayers are subject to income tax on income that is accrued in or derived from Singapore, and on foreign income received or deemed received in Singapore, subject to certain exceptions. A non-resident individual is subject to income tax on the income accrued in or derived from Singapore.

Subject to the provisions of any applicable double taxation treaty, non-resident taxpayers who derive certain types of income from Singapore are subject to a withholding tax on that income at a rate of 22% for the year of assessment 2004 and a rate of 20% with effect from the year of assessment 2005 (or 15% in the case of interest, royalty and rental of movable equipment), subject to certain exceptions. We are obligated by law to withhold tax at the source.

A corporation will be regarded as being resident in Singapore if the control and management of its business is exercised in Singapore (for example, if the corporation’s board of directors meets and conducts the business of the corporation in Singapore). An individual is tax resident in Singapore in a year of assessment if, in the preceding year, he or she was physically present in Singapore or exercised an employment in Singapore (other than as a director of a company) for 183 days or more, or if he or she resides in Singapore.

Dividend distributions

Dividends received in respect of the ordinary shares or ADSs by either a resident or non-resident of Singapore are not subject to Singapore withholding tax.

Dividends paid out of Tax-Exempt Income or Income subject to Concessionary Tax Rates

If we pay dividends on the ordinary shares or ADSs out of income received that is exempt from tax because of our pioneer status or out of our income received that is subject to tax at a concessionary rate, if any, such dividends will be free from Singapore tax in the hands of the holders of the ordinary shares and ADSs. Please see “Item 5. Operating and Financial Review and Prospects — Special Tax Status” for a discussion of our tax incentive status.

83


Table of Contents

Dividends paid out of income subject to normal corporate taxation

Imputation System. Before January 1, 2003 (and to a certain extent between January 1, 2003 and December 31, 2007, pursuant to the transitional rules for the new one-tier corporate tax system (see “New One-Tier Corporate Tax System” below)), the imputation system of corporate taxation applied in Singapore. Under this system, the tax we paid on income subject to tax at the prevailing corporate income tax rate (22% for the year of assessment 2004 and 20% with effect from the year of assessment 2005) would be imputed to, and deemed to be paid on behalf of, our shareholders upon distribution of such income as dividends. Our shareholders would have received dividends (“Franked Dividends”) net of such tax and would be taxed on the gross amount of dividends (that is, on the amount of net dividends plus an amount equal to the amount of gross dividends multiplied by the prevailing corporate tax rate). In this way, the tax we paid would have been available to our shareholders as a tax credit to offset their tax liability on their overall income subject to Singapore income tax (including the gross amount of dividends).

A non-resident shareholder is effectively taxed on Franked Dividends at the corporate income tax rate. Thus, because tax deducted from the dividend and paid by us at the corporate income tax rate is in effect imputed to, and deemed paid on behalf of, our shareholders (as discussed in the preceding paragraph), no further Singapore income tax will be imposed on net dividends received by a non-resident holder of ordinary shares or ADSs. Further, the non-resident shareholder which does not have a permanent establishment in Singapore and deductible expenses attributed to such dividend income would normally not receive any tax refund from the Inland Revenue Authority of Singapore.

New one-tier corporate tax system. A new one-tier corporate tax system became effective from January 1, 2003 (subject to certain transitional rules). Under this new system, the tax on corporate profits is final and dividends paid by a Singapore resident company will be tax exempt in the hands of a shareholder, regardless of whether the shareholder is a company or an individual and whether or not the shareholder is a Singapore tax resident. Accordingly, under the one-tier corporate tax system, no further Singapore income tax will be imposed on the net dividends received by a non-resident holder of ordinary shares or ADSs.

However, to enable companies to make use of their unutilized dividend franking credits as of December 31, 2002, there will be a five year transition period from January 1, 2003 to December 31, 2007, during which a company may remain on the imputation system for the purposes of paying Franked Dividends out of its unutilized dividend franking credits as of December 31, 2002.

Accordingly, for so long as we have not moved to the one-tier corporate tax system, shareholders may continue to receive dividends with credits attached as described above under “Imputation System”.

For the period up to December 31, 2007, when the imputation system will co-exist with the one-tier corporate tax system, if we have not moved to the one-tier system, tax vouchers issued by us will distinguish between franked dividends and normal tax exempt dividends not being exempt dividends under the one-tier system, such as dividends paid out of tax-exempt income, approved deduction or further deduction of expenses or foreign tax credit allowed. If we have fully utilized our dividend franking credits (that is, we are required to move to the one-tier system) or if we elect to move to the one-tier system at an earlier date, tax vouchers issued by us will distinguish between normal tax exempt dividends and exempt dividends under the one-tier system. We do not presently intend to migrate to the new one tier corporate tax system until our dividend franking credits as of December 31, 2002 are fully utilized or until the transition period comes to an end, whichever is earlier.

No comprehensive tax treaty currently exists between Singapore and the U.S.

Gains on Disposal of the Ordinary Shares or ADSs

Singapore does not impose tax on capital gains. However, there are currently no specific laws or regulations which address the characterization of capital gains; hence, gains or profits may be construed to be of an income nature and subject to tax, especially if they arise from activities which the Inland Revenue Authority of Singapore regards as the carrying on of a trade or business in Singapore. Thus, any gains or profits from the disposal of the ordinary shares or ADSs are not taxable in Singapore unless the seller is regarded as carrying on a trade or business (for example, one of dealing in securities) in Singapore, in which case the disposal profits would be taxable as such profits would be considered revenue in nature.

84


Table of Contents

Stamp duty

There is no stamp duty payable in respect of the issuance and holding of ordinary shares or ADSs. Where existing ordinary shares or ADSs evidenced in certificated form are acquired in Singapore, stamp duty is payable on the instrument of transfer of the ordinary shares or ADSs at the rate of S$2.00 for every S$1,000 or part thereof of the consideration for, or market value of, the ordinary shares or ADSs, whichever is higher. The stamp duty is borne by the purchaser unless there is an agreement to the contrary. Where an instrument of transfer is executed outside Singapore or no instrument of transfer is executed, no stamp duty is payable on the acquisition of existing ordinary shares or ADSs. However, stamp duty may be payable if the instrument of transfer is executed outside Singapore and received in Singapore.

Estate duty

In the case of an individual who is not domiciled in Singapore, Singapore estate duty is imposed on the value of immovable properties of the individual situated in Singapore. Estate duty is not imposed on the movable properties in Singapore owned by a non-domiciled person. Thus, an individual holder of the ordinary shares or ADSs who is not domiciled in Singapore at the time of his or her death will not be subject to Singapore estate duty on the value of the ordinary shares or ADSs held by the individual upon the individual’s death.

Prospective purchasers of ordinary shares or ADSs who are individuals, whether or not domiciled in Singapore, should consult their own tax advisers regarding the Singapore estate duty consequences of their investment and ownership of such ordinary shares and/or ADSs.

U.S. FEDERAL TAXATION

The following is a summary of certain material U.S. federal income and estate tax consequences that may be relevant to a U.S. holder with respect to the acquisition, ownership and disposition of ordinary shares or ADSs. For purposes of this summary, a “U.S. holder” is a beneficial owner of ordinary shares or ADSs who is included in at least one of the following categories:

•   citizens or residents of the U.S. for U.S. federal income tax purposes,
 
•   corporations or other entities created or organized under the laws of the U.S. or of any political subdivision thereof,
 
•   estates the income of which is subject to U.S. federal income taxation regardless of source,
 
•   any trust the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust, or, if the trust was in existence on August 20, 1996, has elected to continue to be treated as a U.S. person, or
 
•   persons otherwise subject to U.S. federal income taxation on their worldwide income regardless of its source.

This summary deals only with ordinary shares and ADSs held as capital assets (within the meaning of section 1221 of the Internal Revenue Code of 1986, as amended (the “Code”)) and does not address the tax consequences applicable to holders that may be subject to special tax rules, including without limitation financial institutions, insurance companies, regulated investment companies, dealers in securities or currencies, persons holding ordinary shares or ADSs as a hedge against currency risks or as a position in a “straddle” or “conversion transaction” or other integrated investment transaction for tax purposes, persons whose “functional currency” is not the U.S. dollar, or holders of 10% or more, by voting power or value, of the stock of our company. This summary is based upon the Code, existing temporary and proposed Treasury Regulations, Internal Revenue Service (“IRS”) rulings and judicial decisions as now in effect and as currently interpreted and does not take into account possible changes in such tax laws or interpretations, any of which may be applied retroactively and could affect the tax consequences described below. This summary further is based in part on the assumption that each obligation in the deposit agreement and any related agreement will be performed in accordance with its terms.

85


Table of Contents

Ownership of ADSs

For U.S. federal income tax purposes, U.S. holders of ADSs will be treated as the owners of the ordinary shares represented by such ADSs.

Dividends

Subject to the passive foreign investment company rules discussed below, distributions of cash or property (other than certain distributions of ordinary shares, if any) with respect to ordinary shares will be generally included in income by a U.S. holder as foreign source dividend income at the time of receipt, which in the case of a U.S. holder of ADSs generally will be the date of receipt by the depositary, to the extent such distributions are made from the current or accumulated earnings and profits of our company (as determined under U.S. federal income tax principles). Such dividends will not be eligible for the dividends received deduction generally allowed to corporate U.S. holders. To the extent, if any, that the amount of any distribution by our company exceeds our company’s current and accumulated earnings and profits as determined under U.S. federal income tax principles, it will be treated first as a tax-free return of the U.S. holder’s tax basis in the ordinary shares or ADSs and thereafter as capital gain.

A U.S. holder will not be eligible for a foreign tax credit against its U.S. federal income tax liability for Singapore dividend distribution taxes, if any, paid by our company. U.S. holders should be aware that dividends paid by our company generally will constitute “passive income” or, in the case of certain U.S. holders, “financial services income” for purposes of the foreign tax credit. Dividends paid by our company for taxable years beginning after December 31, 2006 will generally be “passive category income” or, in the case of certain U.S. holders, “general category income” for purposes of the foreign tax credit.

If dividends are paid in Singapore dollars, the amount of the dividend distribution includible in the income of a U.S. holder will be the U.S. dollar value of the payments made in Singapore dollars, determined at a spot exchange rate between Singapore dollars and U.S. dollars on the date the dividend is includible in income by the U.S. holder in accordance with its method of accounting, regardless of whether the payment is in fact converted into U.S. dollars. Generally, gain or loss, if any, resulting from currency exchange fluctuations during the period from the date of distribution to the date such payment is converted into U.S. dollars will be treated as ordinary income or loss.

Dividends received by a non-corporate U.S. holder on the ordinary shares or ADSs for taxable years of such holder beginning after December 1, 2002 and before January 1, 2009 may be taxed at the lower applicable capital gains rate provided that (1) we are not a PFIC (as discussed below) for either our taxable year in which the dividend was paid or the preceding taxable year, (2) our ADSs or ordinary shares, as applicable, are readily tradable on an established securities market in the U.S. and (3) certain holding period requirements are met. You should consult your own tax advisors regarding the availability of the lower rate for dividends paid with respect to ADSs or ordinary shares.

Sale or exchange of ordinary shares or ADSs

Subject to the passive foreign investment company rules discussed below, a U.S. holder generally will recognize capital gain or loss on the sale or exchange of ordinary shares or ADSs equal to the difference between the amount realized on such sale or exchange and the U.S. holder’s tax basis in the ordinary shares or ADSs, as the case may be. Such gain or loss will be long-term capital gain or loss if the ordinary shares or ADSs, as the case may be, were held for more than one year. Gain or loss, if any, recognized by a U.S. holder generally will be treated as U.S. source income or loss for U.S. foreign tax credit purposes.

PFIC rules

A non-U.S. corporation will be classified as a PFIC for U.S. federal income tax purposes if either (i) 75% or more of its gross income for the taxable year is passive income, or (ii) on a quarterly average for the taxable year by value (or, if it is not a publicly traded corporation and so elects, by adjusted basis), 50% or more of its gross assets produce or are held for the production of passive income.

We do not believe that we satisfied either of the tests for PFIC status in 2004. However, there can be no assurances that we will not be a PFIC in 2005 or a later year. If, for example, the “passive income” earned by us exceeds 75% or more of our “gross income”, we will be a PFIC under the “income test”. In addition, it is also

86


Table of Contents

possible that we will be a PFIC under the “asset test”. The determination of the value of our assets will be based in part on the market price of our ordinary shares and ADSs. Because we have historically held, and may continue to hold a substantial amount of passive assets, there is a substantial risk that we may be a PFIC in 2005 or in a later year. Passive income for PFIC purposes includes, among other things, interest, dividends, royalties, rents and annuities. For manufacturing businesses, gross income for PFIC purposes should be determined by reducing total sales by the cost of goods sold. Although not free from doubt, if our cost of goods sold exceeds our total sales by an amount greater than the amount of all of our other income (excluding total sales), such that we are treated as if we had no gross income for PFIC purposes, we would not be a PFIC as a result of the income test.

If we were to be a PFIC at any time during a U.S. holder’s holding period, such U.S. holder would be required to either: (i) pay an interest charge together with tax calculated at maximum ordinary income rates on “excess distributions,” which is defined to include gain on a sale or other disposition of ordinary shares or ADSs, or (ii) so long as the ordinary shares or ADSs are “regularly traded” on a qualifying exchange, elect to recognize as ordinary income each such year the excess in the fair market value, if any, of its ordinary shares or ADSs at the end of the taxable year over such holder’s adjusted basis in such ordinary shares or ADSs and, to the extent of prior inclusions of ordinary income, recognize ordinary loss for the decrease in value of such ordinary shares or ADSs (the “mark to market” election). For this purpose, the Nasdaq National Market will qualify as a qualifying exchange. U.S. holders are strongly urged to consult their own tax advisers regarding the application of the PFIC rules.

Estate taxes

An individual shareholder who is a citizen or resident of the U.S. for U.S. federal estate tax purposes will have the value of the ordinary shares or ADSs owned by such holder included in his or her gross estate for U.S. federal estate tax purposes. An individual holder who actually pays Singapore estate tax with respect to the ordinary shares or ADSs will, however, be entitled to credit the amount of such tax against his or her U.S. federal estate tax liability, subject to certain conditions and limitations.

Backup withholding tax and information reporting requirements

In general, information reporting requirements will apply to payments of dividends in respect of the ordinary shares or ADSs or the proceeds received on the sale, exchange or redemption of the ordinary shares or ADSs by a paying agent within the U.S. or with certain U.S. connections to a non-corporate U.S. holder that is not otherwise exempt, and a backup withholding tax may apply to such amounts if the U.S. holder fails to provide an accurate taxpayer identification number to the paying agent. Amounts withheld as backup withholding will be creditable against the U.S. holder’s U.S. federal income tax liability, provided that the required information is furnished in a timely manner to the Internal Revenue Service.

The above summary is not intended to constitute a complete analysis of all tax consequences relating to ownership of ordinary shares or ADSs. You should consult your tax adviser concerning the tax consequences of your particular situation.

F.   DIVIDENDS AND PAYING AGENTS

Not applicable.

G.   STATEMENT BY EXPERTS

Not applicable.

H.   DOCUMENTS ON DISPLAY

Publicly filed documents concerning our company can be obtained from the Public Reference Section of the SEC, 450 Fifth Street, N.W., Washington D.C. 20549, at prescribed rates.

The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements and other information regarding registrants that make electronic filings with the SEC using its EDGAR system. As a foreign

87


Table of Contents

private issuer, we are now required to use the EDGAR system. We have done so in the past and will continue to do in order to make our reports available over the Internet.

I.   SUBSIDIARY INFORMATION

For more information on our subsidiaries, please see “Item 4. Information on Our Company — Organizational Structure”.

ITEM 11.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Quantitative and qualitative disclosures about market risk

Our exposure to financial market risks derives primarily from the changes in interest rates and foreign exchange rates. To mitigate these risks, our company utilizes derivative financial instruments, the application of which is primarily for hedging purposes and not for speculative purposes.

Interest rate risk

We are exposed to interest rate risk on our existing floating rate debt and on additional debt financing that may periodically be needed for the capital expenditures associated with our capacity expansion and new fabs. The interest rate that we will be able to obtain on debt financing will depend on market conditions at that time, and may differ from the rates we have secured on our current debt.

Our debt obligations are as follows:

                                                                 
    As of December 31, 2004        
    Expected Maturity Date     As of December 31, 2003  
    (in Thousands, except interest rates)     (in Thousands)  
                                            Weighted Average              
    2005     2006     Thereafter     Total     Fair Value     Interest Rate     Total     Fair Value  
LONG TERM DEBT
                                                               
Singapore dollar at fixed
rate(1)
  $ 58,452     $ 15,198           $ 73,650     $ 75,567       5.9129 %   $ 127,299     $ 131,253  
U.S. dollar at floating rate(2)
    294,533       294,533             589,066       589,066       3.2375 %     502,000       502,000  
2.5% convertible notes issued in April 2001(3)
          575,000             575,000       592,810       5.1440 %     575,000       607,059  
Other(4)
          (1,986 )           (1,986 )     (1,986 )           8,453       8,453  
 
                                                   
Total
  $ 352,985     $ 882,745           $ 1,235,730     $ 1,255,457             $ 1,212,752     $ 1,248,765  
 
                                                   
                 
    As of December 31,  
    (in Thousands)  
    2003     2004  
ACCOUNTS PAYABLE
               
U.S dollar
  $ 39,136     $ 73,508  
Singapore dollar
    15,383       11,321  
Japanese Yen
    4,158       44,473  
Others
    1,876       18,359  
 
           
Total Payable
  $ 60,553     $ 147,661  
 
           


(1)   We have entered into forward foreign contracts related to a portion of these amounts to exchange the related cash flows to U.S. dollars. Please see “Foreign Currency Risk” below.
 
(2)   In August 2004, we entered into two interest rate cap contracts in respect of the floating rate obligations associated with $100.0 million of the U.S. dollar loan, with the effect of placing an upper limit on the cash flow and earnings exposure due to market interest rate changes. The floating rate obligations are based on LIBOR rates and are payable semi-annually commencing March 28, 2004. The combination of the cap and the debt obligation results in a maximum interest outflow equal to 2.75%. The notional amount on the interest rate cap is reduced by $25.0 million semi-annually commencing from March 29, 2005 and will mature on September 28, 2006. The fair value of the two interest cap contracts at December 31, 2004 was $0.5 million.
 
(3)   In January 2003, we entered into an additional swap in connection with a previously executed swap in 2001. The previously executed interest rate swap contract is in respect of the fixed-rate obligations associated with $200.0 million of the Convertible Notes, with the effect of swapping the fixed-rate interest obligations to a

88


Table of Contents

    floating-rate obligation based on LIBOR rates to hedge against fair value risk. The fixed-rate obligations on the convertible notes are payable semi-annually on April 2 and October 2 of each year, commencing October 2, 2001. The additional swap has incorporated the hedging of the accreting portion of the bond that was not included in the original swap, thereby increasing the hedge effectiveness. The fair value of the two interest rate swap contracts at December 31, 2004 was $12.9 million.
 
    In August 2003, we entered into an interest rate swap contract in respect of the fixed-rate obligations associated with $375.0 million of the Convertible Notes issued in April 2001, with the effect of swapping the fixed-rate interest obligations to a floating-rate obligation based on LIBOR rates to hedge against fair value risk. The swap also incorporated hedging of the accreting portion of the convertible notes. The fair value of this interest rate swap contract at December 31, 2004 was $48.4 million.
 
(4)   Other long-term debt includes the cumulative fair value change due to changes in interest rates of the Convertible Notes. This change is recorded because the company has entered into interest rate swap contracts that have the effect of swapping the fixed-rate interest to a floating rate. The Company designated these derivative instruments as fair value hedges and carried the same at fair value.

As of December 31, 2004, 6.0% of our outstanding debt obligations bore fixed interest rates. We have no cash flow or earnings exposure due to market interest rate changes for our fixed debt obligations. 94.0% of our outstanding debt obligations bear floating interest rates (inclusive of the $575 million fixed rate interest obligations associated with the Convertible Notes which was swapped into a floating rate obligation). We have cash flow and earnings exposure due to market interest rate changes for our floating debt obligations. A half percentage point change in interest rates would affect our interest payments by 16.1% annually.

Foreign currency risk

Our foreign currency exposures give rise to market risk associated with exchange rate movements of the U.S. dollar, which is our functional currency, against the Japanese yen, the Singapore dollar and the Euro. A substantial part of our debt is denominated in foreign currencies, primarily Singapore dollar. Substantially all of our revenue was denominated in U.S. dollars during 2004 and as a result, we had relatively little foreign currency exchange risk with respect to any of our revenue. In 2004, approximately 21% of our cost of revenue was denominated in Singapore dollars. In addition, approximately 55% of our capital expenditures were denominated in U.S. dollars, approximately 17% were denominated in Euro, approximately 24% were denominated in Japanese yen and approximately 4% were denominated in Singapore dollars.

To protect against reductions in value and the volatility of future cash flows caused by changes in foreign exchange rates, we utilize currency forward contracts to minimize the impact of foreign currency fluctuations on our results of operations. We utilize, from time to time, currency forward contracts as economic hedges so as to minimize our exposure to specific currency risks related to equipment purchase commitments, primarily in Japanese yen and Euro. In addition, we minimize our currency risk by purchasing certain raw materials and equipment in U.S. dollars and borrowing in U.S. dollars. The table below provides information about our derivative financial instruments and presents the information in U.S. dollar equivalents.

                                                 
    As of December 31, 2004        
    Expected Maturity Date Of Notional Amounts     As of December 31, 2003  
    (in Thousands, except exchange rates)     (in Thousands)  
FORWARD FOREIGN                                    
EXCHANGE AGREEMENTS   2005     Thereafter     Total     Fair Value     Total     Fair Value  
(Receive Yen/Pay US$)
                                               
Contract Amount
  $ 69,210           $ 69,210     $ 2,520     $ 11,614     $ 958  
Average Contractual Exchange Rate
    108.21                                        
(Receive S$/Pay US$)
                                               
Contract Amount
  $ 47,842           $ 47,842     $ 1,760     $ 81,983     $ 1,516  
Average Contractual Exchange Rate
    1.70                                        
(Receive Euros/Pay US$)
                                               
Contract Amount
  $ 26,760           $ 26,760     $ 2,857     $ 3,295     $ 354  
Average Contractual Exchange Rate
    1.24                                        
 
                                   
Total Contract Amount
  $ 143,812           $ 143,812     $ 7,137     $ 96,892     $ 2,828  
 
                                   

89


Table of Contents

                                                         
    As of December 31, 2004        
    Expected Maturity Date Of Notional Amounts     As of December 31, 2003  
    (in Thousands)     (in Thousands)  
    2005     2006     Thereafter     Total     Fair Value     Total     Fair Value  
CROSS CURRENCY SWAP
                                                       
(Swapping S$ into US$) Contract Amount(1)
  $ 30,395     $ 15,198           $ 45,593     $ (5 )   $ 73,225     $ (4,495 )
 
                                           
Total
  $ 30,395     $ 15,198           $ 45,593     $ (5 )   $ 73,225     $ (4,495 )
 
                                           


(1)   We have entered into a cross currency swap to convert one of the Singapore dollar fixed rate loans to a U.S. dollar denominated fixed rate instrument.
                                                 
    As of December 31, 2004     As of December 31, 2003  
    (in Thousands, except percentages)     (in Thousands, except percentages)  
    Carrying     Amount     Percentage     Carrying     Amount     Percentage  
    Amount     Hedged     Hedged     Amount     Hedged     Hedged  
NON-U.S. DOLLAR LIABILITIES
                                               
Accounts Payable
                                               
Japanese Yen
  $ 44,473     $ 44,473       100 %   $ 4,158     $ 4,158       100 %
Singapore dollar
    11,321       11,321       100       15,383       15,383       100  
Others
    18,359       18,359       100       1,876       1,876       100  
Foreign Currency Loan
                                               
Singapore dollar
    73,650       73,650       100       127,299       127,299       100  
Future Interest Payable on Debt
                                               
Singapore dollar
    1,445       1,445       100       2,507       2,507       100  
 
                                   
Total
  $ 149,248     $ 149,248       100 %   $ 151,223     $ 151,223       100 %
 
                                   

ITEM 12.   DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

Not applicable.

PART II

ITEM 13.   DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

None.

ITEM 14.   MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

Not applicable.

ITEM 15.   CONTROLS AND PROCEDURES

The company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Also, the company has investments in certain unconsolidated entities. As the company’s ability to influence these entities is limited only to certain management and operational aspects, its disclosure controls and procedures with respect to such entities are necessarily limited compared to those it maintains with respect to its consolidated subsidiaries.

The company carried out an evaluation, under the supervision and with the participation of the company’s management, including the company’s Chief Executive Officer and the company’s Chief Financial Officer, of the

90


Table of Contents

effectiveness of the design and operation of the company’s disclosure controls and procedures as of December 31, 2004. Based on the foregoing, the company’s Chief Executive Officer and Chief Financial Officer concluded that the company’s disclosure controls and procedures were effective as of such date.

There have been no significant changes in the company’s internal controls or in other factors that could significantly affect the internal controls subsequent to the date the company completed its evaluation.

ITEM 16.

A. AUDIT COMMITTEE FINANCIAL EXPERT

Our Audit Committee members are Messrs. Philip Tan Yuen Fah (chairman), Sum Soon Lim, Robert E. La Blanc and Andre Borrel. Please see “Item 6. Directors, Senior Management and Employees” for their experience and qualifications. The Board has determined that as of the date of filing, none of these individuals meet all of the criteria required to be named an Audit Committee “Financial Expert”, as defined in the applicable rules of the Securities and Exchange Commission. In view of the very specific criteria required to be satisfied in order to qualify as an Audit Committee “Financial Expert”, the Board has not yet been able to identify the appropriate person.

B. CODE OF ETHICS

The company has adopted a Code of Ethics that is applicable to all its directors, senior management and employees. The Code of Ethics contains general guidelines for conducting the business of the company.

The company will make available a copy of the Code of Ethics to any person without charge, if a written request is made to its Company Secretary at the company’s registered address at 60 Woodlands Industrial Park D, Street 2, Singapore 738406.

C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

                                         
    Audit fees     Audit-related fees     Tax fees     All other fees     Total  
    (in $ Thousands)  
2003
    466       109       157       1       733  
2004
    473       53       219       527       1,272  

Audit-related fees

Services provided relate to assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and which are not reported under “Audit fees”, including consultations regarding the accounting or disclosure treatment of transactions or events and/or the actual or potential impact of proposed rules, standards or interpretations by regulatory or standard setting bodies.

Tax fees

Services provided primarily consist of routine corporate tax advisory services and compilation of corporate tax returns.

All other fees

Services provided related to assistance with our compliance program pursuant to Section 404 of the Sarbanes-Oxley Act of 2002.

Our Audit Committee has established pre-approval policies and procedures for services to be performed by our Independent Auditors. Under our pre-approval policies and procedures, our Independent Auditors cannot perform services unless they are pre-approved by our Audit Committee. In April 2004 and February 2005, our Audit

91


Table of Contents

Committee pre-approved a list of services that could be rendered by the Independent Auditors in 2004 and 2005 respectively. All of the services performed by our Independent Auditors in 2004 and 2005 were pre-approved by the Audit Committee. None of the services performed by our Independent Auditors were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

The current Nasdaq rules require that our Audit Committee be comprised solely of independent directors. Although one of our Audit Committee members does not qualify as independent director under the Nasdaq rules, we are currently exempt from this requirement pursuant to an exemption we previously received from Nasdaq. In the event we are no longer able to rely on this exemption in the future, we anticipate that we would rely on the Nasdaq rule which permits one non-independent director to be appointed to the Audit Committee for a period of up to two years if the Board makes a determination that, under exceptional and limited circumstances, the director’s membership on the committee is in the best interests of the company and its shareholders.

E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS.

None.

PART III

ITEM 17.   FINANCIAL STATEMENTS

See Item 18 for a list of financial statements filed under Item 17.

ITEM 18.   FINANCIAL STATEMENTS

The following financial statements are filed as part of this document, together with the report of the independent auditors:

Chartered Semiconductor Manufacturing Ltd., Consolidated Financial Statements

    Independent Auditors’ Report
 
    Consolidated Balance Sheets as of December 31, 2003 and 2004
 
    Consolidated Statements of Operations for the years ended December 31, 2002, 2003 and 2004
 
    Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2002, 2003 and 2004
 
    Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2002, 2003 and 2004
 
    Consolidated Statements of Cash Flows for the years ended December 31, 2002, 2003 and 2004
 
    Notes to Consolidated Financial Statements

Silicon Manufacturing Partners Pte Ltd, Financial Statements

    Independent Auditors’ Report
 
    Balance Sheets as of December 31, 2003 and 2004
 
    Profit and Loss Accounts for the years ended December 31, 2002, 2003 and 2004
 
    Statements of Changes in Equity for the years ended December 31, 2002, 2003 and 2004

92


Table of Contents

    Statements of Cash Flows for the years ended December 31, 2002, 2003 and 2004
 
    Notes to the Financial Statements

ITEM 19.   EXHIBITS

         
1(1)  
Memorandum and Articles of Association of the company.
       
 
2.1(2)  
Specimen certificate for ordinary shares.
       
 
2.2(3)  
Deposit Agreement dated November 4, 1999 by and among the company, Citibank, N.A. and the holders and beneficial owners of American Depositary Shares evidenced by American Depositary Receipts issued thereunder (including as an exhibit, the form of American Depositary Receipt).
       
 
       
Loan Agreements and Indentures
       
 

93


Table of Contents

         
       
 
4.1.1(4)  
Credit Agreement dated September 28, 2000 by and among Chartered Silicon Partners Pte Ltd, the banks on the signature pages thereto, as Lenders, and ABN Amro Bank N.V., Singapore Branch, as agent and security trustee (the “CSP Second Phase Credit Agreement”).
       
 
4.1.2(7)  
Supplemental Agreement dated September 18, 2003 by and among Chartered Silicon Partners Pte Ltd as Borrower, the banks on the signature pages thereto, as Lenders, and ABN Amro Bank N.V., Singapore Branch, as Agent and Security Trustee relating to the CSP Second Phase Credit Agreement.
       
 
4.1.3(5)  
Subordination Agreement dated June 28, 2002 by and among the company, Chartered Silicon Partners Pte Ltd as Borrower and ABN Amro Bank N.V. Singapore Branch as Security Trustee, relating to the CSP Second Phase Credit Agreement.
       
 
4.1.4(5)  
Letter dated June 26, 2002 from ABN Amro Bank N.V., Singapore Branch to Chartered Silicon Partners Pte Ltd amending the CSP Second Phase Credit Agreement by incorporating the Subordination Agreement relating to the CSP Second Phase Credit Agreement.
       
 
4.2(6)  
Shareholders’ Undertaking dated December 14, 2000 by and among Chartered Silicon Partners Pte Ltd as Borrower, the company, EDB Investments Pte Ltd, Agilent Technologies Europe B.V., as Shareholders and ABN Amro Bank N.V., Singapore Branch as Security Trustee.
       
 
4.3(9)  
Indenture dated as of April 2, 2001 by and between the company and Wells Fargo Bank Minnesota, National Association.
       
 
4.4(9)  
Supplemental Indenture dated as of April 2, 2001 by and between the company and Wells Fargo Bank Minnesota, National Association.
       
 
4.5(21)(++)  
Facility Agreement dated December 23, 2004 by and among the company as Borrower, JPMorgan Chase Bank, N.A. as Lender, Export-Import Bank of the United States and JPMorgan Chase Bank, N.A as Facility Agent.
       
 
4.6(21)(++)  
Facility Agreement dated December 23, 2004 by and among the company as Borrower, Sumitomo Mitsui Banking Corporation and Oversea-Chinese Banking Corporation Limited as Lenders and Arrangers.
       
 
4.7(21)(++)  
Facility Agreement dated December 23, 2004 by and between the company as Borrower and Sumitomo Mitsui Banking Corporation as Lender.
       
 
4.8(21)(++)  
Facility Agreement dated December 22, 2004 by and between the company as Borrower and Bank of America as Lender.
       
 
4.9(21)(++)  
Letter of Confirmation from Goldman Sachs International to the company dated August 12, 2004 supplementing the ISDA Master Agreement (Multicurrency — Cross Border) dated August 10, 2004 by and between the company and Goldman Sachs International, as counter-party together with the Schedule to the Master Agreement.
       
 
       
Strategic Alliances
       
 
       
CSP
       
 
4.10(10)  
Deed of Accession and Ratification dated October 22, 2001 by and among the company, EDB Investments Pte Ltd, Agilent Technologies Europe B.V. and Singapex Investments Pte Ltd relating to the Joint Venture Agreement dated March 13, 1997, as amended and restated on October 23, 2001 (the “Restated Joint Venture Agreement” dated October 23, 2001).
       
 
4.11(10)  
Amendment Agreement No. 1 dated January 31, 2002 to Restated Joint Venture Agreement dated

94


Table of Contents

         
       
October 23, 2001.
       
 
4.12(2)(+)  
Assured Supply and Demand Agreement dated July 4, 1997 by and among the company, Chartered Silicon Partners Pte Ltd and Hewlett-Packard Company.
       
 
4.13(2)(+)  
Amendment Agreement No. 2 to Assured Supply and Demand Agreement dated June 17, 1999 by and among the company, Chartered Silicon Partners Pte Ltd and Hewlett-Packard Company, which replaces the amendments contained in Amendment Agreement No. 1 to Assured Supply and Demand Agreement dated November 5, 1998.
       
 
4.14(3)  
Novation and Amendment Agreement dated November 9, 1999 by and among Chartered Silicon Partners Pte Ltd, the company, Hewlett-Packard Company and Agilent Technologies, Inc. relating to the Assured Supply and Demand Agreement 64-225 dated July 4, 1997, as amended.
       
 
       
SMP
       
 
4.15(2)(+)  
Joint Venture Agreement dated December 19, 1997 by and between the company and Lucent Technologies Microelectronics Pte Ltd.
       
 
4.16(20)  
Supplemental Agreement dated September 17, 2004 to the Joint Venture Agreement dated December 19, 1997 by and between the company and Agere Systems Singapore Pte Ltd. (formerly known as “Lucent Technologies Microelectronics Pte. Ltd.”).
       
 
4.17(2)(+)  
Assured Supply and Demand Agreement dated February 17, 1998 by and among the company, Silicon Manufacturing Partners Pte Ltd and Lucent Technologies Microelectronics Pte Ltd.
       
 
4.18(2)(+)  
Supplemental Assured Supply and Demand Agreement dated September 3, 1999 by and among the company, Silicon Manufacturing Partners Pte Ltd and Lucent Technologies Microelectronics Pte. Ltd.
       
 
4.19(2)(+)  
License and Technology Transfer Agreement dated February 17, 1998 by and among the company, Lucent Technologies Microelectronics Pte. Ltd. and Silicon Manufacturing Partners Pte Ltd.
       
 
4.20(13)(+)  
Amendment Agreement (No. 1) to License and Technology Transfer Agreement dated July 27, 2000 by and between the company, Lucent Technologies Microelectronics Pte. Ltd. and Silicon Manufacturing Partners Pte Ltd.
       
 
4.21(11)(+)  
Amendment Agreement (No. 2) dated March 22, 2001 to License and Technology Transfer Agreement dated February 17, 1998 by and between the company, Agere Systems Singapore Pte Ltd (formerly known as “Lucent Technologies Microelectronics Pte. Ltd.”) and Silicon Manufacturing Partners Pte Ltd.
       
 
4.22(12)(+)  
Amendment Agreement (No. 3) dated March 28, 2002 to License and Technology Transfer Agreement dated February 17, 1998 by and among the company, Agere Systems Singapore Pte Ltd (formerly known as “Lucent Technologies Microelectronics Pte. Ltd.”) and Silicon Manufacturing Partners Pte Ltd.
       
 
4.23(7)(+)  
Amendment Agreement (No. 4) dated July 1, 2003 to License and Technology Transfer Agreement dated February 17, 1998 by and among the company, Agere Systems Singapore Pte Ltd (formerly known as “Lucent Technologies Microelectronics Pte. Ltd.”) and Silicon Manufacturing Partners Pte Ltd.
       
 
       
Technology transfer, license, joint development and other related agreements
       
 
       
Agere/Lucent
       
 
4.24(2)(+)  
Technology Transfer Agreement dated February 17, 1998 by and between the company and Lucent Technologies Inc.

95


Table of Contents

         
       
 
4.25(11)(+)  
Amendment Agreement (No. 1) dated July 31, 2000 to Technology Transfer Agreement dated February 17, 1998 between Lucent Technologies Inc. and the company.
       
 
4.26(11)(+)  
Amendment Agreement (No. 2) dated March 20, 2001 to Technology Transfer Agreement dated February 17, 1998 between Agere Systems Inc. (formerly known as the “Microelectronics Group of Lucent Technologies Inc.”) and the company.
       
 
4.27(11)(+)  
Amendment Agreement (No. 3) dated March 28, 2002 to Technology Transfer Agreement dated February 17, 1998 between Agere Systems Inc. (formerly known as the “Microelectronics Group of Lucent Technologies Inc.”) and the company.
       
 
4.28(2)(+)  
Patent License Agreement dated January 1, 1998 by and between the company and Lucent Technologies Inc.
       
 
4.29(17)(+)  
Patent License Agreement Amendment dated August 3, 2000 by and between the company and Lucent Technologies Inc.
       
 
4.30(13)  
Letter Agreement dated September 26, 2002 by and between the company and Agere Systems Inc. amending the Patent License Agreement between the parties dated January 1, 1998.
       
 
       
Toshiba
       
 
4.31(2)(+)  
Patent Cross License Agreement dated August 12, 1999 by and between the company and Toshiba Corporation.
       
 
       
IBM
       
 
4.32(10)(+)  
Patent Cross-License Agreement dated January 1, 2001 by and between the company and International Business Machines Corporation.
       
 
4.33(14)(+)  
Amendment No. 1 dated November 26, 2002 to Patent License Agreement dated January 1, 2001 by and between the company and International Business Machines Corporation.
       
 
4.34(14)(+)  
“SF” Process Development and Cost Sharing Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.35(14)(+)  
Copper / Related FEOL Technology License Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.36(15)(+)  
Amendment No. 1 dated June 26, 2003 to “SF” Process Development and Cost Sharing Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.37(19)(+)  
Amended and Restated Amendment No. 2 dated March 9, 2004 to the “SF” Process Development and Cost Sharing Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.38(21)(++)  
Amendment No. 3 dated November 5, 2004 to “SF” Process Development and Cost Sharing Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.39(21)(++)  
Amendment No. 4 dated December 15, 2004 to “SF” Process Development and Cost Sharing Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.40(14)(+)  
Refundable Cross Deposit Agreement dated November 26, 2002 by and between the company and International Business Machines Corporation.
       
 
4.41(18)(+)  
First Supplemental Agreement dated December 19, 2003 to the Refundable Cross Deposit Agreement dated November 26, 2002 by and between the company and International Business

96


Table of Contents

         
       
Machines Corporation.
       
 
       
IBM, Infineon and Samsung
       
 
4.42(19)(+)  
“SF” Process 65nm/45nm Development and Cost Sharing Agreement dated March 5, 2004 by and among the company, International Business Machines Corporation, Infineon Technologies AG and Samsung Electronics Co., Ltd.
       
 
       
Motorola
       
 
4.43(7)(+)  
Patent License Agreement dated July 1, 2003 by and between the company and Motorola, Inc.
       
 
       
Property Agreements
       
 
       
Fab 1
       
 
4.44(8)  
Lease of Lot 2164 Mukim 3-2 Science Park Drive dated January 18, 1995 by and between Ascendas Land (Singapore) Pte Ltd (formerly known as “Technology Parks Private Limited”) and the company.
       
 
       
Fab 2
       
 
4.45(21)  
Sub-Lease dated October 19, 2004 by and between Singapore Technologies Pte Ltd and the company relating to Private Lots A12787 and A12787(a) Mukim No. 13 Sembawang.
       
 
       
Fab 3
       
 
4.46(8)  
Sub-Lease dated February 17, 1998 by and between the company and Silicon Manufacturing Partners Pte Ltd.
       
 
4.47(21)  
Sub-Lease dated October 19, 2004 by and between Singapore Technologies Pte Ltd and the company relating to Private Lot A12787(b) Mukim No. 13.
       
 
       
Fab 6
       
 
4.48(8)  
Building Agreement relating to Private Lot A12787(d) Mukim No. 13 Sembawang dated September 24, 1999 by and between Jurong Town Corporation and Singapore Technologies Pte Ltd.
       
 
4.49(8)  
Agreement for Sub-License and Sub-Lease (Private Lot A12787(d)) dated September 24, 1999 by and between Singapore Technologies Pte Ltd and Chartered Silicon Partners Pte Ltd.
       
 
4.50(21)  
Novation Agreement dated December 31, 2004 by and among Singapore Technologies Pte Ltd, Terra Investments Pte. Ltd. and Chartered Silicon Partners Pte Ltd relating to the Agreement for Sub-License and Sub-Lease (Private Lot A12787(d)) dated September 24, 1999.
       
 
       
Fab 7
       
 
4.51(16)  
Agreement for Sub-License and Sub-Lease (Private Lot A12787(e)) dated July 30, 2001 by and between Singapore Technologies Pte Ltd and the company.
       
 
4.52(16)  
Building Agreement relating to Private Lot A12787(e) Woodlands Industrial Park D, G.S. No. 3696K, Mukim No. 13 dated July 30, 2001 by and between Jurong Town Corporation and Singapore Technologies Pte Ltd.
       
 
4.53(21)  
Novation Agreement dated December 31, 2004 by and among Singapore Technologies Pte Ltd, Terra Investments Pte. Ltd. and the company relating to the Agreement for Sub-License and Sub-Lease (Private Lot A12787(e)) dated July 30, 2001.
       
 
       
Related Party Agreements
       
 
4.54(14)  
Amended and Restated Turnkey Subcontract Agreement for Sort, Assembly and/or Final Test

97


Table of Contents

         
       
Services dated October 30, 2002 by and between the company and ST Assembly Test Services Ltd.
       
 
4.55(18)  
Mr. Chia Song Hwee’s, President and CEO, Contract of Employment.
       
 
8(14)  
Table of the company’s subsidiaries.
       
 
10(21)  
Consent of KPMG.
       
 
12.1(21)  
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
 
12.2(21)  
Certification of the Vice President and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
 
13.1(21)  
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
       
 
13.2(21)  
Certification of the Vice President and Chief Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
       
 

  (1 )  
Filed as an exhibit to our company’s Registration Statement on Form F-1 (Registration No. 333-88397), as filed with the Securities and Exchange Commission on October 4, 1999. The Memorandum and Articles of Association were amended by shareholders resolutions which are filed as an exhibit to our company’s Current Report on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on June 29, 2001, and were as set forth in the proxy statement for the company’s annual general meeting in May 2001 which is filed as an exhibit to our company’s Current Report on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on April 18, 2001, which exhibits are incorporated herein by reference.
       
 
  (2 )  
Filed as an exhibit to our company’s Amended Registration Statement on Form F-1/A, as filed with the Securities and Exchange Commission on October 25, 1999, which exhibit is incorporated herein by reference.
       
 
  (3 )  
Submitted as an exhibit to our company’s Current Report on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on November 23, 1999, which exhibit is incorporated herein by reference.
       
 
  (4 )  
Submitted as an exhibit to our company’s Current Report on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on September 28, 2000, which exhibit is incorporated herein by reference.
       
 
  (5 )  
Submitted as an exhibit to our company’s Second Quarterly Report 2002 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on August 14, 2002, which exhibit is incorporated herein by reference.
       
 
  (6 )  
Filed as an exhibit to our company’s Annual Report on Form 20-F (File No. 000-27811), as filed with the Securities and Exchange Commission on March 21, 2001, which exhibit is incorporated herein by reference.
       
 
  (7 )  
Submitted as an exhibit to our company’s Third Quarterly Report 2003 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on November 13, 2003, which exhibit is incorporated herein by reference.
       
 
  (8 )  
Filed as an exhibit to our company’s Registration Statement on Form F-1 (Registration No. 333-88397), as filed with the Securities and Exchange Commission on October 4, 1999.
       
 
  (9 )  
Submitted as an exhibit to our company’s Current Report on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on April 4, 2001, which exhibit is incorporated herein by reference.
       
 
  (10 )  
Filed as an exhibit to our company’s Annual Report on Form 20-F (File No. 000-27811), as filed with the Securities and Exchange Commission on March 11, 2002, which exhibit is incorporated herein by reference.
       
 
  (11 )  
Submitted as an exhibit to our company’s First Quarterly Report 2001 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on May 15, 2001, which exhibit is incorporated herein by reference.

98


Table of Contents

         
       
 
  (12 )  
Submitted as an exhibit to our company’s First Quarterly Report 2002 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on May 14, 2002, which exhibit is incorporated herein by reference.
       
 
  (13 )  
Submitted as an exhibit to our company’s Third Quarterly Report 2002 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on November 14, 2002, which exhibit is incorporated herein by reference.
       
 
  (14 )  
Filed as an exhibit to our company’s Annual Report on Form 20-F (File No. 000-27811), as filed with the Securities and Exchange Commission on March 13, 2003, which exhibit is incorporated herein by reference.
       
 
  (15 )  
Submitted as an exhibit to our company’s Second Quarterly Report 2003 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on August 13, 2003, which exhibit is incorporated herein by reference.
       
 
  (16 )  
Submitted as an exhibit to our company’s Third Quarterly Report 2001 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on November 14, 2001, which exhibit is incorporated herein by reference.
       
 
  (17 )  
Submitted as an exhibit to our company’s Current Report on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on November 14, 2000, which exhibit is incorporated herein by reference.
       
 
  (18 )  
Filed as an exhibit to our company’s Annual Report on Form 20-F (File No. 000-27811), as filed with the Securities and Exchange Commission on March 3, 2004, which exhibit is incorporated herein by reference.
       
 
  (19 )  
Submitted as an exhibit to our company’s First Quarterly Report 2004 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on May 10, 2004, which exhibit is incorporated herein by reference.
       
 
  (20 )  
Submitted as an exhibit to our company’s Third Quarterly Report 2004 on Form 6-K (File No. 000-27811), as submitted with the Securities and Exchange Commission on November 8, 2004, which exhibit is incorporated herein by reference.
       
 
  (21 )  
Filed herewith.
       
 
  (+ )  
Certain portions of this exhibit have been omitted pursuant to a confidential treatment order of the Securities and Exchange Commission. The omitted portions have been separately filed with the Commission.
       
 
  (++ )  
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omitted portions have been separately filed with the Commission.

99


Table of Contents

SIGNATURES

The company certifies that it meets all of the requirements for filing on Form 20-F and has duly caused this annual report to be signed on its behalf by the undersigned, thereunto duly authorized on this 7th day of March 2005.
         
  CHARTERED SEMICONDUCTOR MANUFACTURING LTD
 
 
  By:   /s/ George Thomas    
    Name:   George Thomas   
    Title:   Vice President and Chief Financial Officer   
 

This annual report has been signed by the following persons in the capacities indicated:

         
SIGNATURE   TITLE   DATE
 
       
/s/ James A. Norling
James A. Norling
  Chairman of the Board   March 7, 2005
/s/ Lim Ming Seong
Lim Ming Seong
  Deputy Chairman of the Board   March 7, 2005
/s/ Chia Song Hwee
Chia Song Hwee
  President and Chief Executive Officer (principal executive officer)   March 7, 2005
/s/ George Thomas
George Thomas
  Vice President and Chief Financial Officer (principal financial and accounting officer)   March 7, 2005
/s/ Sum Soon Lim
Sum Soon Lim
  Director   March 7, 2005
/s/ Robert E. La Blanc
Robert E. La Blanc
  Director   March 7, 2005
/s/ Andre Borrel
Andre Borrel
  Director   March 7, 2005
/s/ Charles E. Thompson
Charles E. Thompson
  Director   March 7, 2005
/s/ Tsugio Makimoto
Tsugio Makimoto
  Director   March 7, 2005
/s/ Tay Siew Choon
Tay Siew Choon
  Director   March 7, 2005
/s/ Peter Seah Lim Huat
Peter Seah Lim Huat
  Director   March 7, 2005
/s/ Philip Tan Yuen Fah
Philip tan yuen fah
  Director   March 7, 2005

100


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD
AND SUBSIDIARIES

Financial Statements for the Years Ended
December 31, 2002, 2003 and 2004

 


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD
AND SUBSIDIARIES

FINANCIAL STATEMENTS INDEX

 


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders
Chartered Semiconductor Manufacturing Ltd:

We have audited the accompanying consolidated balance sheets of Chartered Semiconductor Manufacturing Ltd and subsidiaries as of December 31, 2003 and 2004, and the related consolidated statements of operations, comprehensive income (loss), shareholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2004. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by the management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Chartered Semiconductor Manufacturing Ltd and subsidiaries as of December 31, 2003 and 2004, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2004, in conformity with U.S. generally accepted accounting principles.

As discussed in Note 22 to the consolidated financial statements, the Company changed its method of accounting for asset retirement obligations in 2003.

KPMG

Singapore
February 4, 2005

F-1


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS — in US Dollars
As of December 31
In thousands

                 
    2003     2004  
ASSETS
               
Cash and cash equivalents
  $ 905,472     $ 539,399  
Term deposits
          30,000  
Receivables, net
    141,146       133,636  
Receivables from related parties
    35,642       9,512  
Inventories
    56,433       72,159  
Prepaid expenses
    5,027       6,723  
Other current assets
    15,237       10,038  
 
           
Total current assets
    1,158,957       801,467  
Investment in SMP
    62,257       93,765  
Property, plant and equipment, net
    1,539,440       1,914,515  
Technology licenses, net
    126,713       121,953  
Other non-current assets
    133,660       158,312  
 
           
Total assets
  $ 3,021,027     $ 3,090,012  
 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Payables
    60,553       147,661  
Payables to related parties
    10,990       4,687  
Income taxes payable
    28,607       23,421  
Current installments of long-term debt
    223,660       352,985  
Other current liabilities
    152,825       94,967  
 
           
Total current liabilities
    476,635       623,721  
Long-term debt, excluding current installments
    989,092       882,745  
Other non-current liabilities
    60,745       77,915  
 
           
Total liabilities
    1,526,472       1,584,381  
Commitments and contingencies
               
Share capital: ordinary shares of S$0.26 par value
Authorized 3,076,923 shares
Issued and outstanding: 2,505,480 shares in 2003 and 2,509,238 shares in 2004
    444,953       445,531  
Additional paid-in capital
    2,233,708       2,237,107  
Accumulated deficit
    (1,125,225 )     (1,118,654 )
Accumulated other comprehensive loss
    (58,881 )     (58,353 )
 
           
Total shareholders’ equity
  $ 1,494,555     $ 1,505,631  
 
           
Total liabilities and shareholders’ equity
  $ 3,021,027     $ 3,090,012  
 
           

See accompanying notes to consolidated financial statements.

F-2


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS — in US Dollars
For the Years Ended December 31
In thousands (except per share data)

                         
    2002     2003     2004  
Net revenue
  $ 449,241     $ 551,911     $ 932,131  
Cost of revenue
    (628,726 )     (648,330 )     (769,318 )
 
                 
Gross profit (loss)
    (179,485 )     (96,419 )     162,813  
 
                 
OPERATING EXPENSES
                       
Research and development
    95,285       124,057       118,281  
Fab start-up costs
    8,338       9,219       33,199  
Sales and marketing
    41,182       38,748       37,751  
General and administrative
    43,103       40,762       35,555  
Other operating expenses (income), net
    10,025       (11,001 )     (10,699 )
 
                 
Total operating expenses
    197,933       201,785       214,087  
 
                 
Operating loss
    (377,418 )     (298,204 )     (51,274 )
Equity in income (loss) of SMP
    (84,846 )     23,194       27,563  
Other income
    23,632       23,186       52,299  
Interest income
    16,637       12,168       11,530  
Interest expense
    (41,661 )     (42,222 )     (30,093 )
Foreign exchange gain (loss), net
    (1,966 )     (733 )     1,320  
 
                 
Income (loss) before income taxes and minority interest
    (465,622 )     (282,611 )     11,345  
Income tax expense
    (7,029 )     (11,671 )     (4,774 )
 
                 
Income (loss) before minority interest
    (472,651 )     (294,282 )     6,571  
Minority interest in loss of CSP
    55,563       9,491        
 
                 
Net income (loss) prior to cumulative effect adjustment
    (417,088 )     (284,791 )     6,571  
Cumulative effect adjustment for change in accounting principle
          (6,421 )      
 
                 
Net income (loss)
  $ (417,088 )   $ (291,212 )   $ 6,571  
 
                 
Basic and diluted net earnings (loss) per share:
                       
Prior to cumulative effect adjustment
  $ (0.23 )   $ (0.11 )   $ 0.00  
Cumulative effect adjustment
          (0.01 )      
 
                 
Net earnings (loss) per share
  $ (0.23 )   $ (0.12 )   $ 0.00  
 
                 
Basic and diluted net earnings (loss) per ADS:
                       
Prior to cumulative effect adjustment
  $ (2.32 )   $ (1.14 )   $ 0.03  
Cumulative effect adjustment
          (0.02 )      
 
                 
Net earnings (loss) per ADS
  $ (2.32 )   $ (1.16 )   $ 0.03  
 
                 
Number of shares used in computing:
                       
Basic net earnings (loss) per share
    1,799,106       2,502,294       2,508,376  
Effect of dilutive options
                8,566  
 
                 
Diluted net earnings (loss) per share
    1,799,106       2,502,294       2,516,942  
 
                 
Number of ADSs used in computing:
                       
Basic net earnings (loss) per ADS
    179,911       250,229       250,838  
Effect of dilutive options
                856  
 
                 
Diluted net earnings (loss) per ADS
    179,911       250,229       251,694  
 
                 

See accompanying notes to consolidated financial statements.

F-3


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) — in US Dollars
For the Years Ended December 31
In thousands

                         
    2002     2003     2004  
Net income (loss)
  $ (417,088 )   $ (291,212 )   $ 6,571  
Net change in cash flow hedging activity derivative fair values
    1,313       (207 )     598  
Share of cash flow hedging activity gains of SMP
    1,009       5,298       3,945  
Reclassification of cash flow hedging activity gains (losses) into earnings
    (1,813 )     1,003       (2,942 )
Foreign currency translation
    54       (1,716 )      
Unrealised losses on available for sale securities
          (266 )     (1,073 )
 
                 
Other comprehensive income
    563       4,112       528  
 
                 
Comprehensive income (loss)
  $ (416,525 )   $ (287,100 )   $ 7,099  
 
                 

See accompanying notes to consolidated financial statements.

F-4


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY — in US Dollars
In thousands

                                                 
                                    Accumulated          
                                    Other     Total  
                    Additional             Compre-     Share-  
                    Paid-in     Accumulated     hensive     holders’  
    Ordinary Shares     Capital     Deficit     Loss     Equity  
    No.     $     $     $     $     $  
Balance at January 1, 2002
    1,383,756       280,480       1,782,633       (416,925 )     (63,556 )     1,582,632  
Net loss
                      (417,088 )           (417,088 )
Other comprehensive income
                            563       563  
Issuance of shares
    3,799       547       4,750                   5,297  
Rights offering, net of expenses
    1,109,624       162,686       448,964                   611,650  
Employee stock compensation
                (253 )                 (253 )
Non-employee stock compensation
                2,658                   2,658  
 
                                   
Balance at December 31, 2002
    2,497,179       443,713       2,238,752       (834,013 )     (62,993 )     1,785,459  
Net loss
                      (291,212 )           (291,212 )
Other comprehensive income
                            4,112       4,112  
Issuance of shares
    8,301       1,240       1,753                   2,993  
Employee stock compensation
                4                   4  
Non-employee stock compensation
                (6,801 )                 (6,801 )
 
                                   
Balance at December 31, 2003
    2,505,480       444,953       2,233,708       (1,125,225 )     (58,881 )     1,494,555  
Net income
                      6,571             6,571  
Other comprehensive income
                            528       528  
Issuance of shares
    3,758       578       1,423                   2,001  
Employee stock compensation
                3                   3  
Non-employee stock compensation
                173                   173  
Others
                1,800                   1,800  
 
                                   
Balance at December 31, 2004
    2,509,238       445,531       2,237,107       (1,118,654 )     (58,353 )     1,505,631  
 
                                   

See accompanying notes to consolidated financial statements.

F-5


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS — in US Dollars
For the Years Ended December 31
In thousands

                         
    2002     2003     2004  
Operating Activities
                       
Net income (loss)
  $ (417,088 )   $ (291,212 )   $ 6,571  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
                       
Cumulative effect adjustment
          6,421        
Equity in loss (income) of SMP
    44,651       (23,194 )     (27,563 )
Depreciation and amortization
    452,417       439,283       437,590  
Foreign exchange loss (gain), net
    (1,642 )     26       (19 )
Gain on disposal of property, plant and equipment
    (784 )     (5,917 )     (11,703 )
Cancellation of employee bonus award plan
          (27,531 )      
Minority interest in loss of CSP
    (55,563 )     (9,491 )      
Stock-based compensation
    (253 )     4       3  
Others
    6,093       5,547       (7,035 )
Change in operating working capital:
                       
Receivables
    14,340       (44,065 )     2,555  
Receivables and payables with related parties, net
    (30,661 )     (7,873 )     7,509  
Inventories
    (8,509 )     (35,158 )     (15,726 )
Prepaid expenses and other current assets
    (2,176 )     (946 )     (180 )
Payables and other current liabilities
    (7,651 )     34,160       (55,132 )
Income taxes payable
    (4,089 )     8,029       (5,186 )
 
                 
Net cash provided by (used in) operating activities
    (10,915 )     48,083       331,684  
Investing Activities
                       
Payments for property, plant and equipment
    (419,501 )     (220,761 )     (686,252 )
Payments for technology licenses
    (48,803 )     (59,705 )     (37,083 )
Payments for deposits and other assets
          (110,000 )     (65,000 )
Proceeds from sale of property, plant and equipment
    6,085       6,119       31,217  
Receipts related to refund of deposits and other assets
    14,893             24,403  
 
                 
Net cash used in investing activities
    (447,326 )     (384,347 )     (732,715 )
Financing Activities
                       
Debt
                       
Borrowings
    228,000       125,000       318,000  
Repayments
    (206,176 )     (65,033 )     (287,312 )
Customer deposits, net
    (11,599 )     (32,123 )     450  
Issuance of ordinary shares
    616,947       2,993       2,001  
Others
                1,800  
 
                 
Net cash provided by financing activities
    627,172       30,837       34,939  
Net increase (decrease) in cash and cash equivalents
    168,931       (305,427 )     (366,092 )
Effect of exchange rate changes on cash and cash equivalents
    378       (26 )     19  
Cash and cash equivalents at the beginning of the year
    1,041,616       1,210,925       905,472  
 
                 
Cash and cash equivalents at the end of the year
  $ 1,210,925     $ 905,472     $ 539,399  
 
                 
Supplemental Cash Flow Information
                       
Interest paid (net of amounts capitalized)
  $ 27,099     $ 26,407     $ 18,215  
Income taxes paid
  $ 10,956     $ 6,291     $ 11,276  
Non-cash investing and financing activities:
                       
Equity securities received from sale of technology and equipment
  $     $     $ 11,708  

See accompanying notes to consolidated financial statements.

F-6


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

1.   Background and Summary of Significant Accounting Policies

  (a)   Business and Organization

    Chartered Semiconductor Manufacturing Ltd (the “Company”) is an independent semiconductor foundry providing wafer fabrication services and technologies. The Company operates in Singapore and has service operations in eight countries in North America, Europe and Asia, including Singapore. Its principal markets are the United States of America, Taiwan, Europe and Japan.
 
    The Company’s majority shareholder is Singapore Technologies Semiconductors Pte Ltd (“ST Semiconductors”), which until December 31, 2004, was 100% owned by Singapore Technologies Pte Ltd (“ST”). ST is ultimately wholly-owned by Temasek Holdings (Private) Limited (“Temasek”). Temasek is a holding company through which corporate investments of the government of Singapore are held. On December 31, 2004, Temasek acquired ST’s shareholdings in ST Semiconductors as part of a plan to manage Temasek’s capital structure more efficiently (“ST Restructuring”).
 
    Chartered Silicon Partners Pte Ltd (“CSP”) was formed in March 1997. The Company, EDB Investments Pte Ltd, Agilent Technologies Europe B.V. and Singapex Investments Pte Ltd own a 51%, 26.5%, 15% and 7.5% equity interest in CSP, respectively.
 
    CSP is accounted for as a consolidated subsidiary. Due to cumulative losses, the losses applicable to the minority interest exceeded the minority interest in the equity capital of CSP during 2003. Therefore the excess and further losses applicable to the minority interest have been charged to the consolidated statements of operations from that point forward.
 
    In January 1998, the Company and Lucent Technologies Microelectronics Pte Ltd, subsequently renamed Agere Systems Singapore Pte Ltd (“Agere”), formed Silicon Manufacturing Partners Pte Ltd (“SMP”), in which the Company has a 49% equity interest. The Company accounts for SMP using the equity method.

  (b)   Accounting Principles

    The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
 
    The consolidated financial statements reflect the consolidated accounts of Chartered Semiconductor Manufacturing Ltd and its majority-owned and controlled affiliates. All significant intercompany accounts and transactions have been eliminated in consolidation. Where losses applicable to the minority interest in a subsidiary exceed the minority interest in the equity capital of the subsidiary, such excess and any further losses applicable to the minority interest have been charged to the Company’s consolidated statements of operations, unless the minority interest has a binding obligation, and is able, to make good the losses. When the subsidiary subsequently reports profits, the profits applicable to the minority interest are taken to the consolidated statements of operations until the minority interest’s share of losses previously taken to the consolidated statements of operations is fully recovered.

  (c)   Reclassifications

    Certain reclassifications have been made in prior years’ financial statements to conform to classifications used in the current year.

F-7


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (d)   Use of Estimates

    The preparation of the consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting period. Significant items subject to such estimates and judgements include the recoverability of the carrying value of long-lived assets, the realizability of deferred income tax assets and inventories, and the fair value of stock-based employee compensation awards. Actual results could differ from these estimates.

  (e)   Foreign Currency

    The Company and its subsidiaries utilize the US dollar as their functional currency. Assets and liabilities which are denominated in foreign currencies are translated into the functional currency at the rates of exchange prevailing at the balance sheet date. Foreign currency transactions are translated using the exchange rates prevailing at the date of transactions. Foreign exchange gains or losses, resulting from the settlement of foreign currency transactions and from the translation at financial year-end exchange rates of assets and liabilities denominated in foreign currencies, are included in the line item “foreign currency exchange gain (loss), net” in the consolidated statements of operations.

  (f)   Concentration of Credit Risk

    Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of receivables and derivative financial instruments. The Company is an independent foundry that fabricates integrated circuits on silicon wafers for customers in the semiconductor industry. The five largest customers of the Company accounted for 53%, 41% and 52% of net revenue in the years ended December 31, 2002, 2003 and 2004, respectively. Total accounts receivable from these customers was $58,963 and $49,521 at December 31, 2003 and 2004, respectively. As a result, loss or cancellation of business from, or significant changes in scheduled deliveries or decreases in the prices of products sold to any of these customers could materially and adversely affect the Company’s results of operations or financial position. The Company believes that the concentration of its credit risk in trade receivables is mitigated substantially by its credit evaluation process, credit policies and credit control and collection procedures.
 
    The Company’s cash and cash equivalents and term deposits are placed with major international banks and financial institutions with specific minimum credit standards. Cash and cash equivalents and term deposits with a particular bank accounted for 44% and 43% of total balances at December 31, 2003 and 2004, respectively.
 
    The amounts subject to credit risk related to derivative instruments are generally limited to the amounts, if any, by which a counterparty’s obligations exceed the obligations of the Company with that counterparty. The risk management practices are further described in Note 17. During the year, certain of the Company’s treasury management activities were undertaken by ST or carried out together with other companies in the Temasek Group as further described in Note 2.

  (g)   Cash and Cash Equivalents

    Cash equivalents consist of highly liquid investments that are readily convertible into cash and have original maturities of three months or less.

F-8


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (h)   Derivative Instruments and Hedging Activities

    In accordance with Statement of Financial Accounting Standards (“SFAS”) No. 133, “Accounting for Derivative Instruments and Certain Hedging Activities”, as amended, the Company records derivatives on the balance sheet as assets or liabilities measured at fair value.
 
    Derivatives are recognized on the balance sheet at their fair value in other assets or other liabilities. On the date a derivative contract is entered into, the Company will consider if the derivative instrument is part of a hedging relationship. If the derivative will be designated as a hedge, the Company designates the derivative as either a hedge of the fair value of a recognized asset or liability or of an unrecognized firm commitment (“fair-value” hedge), a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash-flow” hedge), or a foreign-currency fair-value or cash-flow hedge (“foreign-currency” hedge). The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives that are designated as fair-value, cash-flow, or foreign-currency hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items.
 
    Changes in the fair value of derivatives that are highly effective and that are designated and qualify as fair-value hedges are recorded in earnings as interest expense, along with the loss or gain on the hedged assets or liabilities or unrecognized firm commitment of the hedged item that are attributable to the hedged risks. Changes in the fair value of derivatives that are highly effective and that are designated and qualify as cash-flow hedges are recorded in other comprehensive income, until earnings are affected by the variability in cash flows of the designated hedged items. Changes in the fair value of derivatives that are highly effective as hedges and that are designated and qualify as foreign-currency hedges are recorded in either earnings or other comprehensive income, depending on whether the hedge transaction is a fair-value hedge or a cash-flow hedge. Changes in the fair value of derivative instruments that are not designated as part of a hedging relationship are reported in current period earnings.
 
    The Company discontinues hedge accounting prospectively when it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of the hedged item, the derivative expires or is sold, terminated, or exercised, the derivative is de-designated as a hedging instrument because it is unlikely that a forecasted transaction will occur, a hedged firm commitment no longer meets the definition of a firm commitment, or management determines that designation of the derivative as a hedging instrument is no longer appropriate. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the Company continues to carry the derivative on the balance sheet at its fair value, and no longer adjusts the hedged asset or liability for changes in fair value. The adjustment of the carrying amount of the hedged asset or liability is accounted for in the same manner as other components of the carrying amount of that asset or liability. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, the Company continues to carry the derivative on the balance sheet at its fair value, removes any asset or liability that was recorded pursuant to recognition of the firm commitment from the balance sheet and recognizes any gain or loss in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the Company continues to carry the derivative on the balance sheet at its fair value, and gains and losses that were accumulated in other comprehensive income are recognized immediately in earnings. In all other situations in which hedge accounting is discontinued, the Company continues to carry the derivative at its fair value on the balance sheet, and recognizes any changes in its fair value in earnings.

F-9


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (i)   Inventories

    Inventories are stated at the lower of standard cost, which approximates actual cost determined on the weighted average basis, or market (net realizable value). For work-in-progress and manufactured inventories, cost consists of the cost of raw materials, direct labor and an appropriate proportion of production overheads. Labor and overhead costs are allocated to each step in the wafer production process based on normal fab capacity utilization, with un-recovered costs arising from abnormal underutilization of capacity expensed as incurred.

  (j)   Technology Licenses

    Technology license agreements are stated at cost and amortized on the straight-line basis over the shorter of the expected technology life or the license period.

  (k)   Property, Plant and Equipment

    Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is calculated on the straight-line method over the following periods:

         
Buildings
    20 years (or, if shorter, the remaining period of the lease of the land on which the buildings are erected)
Mechanical and electrical installations
    10 years
Equipment and machinery
    5 years
Office and computer equipment
    2 to 5 years

    The Company capitalizes interest with respect to major assets under installation and construction until such assets are ready for use. Interest capitalized is based on the average cost of the Company’s pooled borrowings. Repairs and replacements of a routine nature are expensed, while those that extend the life of an asset are capitalized. Upon retirement or disposal of assets, the cost and related accumulated depreciation are removed from the consolidated balance sheets and any gain or loss is included in the consolidated statements of operations.

  (l)   Impairment of Long-Lived Assets and Intangible Assets

    The Company reviews long-lived assets and certain identifiable intangibles for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of long-lived asset groups to be held and used are measured by a comparison of the carrying amount to the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset group. If an asset group is considered to be impaired, the impairment loss is measured as the amount by which the carrying amount of the long-lived assets exceed their fair value.
 
    For intangible assets that are subject to amortization, an impairment loss is recognized if the carrying amount exceeds the fair value. Intangible assets with an indefinite useful life are evaluated at each reporting period to determine whether events and circumstances continue to support an indefinite useful life. If an intangible asset that is not being amortized is subsequently determined to have a finite useful life, it is amortized prospectively over its estimated remaining useful life and is subject to impairment testing for intangible assets subject to amortization.
 
    Long-lived assets to be disposed of by sale are measured at the lower of their carrying amounts or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be abandoned will be considered held and used until disposed of.

F-10


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (m)   Marketable securities

    Marketable securities classified as available-for-sale are recorded at fair value as determined by the most recently quoted market price of each security at the balance sheet date. Unrealized gains and losses, net of the related tax effect, on available-for-sale securities are excluded from earnings and are reported as a component of other comprehensive income (loss) until realized. Realized gains and losses from the sale of available-for-sale securities are determined on a specific-identification basis. A decline in the market value of any available-for-sale security below cost that is deemed to be other than temporary will result in an impairment, which is charged to earnings.

  (n)   Revenue Recognition

    The Company derives revenue primarily from fabricating semiconductor wafers, and to a lesser extent, for certain arrangements, from providing associated subcontracted assembly and test services, and pre-fabrication services such as engineering services.
 
    In accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 (“SAB 104”), revenue from the production of wafers is recognized upon shipment provided title and risk of loss has passed to the customer, there is evidence of an arrangement, fees are fixed or determinable and collectibility is reasonably assured. Revenue represents the invoiced value of goods and services supplied excluding goods and services tax, less allowances for estimated sales returns. The Company estimates allowances for sales returns based on historical experience and management’s estimate of the level of future claims. Additionally, the Company accrues for specific items at the time their existence is known and amounts are estimable.
 
    In multiple elements revenue arrangements, the Company divides the deliverables into separate units of accounting upon meeting certain specified criteria. From July 1, 2003 onwards, the Company adopted the methodology in FASB Emerging Issues Task Force Issue 00-21, “Revenue Arrangements with Multiple Deliverables” (“EITF 00-21”). The total consideration is allocated to each component of the multiple-element arrangement based on its relative fair value. Revenue on each element is recognized when title and risk of loss have passed to the customer or the contractual obligations have been performed, there is evidence of an arrangement, fees are fixed or determinable, and collectibility is reasonably assured.
 
    Intellectual property license income is classified as non-operating income and is recognized when the license is delivered, collection is reasonably assured and no further obligations with the other party exist.

  (o)   Grants

    Asset-related government grants consist of grants for the purchase of equipment used for research and development activities. Asset-related grants are presented in the consolidated balance sheet as deferred grants and are credited to other income on the straight-line basis over the shorter of the estimated useful lives of the relevant assets or the remaining lives of the relevant grant projects.
 
    Income-related government grants are subsidies of training and research and development expenses. Income-related grants are credited to other income when it becomes probable that expenditures already incurred will constitute qualifying expenditures for purposes of reimbursement under the grants, which is typically substantially concurrent with the expenditures.

F-11


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (p)   Stock-Based Employee Compensation

    The Company measures stock-based employee compensation cost for financial statement purposes in accordance with the intrinsic method of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”) and related interpretations. Employee compensation cost is measured as the excess of fair market value of the stock subject to the option at the grant date over the exercise price of the option.
 
    Compensation cost for stock options granted to non-employees, primarily employees of SMP, are measured in accordance with the fair-value method as the fair market value of the stock options based upon an option pricing model. This cost is recognized over the period in which the options vest in accordance with SFAS No. 123, “Accounting for Stock-Based Compensation”, as amended by SFAS No. 148, “Accounting for Stock-Based Compensation — Transition and Disclosure”.
 
    Had the Company determined employee compensation cost based on the fair value at the grant date for its share options under SFAS No. 123, as amended by SFAS No. 148, the Company’s net income (loss) would have changed to the pro forma amounts indicated below:

                         
    2002     2003     2004  
Stock-based employee compensation cost
                       
As reported (intrinsic method)
  $ (253 )   $ 4     $ 3  
Pro forma (fair-value method)
  $ 49,921     $ 13,526     $ 16,744  
Net income (loss)
                       
As reported
  $ (417,088 )   $ (291,212 )   $ 6,571  
Pro forma
  $ (467,262 )   $ (304,734 )   $ (10,170 )
Basic and diluted net earnings (loss) per share
                       
As reported
  $ (0.23 )   $ (0.12 )   $ 0.00  
Pro forma
  $ (0.26 )   $ (0.12 )   $ (0.00 )
Basic and diluted net earnings (loss) per ADS
                       
As reported
  $ (2.32 )   $ (1.16 )   $ 0.03  
Pro forma
  $ (2.60 )   $ (1.22 )   $ (0.04 )

  (q)   Product Warranties

    The Company guarantees that products will meet the stated functionality as agreed to in each sales arrangement. The Company provides for the estimated warranty costs under these guarantees based upon historical experience and management’s estimate of the level of future claims, and accrues for specific items at the time their existence is known and the amounts are estimable. Expenses for warranty costs were not significant in any of the years presented.

F-12


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (r)   Fab Start-up Costs

    The Company expenses costs related to start-up activities, including fab start-up costs, as they are incurred. Such costs primarily include employee related expenses and engineering activities associated with the start-up of a fab.

  (s)   Income Taxes

    Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the financial statements and their respective tax bases, and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recorded for loss carryforwards and other deferred tax assets where it is more likely than not that such loss carryforwards and deferred tax assets will not be realized.

  (t)   Net Income (Loss) Per Share

    Basic net income (loss) per share is computed using the weighted-average number of common shares outstanding. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding and dilutive potential common shares from the assumed exercise of options outstanding during the period, if any, using the treasury stock method plus other potentially dilutive securities outstanding, such as convertible notes. The share and ADS amounts for 2002 have been adjusted for the bonus element of an eight-for-ten rights offering completed in October 2002. The bonus element arises because the exercise price of the shares at issuance was less than their fair value, and is imputed as the number of shares issued that exceeds the expected number of shares. The expected number of shares is calculated using the fair value per share immediately prior to the rights exercise compared to the actual proceeds of the rights exercise.
 
    The Company excluded potentially dilutive securities for each period presented from its diluted net income (loss) per share computation because either the exercise price of the securities exceeded the average fair value of the Company’s common stock or the Company had net losses, and therefore these securities were anti-dilutive. A summary of the excluded potentially dilutive securities and the range of related exercise prices are as follows:

                         
    Years ended December 31,  
    2002     2003     2004  
Convertible debt and call options
    214,792       214,792       429,584  
Stock options
    99,693       104,223       98,468  

    The conversion price of convertible debt outstanding was S$4.7980 per share (equivalent to approximately US$26.7701 per ADS) as of December 31, 2004. The weighted average exercise prices of options outstanding were $3.49, $2.67 and $2.36 as of December 31, 2002, 2003 and 2004, respectively. The excluded stock options have per share exercise prices ranging from $0.46 to $8.31, $0.39 to $8.31 and $0.63 to $8.31 for the years ended December 31, 2002, 2003 and 2004, respectively. The excluded call options have per share exercise price of $0.93.

F-13


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (u)   Recent Accounting Pronouncements

    In March 2004, a consensus was reached on Financial Accounting Standards Board (“FASB”) Emerging Issues Task Force Issue 03-01, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments” (“EITF 03-01”) regarding recognition and measurement guidance in addressing other-than-temporary impairment evaluations. To assess for other-than-temporary impairments, EITF 03-01 prescribes three sequential steps, the second and third being performed only if the prior step indicates it is necessary. The first step is to determine whether the investment is impaired. If so, the next step is to determine whether the impairment is other-than-temporary. If it is other-than-temporary, the third and final step is to recognize the impairment loss in earnings. The recognition and measurement guidance in EITF 03-01 is effective for reporting periods beginning after June 15, 2004. In September 2004, the FASB issued FASB Staff Position No. 03-1-1 to delay the effective date for the recognition and measurement guidance of EITF 03-01. During the period of delay, an entity holding investments should continue to apply relevant and existing “other-than-temporary” guidance as applicable. EITF 03-01 also requires additional disclosures on investments accounted for under the cost method, which is effective for fiscal periods ending after June 15, 2004. The consensus does not apply to investments accounted for under the equity method. The adoption of EITF 03-01 did not have an impact on the Company’s financial condition and consolidated statements of operations.
 
    In September 2004, a consensus was reached on EITF 04-08 “The Effect of Contingently Convertible Instruments on Diluted Earnings per Share” in that all instruments that have embedded conversion features that are contingent on market conditions indexed to an issuer’s share price should be included in diluted earnings per share computation regardless of whether the market conditions have been met. For purposes of this issue, contingently convertible instruments are instruments that have embedded conversion features that are contingently convertible or exercisable based on a market price trigger or multiple contingencies if one of the contingencies is a market price trigger and the instrument can be converted or share settled based on meeting the specified market condition. In November 2004, the transition provisions of the consensus were changed to require that the guidance be applied to reporting periods ending after December 15, 2004. The adoption of EITF 04-08 did not have an impact on the Company’s financial condition and consolidated statements of operations as it is antidilutive.
 
    In November 2004, the FASB issued FASB Statement No. 151 (“FAS 151”), “Inventory Costs”, an amendment of ARB No. 43, Chapter 4. The amendments made by Statement 151 clarified that abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) should be recognized as current-period charges and required the allocation of fixed production overheads to inventory based on the normal capacity of the production facilities. The guidance is effective for inventory costs incurred during fiscal years beginning after June 15, 2005. The initial adoption of FAS 151 is not expected to have any material impact on the Company’s financial condition and consolidated statements of operations.
 
    In December 2004, the FASB published FASB Statement No. 123 (revised 2004) (“FAS 123(R)”), “Share-Based Payment”. FAS 123(R) requires that the compensation cost relating to share-based payment transactions be recognized in financial statements. That cost will be measured based on the fair value of the equity or liability instruments issued. Public entities will be required to apply FAS 123(R) as of the first interim or annual reporting period that begins after June 15, 2005. FAS 123(R) replaces FASB Statement No. 123, “Accounting for Stock-Based Compensation”, and supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees”. The Company has begun, but has not yet completed, evaluating the impact of adopting FAS 123(R) on its results of operations. The Company currently determines the fair value of stock-based compensation using a Black-Scholes option pricing model. In connection with evaluating the impact of adopting FAS 123(R), the Company is also considering the potential implementation of different valuation models to determine the fair value of stock-based compensation, although no decision has yet been made. However, the Company does believe the adoption of FAS 123(R) may have a material impact on its financial condition and consolidated statements of operations, regardless of the valuation technique used. If the Company were to continue to use a Black-Scholes option pricing model consistent with its current practice and based on existing issued and outstanding stock options as of December 31, 2004, the adoption of FAS 123(R) on July 1, 2005 is expected to result in approximately additional compensation expense of $5 million to $6 million after taxes for the second half of 2005.

F-14


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

2.   Related Party Transactions

  (a)   ST and affiliates

    The Company is a majority owned subsidiary of ST Semiconductors, which is itself a wholly-owned subsidiary of Temasek. Prior to December 31, 2004, ST Semiconductors was a wholly-owned subsidiary of ST. Temasek is a holding company through which the corporate investments of the government of Singapore are held. The Company transacts business in the normal course of its operations with ST Semiconductors and its affiliates as well as with other companies and entities that are partially or wholly owned or controlled by the government of Singapore.
 
    In addition to the transactions with related parties disclosed in Note 3 and Note 13, the Company had the following significant transactions with related parties:

                         
    2002     2003     2004  
Services purchased from STATS ChipPAC
  $ 10,356     $ 13,541     $ 19,104  
Property, plant and equipment purchased from ST affiliates
    275       175       415  
Services purchased from ST affiliates
    1,419       1,398       2,178  
Reimbursement to ST of expenses incurred on behalf of the Company
    14,753       8,528       7,132  
Interest income from ST pooled cash program
    7,514       6,689       2,853  
ST management fees
    4,014       3,384       2,739  
Sub-lease rental for leasehold land from JTC
    1,800       2,482       2,460  
Rental for leasehold land from Ascendas
    264       276       335  

    Included in receivables from related parties and payables to related parties are amounts due from or to ST and its affiliates:

                 
    December 31,  
    2003     2004  
Amounts due from ST and its affiliates
  $ 31     $ 281  
Amounts due to ST and its affiliates
  $ 10,398     $ 4,135  

    Under a service agreement, annual management fees were payable to ST for the provision of specified services on mutually agreed terms which the Company believes approximated the cost of providing those services. Fees were also payable to ST as a proportion of revenues for affiliation and network benefits, and as a percentage of guarantees and similar financial support provided. Expenses incurred on behalf of, or allocated to, the Company by ST were charged to the Company. With the ST Restructuring as discussed in Note 1, the service agreement was terminated with effect from December 31, 2004 and the Company will now perform these services internally or directly contract with other service providers.

F-15


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    Short-term financing was provided by ST to the Company, using ST’s cost competitive corporate banking advantage in the banking community, generally on 3 to 6 months renewable basis. The Company also contracted with ST a majority of its forward purchases of foreign exchange as further discussed in Note 17. Advances to and from ST bore interest at rates comparable to rates offered by commercial banks in Singapore. The Company also participated with ST and/or its affiliates in a pooled cash management arrangement managed by a bank. Under the arrangement, cash balances were pooled and daily cash surpluses or shortfalls might, on a short-term basis, be lent to or borrowed from other ST affiliates participating in the arrangement at prevailing inter-bank rates. The Company also placed short-term deposits with ST and/or its affiliates having maturities of less than three months. With the ST Restructuring as discussed in Note 1, these activities were discontinued on December 31, 2004, and the Company will now manage its financing, foreign exchange purchases and hedging, and cash management activities with other service providers, although outstanding forward exchange contracts at year end with ST will be held until maturity.
 
    The fabs of the Company are built on land held on long-term operating leases from entities controlled by the government of Singapore. Fab 1 was built on land leased by the Company from Ascendas Land (Singapore) Pte Ltd (“Ascendas”), a private company wholly-owned by Jurong Town Corporation (“JTC”), under a long-term lease which expires in 2017, with an option, subject to certain conditions, to extend by another 30 years. JTC is a statutory board established by the Singapore government to develop and manage industrial estates in Singapore. Following the cessation of Fab 1 operations in end March 2004, the Company is still evaluating its options regarding the lease.
 
    Fabs 2, 3, 5 (occupied by SMP) and 6 (occupied by CSP) occupy land leased by ST from JTC. The Company had entered into sub-leases in respect of the underlying land for the entire term of the leases between ST and JTC, expiring in 2024 and 2027, with an option, subject to certain conditions, to extend for another 30 years. With the ST Restructuring as discussed in Note 1, the sub-leases will be transferred to Terra Investments Pte Ltd (“Terra”), a wholly-owned subsidiary of Temasek.
 
    Fab 7 occupies land leased by ST from JTC, which will be transferred to Terra as a result of the ST Restructuring as discussed in Note 1. The Company will enter into a sub-lease with Terra in respect of the underlying land, expiring in 2030, with an option, subject to certain conditions, to extend for another 30 years.
 
    Rental rates on the long term leases are subject to revisions at periodic intervals in accordance with the rental agreements, with such increases generally capped at 4% to 10% per annum.
 
    Rental expense for land leased from ST and Ascendas for the years ended December 31, 2002, 2003 and 2004 was $2,064, $2,758 and $2,795, respectively.
 
    Minimum future rental payments on non-cancellable operating leases of land from the related parties above as of December 31, 2004 are as follows:

Payable in year ending December 31,        
2005
  $ 4,678  
2006
    4,678  
2007
    4,678  
2008
    4,678  
2009
    4,678  
Thereafter
    73,481  
 
     
 
  $ 96,871  
 
     

F-16


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (b)   SMP

    The Company has a 49% equity interest in SMP that is accounted for using the equity method. SMP’s net results are not shared between the Company and SMP’s majority shareholder, Agere, in the same ratio as the equity holding. Instead, each party is entitled to the gross profits from sales to the customers that it directs to SMP after deducting its share of the overhead costs of SMP. Accordingly, the equity in income (loss) of SMP and the share of retained post formation loss that is included in the Company’s consolidated statements of operations and consolidated balance sheets are different than the amount that would be obtained by applying a 49% ownership percentage.
 
    In September 2004, the Company and Agere entered into a supplementary agreement to the joint venture agreement relating to SMP. Among other things, the supplementary agreement provides that SMP can pay dividends out of the profits of the joint venture determined on a year-to-year basis rather than on a cumulative basis, as previously was the case.
 
    The Company and Agere have also entered into an assured supply and demand agreement with SMP under which each is billed for allocated wafer capacity if the wafers started for them are less than their allocated capacity. The allocated wafer capacity billed and billable to the Company was $40,195, $Nil and $Nil for 2002, 2003 and 2004, respectively, and is included in equity in income (loss) of SMP.
 
    The Company bought $6,815, $2,272 and $1,641 of processed wafers from SMP for the years ending December 31, 2002, 2003 and 2004, respectively.
 
    The Company provides management and corporate support services including accounting, financial, sales and marketing services to SMP and allocates a portion of its costs to SMP. Such charges to SMP amounted to $8,266, $9,963 and $9,622 in the years ended December 31, 2002, 2003 and 2004, respectively. The Company also recharged expenses paid on behalf of SMP amounting to $22,899, $29,485 and $23,763 in the years ended December 31, 2002, 2003 and 2004, respectively.
 
    SMP leases its fab from the Company under a long-term lease agreement that expires in 2008. The rental income from SMP for the years ending December 31, 2002, 2003 and 2004 was $14,713, $15,024 and $15,307, respectively.
 
    The Company bought plant and equipment of $1,918, $3,350 and $Nil from SMP during 2002, 2003 and 2004, respectively. The Company also sold plant and equipment of $3,211, $14,218 and $505 to SMP during 2002, 2003 and 2004, respectively.
 
    Included in receivables from related parties and payables to related parties are amounts due from or to SMP:

                 
    December 31,  
    2003     2004  
Amounts due from SMP
  $ 35,611     $ 9,231  
Amounts due to SMP
  $ 592     $ 552  

F-17


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

3.   Cash and Cash Equivalents

     Cash and cash equivalents consist of the following:

                 
    December 31,  
    2003     2004  
Cash at banks and on hand
  $ 101,091     $ 87,485  
ST pooled cash
    13,192        
Cash equivalents
               
Short-term deposits with banks
    425,320       451,914  
Short-term deposits with ST
    365,869        
 
           
 
  $ 905,472     $ 539,399  
 
           

    During the year, certain of the Company‘s treasury management activities were undertaken by ST or its affiliates, including a pooled cash management arrangement as discussed in Note 2.
 
4.   Term Deposits
 
    These are short-term deposits placed with a bank. The interest rates for such term deposits ranged from 1.8800% to 2.5050% at December 31, 2004.
 
5.   Receivables, Net
 
    Receivables consist of the following:

                 
    December 31,  
    2003     2004  
Trade receivables
  $ 120,838     $ 122,986  
Allowance for doubtful accounts
    (1,083 )     (1,178 )
Allowance for sales returns
    (9,556 )     (6,537 )
 
           
Trade receivables, net of allowances
    110,199       115,271  
Grant and other receivables
    30,947       18,365  
 
           
 
  $ 141,146     $ 133,636  
 
           

    Movements in the allowance for doubtful accounts are as follows:

                         
    2002     2003     2004  
Beginning
  $ 4,036     $ 2,460     $ 1,083  
Utilized in year
    (1,078 )     (1,022 )     (38 )
Charge for the year
    478       351       1,106  
Reversal of specific allowances due to collection
    (976 )     (706 )     (973 )
 
                 
Ending
  $ 2,460     $ 1,083     $ 1,178  
 
                 

    Movements in the allowance for sales returns are as follows:

                         
    2002     2003     2004  
Beginning
  $ 4,895     $ 10,687     $ 9,556  
Utilized in year
    (5,075 )     (7,026 )     (7,769 )
Charge for the year
    10,867       5,895       4,750  
 
                 
Ending
  $ 10,687     $ 9,556     $ 6,537  
 
                 

F-18


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

6.   Inventories
 
    Inventories consist of the following:

                 
    December 31,  
    2003     2004  
Raw materials
  $ 2,609     $ 5,414  
Work-in-process
    52,709       60,293  
Consumable supplies and spares
    1,115       6,452  
 
           
 
  $ 56,433     $ 72,159  
 
           

7.   Investment in SMP
 
    The investment in SMP is discussed further in Note 2 and consists of the following:

                 
    December 31,  
    2003     2004  
SMP
               
Cost
  $ 120,959     $ 120,959  
Share of retained post-formation losses
    (54,730 )     (27,167 )
Share of accumulated other comprehensive losses
    (3,972 )     (27 )
 
           
 
  $ 62,257     $ 93,765  
 
           

    Reconciliation of equity in income (loss) of SMP between consolidated statements of operations and consolidated statements of cash flows:

                         
    2002     2003     2004  
Equity in income (loss) of SMP in consolidated statements of operations
  $ (84,846 )   $ 23,194     $ 27,563  
Allocated wafer capacity cost
    40,195              
 
                 
Equity in income (loss) of SMP in consolidated statements of cash flows
  $ (44,651 )   $ 23,194     $ 27,563  
 
                 

     Shown below is summarized financial information for SMP:

                         
            December 31,  
            2003     2004  
Current assets
          $ 213,948     $ 85,597  
Other assets
            1,680       82  
Property, plant and equipment
            262,349       132,258  
Current instalments of long-term debt
            (107,142 )      
Other current liabilities
            (96,456 )     (23,078 )
Long-term debt
            (64,286 )      
Other liabilities
            (7,310 )      
 
                   
Shareholders’ equity
          $ 202,783     $ 194,859  
 
                   
 
                       
 
  2002     2003     2004  
Net revenue
  $ 254,970     $ 329,535     $ 303,570  
Gross profit
    12,221       43,073       34,827  
Operating income
    8,632       42,419       30,070  
Net income (loss)
  $ (20,534 )   $ 23,784     $ 20,706  

    Net revenue includes billings for allocated wafer capacity to joint venture partners of $49,512, $Nil and $Nil for 2002, 2003 and 2004, respectively.

8.   Property, plant and equipment
 
    Property, plant and equipment consist of the following:

                 
    December 31,  
    2003     2004  
Cost
               
Buildings
  $ 192,230     $ 192,230  
Mechanical and electrical installations
    403,027       426,975  
Equipment and machinery
    2,808,521       2,818,804  
Office and computer equipment
    84,818       96,058  
Assets under installation and construction
    394,254       937,927  
 
           
Total cost
  $ 3,882,850     $ 4,471,994  
 
           
Accumulated depreciation
  $ 2,343,410     $ 2,557,479  
 
           
Property, plant and equipment (net)
  $ 1,539,440     $ 1,914,515  
 
           

F-19


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    Depreciation was charged to consolidated statements of operations and amounted to $434,327, $418,195 and $420,217 for the years ended December 31, 2002, 2003 and 2004, respectively. Buildings consist of wafer plants, including administrative offices, built on land sub-leased to the Company, as discussed in Note 2.
 
    Capitalized interest relating to property, plant and equipment amounted to $10,400, $5,466 and $15,177 in the years ended December 31, 2002, 2003 and 2004, respectively.
 
9.   Technology Licenses

                                 
                    Weighted average  
                    amortization  
                    period (years)  
    December 31,     December 31,  
    2003     2004     2003     2004  
Technology licenses, at cost
  $ 148,009     $ 159,512       7       7  
Accumulated amortization
    (21,296 )     (37,559 )                
 
                           
 
  $ 126,713     $ 121,953                  
 
                           

    Amortization charged to results of operations amounted to $2,080, $14,383 and $16,263 for 2002, 2003 and 2004, respectively. Estimated amortization for future periods is as follows:

         
2005
  $ 21,940  
2006
    25,099  
2007
    23,177  
2008
    21,195  
2009
    8,417  
Thereafter
    22,125  
 
     
 
  $ 121,953  
 
     

10.   Payables
 
    Payables relate to the following:

                 
    December 31,  
    2003     2004  
Trade purchases
  $ 38,244     $ 18,514  
Fixed asset purchases
    22,309       129,147  
 
           
 
  $ 60,553     $ 147,661  
 
           

F-20


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

11.   Other Current Liabilities

                 
    December 31,  
    2003     2004  
Accrued operating expenses
               
Unbilled purchases
  $ 39,890     $ 36,438  
Employee bonuses and related expenses
    29,402       22,657  
Interest
    4,697       5,251  
Others
    4,613       3,318  
 
           
 
    78,602       67,664  
Obligations payable under technology license agreements
    25,000       1,000  
Other current liabilities
    49,223       26,303  
 
           
 
  $ 152,825     $ 94,967  
 
           

12.   Income Taxes
 
    Income tax expense consists of the following:

                         
    2002     2003     2004  
Current
  $ 7,204     $ 14,313     $ 6,090  
Deferred
    (175 )     (2,642 )     (1,316 )
 
                 
Total
  $ 7,029     $ 11,671     $ 4,774  
 
                 

    All but an insignificant portion of pre-tax income (loss) and income tax expense is from Singapore sources.
 
    The Company has been granted pioneer status under the Economic Expansion Incentives (Relief from Income Tax) Act, Chapter 86 of Singapore for:

  •   the manufacture of integrated circuits using submicron technology at Fab 2 for a ten year period beginning July 1, 1996;
 
  •   the manufacture of integrated circuits using submicron technology at Fab 3 for a ten year period beginning July 1, 1999; and
 
  •   the wafer fabrication of Application Specific Integrated Circuits (ASIC) and other advanced semiconductor devices at Fab 6 for a ten year period beginning September 1, 2003 (granted on November 8, 2004).

    Under the Economic Expansion Incentives (Relief from Income Tax) Act (Chapter 86) of Singapore, the Company has also been granted:

  •   post-pioneer enterprise status for the manufacture of integrated circuits using submicron technology at Fab 2 for a five year period beginning July 1, 2006;
 
  •   development and expansion incentive status for the manufacture of integrated circuits using submicron technology at Fab 3 for a five year period beginning July 1, 2009; and
 
  •   development and expansion incentive status for the wafer fabrication of ASICs and other advanced semiconductor devices at Fab 6 for a five year period beginning September 1, 2013.

    During the period for which pioneer status is effective, subject to compliance with certain conditions, income from pioneer trade (that is, sale of integrated circuits) is exempt from Singapore income tax. During the periods for which post-pioneer status and development and expansion incentive status are effective, subject to compliance with certain conditions, income from post-pioneer trade and development and expansion activities are taxed at a concessionary rate of 10%. Without these exemptions from income tax or the concessionary tax rate of 10%, the Company would be subject to income tax at the Singapore corporate income tax rate of 20% for the year ended December 31, 2004, and 22% for the years ended December 31, 2003 and 2002.

F-21


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    Tax losses accumulated before the pioneer status period cannot be carried forward. Tax losses accumulated in the pioneer status period may be carried forward and may be offset against income from the same pioneer trade arising both during the pioneer status and after the expiration of the pioneer status period, subject to compliance with certain conditions. Accordingly, loss carryforwards are determined on a fab-by-fab basis. As of December 31, 2004, the Company does not have any loss carryforwards.
 
    Interest income is not exempt from taxation during the pioneer status period or entitled to the concessionary tax rate during the post-pioneer status period or the development and expansion incentive status period. The income tax expense for the years ended December 31, 2002, 2003 and 2004 represents primarily income tax payable on non-pioneer income, principally interest and rental income.
 
    The Company was granted development and expansion incentive status for wafer fabrication of integrated circuits at Fab 1 for a five-year period beginning January 1, 2001, subject to compliance with certain conditions during that period. In February 2003, the Company announced its plan to consolidate the business of Fab 1 into Fab 2, and close Fab 1 during 2004. This closure would result in non-compliance with the conditions of the development and expansion incentive status, and accordingly at that time the Company accrued additional taxes payable for the period subsequent to January 1, 2001 at the full corporate tax rate. During 2004, the relevant authority agreed to allow the development and expansion incentive status through December 31, 2004, although the conditions would not be met for the original five-year period. Accordingly, the Company revised its accruals to the concessionary tax rate of 10% resulting in a reduction in tax expense of $9,784 for the year ended December 31, 2004.
 
    Under Singapore tax law, tax depreciation of property, plant and equipment (referred to as wear and tear allowances) is deductible only to the extent of taxable income before tax depreciation. Unutilized wear and tear allowances are carried forward to future tax years. As of December 31, 2004, the Company has unutilized wear and tear allowance carryforwards of approximately $968,000. Of this amount, approximately $637,000 is expected to reverse within the pioneer tax-exempt period, and accordingly has been recognized at a zero percent tax rate. The amount expected to reverse during the post-pioneer status period or the development and expansion incentive status period is approximately $108,000, and has been recognized at a 10% tax rate. The remaining amount is expected to reverse after the post-pioneer status period or the development and expansion incentive status period, and has been recognized at a 20% tax rate. The deferred tax asset for unutilized wear and tear allowances is lower than the amount at December 31, 2003, due to changes in estimates of the timing of future taxable income, and therefore an increase in the amount expected to reverse during the pioneer tax-exempt period.
 
    Loss carryforwards as well as unutilized wear and tear allowances are available indefinitely, subject to 50% or more of the Company’s equity staying with the same shareholders from the incurrence of the tax loss to its utilization and in the case of wear and tear allowances, an additional test that the same trade must be carried on.

F-22


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

                 
    December 31,  
    2003     2004  
Deferred tax assets
               
Unutilized wear and tear allowances
  $ 71,290     $ 55,324  
Deferred interest
    9,717       11,386  
Property, plant and equipment
    9,091       8,841  
Other accrued expenses
    92       1,570  
 
           
 
    90,190       77,121  
Valuation allowance
    (82,003 )     (68,205 )
 
           
 
  $ 8,187     $ 8,916  
 
           
Deferred tax liabilities
               
Property, plant and equipment
  $ (2,247 )   $ (1,316 )
Intangibles
    (438 )     (796 )
Other
    (14 )      
 
           
 
  $ (2,699 )   $ (2,112 )
 
           
Net deferred tax asset
  $ 5,488     $ 6,804  
 
           

    In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment.
 
    The valuation allowance was $Nil at January 1, 2002. During the years ended December 31, 2002, 2003 and 2004, the valuation allowance increased (decreased) by $6,285, $75,718 and ($13,798), respectively.
 
    As of December 31, 2004, the Company recorded deferred tax assets of $55,324 relating to the Company’s unutilized wear and tear allowances that are expected to be carried forward to offset future taxable income arising after the expiration of the Company’s pioneer periods. Based upon the level of historical taxable income and projections for future taxable income over the periods that the deferred tax assets are deductible, management believes it is more likely than not the Company will not realize the benefits of these deductible differences. Accordingly, a valuation allowance of the same amount was recorded as at December 31, 2004.
 
    The remaining valuation allowance as of December 31, 2004 primarily relates to the yield to maturity interest expense for the Company’s convertible debt. As of December 31, 2004, the Company has recorded a deferred tax asset for the differences in the tax and book basis for this interest expense. Based on the projections of future interest income against which this interest expense would be deductible, management believes that it is more likely than not that the Company will not realize the benefits of this deduction, and accordingly has recorded a valuation allowance.
 
    The deferred tax effects of the remaining difference in the tax and book basis of property, plant and equipment are recognized because the Company believes that it is more likely than not that future taxable income will be generated over the periods which the deferred tax assets are deductible.
 
    A reconciliation of the expected tax expense computed by applying statutory rates to pre-tax income (loss) to the actual tax expense is as follows:

F-23


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

                         
    December 31,  
    2002     2003     2004  
Income taxes computed at Singapore statutory tax rate of 20% (22% in 2002 and 2003)
  $ (102,437 )   $ (62,174 )   $ 2,269  
Permanent non-deductible expenses
    33,372       44,360       12,582  
Effect of pioneer status, including losses and allowances not recognized as deferred tax benefit
    65,383       38,480       6,263  
Effect of post-pioneer status
    (175 )     (2,642 )     (2,263 )
Non-taxable increase (decrease) in equity method investment
    9,823       (5,103 )     (5,512 )
Effect of change in concessionary tax status
                (6,884 )
All other items, net
    1,063       (1,250 )     (1,681 )
 
                 
Income tax expense
  $ 7,029     $ 11,671     $ 4,774  
 
                 

    The pioneer tax status had the effect of increasing (decreasing) basic and diluted net earnings (loss) per share by ($0.04), ($0.02) and $0.00 and basic and diluted net earnings (loss) per ADS by ($0.36), ($0.15) and $0.02 for the years ended December 31, 2002, 2003 and 2004, respectively.
 
13.   Long-term Debt
 
    Long-term debt consists of:

                 
    December 31,  
    2003     2004  
Singapore dollar loans at fixed rates of 4% to 4.25%
  $ 127,299     $ 73,650  
US dollar loan at floating rates
    502,000       589,066  
Senior convertible notes
    575,000       575,000  
Other
    8,453       (1,986 )
 
           
 
    1,212,752       1,235,730  
Less current installments
    (223,660 )     (352,985 )
 
           
Long-term debt, excluding current installments
  $ 989,092     $ 882,745  
 
           

    Other long-term debt includes the cumulative fair value change due to changes in interest rates of the senior convertible notes. This change is recorded because the Company has entered into interest rate swap contracts that have the effect of swapping the fixed-rate interest to a floating rate. The Company designated these derivative instruments as fair value hedges and carried the same at fair value.

                 
    Weighted Average  
    Interest Rates  
    December 31,  
    2003     2004  
Singapore dollar loans at fixed rates of 4% to 4.25%
    5.7774 %     5.9129 %
US dollar loan at floating rates
    1.9375 %     3.2375 %
Senior convertible notes
    3.9920 %     5.1440 %

    The Singapore dollar fixed rate loans, from the Singapore Economic Development Board, consist of $28,057 maturing in 2005 and $45,593 maturing in 2006, and are repayable in semi-annual installments. ST has guaranteed $28,057 of these loans until their maturity in 2005.
 
    The US dollar floating rate loan matures in September 2006. The loan facility is for an amount of $820,000 of which $502,000 and $589,066 was outstanding as of December 31, 2003 and 2004, respectively. The loan bears interest at 0.60% to 0.85% (depending on certain criteria relating to wafer starts and debt/equity ratio) above the LIBOR rates for US dollars deposits quoted by specified banks to the lender. Interest is payable semi-annually in US dollars and principal is payable in six semi-annual installments which commenced March 2004. Borrowings under this facility are secured by a floating charge over a project bank account and a fixed charge over a debt service reserve account, both of which were established pursuant to this loan.

F-24


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    The senior unsecured convertible notes mature on April 2, 2006. The notes bear a coupon rate of 2.50% per year and have a yield to maturity of 5.25% per year. The notes are convertible into the Company’s ordinary shares or American Depository Shares (“ADS”). The Company may redeem all or a portion of the notes at any time on or after April 2, 2003 at a price to yield of 5.25% per year on the redemption date if the Company’s shares or ADS’s trade at 125% of the conversion price for a period of 20 days in any consecutive 30 trading day period.
 
    The conversion price per ordinary share, adjusted for the Company’s rights offering in 2002, is S$4.7980 (equivalent to approximately US$26.7701 per ADS, based on the terms of the notes for a fixed exchange rate of US$1.00 = S$1.7923 and the ordinary share to ADS ratio of 10:1).
 
    Annual maturities of long-term debt as of December 31, 2004 are as follows:

         
Payable in year ending December 31,
       
2005
  $ 352,985  
2006
    882,745  
 
     
 
  $ 1,235,730  
 
     

    As of December 31, 2004, the Company has secured financing to support Fab 7’s phase 1 ramp to 15,000 300-mm wafers per month capacity. This includes a $653,000 term loan facility from J.P. Morgan, guaranteed by the Export-Import Bank of the United States which is to be drawndown for purchase of Fab 7 equipment from vendors in the United States, a $200,000 term loan facility (with the option to increase the facility by $100,000) from Sumitomo Mitsui Banking Corporation and Oversea Chinese Banking Corporation, a $50,000 term loan facility from Bank of America, and a $150,000 revolving credit facility from Sumitomo Mitsui Banking Corporation. The commitment fees relating to these facilities amounted to $7,720.
 
    As of December 31, 2004, the Company has total unutilized banking facilities of approximately $1,116,608 for short-term advances, term loans and bankers’ guarantees.
 
    The Company’s loans and available credit facilities contain various financial, shareholding and other restrictive covenants which are customary to loan documents. Under the financial covenants, the Company is required to maintain certain financial conditions and ratios such as consolidated net worth, EBITDA, total debt to net worth ratio, and historical debt service coverage ratio. Under the shareholding covenants, Temasek and ST are required to own directly or indirectly, a certain percentage of the Company’s outstanding shares. As a result of the ST Restructuring discussed in Note 1, certain loan agreements with ST shareholding covenants were amended to replace ST with Temasek. In addition, some of the loans and available credit facilities also impose other restrictive covenants such as the restriction from incurring further indebtedness, creating security interests over assets, payment of dividends, disposal of assets and merger and corporate restructuring.
 
14.   Shareholders’ Equity
 
    Share Capital
 
    Share capital consists of the following:

                 
    December 31,  
    2003     2004  
Issued and paid-up share capital
  $ 383,792     $ 384,370  
Capital reduction
    61,161       61,161  
 
           
 
  $ 444,953     $ 445,531  
 
           

F-25


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    In November 1992, the Company reorganized its paid-up share capital by the extinguishment of accumulated losses of $61,161 against the paid-up share capital in a capital reduction sanctioned by the High Court of Singapore. The capital reduction does not qualify as a quasi-reorganization under US GAAP and accordingly has not been reflected in the financial statements.
 
    Additional Paid-in Capital
 
    Additional paid-in capital as of December 31, 2003 and 2004 represents principally the excess of proceeds received from issue of share capital (net of the costs of issue) over the par value of shares issued, which under Singapore law must be credited to the share premium account. The share premium may only be applied in paying up unissued shares to be issued to shareholders, paying up in whole or in part the balance unpaid on shares in issue, in writing off preliminary expenses and share and debenture issue expenses and by provision for premiums payable on the redemption of redeemable preferred shares. The share premium account had a balance of $2,207,783 as at December 31, 2004.
 
    In August 2004, the Company entered into a bilateral option transaction with Goldman Sachs International as counter-party, to pro-actively manage the senior convertible notes (“Notes”). Under the transaction, the Company has a choice of physical or cash settlement. The counter-party may purchase 214,800 of the Company’s shares at $0.93 per share (approximately S$1.60 per share, based on an exchange rate of $1.00 = S$1.71) and the Company will receive approximately $200,000. The number of shares under the option transaction is equal to the number of shares that were originally planned for issuance under the existing Notes. The option transaction, which is contractually separate from the Notes, is exercisable by the counter-party from January 2, 2005 and will expire on April 2, 2006, matching the maturity date of the Notes. The option transaction also has a feature that allows the Company to elect for early termination if the trading price of the Company’s ordinary shares listed and quoted on the Singapore Exchange rises and remains above $1.17 for a defined period of time. In such an event, the Company may elect to settle in cash or physically by delivering its ordinary shares.
 
    Accumulated Deficit
 
    Singapore law allows dividends to be paid only out of profits of the Company. Shareholders of ordinary shares are not liable for Singapore income tax on dividends paid by the Company out of its tax exempt profits from pioneer activities. Some of the Company’s loan agreements restrict the ability of the Company to pay dividends without prior approval from the lender.
 
    Distributions of profits from non-pioneer activities which have been subject to income tax are paid with a franking tax credit which Singapore tax-resident shareholders can apply as a prepayment of income tax on the dividend. Shareholders who are not tax-resident in Singapore are not liable for further Singapore income tax.
 
    Under the one-tier system with effect from January 1, 2003, tax payable by the Company on its non-pioneer chargeable income constitutes a final tax. Companies that have moved to the one-tier system can henceforth pay dividends that are exempt from tax in the hands of their shareholders.
 
    During the transitional period, the Company has up to December 31, 2007 to utilize any available balance under the old imputation system to pay a franked dividend to its shareholders. As at December 31, 2004, the Company has approximately $54,000 of available balances under the old imputation system.
 
    Accumulated deficit includes $27,167 of post-formation losses of SMP.

F-26


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    Accumulated Other Comprehensive Loss
 
    Accumulated other comprehensive loss consists of the following:

                 
    December 31,  
    2003     2004  
Currency translation loss
  $ 54,380     $ 54,380  
Effects of net unrealised losses on available for sale securities
    266       1,339  
Unrealized net cash flow hedging activity derivative losses
    4,235       2,634  
 
           
 
  $ 58,881     $ 58,353  
 
           

    The currency translation loss is not adjusted for income taxes as it arose from a change in functional currency in prior years which is not tax deductible. The unrealized net cash flow hedging activity derivative losses are not adjusted for income taxes because such losses are expected to be realized during the pioneer status. No income tax benefit is recognized for unrealized losses on available for sale securities.

15.   Share Options and Incentive Plans

  (a)   1999 Option Plan

    Effective March 1999, the Company adopted the Chartered Semiconductor Manufacturing Ltd Share Option Plan 1999 (the “1999 Option Plan”) which provided for a maximum of 107,160 shares (subject to adjustment under the plan) to be reserved for option grants. This amount was increased to 197,160 shares in May 2002. As a result of the Company’s rights offering in October 2002, the shares available for future grants were increased by 30,488 shares. The total shares provided under the 1999 Option Plan is hence 227,648 shares. The remaining shares available for future grants at December 31, 2004 are 93,145. Options granted under the plan may include non-statutory options as well as incentive stock options intended to qualify under Section 422 of the United States Internal Revenue Code.
 
    The plan is administered by a committee appointed by the Directors. Employees, outside directors and consultants are eligible for the grant of options subject to certain exceptions as provided in the 1999 Option Plan.
 
    The exercise price of an incentive stock option is generally the fair market value of the shares at the date of the grant. In certain circumstances, the exercise price may be higher than the fair market value but in no event will the exercise price be below the par value of the share.
 
    As a result of the Company’s rights offering which was completed in October 2002, changes were made to both the exercise price and the number of shares of all outstanding options offered or granted. The adjustments were made so that the aggregate intrinsic value of the options and the ratio of the exercise price per share to the market value per share for each outstanding option tranche remain unchanged immediately after the rights offering. The adjustments were made by multiplying each existing option exercise price by 0.8531 and dividing the number of shares issuable upon exercise of each option by 0.8531.
 
    Option periods do not exceed 10 years from the date of grant. Upon leaving the employment of the Company, outstanding options remain exercisable for a specified period.

F-27


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    Information on options granted is as follows:

                 
            Weighted  
            Average  
            Exercise  
    Options     Price  
Outstanding at January 1, 2002
    87,925     $ 4.19  
Granted
    31,457     $ 1.46  
Exercised
    (3,018 )   $ 1.10  
Lapsed
    (16,671 )   $ 3.78  
 
           
Outstanding at December 31, 2002
    99,693     $ 3.49  
Granted
    29,528     $ 0.55  
Expired
    (4 )   $ 0.88  
Exercised
    (461 )   $ 0.52  
Lapsed
    (24,533 )   $ 3.52  
 
           
Outstanding at December 31, 2003
    104,223     $ 2.67  
Granted
    20,905     $ 0.93  
Expired
    (919 )   $ 1.65  
Exercised
    (1,074 )   $ 0.46  
Lapsed
    (10,481 )   $ 2.89  
 
           
Outstanding at December 31, 2004
    112,654     $ 2.36  
Exercisable at end of year
    52,719     $ 3.39  
 
           

    Weighted average fair values of options granted in 2002, 2003 and 2004 were $1.13, $0.40 and $0.63 respectively.
 
    The following table summarizes information about fixed stock options outstanding at December 31, 2004.

                                         
    Options Outstanding   Options Exercisable  
            Weighted              
    Number     average     Weighted             Weighted  
Range   outstanding     remaining     average     Number     average  
of exercise   at     contractual     exercise     exercisable     exercise  
prices   12/31/2004     life     price     12/31/2004     price  
$0.39 to $1.00
    47,781     8.3 years   $ 0.71       10,265     $ 0.56  
$1.06 to $1.95
    23,699     6.7 years   $ 1.41       11,809     $ 1.46  
$2.14 to $2.44
    18,744     5.9 years   $ 2.33       12,118     $ 2.32  
$5.81
    12,881     5.2 years   $ 5.81       10,619     $ 5.81  
$8.31
    9,549     4.6 years   $ 8.31       7,908     $ 8.31  
 
                                   
 
    112,654                       52,719          
 
                                   

    The options vest over one to five years and expire on dates ranging from April 2005 to December 2014. The 1999 Option Plan is accounted for in accordance with fixed-plan accounting under APB 25 and related interpretations. Total compensation expense recognized for 2002, 2003 and 2004 totalled $(253), $4 and $3 respectively.
 
    The fair value of the option grants are estimated using the Black-Scholes option pricing model with the following assumptions used for grants in 2002, 2003 and 2004.

F-28


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

                         
      2002       2003       2004    
Risk free interest rate
    3.195% to 5.060%       2.710% to 4.450%       2.97% to 4.14%    
Expected volatility
    67.690% to 75.89%       66.61% to 70.16%       61.94% to 65.04%    
Expected lives
    5 to 10 years       5 to 9 years       5 to 8 years    
Dividend yield
    NA       NA       NA    

    Options of 1,474, 1,284 and 595 shares of the Company were granted to employees of SMP in 2002, 2003 and 2004, respectively. SMP bears the stock-based compensation charge in respect of these options.

  (b)   2001 Share Purchase Plans

    As approved by the shareholders in May 2001, the Company adopted the Chartered Semiconductor Manufacturing Ltd Employee Share Purchase Plan 2001 (the “Chartered Purchase Plan”) and the Share Purchase Plan 2001 for Employees of Silicon Manufacturing Partners Pte Ltd (the “SMP Purchase Plan”), collectively “the 2001 Plans”, which provided for the issuance of a maximum of 10,000 shares (subject to adjustment under the Plans). The amount was subsequently revised to 11,722 shares as a result of the Company’s rights offering which was completed in October 2002.
 
    The 2001 Plans permitted eligible employees to purchase shares through payroll deductions of between 1 percent to 10 percent of an employee’s compensation, including salaries, wages, bonuses, incentive compensations, commissions, overtime pay and shift premiums. The offering periods consisted of the six-month periods commencing on each March 1 and September 1. The purchase price for each share purchased at the close of an offering period was the lower of 85% of the fair market value of the share on the last trading day in such offering period or last trading day before the commencement of such offering period. The purchase price for each share would in no event be less than the par value of each share. The 2001 Plans were intended to qualify under Section 423 of the United States Tax Code.
 
    The 2001 Plans were administered by a committee appointed by the Directors. Approximately 2,700 shares were purchased at $0.56 (S$0.94) in 2004 under the 2001 Plans. As of February 2004, all shares available under the 2001 Plans had been issued and allotted and as a result, the 2001 Plans were terminated.

  (c)   2004 Share Purchase Plans

    As approved by the shareholders in April 2004, the Company has adopted a new Chartered Semiconductor Manufacturing Ltd Employee Purchase Plan 2004 (“Chartered ESPP 2004”) and a new share purchase plan for the employees of Silicon Manufacturing Partners Pte Ltd (“SMP ESPP 2004”), collectively “ESPP 2004 Plans”. The ESPP 2004 Plans provide for the issuance of a maximum of 30,000 shares (subject to adjustment under the Plans).
 
    The terms of the ESPP 2004 Plans and the 2001 Plans are similar except for the following significant differences:

  (i)   the ESPP 2004 Plans give the committee appointed by the Directors to administer the plans (“Committee”) the right to stipulate that the purchase price for each Ordinary Share purchased at the close of an offering period be determined by an alternative method, which is to be prescribed by the Committee, if the Committee determines that the existing method of determining the purchase price would cause the Company to incur any stock-based compensation charge; and
 
  (ii)   the ESPP 2004 Plans impose a limit of 3,000 Ordinary Shares per calendar year (and a limit of 1,500 Ordinary Shares per offering period) on the number of Ordinary Shares available for purchase by participants in the ESPP 2004 Plans. The ESPP 2004 Plans continue to provide for two offering periods in a calendar year commencing on each March 1 and September 1.

    No shares were issued in 2004 under the ESPP 2004 Plans.

F-29


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

16.   Commitments and Contingencies

  (a)   Commitments

    The Company has the following capital commitments:

                 
    December 31,  
    2003     2004  
Contracts for capital expenditure
  $ 398,296     $ 312,883  

    Minimum future rental payments on non-cancellable operating leases, excluding amounts payable to related parties disclosed in Note 2, as at December 31, 2004, are as follows:

         
Payable in year ending December 31,
       
2005
  $ 4,057  
2006
    2,338  
2007
    391  
2008
    276  
2009
    186  
Thereafter
    189  
 
     
 
  $ 7,437  
 
     

    Rental expense, excluding amounts payable to related parties disclosed in Note 2, for the years ended December 31, 2002, 2003 and 2004 was $5,484, $5,031 and $5,473 respectively.
 
    The Company has a patent license agreement with a technology partner under which the parties grant to one another a license to use certain of each other’s patents. Under the terms of the patent license agreement, the Company may provide wafer capacity in lieu of payment for royalties. Such royalties under the patent license agreement are waived until such time as the interest of the technology partner in SMP falls below 49%. In exchange the Company has waived capacity shortfall obligations from the technology partner. The patent license agreement continues for as long as the joint venture agreement between the parties remains.
 
    The Company entered into subscription and participation agreements with seven customers (the “Equity Investor Customers”), a technology partner and an investor to raise equity for the establishment of a new fab. Under the agreements, the Equity Investor Customers, technology partner and the investor subscribed for shares with the right to subscribe for new shares pro-rata to their interest in the Company. The subscription and participation agreements were terminated on November 5, 1999. The Company is committed to provide the Equity Investor Customers and technology partner with rights to wafer capacity first granted under those agreements through August 2005.
 
    The Company has entered into manufacturing agreements with several customers whereby the Company has committed to make available production capacity to customers over the term of the agreement.
 
    As discussed in Note 2, pursuant to the assured supply and demand agreement that the Company and Agere signed with SMP, each partner is required to purchase a specified percentage of SMP’s output. However, if one party does not purchase its share of wafers, the other party is entitled to utilize that unused capacity. In the event such other party does not utilize the unused capacity, the party who does not purchase its entitlement will be required to compensate SMP for any unrecovered costs it incurs in connection with such unused capacity.
 
    The Company has entered into agreements to purchase technology licenses, jointly perform research and development, and swap capacity commitments. The future payment obligations under these agreements at December 31, 2004 are $266,000.

F-30


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

  (b)   Contingencies

    The Company may from time to time be a party to claims that arise in the normal course of business. These claims include allegations of infringement of intellectual property rights of others as well as other claims of liability. In addition, the Company, on a case-by-case basis, includes intellectual property indemnification provisions in the terms of sale and technology licenses with third parties. The Company is also subject to various taxes in the different jurisdictions in which it operates. These include taxes on income, property, goods and services, and other taxes. The Company submits tax returns and claims with the respective government taxing authorities which are subject to agreement by those taxing authorities. The Company accrues costs associated with these matters when they become probable and reasonably estimable. The Company does not believe that it is probable that losses associated with these matters beyond those already recognized will be incurred in amounts that would be material to its financial position or consolidated statements of operations.
 
17.   Derivative Instruments
 
    The Company has the following notional amounts of derivative instruments:

                 
    December 31,  
    2003     2004  
Forward foreign exchange contracts to hedge:
               
— Singapore dollar transactions
  $ 81,983     $ 47,842  
— Plant and equipment purchases (mainly Japanese yen and Euro)
    14,909       95,970  
Cross currency swap
    73,225       45,593  
Convertible notes interest rate swap
    575,000       575,000  
Interest rate cap
          100,000  
 
           
 
  $ 745,117     $ 864,405  
 
           

    The Company’s primary objective for holding derivative financial instruments is to manage currency and interest rate risks. To protect against volatility of future cash flows caused by changes in exchange rates, the Company may use currency forward contracts and currency swaps on anticipated transactions such as operating costs and expenses and capital purchases. To manage the interest rate risk, the Company may enter into interest rate swap or cap agreements to modify the interest characteristics of its outstanding debts.
 
    During 2001, the Company entered into an interest rate swap contract to hedge fixed-rate interest obligations associated with $200,000 of the convertible notes issued in April 2001, with the effect of swapping the fixed-rate coupon interest obligations to floating-rate obligations based on LIBOR rates. The Company has designated this interest rate swap contract as a fair-value hedge. In January 2003, the Company entered into an additional swap to incorporate hedging of the accreting portion of the bond which was not included in the original swap, thereby increasing the hedge effectiveness. In August 2003, the Company entered into an interest rate swap contract in respect of the fixed-rate coupon interest obligations associated with the remaining $375,000 of the convertible notes issued in April 2001, with the effect of swapping the fixed-rate interest obligations to a floating-rate obligation based on LIBOR rates. The Company has designated this interest rate swap contract as a fair-value hedge. The swap incorporated hedging of the accreting portion of the convertible notes. For the fair-value hedge transactions, changes in fair value of the derivative and changes in the fair value of the item being hedged are recorded in earnings as interest expense. Net realized gains (losses) arising from ineffectiveness of fair value hedges were $283, $1,516 and ($1,771) in the years ended December 31, 2002, 2003 and 2004, respectively.

F-31


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    The Company also uses derivative instruments to manage identified foreign currency risks resulting from its Singapore dollar denominated debt and its foreign currency denominated purchase commitments which are denominated principally in Japanese yen and Euro. The Company has also entered into a cross currency swap to convert a Singapore dollar fixed rate loan to a US dollar denominated fixed rate instrument. The Company uses foreign currency forward contracts to manage these risks and has designated them as foreign currency cash-flow hedges. The Company uses foreign currency forward contracts which match the terms of the individual foreign currency exposures and as a result, any ineffectiveness of the Company’s hedges is negligible. Amounts included in other comprehensive income (loss) related to hedges of Singapore dollar denominated debt are reclassified into earnings in amounts equal to the transaction gain or loss resulting from the remeasurement of the debt into US dollars. The amounts reclassified into earnings are included in foreign exchange gain (loss). Amounts included in other comprehensive income (loss) related to hedges of foreign currency purchase commitments are reclassified into earnings (foreign exchange gain (loss)) when the asset related to the purchase commitment is depreciated.
 
    In August 2004, the Company entered into two interest rate cap contracts in respect of the floating rate obligations associated with $100,000 of the US dollar loan, with the effect of placing an upper limit on the cash flow and earnings exposure due to market interest rate changes. Amounts included in other comprehensive income (loss) related to hedges of the floating rate US dollar loan represents the intrinsic value of the interest rate cap and are reclassified into earnings (interest expense) upon settlement.
 
    A $30,000 self-referenced credit-linked deposit (‘CLD’) was placed with a financial institution in June 2003. If a “credit event” (as defined in the CLD) occurs, which includes default in the payment of the Company’s senior convertible notes due 2006 or bankruptcy of the Company, the principal will not be returned in full. Rather, the Company will receive the market value of $30,000 face amount of the Company’s Notes, less costs incurred by the financial institution.
 
    Most of the Company’s derivatives are formally designated as cash flow foreign currency hedges and fair value hedges. However, certain derivative instruments are not designated as part of a hedging relationship. These consist primarily of foreign currency forward contracts related to groups of forecasted foreign currency denominated payments. While the Company expects these derivatives to be effective in hedging the variability in cash flows resulting from changes in foreign exchange rates, it does not believe it is practicable to formally document the hedging relationship and link the derivatives to specific forecasted transactions. Gains and losses on these instruments are included in foreign exchange gain (loss).
 
    At December 31, 2004, the estimated net amount of existing losses from cash flow hedges expected to be reclassified into earnings within the next year is $285. For the year ended December 31, 2004, net realized loss recognized from cash flow hedges was $2,942.
 
    The components of other comprehensive income (loss) related to derivative and hedging activities consist of the following:

                 
    December 31,  
    2003     2004  
Beginning
  $ (10,329 )   $ (4,235 )
Reclassification of cash flow hedging activity gains (losses) into earnings
    1,003       (2,942 )
Share of cash flow hedging activity gains of SMP
    5,298       3,945  
Net changes in cash flow hedging activity derivative fair values
    (207 )     598  
 
           
Ending
  $ (4,235 )   $ (2,634 )
 
           

    By using derivative instruments to hedge exposures to changes in foreign currency rates and interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company owes the counterparty and, therefore, it does not possess credit risk. The Company anticipates, however, that counterparties will be able to fully satisfy their obligations under the contracts. The Company does not obtain collateral or other security to support financial instruments subject to credit risk but monitors the credit standing of counterparties.

F-32


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    Market risk is the adverse effect on the value of a financial instrument that results from a change in interest rates or currency exchange rates. The market risk associated with interest rate contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. The Company assesses interest rate cash flow risk and currency exchange cash flow risk by continually identifying and monitoring changes in interest rate or currency exchange rate exposures that may adversely impact expected future cash flows and by evaluating hedging opportunities.
 
18.   Fair Values of Financial Instruments

                                 
    December 31,  
    2003     2004  
    Carrying     Estimated     Carrying     Estimated  
Asset/(Liability)   amount     fair value     amount     fair value  
    $     $     $     $  
Long term debt
    (1,212,752 )     (1,248,765 )     (1,235,730 )     (1,255,457 )
Forward foreign exchange contracts
    2,828       2,828       7,141       7,141  
Forward foreign exchange contracts
                (4 )     (4 )
Cross currency swap
    (4,495 )     (4,495 )     (5 )     (5 )
Interest rate swap
    (37,008 )     (37,008 )     (61,299 )     (61,299 )
Credit default swap
    1,479       1,479              
Interest rate cap
                456       456  

    Cash and cash equivalents, amounts owing from and to ST and affiliates, term deposits, accounts receivable and accounts payable. The carrying amounts approximate fair value in view of the short term nature of these balances.
 
    Long-term debt. The fair value is based on current interest rates available to the Company for issuance of debts of similar terms and remaining maturities, or by obtaining quotes from brokers.
 
    Forward foreign exchange contracts. The fair value is estimated by reference to market quotations for forward contracts with similar terms, adjusted where necessary for maturity differences.
 
    Cross currency swap. The fair value is estimated by obtaining quotes from brokers.
 
    Interest rate swap. The fair value is estimated by obtaining quotes from brokers.
 
    Interest rate cap. The fair value is estimated by obtaining quotes from brokers.
 
    Credit default swap. The fair value is estimated by obtaining quotes from brokers.
 
    Limitations. Fair value estimates are made at a specific point in time, and are based on relevant market information and information about the financial instruments. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
 
19.   Business Segment, Geographic and Major Customer Data
 
    Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is the Chief Executive Officer of the Company. The Company has identified its individual fabs as its operating segments. Further, the Company has determined that all of the tests and conditions established in SFAS No. 131 “Disclosures About Segments of an Enterprise and Related Information” that permits aggregation have been met. Accordingly, the operating segment information has been aggregated into one reporting segment.

F-33


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    The following table presents a summary of revenues by country of domicile of customers and long-lived assets by geographic region. The Company geographically categorizes a sale based on the country in which the customer is headquartered.

                         
    2002     2003     2004  
Revenues
                       
Americas
  $ 315,660     $ 351,930     $ 631,150  
Europe
    38,643       72,249       85,125  
Japan
    43,967       24,799       33,258  
Singapore
    2,043       2,862       3,392  
Taiwan
    44,894       92,245       161,420  
Others
    4,034       7,826       17,786  
 
                 
 
  $ 449,241     $ 551,911     $ 932,131  
 
                 
Long-lived assets
                       
Singapore
  $ 1,860,555     $ 1,538,782     $ 1,913,945  
Others
    676       658       570  
 
                 
 
  $ 1,861,231     $ 1,539,440     $ 1,914,515  
 
                 
                         
    2002     2003     2004  
Customer A
    10.7 %     15.1 %     20.7 %
Customer B
    19.2       *       13.4  
Customer C
    *       *       10.1  
Customer D
    11.0       *       *  

   * less than 10% of net revenue for the year
 
    The top five customers of the Company accounted for 53%, 41% and 52%, of the Company’s net revenue in the years ended December 31, 2002, 2003 and 2004, respectively. As a result, loss or cancellation of business from, or significant changes in scheduled deliveries or decreases in the prices of products sold to, any of these customers could materially and adversely affect the Company’s results of operations or financial position.
 
20.   Other Operating Expenses (Income)
 
    Other operating expenses (income) consisted of:
 
    A property, plant and equipment impairment charge in 2002 of $4,868 resulting from the decision to abandon certain production processes. As the associated machinery had no further productive use, it was taken out of service and, as the associated machinery had no value on the secondary machinery market, its carrying value was reduced to zero. A restructuring charge of $5,157 was also recorded in 2002 related to a workforce reduction in the fourth quarter, and represented the cost of the compensation package paid to the affected employees. The compensation was substantially paid during the fourth quarter of 2002.
 
    A gain of $27,531 in 2003 associated with the cancellation of an employee bonus award plan. As a result of the cancellation, compensation accrued for past services under the bonus award plan of $27,531 was eliminated by decreasing compensation expense in the period of cancellation.
 
    An impairment charge of $8,986 in 2003 on certain machinery and equipment which were classified as held for sale at December 31, 2003. The impairment charge resulted from the decision to rationalize capacity across the Company. The machinery and equipment were expected to be sold on the open market within twelve months of classification as held for sale. These assets were written down to the lower of their fair value, less costs to sell or their net book value. At December 31, 2004, some of this machinery and equipment remained unsold and were reclassified to held for use. These machinery and equipment were measured individually at the lower of their (a) carrying amount before being classified as held for sale, adjusted for any depreciation expense that would have been recognized had the asset been continuously classified as held for use, or (b) fair value at date of reclassification. A write-down of $979 was recorded on these machinery and equipment during 2004.

F-34


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

    A gain of $15,300 in 2004 associated with the resolution of a goods and services tax matter amounting to $4,900 and a gain of $10,400 resulting from an equipment disposition with CSMC Technologies Corporation.
 
    A restructuring charge of $12,421 and $4,558 in December 31, 2003 and 2004, respectively, relating to the closing of the Company’s Fab 1, in accordance with SFAS No. 146, “Accounting for Costs Associated with Exit or Disposal Activities”. In February 2003, the Company announced that as a result of continuing under-utilization of its fabs resulting from the deep and continuing semiconductor industry downturn, it would close Fab 1 and consolidate that business into Fab 2. The production in Fab 1 ceased at the end of March 2004. A summary of estimated and actual costs incurred is shown below. These amounts do not include gain on disposition of fixed assets. Plant closure, customer assistance and related expenses mainly relate to product qualification, prototyping, reticles, unhook and decommissioning of equipment and other activities to be carried out for consolidating the Fab 1 business into Fab 2.

                 
    Total     Cumulative  
    estimated     expense  
    costs     to-date  
Employee termination benefits
  $ 8,000     $ 7,673  
Plant closure, customer assistance and related expenses
  9,000 to 12,000     9,306  
 
           
Total
  $ 17,000 to 20,000     $ 16,979  
 
           
                                 
    Year Ended December 31, 2004  
    Beginning     Current             Ending  
    liability     year     Amount     liability  
    balances     additions     paid     balances  
Employee termination benefits
  $ 6,627     $ 1,046     $ 7,673     $  
Plant closure, customer assistance and related expenses
    2,339       3,512       5,851        
 
                       
Total
  $ 8,966     $ 4,558     $ 13,524     $  
 
                       
                                 
    Year Ended December 31, 2003  
    Beginning     Current             Ending  
    liability     year     Amount     liability  
    balances     additions     paid     balances  
Employee termination benefits
  $     $ 6,627     $     $ 6,627  
Plant closure, customer assistance and related expenses
          5,794       3,455       2,339  
 
                       
Total
  $     $ 12,421     $ 3,455     $ 8,966  
 
                       

F-35


Table of Contents

CHARTERED SEMICONDUCTOR MANUFACTURING LTD AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — in US Dollars
In thousands (except per share data)

21.   Other Income
 
    In 2004, other income included grant income of approximately $29,000 and the recognition of a gain of approximately $14,000 from the sale of technology to CSMC Technologies Corporation.
 
22.   Cumulative Effect Adjustment
 
    Effective January 1, 2003, the Company adopted the provisions of SFAS No. 143, “Accounting for Asset Retirement Obligations”, which addresses financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and associated asset retirement costs. Accordingly, the Company recorded a liability of $13,223 related to the requirements in its lease agreements for the return of buildings to tenantable condition and the return of land on which fabs have been built to original condition. The associated cost was capitalized as an increase in “property, plant and equipment” of the same amount and will be depreciated over the remaining useful lives of the facilities. The adoption of SFAS No. 143 as of January 1, 2003, resulted in a cumulative effect loss of $6,421, after a reduction in minority interest of $475. The cumulative effect loss represents the depreciation and accretion expense that would have been recorded previously if SFAS No. 143 had been in effect in prior years. The proforma effect of retroactive application of SFAS No. 143 in 2002 would not have had a material impact on the net loss, net loss per share and net loss per ADS, as reported.

F-36


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD

Financial Statements for the years ended
December 31, 2002, 2003 and 2004

 


SILICON MANUFACTURING PARTNERS PTE LTD

FINANCIAL STATEMENTS INDEX

         
    Page Number  
    F-37  
    F-38  
    F-39  
    F-40  
    F-41  
    F-42  

 


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Members of
Silicon Manufacturing Partners Pte Ltd:

We have audited the accompanying balance sheet of Silicon Manufacturing Partners Pte Ltd as of December 31, 2004, and the related profit and loss accounts, statement of changes in equity and statement of cash flows for the years ended December 31, 2002 and 2004. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by the management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Silicon Manufacturing Partners Pte Ltd as of December 31, 2004, and the results of its operations and cash flows for the years ended December 31, 2002 and 2004, in conformity with Singapore Financial Reporting Standards.

Singapore Financial Reporting Standards vary in certain significant respects from accounting principles generally accepted in the United States of America. Information relating to the nature and effect of such differences is presented in Note 22 to the financial statements.

We have not audited or reviewed the accompanying 2003 financial statements and, accordingly, do not express an opinion or any other form of assurance on them.

KPMG

Singapore
February 4, 2005

F-37


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
BALANCE SHEETS
As of December 31
In thousands of US Dollars

                         
    Note     2003     2004  
            (Unaudited)        
            $     $  
Non-current assets
                       
Property, plant and equipment
    3       262,160       131,685  
Intangible assets
    4       189       573  
Deferred expense
            1,680        
Deferred income tax asset
    5             82  
 
                   
 
            264,029       132,340  
 
                   
Current assets
                       
Inventories
    6       31,127       20,913  
Trade and other receivables, net
    7       53,195       27,247  
Cash and cash equivalents
    8       129,625       37,427  
 
                   
 
            213,947       85,587  
 
                   
Less:
                       
Current liabilities
                       
Trade and other payables
    9       91,652       21,531  
Interest-bearing liabilities
    10       107,142        
Current tax payable
            1,383       1,548  
 
                   
 
            200,177       23,079  
 
                   
Net current assets
            13,770       62,508  
 
                   
 
            277,799       194,848  
Non-current liabilities
                       
Deferred income tax liability
    5       18        
Interest-bearing liabilities
    10       64,286        
 
                   
 
            64,304        
 
                   
Net assets
            213,495       194,848  
 
                   
 
Share capital
    11       252,389       252,389  
Accumulated losses
            (38,894 )     (57,541 )
 
                   
Shareholders’ equity
            213,495       194,848  
 
                   

The accompanying notes form an integral part of these financial statements.

F-38


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
PROFIT AND LOSS ACCOUNTS
For the Years Ended December 31
In thousands of US Dollars

                                 
    Note     2002     2003     2004  
                    (Unaudited)        
            $     $     $  
Revenue
            205,458       329,535       303,570  
Cost of sales
            (242,749 )     (286,462 )     (268,743 )
 
                         
Gross profit/(loss)
            (37,291 )     43,073       34,827  
Other operating income
    13       51,578       4,840       1,614  
Sales and marketing expenses
            (85 )     (41 )     (23 )
General and administrative expenses
            (3,954 )     (4,342 )     (9,741 )
Other operating expenses
    14             (178 )      
 
                         
Profit from operations
    15       10,248       43,352       26,677  
Finance costs
    16       (30,080 )     (21,908 )     (8,579 )
 
                         
Profit/(Loss) from ordinary activities before taxation
            (19,832 )     21,444       18,098  
Income tax expense
    17       (485 )     (275 )     (65 )
 
                         
Net profit/(loss) for the year
            (20,317 )     21,169       18,033  
 
                         

The accompanying notes form an integral part of these financial statements.

F-39


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
STATEMENTS OF CHANGES IN EQUITY
For the Years Ended December 31
In thousands of US Dollars (except per share data)

                                 
                    Accumulated        
            Share     profits/        
    Note     capital     (losses)     Total  
            $     $     $  
Year ended December 31, 2002
                               
At January 1, 2002
            252,389       14,996       267,385  
Net loss for the year
                  (20,317 )     (20,317 )
 
                         
At December 31, 2002
            252,389       (5,321 )     247,068  
 
                         
 
                               
Year ended December 31, 2003 (Unaudited)
                               
At January 1, 2003
            252,389       (5,321 )     247,068  
Net profit for the year
                  21,169       21,169  
First interim dividend declared of $0.0011 per “B” ordinary share less tax at 22%
    18             (234 )     (234 )
Second interim dividend declared of $0.2515 per “B” ordinary share, tax exempt
    18             (54,508 )     (54,508 )
 
                         
At December 31, 2003
            252,389       (38,894 )     213,495  
 
                         
 
                               
Year ended December 31, 2004
                               
At January 1, 2004
            252,389       (38,894 )     213,495  
Net profit for the year
                  18,033       18,033  
Third interim dividend paid of $0.0308 per “B” ordinary share, tax exempt
    18             (6,680 )     (6,680 )
Fourth interim dividend paid of $0.1384 per “B” ordinary share, tax exempt
    18             (30,000 )     (30,000 )
 
                         
At December 31, 2004
            252,389       (57,541 )     194,848  
 
                         

The accompanying notes form an integral part of these financial statements.

F-40


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
STATEMENTS OF CASH FLOWS
For the Years Ended December 31
In thousands of US Dollars

                                 
    Note     2002     2003     2004  
                    (Unaudited)        
            $     $     $  
Operating activities
                               
Profit/(Loss) from ordinary activities before taxation
            (19,832 )     21,444       18,098  
Adjustments for:
                               
Amortization of deferred finance expenses
            1,008       1,008       1,680  
Amortization of intangible assets
            795       324       217  
Depreciation of property, plant and equipment
            150,367       159,691       137,198  
Assets impairment
                  178        
(Gain)/Loss on disposal of property, plant and equipment
            728             (5 )
Gain on disposal of intangible assets
            (178 )            
Interest expense, net of amount capitalized
            28,797       20,870       6,879  
Interest income
            (1,882 )     (1,252 )     (823 )
 
                         
Operating profit before working capital changes
            159,803       202,263       163,244  
Changes in working capital:
                               
Inventories
            (10,590 )     (14,011 )     10,214  
Trade and other receivables
            42,155       (26,114 )     27,466  
Trade and other payables
            7,345       13,025       (23,852 )
 
                         
Cash generated from operations
            198,713       175,163       177,072  
Interest received
            1,823       1,349       855  
Interest paid, net of amount capitalized
            (29,320 )     (21,357 )     (7,764 )
Income taxes paid
            (71 )     (59 )      
 
                         
Cash flows from operating activities
            171,145       155,096       170,163  
 
                         
 
                               
Investing activities
                               
Proceeds on disposal of property, plant and equipment
            4,595       3,350       54  
Purchase of property, plant and equipment including interest paid of $1,240, $243 and $21 for 2002, 2003 and 2004, respectively
            (49,918 )     (14,088 )     (19,198 )
Proceeds on disposal of intangible assets
            294              
Purchase of intangible assets
            (109 )     (77 )     (601 )
 
                         
Cash flows from investing activities
            (45,138 )     (10,815 )     (19,745 )
 
                         
 
                               
Financing activities
                               
Repayment of bank loan
            (96,429 )     (107,143 )     (171,428 )
Dividends paid
                  (20,234 )     (71,188 )
 
                         
Cash flows from financing activities
            (96,429 )     (127,377 )     (242,616 )
 
                         
 
                               
Net increase/(decrease) in cash and cash equivalents
            29,578       16,904       (92,198 )
Cash and cash equivalents at beginning of year
            83,143       112,721       129,625  
 
                         
Cash and cash equivalents at end of year
    8       112,721       129,625       37,427  
 
                         

The accompanying notes form an integral part of these financial statements.

F-41


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

These notes form an integral part and should be read in conjunction with the accompanying financial statements.

The financial statements were authorized for issue by the directors on February 28, 2005.

1.   Domicile and Activities
 
    Silicon Manufacturing Partners Pte Ltd (the “Company”) is incorporated and domiciled in the Republic of Singapore and has its registered office at 60 Woodlands Industrial Park, Street 2, Singapore 738406.
 
    The principal activities of the Company are those relating to an independent foundry of semiconductor integrated circuits using its advanced production facilities and proprietary integrated circuit designs of its customers.
 
    The immediate and ultimate holding companies during the financial year are Agere Systems Singapore Pte Ltd and Agere Systems Inc., which are incorporated in the Republic of Singapore and the United States of America, respectively.
 
2.   Summary of Significant Accounting Policies

  (a)   Basis of Preparation
 
      The financial statements have been prepared in accordance with Singapore Financial Reporting Standards (“FRS”) including related Interpretations promulgated by the Council on Corporate Disclosure and Governance (“CCDG”).
 
      The historical cost basis is used. Amounts are expressed in the United States (“US”) dollars, unless otherwise stated.
 
      The preparation of financial statements in conformity with FRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the financial year. Although these estimates are based on management’s best knowledge of current events and actions, actual results may ultimately differ from those estimates.
 
  (b)   Measurement currency
 
      The measurement currency of the Company is US dollars. As sales and purchases are denominated primarily in US dollars and net receipts from operations are usually retained in US dollars, the directors are of the opinion that US dollars reflects the economic substance of the underlying events and circumstances relevant to the Company.
 
  (c)   Foreign Currency Transactions
 
      Monetary assets and liabilities in foreign currencies are translated into US dollars at rates of exchange ruling at the balance sheet date or at contracted rates where they are covered by forward exchange contracts. Transactions in foreign currencies are translated at rates ruling on transaction dates. Foreign exchange gains and losses, resulting from the settlement of foreign currency transactions and from the translation at financial year-end exchange rates of monetary assets and liabilities denominated in foreign currencies, are included in the profit and loss account.

F-42


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

2.   Summary of Significant Accounting Policies (cont’d)

  (d)   Property, Plant and Equipment

  (i)   Owned Assets
 
      Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses.
 
  (ii)   Subsequent Expenditure
 
      Subsequent expenditure relating to property, plant and equipment that has already been recognized is added to the carrying amount of the asset when it is probable that future economic benefits, in excess of the originally assessed standard of performance of the existing asset, will flow to the Company and the cost can be reliably measured. All other subsequent expenditure is recognized as an expense in the period in which it is incurred.
 
  (iii)   Disposal
 
      Gains or losses arising from the retirement or disposal of property, plant and equipment are determined as the difference between the net disposal proceeds and the carrying amount of the asset and are recognized in the profit and loss account on the date of retirement or disposal.
 
  (iv)   Depreciation
 
      No depreciation is provided for property, plant and equipment under installation or construction. Depreciation is provided on a straight-line basis so as to write off the cost of other property, plant and equipment over their estimated useful lives as follows:

                 
Equipment and machinery
        5 years
Mechanical and electrical installations
        10 years
Office furniture, fittings and equipment
        5 years
Computers
        2 to 3 years  

      Interest incurred during the year of installation and construction of major items of property, plant and equipment is capitalized into cost of property, plant and equipment. Interest capitalized is based on the average cost of the Company’s pooled borrowings.

  (e)   Intangible Assets

  (i)   Computer software
 
      Computer software, not forming an integral part of a related hardware, which is acquired by the Company, is stated at cost less accumulated amortization and accumulated impairment losses.
 
  (ii)   Subsequent expenditure
 
      Subsequent expenditure on capitalized intangible assets is capitalized only when it increases the future economic benefits embodied in the specific asset to which it relates. All other expenditure is expensed as incurred.

F-43


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

2.   Summary of Significant Accounting Policies (cont’d)

  (e)   Intangible Assets (cont’d)

  (iii)   Amortization
 
      Amortization is charged to the profit and loss account on a straight-line basis over the estimated useful lives of 2 to 3 years of the computer software.

  (f)   Derivatives and Hedging
 
      Derivative financial instruments are used to manage exposure to foreign exchange and interest rate risks arising from operational, financing and investment activities. Derivative financial instruments are not used for trading purposes.
 
      The Company only recognizes the accounting effect of derivative instruments as, and to the extent that, the derivative financial instruments have an effect on the Company’s cash flows.
 
  (g)   Deferred Expense
 
      The deferred expense represents the arrangement fees incurred for the long-term bank loan. The amount is amortized over the repayment term of the long-term bank loan.
 
  (h)   Inventories
 
      Inventories are stated at the lower of standard cost, which approximates actual cost determined on the weighted average basis, or market (net realizable value). For work-in-progress and manufactured inventories, cost consists of the cost of raw materials, direct labor and an appropriate proportion of production overheads. Labor and overhead costs are allocated to each step in the wafer production process based on normal fab capacity utilization, with un-recovered costs arising from abnormal underutilization of capacity expensed as incurred.
 
  (i)   Affiliated Companies
 
      An affiliated company is defined as one, other than a related company, which has common direct or indirect shareholders or common directors with the Company.
 
  (j)   Cash and Cash Equivalents
 
      For the purpose of the statement of cash flows, cash and cash equivalents comprise cash balances, bank deposits and highly liquid investments which are readily convertible to cash and which are subject to an insignificant risk of changes in value.

F-44


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

2.   Summary of Significant Accounting Policies (cont’d)

  (k)   Impairment
 
      The carrying amounts of the Company’s long-lived and intangible assets are reviewed at each balance sheet date to determine whether there is any indication of impairment. An impairment loss is recognized whenever the carrying amount of an asset or its cash-generating unit exceeds its recoverable amount, which is the higher of an asset’s or its cash-generating unit’s net selling price and its value in use. Impairment losses are recognized in the profit and loss account.
 
      An impairment loss is reversed if there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. There were no impairment loss reversals for the years ended December 31, 2002, 2003 and 2004.
 
  (l)   Provision for Sales Returns
 
      A provision for sales returns is recognized when the underlying products or services are sold. The provision is based on historical experience and management’s estimate of the level of future claims and accrued for specific items at the time their estimate is known and the amounts are determinable.
 
  (m)   Deferred Tax
 
      Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. The amount of deferred tax provided is based on the expected manner of realization or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the balance sheet date.
 
      A deferred tax asset is recognized to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized.
 
  (n)   Dividends
 
      Dividends on ordinary shares are recognized as a liability in the period in which they are declared, provided all necessary conditions attached to the dividend declaration have been met.
 
  (o)   Revenue Recognition
 
      Provided it is probable that the economic benefits will flow to the Company and the revenue and costs, if applicable, can be measured reliably, revenue is recognized in the profit and loss account as follows:

  (i)   Sale of goods
 
      Revenue is recognized when significant risks and rewards of ownership have been transferred to the buyer upon shipment of goods. Revenue represents the invoiced value of goods and services supplied, excluding goods and services tax, less an allowance for returns.

F-45


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

2.   Summary of Significant Accounting Policies (cont’d)

  (o)   Revenue Recognition (cont’d)

  (ii)   Allocated wafer capacity cost recovery
 
      Allocated wafer capacity cost recoveries billed, under the terms of the assured supply demand agreement, are recognized when the quarterly capacity allocated to a shareholder is not fully utilized and there is no waiver made by the shareholders. Such recoveries represent the unrecovered cost when the capacity allocated to the shareholders is not met.
 
  (iii)   Interest income
 
      Interest income from bank deposits is accrued on a time-apportioned basis using the effective interest method.
 
  (iv)   Grants
 
      Income-related government grants are subsidies of training expenses. Income-related grants are credited to other operating income when it becomes probable that expenditures already incurred will constitute qualifying expenditures for purposes of reimbursement under the grants, which is typically substantially concurrent with the expenditures.

  (p)   Operating Leases
 
      Leases of assets in which the Company does not assume substantially the risks and rewards of ownership are classified as operating leases.
 
      Where the Company has the use of assets under operating leases, payments made under the leases are recognized in the profit and loss account on a straight-line basis over the term of the lease. Lease incentives received are recognized in the profit and loss account as an integral part of the total lease payments made. Contingent rentals are charged to the profit and loss account in the accounting period in which they are incurred.
 
  (q)   Finance Costs
 
      Finance costs are expensed in the profit and loss account in the period in which they are incurred, except to the extent that they are capitalized as being directly attributable to the acquisition, construction or production of an asset which necessarily takes a substantial period of time to get ready for its intended use or sale.

F-46


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

3.   Property, Plant and Equipment

                                                 
                    Office                      
    Equipment     Mechanical and     furniture,             Assets under        
2003 (unaudited)   and     electrical     fittings and             installation and        
Cost   machinery     installations     equipment     Computers     construction     Total  
    $     $     $     $     $     $  
At January 1, 2003
    771,343       2,773       975       4,219       9,613       788,923  
Additions
                            20,698       20,698  
Transfers
    28,543       1,483             172       (30,198 )      
Disposals
    (5,911 )                 (41 )           (5,952 )
Assets impairment
    (2,406 )                             (2,406 )
 
                                   
At December 31, 2003
    791,569       4,256       975       4,350       113       801,263  
 
                                   
 
                                               
Accumulated depreciation
                                               
At January 1, 2003
    378,384       1,200       795       3,863             384,242  
Depreciation charge for the year
    158,875       365       127       324             159,691  
Disposals
    (2,561 )                 (41 )           (2,602 )
Assets impairment
    (2,228 )                             (2,228 )
 
                                   
At December 31, 2003
    532,470       1,565       922       4,146             539,103  
 
                                   
 
                                               
Carrying amount
                                               
December 31, 2003
    259,099       2,691       53       204       113       262,160  
 
                                   
                                                 
                    Office                      
    Equipment     Mechanical and     furniture,             Assets under        
2004   and     electrical     fittings and             installation and        
Cost   machinery     installations     equipment     Computers     construction     Total  
    $     $     $     $     $     $  
At January 1, 2004
    791,569       4,256       975       4,350       113       801,263  
Additions
    8                   5       6,759       6,772  
Transfers
    5,425                   965       (6,390 )      
Disposals
    (181 )                 (54 )           (235 )
 
                                   
At December 31, 2004
    796,821       4,256       975       5,266       482       807,800  
 
                                   
                                                 
Accumulated depreciation
                                               
At January 1, 2004
    532,470       1,565       922       4,146             539,103  
Depreciation charge for the year
    136,435       426       27       310             137,198  
Disposals
    (133 )                 (53 )           (186 )
 
                                   
At December 31, 2004
    668,772       1,991       949       4,403             676,115  
 
                                   
                                                 
Carrying amount
                                               
December 31, 2004
    128,049       2,265       26       863       482       131,685  
 
                                   

    During the year, interest expense of $1,218, $237 and $19 for 2002, 2003 and 2004, respectively, was capitalized in the cost of property, plant and equipment.

F-47


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

4.   Intangible Assets

                 
    2003     2004  
    (Unaudited)        
    $     $  
Computer Software
               
Cost
               
At January 1,
    3,448       3,525  
Additions
    77       601  
 
           
At December 31,
    3,525       4,126  
 
           
                 
Accumulated amortization
               
At January 1,
    3,012       3,336  
Charge for the year
    324       217  
 
           
At December 31,
    3,336       3,553  
 
           
                 
Carrying amount
               
December 31,
    189       573  
 
           

5.   Deferred Income Tax Asset/(Liability)
 
    Deferred income tax asset and liability is offset when there is a legally enforceable right to set off current income tax asset against current income tax liability and when the deferred income tax relates to the same fiscal authority. The amounts, determined after appropriate offsetting, are shown on the balance sheets as follows:

                 
    2003     2004  
    (Unaudited)        
    $     $  
To be recovered/(settled) after more than 12 months
               
Deferred income tax asset
    7       82  
Deferred income tax liability
    (25 )      
 
           
 
    (18 )     82  
 
           

 
    The above deferred income tax asset/(liability) arose due to temporary difference on property, plant and equipment.
 
    The movement in the deferred income tax account is as follows:

                 
    2003     2004  
    (Unaudited)        
    $     $  
At January 1,
          (18 )
Tax (charge to)/credit:
               
- profit and loss account
    (18 )     100  
 
           
At December 31,
    (18 )     82  
 
           

F-48


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

5.   Deferred Income Tax Asset/(Liability) (cont’d)
 
    Deferred income tax asset is recognized for tax losses carried forward to the extent that realization of the related tax benefits through future taxable profits is probable. The Company has no unrecognized tax losses and capital allowances which can be carried forward and used to offset against future taxable income.
 
6.   Inventories

                 
    2003     2004  
    (Unaudited)        
    $     $  
Raw materials
    1,118       579  
Work-in-progress
    29,849       20,168  
Consumable supplies and spares
    568       336  
 
           
 
    31,535       21,083  
Less:
               
Allowance for inventories obsolescence
    408       170  
 
           
 
    31,127       20,913  
 
           

    Included in work-in-progress is an amount of $Nil and $1,672 for 2003 and 2004, respectively, stated at net realizable value.
 
7.   Trade and Other Receivables, net

                 
    2003     2004  
    (Unaudited)        
    $     $  
Trade receivables
    17,034       6,081  
Provision for sales returns
    (3,055 )     (1,505 )
 
           
 
    13,979       4,576  
 
               
Deposits
    29       20  
Prepayments
    2,426       2,315  
Staff loans and advances
    11        
Other receivables
    260       8  
Amount due from related companies and affiliated companies
               
- minority shareholder (trade)
    592       582  
- related company (trade)
    212       2,048  
- immediate holding company (trade)
    35,686       17,698  
 
           
 
    53,195       27,247  
 
           

F-49


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

7.   Trade and Other Receivables (cont’d)
 
    Movements in provision for sales returns are as follows:

                 
    2003     2004  
    (Unaudited)        
    $     $  
At January 1,
    2,656       3,055  
Provisions made during the year
    7,327       2,536  
Provisions utilized during the year
    (6,928 )     (4,086 )
 
           
At December 31,
    3,055       1,505  
 
           

    The provision for sales returns is made based on historical experience and management’s estimate of the level of future claims. The Company expects to incur the liability within one year.
 
8.   Cash and Cash Equivalents

                 
    2003     2004  
    (Unaudited)        
    $     $  
Cash at banks and on hand
    6,587       13,421  
Cash equivalents
               
Short-term deposits with banks
    123,038       24,006  
 
           
 
    129,625       37,427  
 
           

9.   Trade and Other Payables

                 
    2003     2004  
    (Unaudited)        
    $     $  
Trade payables
    5,942       3,619  
Payables for purchase of property, plant and equipment
    107       174  
Accrued operating expenses
    14,386       8,090  
Liability for short-term accumulated compensated absences
    210       55  
Dividend payable
    34,508        
Other payables
    247       237  
Amount due to related companies and affiliated companies
               
- affiliated company (trade)
    467       412  
- related company (trade)
    543       63  
- minority shareholder (trade)
    35,144       8,850  
- immediate holding company (trade)
    98       31  
 
           
 
    91,652       21,531  
 
           

F-50


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

10.   Interest-Bearing Liabilities
 
    The bank loan, which consists of $128,571 and $Nil for 2003 and 2004, respectively, from Tranche A, and $42,857 and $Nil for 2003 and 2004, respectively, from Tranche B, is secured by a debenture, giving the holder thereof a first floating charge on all of the Company’s assets.
 
    Tranche A bears interest at a margin rate of 1% to 1.35% above London inter-bank offering rates (depending on the debt to equity ratio) and is repayable over seven equal semi-annual instalments commencing on March 17, 2002.
 
    Tranche B bears interest at a margin rate of 1% to 1.45% above London inter-bank offering rates (depending on the debt to equity ratio) and is repayable over seven equal semi-annual instalments commencing on December 3, 2002.
 
    In June 2004, the Company made an early repayment on its outstanding long-term loan.

                 
    2003     2004  
    (Unaudited)        
    $     $  
Repayable as follows:
               
Due within 12 months
    107,142        
Due after 12 months
    64,286        
 
           
 
    171,428        
 
           

11.   Share Capital

                 
    2003     2004  
    (Unaudited)          
Authorized:
               
490,000,000 (2003: 490,000,000) “A” ordinary shares of S$1 (2003: S$1) each
    S$490,000       S$490,000  
 
           
 
               
510,000,000 (2003: 510,000,000) “B” ordinary shares of S$1 (2003: S$1) each
    S$510,000       S$510,000  
 
           
 
               
Issued and fully-paid:
               
208,250,000 (2003: 208,250,000) “A” ordinary shares of S$1 (2003: S$1) each
    123,670       123,670  
216,750,000 (2003: 216,750,000) “B” ordinary shares of S$1 (2003: S$1) each
    128,719       128,719  
 
           
 
    252,389       252,389  
 
           

    The “A” and “B” ordinary shares rank pari passu in all respects, except that the rates of dividend may differ. All shares issues have been made at par for cash considerations.

F-51


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

12.   Shareholders’ Agreements
 
    Under the strategic alliance agreement with the two shareholders of the Company, the shareholders do not share the Company’s net results in the same ratio as the equity holding. Instead, each shareholder is entitled to the gross profits from sales to the customers that it directs to the Company after deducting its share of the overhead costs of the Company.
 
    Under the assured supply and demand agreement that both the shareholders signed with the Company, the shareholders are billed with effect from January 1, 2001 for allocated wafer capacity if the wafers started for them are less than their allocated capacity. Such amounts represent the unrecovered cost to the Company when the allocated capacity is not taken up by one, or both, of the shareholders. During the year ended December 31, 2004, the shareholders jointly agreed with the Company to waive the requirement for such billings even though their wafers fell below their allocated capacities.
 
    In September 2004, the two shareholders of the Company entered into a supplementary agreement to the strategic alliance agreement. Among other things, the supplementary agreement provides that the Company can pay dividends out of the profits determined on a year-to-year basis rather than on a cumulative basis, as previously was the case.
 
13.   Other Operating Income

                                 
    Note     2002     2003     2004  
                    (Unaudited)        
            $     $     $  
Allocated wafer capacity cost recovery
    12, 19       49,512              
Interest income
                               
— banks
            133       914       823  
— cash pool deposits with an affiliated company
            1,749       338        
Reversal of Economic Value Added bonus provision
                  3,578        
Gain on disposal of intangible assets
            178              
Gain on disposal of property, plant and equipment
                        5  
Grant income
            3             781  
Others
            3       10       5  
 
                         
 
            51,578       4,840       1,614  
 
                         

    In prior years, the Company had an employee bonus plan with respect to the payment of bonuses to employees. In March 2003, the Company cancelled the employee bonus award plan. As a result, compensation accrued for past services under the bonus award plan of $3,578 was eliminated by decreasing compensation expense in the period of the cancellation.

F-52


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

14.   Other Operating Expenses
 
    The Company recorded an impairment charge of $178 on certain property, plant and equipment which have been identified for sale as at December 31, 2003. These assets were written down to their net selling prices. The selling prices were determined based on independent quotes from third party vendors.
 
15.   Profit From Operations
 
    The following items have been included in arriving at profit from operations:

                                 
    Note     2002     2003     2004  
                    (Unaudited)        
            $     $     $  
Allowance made for inventories
            501       (131 )     (238 )
Amortization of intangible assets
    4       795       324       217  
Loss on disposal of property, plant and equipment
            728              
Exchange loss
            547       357       2,470  
Depreciation of property, plant and equipment
    3       150,367       159,691       137,198  
Operating lease expenses
            15,705       15,567       15,881  
Staff costs
            16,788       15,799       21,061  
Contributions to defined contribution plans included in staff costs
            931       964       949  

    The number of employees as at December 31, 2002, 2003 and 2004 is 551, 602 and 619, respectively.
 
16.   Finance Costs

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Interest paid and payable to banks
    30,015       21,107       6,898  
Other finance costs paid and payable to banks
    1,283       1,038       1,700  
 
                 
Total finance costs
    31,298       22,145       8,598  
Less:
                       
Finance costs capitalized into property, plant and equipment
    (1,218 )     (237 )     (19 )
 
                 
 
    30,080       21,908       8,579  
 
                 

    In 2004, the remaining $1,680 of unamortized deferred expenses was charged to finance costs as the Company made an early repayment on its outstanding long-term loan.

F-53


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

17.   Income Tax Expense

  (a)   Recognized in the profit and loss account

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Current tax
    414       257       165  
Deferred tax
    71       18       (100 )
 
                 
 
    485       275       65  
 
                 

    All of pre-tax income/(loss) and income tax expense are from Singapore sources.

  (b)   Reconciliation of effective tax rate

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Profit/(Loss) before tax
    (19,832 )     21,444       18,098  
 
                 
Income taxes using Singapore tax rate of 20% (22% for 2002 and 2003)
    (4,363 )     4,718       3,620  
Expenses not deductible for tax purposes
    1,135       381       1,301  
Exempt pioneer profits
          (4,824 )     (4,856 )
Pioneer losses and allowances not recognized as deferred benefit
    3,713              
 
                 
 
    485       275       65  
 
                 

    The Company has been granted pioneer status for a period of ten years under the Singapore Economic Expansion Incentives (Relief from Income Tax) Act, Chapter 86 (“the Income Tax Act”), for the wafer fabrication of integrated circuits effective from May 1, 2000. During the pioneer status period, income from pioneer trade is exempt from income tax, subject to compliance with the conditions stated in the pioneer certificate and the Income Tax Act.
 
    The income tax expense of the Company is for income tax payable on income derived from non-pioneer activities, principally interest income.
 
    As at December 31, 2003 and 2004, the Company has no unutilized property, plant and equipment related wear and tear allowance carryforwards.

F-54


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

18.   Dividend
 
    As disclosed in note 12, under the strategic alliance agreement, the shareholders of the Company do not share the Company’s net results in the same ratio as their equity holding.
 
    During the year, the Company declared/paid the following interim dividends to the holder of the “B” ordinary shares:

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
First interim dividend declared of $0.0011 per share, net of tax at 22%
          234        
Second interim dividend declared of $0.2515 per share, tax exempt
          54,508        
Second interim dividend paid of $0.1592 per share, tax exempt
                34,508  
Third interim dividend paid of $0.0308 per share, tax exempt
                6,680  
Fourth interim dividend paid of $0.1384 per share, tax exempt
                30,000  
 
                 
 
          54,742       71,188  
 
                 

    In 2004, the Company declared tax exempt dividends to the holder of “A” ordinary shares of $0.1145 per share amounting to $23,844, and tax exempt dividends to the holder of “B” ordinary shares of $0.2418 per share amounting to $52,401. The Company has paid $36,680 of the total amount declared in 2004 to the holder of “B” ordinary shares. The remaining amounts declared have not been recognized as a liability as all necessary conditions attached to the dividend declaration have not been met.
 
19.   Significant Related Party Transactions
 
    For the purpose of these financial statements, parties are considered to be related to the Company if the Company has the ability, directly or indirectly, to control the party or exercise significant influence over the party in making financial and operating decisions, or vice versa, or where the Company and the party are subject to common control or common significant influence. Related parties may be individuals or other entities.
 
    During the financial year, there were the following significant transactions with related parties on terms agreed between the parties:

                                 
    Note     2002     2003     2004  
                    (Unaudited)        
            $     $     $  
Immediate Holding Company
                               
Recharge of employee related and other expenses to Company
            73       117       82  
Sale of processed wafers
            158,456       191,493       162,927  
Allocated wafer capacity cost recovery
    13       9,317              
Purchase of wafers
            3,599       2,277        
Dividend income
                  54,742       36,680  

F-55


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

19.   Significant Related Party Transactions (cont’d)

                                 
    Note     2002     2003     2004  
                    (Unaudited)        
            $     $     $  
Related Companies
                               
Recharge of employee related and other expenses to Company
            2,096       2,271       3,882  
Sale of processed wafers
            7,779       3,593       12,773  
Minority Shareholder
                               
Purchase of processed wafers
            724              
Purchase of property, plant and equipment
            3,211       12,703       462  
Payment of rental expense
            14,713       15,024       15,307  
Recharge of employee related and other expenses to Company
            27,957       46,552       33,199  
Sale of processed wafers
            6,650       1,818       1,371  
Allocated wafer capacity cost recovery
    13       40,195              
Sale of property, plant and equipment
            1,069       3,350        
Recharge of other expenses from Company
            476       195       499  
Affiliated Companies
                               
Purchase of property, plant and equipment
                  1,515       43  
Purchase of processed wafers
            116       447       180  
Recharge of other expenses to Company
            93       215       217  
Sale of processed wafers
            165       454       270  
Sale of property, plant and equipment
            849              
Recharge of other expenses from Company
            67       101        
Interest income
            1,749       338        
 
                         

20.   Commitments

  (a)   Capital commitments

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Contracted but not provided for
    6,434       6,148       1,079  
Authorized but not contracted for
    10,661       10,391       2,777  
 
                 

F-56


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

20.   Commitments (cont’d)

  (b)   Operating lease commitments
 
      The Company leases its fab from its minority shareholder, under a long-term lease agreement which expires in 2008. At December 31, the Company had commitments for future minimum lease payments under the non-cancellable operating leases as follows:

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Payable:
                       
Within 1 year
    15,391       15,561       16,015  
After 1 year but within 5 years
    60,640       50,169       35,829  
After 5 years
    3,786              
 
                 
 
    79,817       65,730       51,844  
 
                 

21.   Financial Instruments
 
    The Company uses derivative financial instruments principally to manage identified interest rate risks resulting from its floating rate loan and, to a lesser extent, its foreign currency purchase commitments which are principally denominated in Japanese yen. While these are subject to the risk of market rates changing subsequent to acquisition, such changes are generally offset by opposite effects on the items being hedged. The Company’s accounting policies in relation to the derivative financial instruments are set out in note 2(f).
 
    By using derivative instruments to hedge exposures to changes in interest rates and foreign currency rates, the Company exposes itself to credit risk and market risk.

  (a)   Credit risk
 
      Credit risk is the potential financial loss resulting from the failure of a customer or a counterparty to settle its financial and contractual obligations to the Company, as and when they fall due.
 
      The Company has established credit limits for customers and monitors their balances. Cash and fixed deposits are placed with banks and financial institutions which are regulated. Investments and transactions involving derivative financial instruments are allowed only with counterparties that are of high quality.
 
  (b)   Liquidity risk
 
      The Company monitors and maintains a level of cash and cash equivalents deemed adequate by management to finance the Company’s operations and to mitigate the effects of fluctuations in cash flows.

F-57


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

21.   Financial Instruments (cont’d)
 
(c)   Interest rate risk
 
    Interest rate risk is the adverse effect on the value of a financial instrument that results from a change in interest rates or currency exchange rates. The Company uses interest rate swaps to redenominate its floating rate interest obligations of its loan to fixed rate interest obligations. In June 2004, the Company made an early repayment on its outstanding long-term debt and terminated the associated interest rate swap.
 
(d)   Foreign currency risk
 
    The Company incurs foreign currency risk on purchases, primarily of fixed assets, that are denominated in currencies other than US dollars. The currencies giving rise to this risk are primarily the Singapore dollar and the Japanese yen.
 
    The Company uses forward exchange contracts to hedge its foreign currency risk. The Company fully hedges its payables, and estimated foreign currency exposure in respect of forecast purchases over the following six months, relating to fixed asset purchases. Where necessary, the forward exchange contracts are rolled over at maturity at market rates. The Company only enters into forward exchange contracts with maturities of less than one year.
 
    In respect of other monetary liabilities denominated in currencies other than the US dollar, the Company ensures that the net exposure is kept to an acceptable level by buying or selling foreign currencies at spot rates, where necessary.
 
(e)   Effective interest rates and repricing analysis
 
    In respect of interest-earning financial assets and interest-bearing financial liabilities, the following table indicates their effective interest rates at the balance sheet date and the periods in which they reprice:

                                                 
            Effective                            
            Interest             Within     1 to 5     After  
    Note     Rate     Total     1 year     years     5 years  
            %     $     $     $     $  
2004
                                               
Financial Assets
                                               
Cash and cash equivalents
    8       2.00       37,427       37,427              
 
                                   
 
                                               
2003 (unaudited)
                                               
Financial Assets
                                               
Cash and cash equivalents
    8       1.02       129,625       129,625              
 
                                   
 
                                               
Financial Liabilities
                                               
Secured US$ floating rate bank loan
    10       2.20       (171,428 )     (171,428 )            
Effect of interest rate swaps
            5.59             171,428       (171,428 )      
 
                                     
 
            7.79       (171,428 )           (171,428 )      
 
                                   

F-58


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

21.   Financial Instruments (cont’d)

  (f)   Fair values

  (i)   Recognized financial instruments, cash and cash equivalents, amount due from and to related companies and affiliated companies, accounts receivable and accounts payable.
 
      The carrying amounts approximate fair value in view of the short-term nature of these balances.
 
  (ii)   Bank loan
 
      The carrying amount approximated fair value in view of the debt bearing floating interest rate.
 
  (iii)   Unrecognized financial instruments
 
      The valuation of financial instruments not recognized in the balance sheet reflects amounts which the Company expects to pay or receive to terminate the contracts or replace the contracts at their current market rates at the balance sheet date.
 
      The notional amount and net fair value of financial instruments not recognized in the balance sheet as at December 31, are:

                                 
    Notional     Fair     Notional     Fair  
    amount     value     amount     value  
    2003     2003     2004     2004  
    (Unaudited)     (Unaudited)              
    $     $     $     $  
Interest rate swap agreements
    (211,429 )     (10,714 )            
Forward foreign exchange contracts
    (1,000 )     1       (2,005 )     11  
 
 
                       

22.   Reconciliation from FRS to US GAAP
 
    The Company’s financial statements are prepared in accordance with FRS which differs in certain respects from US GAAP. The effect of such differences on net profit/(loss) and shareholders’ equity is summarized below.
 
    Accounting for Derivative Financial Instruments
 
    Under FRS applicable for the periods presented, there are no established principles for recognizing and measuring derivative financial instruments. Consequently, the Company only recognizes the accounting effect of derivative financial instruments as, and to the extent, the derivative financial instruments have an effect on the Company’s cash flows.

F-59


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

22.   Reconciliation from FRS to US GAAP (cont’d)
 
    Accounting for Derivative Financial Instruments (cont’d)
 
    Under US GAAP, all derivatives are recognized on the balance sheet at their fair value in other assets or other liabilities. On the date a derivative contract is entered into, the Company will consider if the derivative instrument is part of a hedging relationship. If the derivative will be designated as a hedge, the Company designates the derivative as either a hedge of the fair value of a recognized asset or liability or of an unrecognized firm commitment (“fair-value” hedge), a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash-flow” hedge), or a foreign-currency fair-value or cash-flow hedge (“foreign-currency” hedge). The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives that are designated as fair-value, cash-flow, or foreign-currency hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items.
 
    Changes in the fair value of derivatives that are highly effective and that are designated and qualify as fair-value hedges are recorded in earnings as interest expense, along with the loss or gain on the hedged assets or liabilities or unrecognized firm commitment of the hedged item that are attributable to the hedged risks. Changes in the fair value of derivatives that are highly effective and that are designated and qualify as cash-flow hedges are recorded in other comprehensive income, until earnings are affected by the variability in cash flows of the designated hedged items. Changes in the fair value of derivatives that are highly effective as hedges and that are designated and qualify as foreign-currency hedges are recorded in either earnings or other comprehensive income, depending on whether the hedge transaction is a fair-value hedge or a cash-flow hedge. Changes in the fair value of derivative instruments that are not designated as part of a hedging relationship are reported in current period earnings.
 
    The Company discontinues hedge accounting prospectively when it is determined that a derivative is no longer effective in offsetting changes in the fair value or cash flows of the hedged item, the derivative expires or is sold, terminated, or exercised, the derivative is de-designated as a hedging instrument because it is unlikely that a forecasted transaction will occur, a hedged firm commitment no longer meets the definition of a firm commitment, or management determines that designation of the derivative as a hedging instrument is no longer appropriate.
 
    When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair-value hedge, the Company continues to carry the derivative on the balance sheet at its fair value, and no longer adjusts the hedged asset or liability for changes in fair value. The adjustment of the carrying amount of the hedged asset or liability is accounted for in the same manner as other components of the carrying amount of that asset or liability.

F-60


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

22.   Reconciliation from FRS to US GAAP (cont’d)
 
    Accounting for Derivative Financial Instruments (cont’d)
 
    When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, the Company continues to carry the derivative on the balance sheet at its fair value, removes any asset or liability that was recorded pursuant to recognition of the firm commitment from the balance sheet and recognizes any gain or loss in earnings. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the Company continues to carry the derivative on the balance sheet at its fair value, and gains and losses that were accumulated in other comprehensive income are recognized immediately in earnings. In all other situations in which hedge accounting is discontinued, the Company continues to carry the derivative at its fair value on the balance sheet, and recognizes any changes in its fair value in earnings.

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Net profit/(loss) in accordance with FRS
    (20,317 )     21,169       18,033  
Adjustment:
                       
Fair value adjustment for ineffective hedge elements of derivative contracts
    (217 )     2,615       2,673  
 
                 
Net profit/(loss) in accordance with US GAAP
    (20,534 )     23,784       20,706  
 
                 
 
                       
Other comprehensive income in accordance with FRS
                 
Adjustment:
                       
Fair value adjustment for effective hedge elements of derivative contracts, net of nil tax
    2,059       10,815       8,050  
 
                 
Other comprehensive income in accordance with US GAAP
    2,059       10,815       8,050  
 
                 
 
                       
Shareholders’ equity in accordance with FRS
    247,068       213,495       194,848  
Adjustment:
                       
Fair value adjustment related to derivative contracts
    (24,142 )     (10,712 )     11  
 
                 
Shareholders’ equity in accordance with US GAAP
    222,926       202,783       194,859  
 
                 

F-61


Table of Contents

SILICON MANUFACTURING PARTNERS PTE LTD
NOTES TO THE FINANCIAL STATEMENTS
In thousands of US Dollars (except share and per share data)

22.   Reconciliation from FRS to US GAAP (cont’d)
 
    Accounting for Derivative Financial Instruments (cont’d)

                         
    2002     2003     2004  
            (Unaudited)        
    $     $     $  
Accumulated other comprehensive loss in accordance with FRS
                 
Adjustment:
                       
Fair value adjustment for effective hedge elements of derivative contracts
    (18,920 )     (8,105 )     (55 )
 
                 
Accumulated other comprehensive loss in accordance with US GAAP
    (18,920 )     (8,105 )     (55 )
 
                 

23.   Subsequent Event
 
    Subsequent to December 31, 2004, a tax exempt dividend was paid to the holder of “B” ordinary shares of $0.0415 per share amounting to $9,000. These financial statements do not reflect this dividend as all necessary conditions attached to the dividend were not met at December 31, 2004.

F-62